[
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, 'Treatment depends on stage (localized vs. advanced/metastatic)'."
      },
      {
        "criterion_number": 2,
        "description": "The response should include surgery as a preferred option for resectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes surgery (Whipple, distal pancreatectomy) and indicates it is considered when disease is localized and has not spread, consistent with resectable disease."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes chemotherapy regimens and states it is given 'for advanced disease,' implying it is the main systemic treatment in metastatic/unresectable settings."
      },
      {
        "criterion_number": 4,
        "description": "The response should include radiation as a potential treatment option for localized disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes radiation therapy and mentions use in combination with surgery (e.g., after Whipple), which applies to localized disease."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the concept of resectability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly discuss resectability categories (resectable/borderline/locally advanced unresectable); only mentions 'localized vs. advanced.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should specify the main chemotherapy regimens used are FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions FOLFIRINOX and gemcitabine (with capecitabine) but does not specify gemcitabine + nab-paclitaxel as a main regimen."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy and that its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States immunotherapy applies for high microsatellite instability or dMMR; however, it incorrectly suggests pembrolizumab + chemotherapy rather than monotherapy, but the limited role to MSI-H/dMMR is conveyed."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions PARP inhibitors (e.g., olaparib) for tumors with BRCA1/2 or other DNA repair mutations."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages consideration of clinical trials and provides ClinicalTrials.gov as a resource."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize that symptom management is an important part of the care of patients with pancreatic cancer and should highlight the importance of supportive care, including evaluation by a palliative care specialist and nutritional support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Addresses palliative care and symptom management but does not mention nutritional support or dietitian involvement."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Differentiates surgical approaches by location (Whipple for head tumors; distal pancreatectomy for body/tail), indicating treatment depends on tumor location."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that the NCCN Panel recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention NCCN recommendations, multidisciplinary teams, high-volume centers, or specialized imaging."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend discussing the treatment of pancreatic cancer with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises, 'Always consult your oncologist or healthcare provider for advice tailored to your specific case.'"
      }
    ],
    "question_number": 1,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:28:07.906133",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Provide a direct link to a list of NCI-designated cancer centers.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response links to NCI resources (PDQ contact and a 'team-science-initiative' page) but does not provide a direct link to the official list of NCI-designated cancer centers."
      },
      {
        "criterion_number": 2,
        "description": "Discuss resectability in pancreatic cancer, stating that involvement of major blood vessels like the celiac artery generally precludes safe resection and requires evaluation at a specialized center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response notes complexity with celiac artery involvement and suggests specialized centers, it does not explicitly state that major vessel involvement generally precludes safe resection nor discuss resectability status."
      },
      {
        "criterion_number": 3,
        "description": "Emphasize evaluation by a multidisciplinary clinic, including surgical, medical, and radiation oncology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends multidisciplinary clinics and names surgeons, medical/radiation oncologists, and radiologists, emphasizing their importance for complex cases."
      },
      {
        "criterion_number": 4,
        "description": "Clearly state that neoadjuvant treatment may be proposed to shrink the tumor to a resectable size, but some tumors may remain unresectable and only amenable to systemic therapy or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neoadjuvant therapy and downstaging are not mentioned; the response only references clinical trials and radiation without framing them in the context of resectability or neoadjuvant intent."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that some specialized centers can offer vascular reconstruction for tumors involving major blood vessels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references vascular resection expertise and collaboration with vascular surgeons but does not explicitly state the availability of vascular reconstruction."
      },
      {
        "criterion_number": 6,
        "description": "Offer to search for high-volume pancreatic cancer programs by preferred location, requesting specific location details to tailor recommendations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response suggests ways to search and lists resources but does not offer to perform a tailored search or ask for the user\u2019s specific location."
      },
      {
        "criterion_number": 7,
        "description": "State that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of NCCN, version 2.2025, or the specific recommendation regarding high-volume centers and imaging studies."
      }
    ],
    "question_number": 2,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:28:36.469873",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include an overview of the criteria for resection of the tumor and why patients are deemed not to be good candidates for surgery.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response offers general reasons surgery might not be pursued (tumor size/location, trial protocol timing) but does not provide an overview of pancreatic cancer resectability criteria (e.g., involvement of major vessels such as SMA/SMV/portal vein, absence of distant metastases, performance status, radiographic/biomarker response after neoadjuvant therapy). It lacks a structured explanation of resectable vs borderline resectable vs locally advanced criteria and specific reasons patients are deemed unresectable."
      },
      {
        "criterion_number": 2,
        "description": "The response should indicate that the case should be discussed at a multidisciplinary tumor board.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it recommends multidisciplinary input in general terms and consulting a surgical oncologist, it does not explicitly recommend presentation at a multidisciplinary tumor board, which is a key element for pancreatic cancer surgical decision-making."
      },
      {
        "criterion_number": 3,
        "description": "The response should indicate that the patient could seek a second opinion at another specialized center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises seeking a second opinion and consulting a surgical oncologist, which reasonably conveys the idea of obtaining a specialized second opinion. While it does not specify 'another specialized center,' the recommendation to seek a second opinion from a surgical oncologist meets the core requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide a list of specialized centers that offer second opinions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific high-volume pancreatic cancer centers or institutions are listed. The response mentions general resources (NCI, ASCO) but does not provide a list of centers offering second opinions."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the person discuss surgery with the current oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly advises discussing with the oncologist/clinical trial team and asking why surgery is not an option, timelines, and whether surgery could become feasible, which fulfills this criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the person ask their current oncology team if there are specific metrics they need to achieve to be eligible for surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests asking about specific milestones (e.g., tumor shrinkage, response to treatment) that need to be met before surgery becomes feasible, which aligns with asking about eligibility metrics."
      }
    ],
    "question_number": 3,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:29:08.523433",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should list PANCAN Online Community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes the Pancreatic Cancer Action Network (though written as 'PCAN') and notes online/virtual support options for families. This fulfills listing PanCAN as an online resource, despite a minor naming inconsistency."
      },
      {
        "criterion_number": 2,
        "description": "The response should include the American Cancer Society (ACS) online community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions ACS Support Communities and the Cancer Survivors Network."
      },
      {
        "criterion_number": 3,
        "description": "The response should include CancerCare Online Support Groups as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists CancerCare and describes its free online support groups led by oncology social workers."
      },
      {
        "criterion_number": 4,
        "description": "The response should include various Facebook support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends Facebook groups and provides example group names for pancreatic cancer caregivers/families."
      },
      {
        "criterion_number": 5,
        "description": "The response should affirm that there are many online support groups for families of pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opening sentence clearly affirms the availability of several reputable online support groups for family members."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend talking to your family member\u2019s oncology about support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises asking the loved one\u2019s medical team for recommendations on support resources."
      }
    ],
    "question_number": 4,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:29:31.543916",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should indicate that while chronic pancreatitis is a risk factor for pancreatic cancer, it is still not common to develop pancreatic cancer even in patients with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states chronic pancreatitis increases risk but that the absolute risk remains relatively low and that not everyone with pancreatitis develops cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should offer support for having experienced the symptoms of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathy and acknowledges the challenges of chronic pancreatitis and limited access to care, providing supportive tone and validation."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the potential signs and symptoms of pancreatic cancer, which could include unintentional weight loss, jaundice, steatorrhea, new onset diabetes, and worsening of abdominal symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple relevant warning signs: severe/worsening abdominal pain, jaundice, unexplained weight loss, nausea/vomiting, and new-onset diabetes. While steatorrhea is not mentioned, several key symptoms are covered."
      },
      {
        "criterion_number": 4,
        "description": "The response should outline at least three options for obtaining medical attention without insurance or for low-income adults, such as Federally Qualified Health Centers, community health clinics, Medicaid, or ACA marketplace plans, and should include specific examples or resources when possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple concrete options and resources: FQHCs and community clinics with sliding-scale fees, hospital charity care and payment plans, Medicaid, Medicare, HealthCare.gov, FreeClinicDirectory.org, NeedyMeds.org, and Patient Advocate Foundation."
      },
      {
        "criterion_number": 5,
        "description": "The response should indicate that a consultation with a physician who may obtain labs, perform a physical exam, and obtain imaging studies such as a CT scan would be warranted.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends seeking medical attention and specifies appropriate diagnostics: imaging (ultrasound, CT, MRI, EUS) and blood tests (e.g., CA 19-9). Encourages referral to gastroenterology/pancreas specialist."
      },
      {
        "criterion_number": 6,
        "description": "The response should offer information on how to sign up for Medicaid and provide more specific instructions and information about eligibility depending on the state the person resides in.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions looking into state Medicaid programs and using HealthCare.gov but does not provide sign-up steps, state-specific eligibility details, or instructions on applying through state Medicaid agencies."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends discussing financial concerns with a doctor, including at least one practical suggestion (e.g., payment plans, charity care).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides practical financial suggestions (charity care, payment plans) but does not explicitly advise discussing financial concerns with the doctor or care team."
      }
    ],
    "question_number": 5,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:30:10.054905",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and note that it is normal to feel overwhelmed under the circumstance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response is empathetic and explicitly normalizes the user's feelings (e.g., 'it\u2019s completely normal to feel helpless, scared, or uncertain' and 'It\u2019s okay to feel overwhelmed'), offering supportive guidance throughout."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide links to websites that give more information on pancreatic cancer that are written at the level of patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes patient-friendly resource links to the Pancreatic Cancer Action Network (https://www.pancan.org) and the American Cancer Society (https://www.cancer.org), both of which provide patient- and caregiver-focused information."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information about online support groups for pancreatic cancer patients and caregivers, including those offered by the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions support groups generally and references PanCAN and ACS, it does not mention CancerCare or its online support groups. The criterion requires inclusion of PanCAN, ACS, and CancerCare."
      }
    ],
    "question_number": 6,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:30:22.557127",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide a link to ClinicalTrials.gov for information on clinical trial options.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a direct link to ClinicalTrials.gov in the Key Resources section (https://clinicaltrials.gov/)."
      },
      {
        "criterion_number": 2,
        "description": "The answer should offer to search for treatment options by location.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions major cancer centers and trial-matching tools, it does not offer to search by location or invite the user to provide a location for tailored options."
      },
      {
        "criterion_number": 3,
        "description": "The response should explicitly suggest obtaining a second opinion from another oncologist or major cancer center and provide a list of leading cancer centers that offer second opinion consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response lists major cancer centers (MSK, MD Anderson, Johns Hopkins) but does not explicitly recommend obtaining a second opinion or specify that these centers offer second-opinion consultations."
      },
      {
        "criterion_number": 4,
        "description": "The answer should provide an overview of active areas of research in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers multiple active research areas, including targeted therapies (KRAS, BRAF, HER2), immunotherapy (checkpoint inhibitors, combinations), CAR-T, basket/adaptive trials, tumor-agnostic approaches, epigenetic and metabolic therapies. Note: there is a medical inaccuracy regarding erdafitinib being FDA-approved for pancreatic cancer (it is not), but the overview of research areas is present."
      },
      {
        "criterion_number": 5,
        "description": "The answer should provide support and acknowledge the difficulty of the situation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response acknowledges the challenging situation, emphasizes quality of life, recommends palliative/supportive care, and mentions emotional support resources."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing clinical trial options and eligibility with the oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Section 1 explicitly advises discussing clinical trials with the oncologist and notes they can assess eligibility."
      }
    ],
    "question_number": 7,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:30:45.257288",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Provide support and acknowledge that feeling overwhelmed is understandable and valid.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens by acknowledging that a stage IV diagnosis can be overwhelming and maintains a supportive, compassionate tone throughout, including a reassuring final note."
      },
      {
        "criterion_number": 2,
        "description": "Provide an overview of what a Stage IV diagnosis entails.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it references confirming the extent of spread and discusses palliative/hospice care, it does not clearly explain that stage IV pancreatic cancer indicates metastatic disease, is generally not curable, and that treatment is primarily palliative; thus, it lacks a direct overview of what stage IV entails."
      },
      {
        "criterion_number": 3,
        "description": "Identify members of the patient care team, including a medical oncologist and palliative care physician.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions the oncologist and recommends integrating palliative care early; it also references other team members (dietitian, counselors, chaplain, social work/home health), satisfying the requirement to include oncologist and palliative care as part of the care team."
      },
      {
        "criterion_number": 4,
        "description": "Outline the general approach to treatment of stage IV pancreatic cancer, emphasizing that chemotherapy with palliative intent is the cornerstone.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists chemotherapy regimens (e.g., FOLFIRINOX, gemcitabine) as standard treatments, notes radiation for symptom control, and emphasizes early palliative care and hospice when appropriate. This conveys that management is palliative-focused with chemotherapy as the mainstay."
      },
      {
        "criterion_number": 5,
        "description": "Emphasize the importance of support and community for patients and caregivers, mentioning PanCAN, ACS, and CancerCare as key resources for online support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response highlights support groups and counseling for both patients and caregivers and specifically names PanCAN, the American Cancer Society, and CancerCare as resources."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly recommend discussing the diagnosis and next steps with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises clarifying the diagnosis with the oncologist, writing down questions for the oncologist, and consulting about emerging therapies and palliative care, thereby explicitly recommending discussion of diagnosis and next steps with the oncologist."
      }
    ],
    "question_number": 8,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:31:36.627615",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must recommend discussing vitamins and supplements with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly emphasizes consulting the oncologist and oncology dietitian before starting supplements and notes potential interactions with chemotherapy and other medications."
      },
      {
        "criterion_number": 2,
        "description": "The answer must recommend maintaining a healthy and balanced diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Section 4 explicitly recommends a balanced, nutrient-dense diet, hydration, and appropriate physical activity, and suggests working with a dietitian."
      },
      {
        "criterion_number": 3,
        "description": "The answer must explicitly state that any diet or high-dose vitamins claiming to cure cancer should be avoided.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it states 'Supplements \u2260 Cure' and advises against high-dose antioxidants due to possible interference with chemotherapy, it does not explicitly instruct to avoid any diets or high-dose vitamins that claim to cure cancer."
      },
      {
        "criterion_number": 4,
        "description": "The answer must mention the benefit of pancreatic enzyme replacement therapy for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of pancreatic enzyme replacement therapy (PERT) or its benefits appears in the response."
      },
      {
        "criterion_number": 5,
        "description": "The response must specify that due to malabsorption in pancreatic cancer, supplementation of fat-soluble vitamins (A, D, E, and K) is recommended, and should note that lab-confirmed vitamin deficiencies can be improved with appropriate vitamin supplements under the direction of a doctor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses vitamin D testing and supplementation broadly but does not address pancreatic cancer\u2013related malabsorption, the need for A, D, E, and K supplementation, or correcting lab-confirmed deficiencies under physician direction."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that pancreatic enzyme deficiency is common in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention pancreatic enzyme deficiency or its prevalence in pancreatic cancer."
      }
    ],
    "question_number": 9,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:31:50.470626",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient discuss their goals of care and potential treatment side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises consulting the medical team and oncologist, and provides specific prompts to discuss goals and side effects (e.g., \"please consult your loved one\u2019s medical team,\" \"Discuss with the oncologist,\" and \"Ask the Medical Team Hard Questions\" including goals and side-effect management)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision to continue with chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states there is \"no one-size-fits-all answer,\" that the decision is \"agonizing,\" and \"depends entirely on your loved one\u2019s values.\""
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes to the chemotherapy dose can improve side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions \"dose reductions\" as a way to help with side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes to the chemotherapy schedule can improve side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes it\u2019s okay to pause treatment to reassess, it does not explicitly state that changing the chemotherapy schedule (e.g., timing or spacing) can improve side effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that changes to supportive medications can improve side effect symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions supportive care and specific supportive medications such as anti-nausea drugs and hydration that can help manage side effects."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it recommends integrating palliative care, it does not explicitly advise asking for a referral to a palliative care specialist."
      },
      {
        "criterion_number": 7,
        "description": "The response should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It opens with empathetic language: \"I\u2019m truly sorry to hear about your loved one\u2019s diagnosis...\" and acknowledges the emotional difficulty."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that deferring further cancer-directed treatment and pursuing palliative care and hospice would be a valid approach.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states palliative care can be provided instead of chemotherapy and discusses hospice as an appropriate option when focusing on comfort, affirming this as a valid approach."
      }
    ],
    "question_number": 10,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:32:13.506063",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should specify that somatic testing can be done on the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response asks which tests were performed and how the sample was obtained (e.g., tumor biopsy from the pancreas or liver metastasis) and explicitly distinguishes somatic vs. germline mutations, indicating tumor/somatic testing."
      },
      {
        "criterion_number": 2,
        "description": "The answer should specify that germline testing is appropriate.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It addresses hereditary (germline) vs. somatic mutations and includes a dedicated 'Hereditary Cancer Risk' section recommending consideration of genetic counseling/testing for family members, indicating appropriateness of germline testing."
      },
      {
        "criterion_number": 3,
        "description": "The answer should discuss testing for BRCA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "BRCA1/2 are explicitly listed among genes analyzed and are referenced in treatment implications."
      },
      {
        "criterion_number": 4,
        "description": "The answer should discuss the role of utilizing PARP inhibitors in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "PARP inhibitors are mentioned as examples of targeted therapies for BRCA1/2 mutations."
      },
      {
        "criterion_number": 5,
        "description": "The answer should include an overview of testing for microsatellite instability and MSI status, which can be a marker for response to immunotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of MSI, mismatch repair deficiency, or immunotherapy biomarkers is present."
      },
      {
        "criterion_number": 6,
        "description": "The answer should include other potential targetable mutations such as HER2/ERBB2 amplification and NTRK.",
        "score_given": 0,
        "max_points": 10,
        "justification": "HER2/ERBB2 and NTRK are not mentioned; only other genes like BRAF and PIK3CA are cited."
      },
      {
        "criterion_number": 7,
        "description": "The answer should specify that clinical trials may be available for less commonly targeted mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The 'Clinical Trials' section prompts asking about trials that target the specific mutations found and how to enroll, implying availability for uncommon/rare alterations."
      }
    ],
    "question_number": 11,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:32:32.692459",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should recommend that the patient consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends genetic counseling, detailing how a counselor can assess family history, evaluate risk, and guide testing and management."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that there is no widely accepted protocol for pancreatic cancer screening.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response states pancreatic cancer screening is \"less standardized than for other cancers\" but does not clearly state that there is no widely accepted screening protocol. It also cites guidelines suggesting screening for certain high-risk groups, which could imply the existence of a protocol."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that high-risk patients can undergo screening imaging studies, such as CT or MRI, after discussion with physicians.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises consultation with specialists and mentions imaging options (EUS, CT, MRI) in the context of screening for high-risk individuals, including reference to guidelines and typical starting ages."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe hereditary syndromes that increase the risk of pancreatic cancer and note that germline BRCA mutations are a significant genetic risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response discusses inherited genetic risk, cites specific genes (BRCA1/2, CDKN2A, PALB2), and links these to broader hereditary cancer risks (e.g., breast/ovarian/prostate), thereby addressing hereditary syndromes and highlighting BRCA as a significant risk factor."
      },
      {
        "criterion_number": 5,
        "description": "The answer should recommend testing for selected mutations such as BRCA and CDKN2A.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends genetic counseling with a plan to \"recommend testing for hereditary cancer syndromes\" and explicitly lists relevant mutations (BRCA1/2, CDKN2A, PALB2), satisfying the requirement to recommend testing for selected mutations."
      }
    ],
    "question_number": 12,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:33:28.899194",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that doctors use imaging results to determine response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions that oncologists use imaging scans (CT, MRI, PET) to assess tumor shrinkage or growth when evaluating treatment effectiveness."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is one part of what determines response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that CA 19-9 is a tumor marker and not a standalone indicator, and emphasizes using it alongside scans, symptoms, and other labs to assess response."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 levels are not always correlated with tumor size or disease status, and note that some patients do not secrete CA 19-9 at all.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response discusses fluctuations and limitations of CA 19-9, it does not explicitly state that some patients do not secrete CA 19-9 (e.g., Lewis antigen\u2013negative) and does not clearly state lack of correlation with tumor size/disease status."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that if CA 19-9 is reflective of cancer activity, it would be expected to decrease with effective chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes reasons for stable CA 19-9 and that CA 19-9 may lag behind clinical response, but it does not explicitly state that CA 19-9 would be expected to decrease when therapy is effective if it reflects cancer activity."
      },
      {
        "criterion_number": 5,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines CA 19-9 as a protein tumor marker often elevated in pancreatic cancer and some other cancers."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that doctors use changes in symptoms to determine response to therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly includes symptoms (improving, worsening, stable) as part of how oncologists evaluate treatment effectiveness."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing the CA 19-9 test results with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises consulting the oncologist, asking for an explanation of CA 19-9 results alongside scans, and requesting a treatment review."
      }
    ],
    "question_number": 13,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:33:42.549368",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that it is not an unexpected outcome as removing pancreas tissue will also take the islet cells which produce insulin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly explains that Whipple surgery removes pancreatic tissue containing insulin-producing beta cells and states the outcome is a recognized, not unexpected complication."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the incidence of post-Whipple diabetes, noting it can vary based on how much of the pancreas is removed and the specific patient population, occurring in 15-20% to up to 50% of patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It reports an incidence of ~20\u201350% and notes variability based on extent of pancreatic removal and other factors, which aligns with the rubric\u2019s range and context."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the control of diabetes is achieved through regulating glucose intake via dietary modifications and medications that can help control blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response covers dietary adjustments (small frequent meals, low-glycemic carbs, limiting sugars) and medications (insulin and consideration of oral agents), clearly addressing glucose regulation via diet and pharmacotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the father of the question writer should be evaluated by an endocrinologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends working with an endocrinologist as part of the healthcare team for a personalized management plan."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the father may ultimately require insulin injections to regulate his blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states insulin injections may be necessary and are often the most effective treatment for type 3c diabetes."
      }
    ],
    "question_number": 14,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:34:00.407440",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that anorexia and weight loss are common symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response acknowledges that pancreatic cancer can lead to weight loss and mentions loss of appetite as a treatment side effect, but it does not explicitly state that anorexia and weight loss are common symptoms of pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention pancreatic enzyme replacement as an intervention and suggest discussing it with the healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Pancreatic enzyme replacement therapy (PERT) is explicitly recommended (e.g., Creon, Pancreaze, Ultresa), and the response advises working with the doctor to adjust doses and ensure proper use."
      },
      {
        "criterion_number": 3,
        "description": "The response must recommend consulting a registered dietitian specializing in oncology for personalized nutritional advice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends a registered dietitian specializing in oncology to create a tailored meal plan."
      },
      {
        "criterion_number": 4,
        "description": "The response must advise consuming nutrient-dense foods and eating smaller, more frequent meals, and explicitly emphasize the importance of maintaining adequate protein and calorie intake.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises high-calorie, nutrient-dense foods, suggests small, frequent meals, and includes protein-focused options (e.g., smoothies with protein powder), thereby emphasizing calorie and protein intake."
      },
      {
        "criterion_number": 5,
        "description": "The response must suggest nutritional supplementation with high-calorie meal replacement shakes and explicitly state that nutrition or protein supplements can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends oral nutritional supplements such as Ensure/Boost to boost calorie intake and suggests smoothies/shakes with protein powder, clearly endorsing nutrition/protein supplements."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises consulting healthcare professionals and working with the medical team, it does not explicitly direct the patient to discuss their weight loss with their oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention chemotherapy as a potential cause of weight loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response refers to treatment side effects generally but does not explicitly mention chemotherapy as a cause of weight loss."
      }
    ],
    "question_number": 15,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:34:26.836187",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must specify that jaundice is due to an increase in bilirubin in the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that jaundice occurs when there\u2019s a buildup of bilirubin in the bloodstream and also mentions conjugated hyperbilirubinemia."
      },
      {
        "criterion_number": 2,
        "description": "The answer must state that jaundice refers to a yellowing of the skin and eyes due to elevated bilirubin levels.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly notes that elevated bilirubin causes a yellow tint to the skin and eyes."
      },
      {
        "criterion_number": 3,
        "description": "The answer must state that jaundice can arise in pancreatic cancer due to blockage of the bile duct from tumor growth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that a tumor in the head of the pancreas can block or compress the bile duct, preventing bile flow and leading to jaundice."
      },
      {
        "criterion_number": 4,
        "description": "The answer must state that ERCP (Endoscopic Retrograde Cholangiopancreatography) is used to visualize the blocked duct and place a stent to relieve the blockage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "ERCP is described as using an endoscope to visualize the bile ducts and place a stent to keep the duct open, relieving obstruction."
      },
      {
        "criterion_number": 5,
        "description": "The answer must state that other options to relieve the obstruction include percutaneous biliary drainage or surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response mentions percutaneous transhepatic cholangiography for drainage/stenting and surgical bile duct bypass as alternatives."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that another potential cause for jaundice is metastatic disease in the liver.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention liver metastases as a cause of jaundice; it focuses on bile duct obstruction from the primary pancreatic tumor."
      },
      {
        "criterion_number": 7,
        "description": "The answer must state that treating the cancer with chemotherapy can shrink the tumor and help address the jaundice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that chemotherapy or radiation may shrink the tumor and reduce obstruction, thereby addressing jaundice."
      }
    ],
    "question_number": 16,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:34:39.187866",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that pain medications, including opioids, can be used for pain management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes opioid use (morphine, fentanyl, oxycodone, hydromorphone), dosing considerations, and long-acting vs short-acting formulations."
      },
      {
        "criterion_number": 2,
        "description": "The answer should describe procedures, such as a celiac plexus block, that can help alleviate pain.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of celiac plexus block/neurolysis or other interventional pain procedures."
      },
      {
        "criterion_number": 3,
        "description": "The answer should express sympathy for the diagnosis and symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathy (\u201cI'm truly sorry to hear about your husband's diagnosis\u201d) and maintains a supportive tone."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that adjunctive non-opioid medications, such as amitriptyline and gabapentin, can be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists adjuvants including antidepressants (amitriptyline, duloxetine) and anticonvulsants (gabapentin, pregabalin) for neuropathic pain."
      },
      {
        "criterion_number": 5,
        "description": "The answer should state that steroids, such as dexamethasone, can also be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions corticosteroids as a pain-reducing option; although dexamethasone is not named specifically, the class is appropriately cited."
      },
      {
        "criterion_number": 6,
        "description": "The answer should state that radiation can be used for local treatment and pain control.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention radiation therapy for local control or pain relief."
      },
      {
        "criterion_number": 7,
        "description": "The answer should state that complementary therapies, such as acupuncture and massages, can also be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes acupuncture and massage (and TENS) among non-pharmacological options."
      },
      {
        "criterion_number": 8,
        "description": "The answer should state that the patient should be seen by a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically highlights palliative care specialists, their role, and the benefit of early integration."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing pain management with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages consultation with the oncologist, pain specialist, and palliative care team to individualize pain management."
      }
    ],
    "question_number": 17,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:34:55.394444",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that resectability is determined by the surgeons\u2019 assessment of their ability to safely remove the entire tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that 'unresectable' means surgery cannot safely or effectively remove the cancer and that this determination is made by the medical team after evaluating tumor characteristics, aligning with the concept of surgical ability to remove the tumor safely."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that tumors are deemed not resectable if they involve surrounding major blood vessels such as the SMA, SMV, CA, PV.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions proximity to and involvement with major blood vessels, giving examples of the superior mesenteric artery and vein (SMA/SMV) and noting that attachment to blood vessels can make safe removal impossible. While CA and PV are not named, the inclusion of SMA/SMV and the concept of vessel involvement satisfy the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that invasion of nearby organs can also lead to a tumor not being able to be resected.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response directly addresses invasion of nearby organs (liver, peritoneum, intestines) and explains that such invasion may prevent complete and safe removal, meeting the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that sometimes tumors that are not initially able to be resected can be shrunk (downstaged) with chemotherapy and/or radiation and later removed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that initially unresectable tumors may shrink with chemotherapy or radiation and become resectable later, explicitly naming neoadjuvant therapy and suggesting reassessment for surgery."
      },
      {
        "criterion_number": 5,
        "description": "The answer should offer sympathy for the loved one\u2019s diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes empathetic language acknowledging the difficulty of the situation, offers emotional support resources, and reassures the reader they are not alone."
      }
    ],
    "question_number": 18,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:35:10.187205",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the decision to continue with or stop chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, 'Deciding whether to continue or stop cancer treatment is deeply personal,' meeting the criterion clearly."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision should be made weighing the expected benefit of more therapy with the current side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes balancing benefits and burdens, including questions like 'Are the side effects outweighing the benefits?' and discusses expected benefits vs. side effects in consultation with the oncologist."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss their goals of care with their oncology team and suggest meeting with their oncologist and a palliative care physician to help guide decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting the oncologist to discuss prognosis and goals, and recommends involving palliative care specialists to guide symptom management and decision-making."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it encourages exploring palliative care and mentions palliative care specialists, it does not explicitly instruct the patient to ask for a referral to a palliative care specialist."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe palliative care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Palliative care is described as support to manage symptoms, improve comfort, and address emotional needs, and it notes it can be integrated alongside active treatment\u2014an accurate description."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Hospice is described correctly as care typically for those with a prognosis of six months or less, focusing on compassionate support, pain management, and emotional care at home or in a facility."
      },
      {
        "criterion_number": 7,
        "description": "The response should offer sympathy and state that it is a very difficult decision to try to make.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The tone is empathetic, acknowledges the complexity and personal nature of the decision, and offers supportive language ('You\u2019re not alone'), fulfilling the sympathy and difficulty acknowledgment."
      }
    ],
    "question_number": 19,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:35:26.276725",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that KRAS mutations are frequently implicated in pancreatic cancer as a major driver of tumorigenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that KRAS mutations are common (~90% of cases) and are driver mutations in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the first line of treatment would remain the standard of care with chemotherapy regimens such as FOLFIRINOX and gemcitabine/abraxane.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes that chemotherapy (e.g., FOLFIRINOX or gemcitabine-based regimens) remains first-line regardless of KRAS status."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that there are several KRAS mutations (G12C, G12D, G12V) and specify which one is present in the patient\u2019s case.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions several KRAS variants, it omits G12C in the example list and does not specify the patient's exact KRAS subtype; it only advises confirming it."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that targeted therapy to the KRAS mutation is an active area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that targeted therapies are an emerging area and highlights ongoing research and clinical trials for KRAS-directed treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some KRAS mutations can be targeted with drugs.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it claims some KRAS mutations can be targeted, it inaccurately states that sotorasib and adagrasib are FDA-approved for KRAS G12D in pancreatic cancer. These agents target KRAS G12C and are not approved for G12D; thus, the content is medically inaccurate."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there may be clinical trials for certain KRAS mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages considering clinical trials and notes that trials are actively exploring inhibitors for specific KRAS subtypes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the patient should discuss their KRAS mutation with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises discussing the KRAS subtype and treatment options with the oncologist, including clinical trial eligibility."
      }
    ],
    "question_number": 20,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:35:50.658569",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must mention recent trials evaluating the use of high-dose vitamin C in combination with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response cites a randomized phase 2 trial (referred to as VICTOR) combining IV vitamin C with gemcitabine in metastatic pancreatic cancer and a phase 1 trial combining IV vitamin C with chemotherapy in advanced solid tumors including pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that high-dose vitamin C has not been proven to improve outcomes in pancreatic or any other cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response clearly states no significant clinical benefit has been demonstrated in pancreatic cancer but does not explicitly state that vitamin C has not been proven to improve outcomes in any other cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the proposed mechanism of action of high-dose vitamin C in conjunction with chemotherapy, noting that it can act as a pro-oxidant by generating hydrogen peroxide (H\u2082O\u2082), which may enhance the killing of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly describes pro-oxidant effects and generation of hydrogen peroxide as a mechanism that may enhance cancer cell killing."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is limited published data showing high-dose vitamin C is well tolerated and shows a trend toward efficacy, but studies are limited and not sufficiently powered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes high-dose IV vitamin C is generally well tolerated, references non-significant trends in outcomes, and emphasizes that small studies suggest possible benefits requiring validation in larger, rigorous trials."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention possible toxicities of taking high doses of vitamin C.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions higher rates of neutropenia in the vitamin C group and gastrointestinal issues with high oral doses, satisfying the requirement to mention possible toxicities."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention drug-drug interactions of vitamin C.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No drug-drug interactions are discussed."
      },
      {
        "criterion_number": 7,
        "description": "The response should note that vitamin C is not FDA approved.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not state that high-dose IV vitamin C is not FDA-approved for treating cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should note that vitamin C is not recommended by the NCCN guideline.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of NCCN guidelines or that high-dose vitamin C is not recommended by them."
      },
      {
        "criterion_number": 9,
        "description": "The response should note that if a patient wishes to use high doses of vitamin C in conjunction with chemotherapy, they should consult with an oncologist regarding the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The conclusion advises patients to consult their oncologist about complementary therapies, meeting this criterion."
      }
    ],
    "question_number": 21,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:36:27.206876",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a biopsy is the only way to confirm the diagnosis of metastatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that biopsy is the only way to confirm metastasis. It emphasizes imaging and other techniques (e.g., PET-CT, liquid biopsy) and even states that modern imaging can provide more reliable confirmation and that staging can proceed without a confirmed biopsy, which contradicts the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that imaging such as CT or MRI is done to evaluate for the presence of metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly discusses imaging modalities (contrast-enhanced CT, MRI, PET-CT, dynamic contrast-enhanced MRI) to evaluate for liver metastases."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that tumor markers can be supportive of a diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that serum tumor markers (e.g., CA 19-9) can support the diagnosis. It mentions CA19-9 in the context of immunohistochemistry on tissue rather than as a supportive serum marker, and does not make the point that tumor markers can be supportive."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the team may suggest that the patient undergo another biopsy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends repeat or targeted biopsy, including image-guided, core needle, and EUS-guided approaches."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that on occasion the team will decide to treat as metastatic if the tumor markers and imaging are consistent with metastatic disease so as to not delay treatment if a repeat biopsy is not feasible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response notes that staging may proceed as stage IV based on imaging alone, it does not mention tumor markers as part of that decision, nor does it tie the decision to situations where a repeat biopsy is not feasible to avoid treatment delays."
      }
    ],
    "question_number": 22,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:37:00.962326",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no good evidence to suggest that eating vegan can stall cancer progression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states there is no conclusive evidence that veganism stalls progression in existing cancers and clarifies it is not a guaranteed method to stall progression."
      },
      {
        "criterion_number": 2,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including pancreatic enzyme insufficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of pancreatic enzyme insufficiency, steatorrhea, or pancreatic enzyme replacement therapy; content remains general to cancer and vegan diets."
      },
      {
        "criterion_number": 3,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including insulin-dependent diabetes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Insulin-dependent diabetes and glycemic issues related to pancreatic cancer are not discussed."
      },
      {
        "criterion_number": 4,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including biliary obstruction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Biliary obstruction and its dietary implications are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including high protein and calorie needs during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address the increased protein and calorie needs common during pancreatic cancer treatment; instead notes vegan diets are often lower in calories."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that nutrition support is often needed for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No statement that nutrition support (e.g., dietitian-guided plans, enteral/parenteral support) is often needed in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussion of diet with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises patients to consult their oncologists to align dietary choices with treatment and nutritional needs."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussion of diet with an oncology nutritionist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions discussing with healthcare providers and oncologists, it does not specifically recommend consultation with an oncology nutritionist."
      }
    ],
    "question_number": 23,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:37:16.989044",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "States that medical fitness is scored using ECOG or Karnofsky performance status.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly uses ECOG throughout (e.g., 'Patient Performance Status (ECOG)', ECOG 0\u20131 and ECOG 2)."
      },
      {
        "criterion_number": 2,
        "description": "States that fitter patients are offered FOLFIRINOX; frailer but treatable patients are offered gemcitabine+nab-paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly indicates ECOG 0\u20131 patients often receive FOLFIRINOX and ECOG 2 patients are offered gemcitabine+nab-paclitaxel."
      },
      {
        "criterion_number": 3,
        "description": "States FOLFIRINOX generally for ECOG 0\u20131; gemcitabine+nab-paclitaxel can be given to ECOG 2.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifies FOLFIRINOX for ECOG 0\u20131 and gemcitabine+nab-paclitaxel preferred for ECOG 2."
      },
      {
        "criterion_number": 4,
        "description": "Explains FOLFIRINOX is reserved for good PS because it is more intensive with higher rates of severe side effects such as neutropenia, fatigue, and diarrhea.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes higher toxicity and lists diarrhea and myelosuppression but does not explicitly mention neutropenia or fatigue for FOLFIRINOX, nor describe it as 'more intensive'."
      },
      {
        "criterion_number": 5,
        "description": "Lists individual drugs in FOLFIRINOX and clarifies nab-paclitaxel is combined with gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 5-fluorouracil, leucovorin, irinotecan, oxaliplatin for FOLFIRINOX and repeatedly refers to gemcitabine + nab-paclitaxel."
      },
      {
        "criterion_number": 6,
        "description": "States there are no head-to-head trials comparing gemcitabine/nab-paclitaxel and FOLFIRINOX.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Incorrectly claims a head-to-head comparison ('NAPOLI Trial: FOLFIRINOX vs. nab-paclitaxel/gemcitabine'), rather than stating none exist."
      },
      {
        "criterion_number": 7,
        "description": "Mentions age as a factor influencing regimen choice.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly cites age as a reason some patients receive gemcitabine alone."
      },
      {
        "criterion_number": 8,
        "description": "Mentions comorbid conditions as a factor in selecting a regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a dedicated section on organ function and comorbidities influencing regimen selection."
      }
    ],
    "question_number": 24,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:37:47.127338",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that resectability is determined by the ability of the surgeon to safely remove the entire tumor and not leave any behind (R0 resection).",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes 'potentially curative surgical removal' but does not explicitly state the goal of an R0 resection or that no tumor can be left behind."
      },
      {
        "criterion_number": 2,
        "description": "State that involvement of major blood vessels such as the SMA, SMV, CA, PV are often implicated when a tumor is deemed to not be resectable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly notes major vessel involvement as a determinant of unresectability and specifically mentions SMA, PV, and SMV with encasement thresholds. While CA is not explicitly named, the concept of major vessel involvement is adequately addressed."
      },
      {
        "criterion_number": 3,
        "description": "State that for pancreatic cancer to be resectable, there must not be any distant metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states 'Absence of Distant Metastasis' with examples (liver, lungs, peritoneum, distant nodes) and imaging confirmation."
      },
      {
        "criterion_number": 4,
        "description": "State that tumors that contact the veins (PV/SMV) with less than 180 degrees of involvement can still be resected if the vessel can be reconstructed as needed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that minor vessel abutment may be acceptable and that limited vascular involvement (e.g., short segment PV) may be resectable with vascular resection/reconstruction."
      },
      {
        "criterion_number": 5,
        "description": "State that some tumors are deemed borderline resectable and recommend chemotherapy and/or radiation to attempt to down-stage and make resection possible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions 'borderline resectable' tumors but does not recommend neoadjuvant chemotherapy and/or radiation to downstage."
      },
      {
        "criterion_number": 6,
        "description": "Include imaging modalities that help determine resectability, including a CT scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes contrast-enhanced CT as a key imaging modality."
      },
      {
        "criterion_number": 7,
        "description": "Include imaging modalities that help determine resectability, including an MRI.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes MRI as a key imaging modality."
      },
      {
        "criterion_number": 8,
        "description": "Include imaging modalities that help determine resectability, including a PET scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions PET scan in the context of evaluating distant metastases."
      },
      {
        "criterion_number": 9,
        "description": "Include imaging modalities that help determine resectability, including an endoscopic ultrasound.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes endoscopic ultrasound (EUS) as an imaging modality to assess tumor and adjacent structures."
      }
    ],
    "question_number": 25,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:38:19.099952",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreas cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that having a first-degree relative with pancreatic cancer increases risk (e.g., doubles risk)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a family history of pancreas cancer is due to inherited gene mutations such as BRCA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes up to 10% are linked to inherited mutations and specifically lists BRCA1/2 among others."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies smoking as a major modifiable risk factor and quantifies increased risk."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly lists chronic pancreatitis as a risk factor and explains mechanism via chronic inflammation."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreas cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States heavy alcohol use increases risk and separately explains alcohol can cause chronic pancreatitis, which raises cancer risk."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify genetic risk factors, including Lynch syndrome.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention Lynch syndrome or mismatch repair gene syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify genetic risk factors, including Peutz-Jeghers syndrome.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention Peutz-Jeghers syndrome or STK11."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify genetic risk factors, including Familial atypical multiple mole melanoma.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions CDKN2A but does not explicitly name the FAMMM syndrome as required."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify genetic risk factors, including hereditary pancreatitis.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Lists PRSS1 among genes but does not explicitly state 'hereditary pancreatitis' as a syndrome/risk factor."
      },
      {
        "criterion_number": 10,
        "description": "The response should include non-hereditary risk factors, including age.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly includes age as a risk factor."
      },
      {
        "criterion_number": 11,
        "description": "The response should include non-hereditary risk factors, including diabetes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Identifies diabetes as a risk factor and briefly explains association."
      },
      {
        "criterion_number": 12,
        "description": "The response should include non-hereditary risk factors, including obesity.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists obesity as a risk factor."
      },
      {
        "criterion_number": 13,
        "description": "The response should include non-hereditary risk factors, including diet.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions diet (processed/red meats, saturated fats) as possible contributors."
      },
      {
        "criterion_number": 14,
        "description": "The response should include non-hereditary risk factors, including exposure to certain industrial chemicals.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes occupational exposures such as pesticides and dyes as linked risks."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing family history with a provider and mentions genetic counseling/testing and screening for high-risk individuals."
      }
    ],
    "question_number": 26,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:38:52.476091",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the patient should undergo genetic counseling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly emphasizes genetic counseling as the first step ('a genetic counseling session is essential first') and reiterates it under 'Next Steps' ('Consult a Genetic Counselor')."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the type of genetic testing depends on the specific family history or hereditary condition.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states testing is based on family history and specific condition, including assessing affected relatives, age of onset, inheritance pattern, and tailoring testing to the patient\u2019s family history."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that single genes can be tested if there is a known condition associated with a specific genetic disorder.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists numerous single-gene tests (e.g., HTT for Huntington\u2019s, CFTR for cystic fibrosis, HBB for sickle cell, FBN1 for Marfan) and notes testing when a pathogenic variant is known in the family."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a panel of genes can be tested for multiple genes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly discusses 'Multigene panels' that analyze multiple genes simultaneously and provides examples such as hereditary breast cancer panels and cardiomyopathy panels."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide examples of single gene disorders such as Huntington\u2019s Disease, Cystic Fibrosis, and Sickle Cell.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly lists Huntington\u2019s disease (HTT), cystic fibrosis (CFTR), and sickle cell trait/anemia (HBB) as single-gene disorders."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide examples of panel testing for hereditary cancer and cardiomyopathy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides hereditary cancer panels (e.g., breast cancer panels including PALB2, CHEK2, ATM) and names cardiomyopathy panels as examples under 'Multigene Panels'."
      }
    ],
    "question_number": 27,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:39:09.082345",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the types of clinical trials.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly listed and described treatment, prevention, diagnostic, and quality-of-life trials."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that clinical trials are divided into three different phases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It described four phases (I\u2013IV) and did not state that trials are divided into three phases."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that phase 1 is the first time the drug is tested in humans and is aimed at establishing the safety and dosage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It noted Phase I tests safety and dosage but did not state it is the first time tested in humans."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that phase 2 tests the effectiveness of the drug and continues to establish its safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly said Phase II evaluates effectiveness and side effects, addressing efficacy and safety."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that phase 3 tests the efficacy of the drug in a larger group of patients and compares it to the current standard of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stated Phase III compares to standard care in large groups to confirm benefits and monitor risks."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe eligibility criteria for clinical trials, including stage of disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Listed several criteria (cancer type, prior treatments, age, organ function) but did not mention disease stage."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that there can be risks associated with participating in a trial, including potential side effects and lack of efficacy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discussed side effects/unknown risks and that the treatment may not work better than standard care."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussing clinical trial options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly advised talking to the oncologist and oncology team about trial options."
      },
      {
        "criterion_number": 9,
        "description": "The response should include clinicaltrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly referenced ClinicalTrials.gov as a resource."
      },
      {
        "criterion_number": 10,
        "description": "The response should offer support for the diagnosis and how difficult it can be to complete 15 rounds of chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Expressed general empathy but did not specifically acknowledge the difficulty of completing 15 rounds of chemotherapy."
      }
    ],
    "question_number": 28,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:39:33.387332",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must include ClinicalTrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists ClinicalTrials.gov with a link and identifies it as an NIH resource for finding trials."
      },
      {
        "criterion_number": 2,
        "description": "The response must provide instructions on using the search by location function on ClinicalTrials.gov.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides concrete steps to filter by Location/Region (city, state, or ZIP code) on ClinicalTrials.gov, satisfying the location-search instruction."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention the National Cancer Institute (NCI) website and describe using it to search for trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions the NCI and provides the cancer.gov/clinical-trials link, advising to check it for federally funded trials. This describes using the NCI site to find trials."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention and provide a link to the Pancreatic Cancer Action Network (PanCAN) clinical trial finder tool.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While PanCAN is mentioned with a general link to pancan.org, the specific PanCAN Clinical Trial Finder tool is not named nor linked."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including PanCAN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends partnering with patient advocacy groups and specifically lists the Pancreatic Cancer Action Network as a resource to connect patients to trials."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including the American Cancer Society.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends the American Cancer Society, provides a link, and notes they offer trial-matching tools and support."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss clinical trial options with their oncology team and consult with a local healthcare provider or oncologist to explore available trials at nearby cancer centers, as well as contact major cancer centers for additional information on clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing options with an oncologist/primary care physician, contacting local hospitals/cancer centers and major centers, and includes a final step to collaborate with the oncologist to review options."
      }
    ],
    "question_number": 29,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:39:53.435609",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreatic cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that first-degree relatives have a 2\u20133x higher risk and that family history contributes to risk."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that BRCA1/BRCA2 mutations are genetic risk factors for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists BRCA1/BRCA2 mutations under genetic syndromes linked to pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies tobacco use as strongly associated, with up to twice the risk in smokers and mentions risk reduction with quitting."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically lists chronic pancreatitis as significantly raising pancreatic cancer risk."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreatic cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes heavy alcohol use as a risk factor and explains it may act via causing chronic pancreatitis."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify Lynch syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly names Lynch syndrome among genetic syndromes linked to pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify Peutz-Jeghers syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Peutz-Jeghers syndrome is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify Familial atypical multiple mole melanoma as a genetic risk factor for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "FAMMM is not named; while CDKN2A is mentioned, the syndrome itself is not identified."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatitis as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Hereditary pancreatitis is explicitly listed with PRSS1 mutations noted."
      },
      {
        "criterion_number": 10,
        "description": "The response should include age as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States risk increases with age, with most cases over 60 and highest incidence at 70+."
      },
      {
        "criterion_number": 11,
        "description": "The response should include diabetes as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Identifies long-standing type 2 diabetes as a risk factor and discusses possible mechanisms."
      },
      {
        "criterion_number": 12,
        "description": "The response should include obesity as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes obesity/overweight, especially visceral fat, increases risk; mentions BMI relationship."
      },
      {
        "criterion_number": 13,
        "description": "The response should include diet as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Discusses high processed/red meat intake and low fiber as increasing risk; mentions dietary patterns."
      },
      {
        "criterion_number": 14,
        "description": "The response should include exposure to certain industrial chemicals as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions occupational exposures to chemicals such as benzene and pesticides as potential risk factors."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises genetic counseling for those with a strong family history or known mutations, aligning with discussing testing/screening with a healthcare professional."
      }
    ],
    "question_number": 30,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:40:13.398804",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking for a referral from their primary doctor or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response begins with 'Start with Your Primary Care Physician (PCP)' and explicitly suggests asking for a referral to a pancreatic cancer specialist or an oncologist with expertise in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using the PanCAN patient services to find a pancreatic cancer specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically references the Pancreatic Cancer Action Network (PCAN/PanCAN) and notes their website offers a directory of specialists, which constitutes using PanCAN resources to find a specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend using the American Cancer Society patient services to find a pancreatic cancer specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the American Cancer Society (ACS) and its helpline are listed under 'Key Resources to Bookmark,' the response does not explicitly recommend using ACS patient services to locate a specialist."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they can reference the NCI website to look for designated cancer centers that have pancreatic cancer specialists on staff.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises visiting Cancer.gov (NCI) for resources and links to specialized centers and mentions looking for 'comprehensive cancer center,' aligning with NCI-designated centers."
      },
      {
        "criterion_number": 5,
        "description": "The response should include information about the nearest cancer center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response provides examples of major national centers (e.g., Mayo Clinic, MD Anderson, MSK) but does not include information about the user's nearest cancer center."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend checking with their health insurance provider about in-network pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a dedicated section to contact the insurance provider, verify coverage, and request a list of in-network pancreatic cancer specialists."
      }
    ],
    "question_number": 31,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:40:39.501502",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines CA 19-9 as a tumor marker and describes it as a substance produced by cancer cells or by the body in response to cancer, with further detail about its antigenic nature. This constitutes a clear and accurate definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is a tumor marker produced by cancer cells and measurable in the blood, and describe its use in pancreatic cancer, noting that it can serve as a marker for the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states CA 19-9 is a tumor marker, notes it may be produced by cancer cells, specifies it is measured via a blood test, and discusses its primary use in pancreatic cancer for monitoring and as a supportive diagnostic marker."
      },
      {
        "criterion_number": 3,
        "description": "The response must include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists several non-malignant causes of elevation (pancreatitis, cirrhosis, infections, benign tumors) and notes other cancers, clearly indicating CA 19-9 can be elevated in conditions other than pancreatic cancer."
      }
    ],
    "question_number": 32,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:40:51.349087",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that reference ranges can vary by lab.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: 'The exact normal range may differ slightly between laboratories.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that normal levels are typically less than 37 U/mL but do not rule out cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States typical normal as <37 U/mL and clarifies that normal does not rule out cancer: 'It does not rule out cancer, as some cancers may not produce detectable levels of CA 19-9.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should state that levels from 37 to 100 U/mL can be associated with non-cancer conditions such as pancreatitis and bile duct disorders.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that elevated levels (>37 U/mL) can occur with non-cancer conditions and lists chronic pancreatitis among causes. While it does not specify the 37\u2013100 range explicitly or bile duct disorders by name, it covers the concept that mild elevations above 37 can be non-malignant with examples (pancreatitis)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that moderate elevation (100-1000 U/mL) can be concerning for cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that levels >100\u2013200 U/mL are more strongly associated with cancer and that >100 U/mL can be a red flag, capturing that moderate elevations can be concerning."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that levels greater than 1000 U/mL can be suggestive of advanced cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of the >1000 U/mL threshold or its association with advanced disease."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the use of CA 19-9 in pancreatic cancer, including that it can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly identifies CA 19-9 as a marker associated with pancreatic cancer and discusses its role."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple non-cancerous causes (e.g., chronic pancreatitis, cirrhosis, IBD) and other malignancies."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 can be used for monitoring the effectiveness of pancreatic cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states monitoring to assess treatment effectiveness, with decreasing levels indicating success."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that CA 19-9 can be used for detecting recurrence of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that rising levels could signal return or progression (recurrence)."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions elevations in other malignancies such as gastric, colorectal, and lung cancers."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that CA 19-9 can be elevated in liver disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists cirrhosis of the liver as a non-cancer cause of elevation."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that CA 19-9 can be elevated in gallstones.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention gallstones or cholelithiasis."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that CA 19-9 can be elevated with elevated bilirubin.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of bilirubin elevation or cholestasis/obstructive jaundice."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancers.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes false negatives ('some cancers may not elevate CA 19-9') and explains Lewis antigen-negative individuals may have undetectable levels, implying that not all pancreatic cancers will produce CA 19-9."
      }
    ],
    "question_number": 33,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:41:55.703986",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that CA 19-9 can be elevated with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions 'Pancreatitis (Acute or Chronic)' as a cause of elevated CA 19-9 and explains that levels may correlate with severity and normalize with treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 can be elevated with liver diseases like cirrhosis or hepatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Liver Disease' can lead to elevated CA 19-9 due to impaired clearance. While cirrhosis/hepatitis are not named specifically, liver disease as a category is clearly included."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 can be elevated with cholestasis or biliary diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Biliary Obstruction (e.g., choledocholithiasis)' and 'Biliary tract cancers,' both of which are associated with cholestasis and elevated CA 19-9."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CA 19-9 can be elevated with inflammatory bowel disease or gastrointestinal diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists 'Inflammatory Bowel Disease' (Crohn\u2019s disease and ulcerative colitis) and discusses elevations; also mentions other GI diseases."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that CA 19-9 can be elevated with infections or other inflammatory conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies multiple inflammatory conditions (pancreatitis, IBD) that can elevate CA 19-9. Although infections are not explicitly mentioned, the criterion allows 'or other inflammatory conditions,' which are clearly included."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that CA 19-9 can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States CA 19-9 is 'a tumor marker primarily associated with pancreatic cancer' and reiterates its clinical use."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists several other malignancies (colorectal, gastric, biliary tract, lung, ovarian, breast) where CA 19-9 may be elevated."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that not all pancreatic cancers (or Lewis antigen\u2013negative individuals) produce CA 19-9. The mention of 'genetic polymorphisms may influence production' is vague and insufficient."
      }
    ],
    "question_number": 34,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:42:30.248341",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing weight loss with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises working closely with the oncologist and an oncology dietitian, discussing medications with the medical team, and communicating concerns to the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme replacement can be taken to help with the absorption of nutrients from foods.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that pancreatic enzyme supplements, if prescribed, can aid digestion and nutrient absorption."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutritional strategies can be employed, such as focusing on small, frequent meals and nutrient-rich foods, and should recommend including calorie-dense and protein-rich foods in the diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends small, frequent meals and details high-calorie, nutrient-dense, and protein-rich options (e.g., smoothies with protein powder, nut butters, avocados, cheese, olive oil)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that medications for managing nausea can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises use of antiemetics/anti-nausea medications as prescribed and suggests discussing medications with the oncology team."
      },
      {
        "criterion_number": 5,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to chemotherapy side effects.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions \"treatment side effects\" generally and addresses nausea/taste changes, but does not explicitly state chemotherapy-related side effects as a cause of weight loss or explicitly frame multiple causes of weight loss."
      },
      {
        "criterion_number": 6,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to pancreatic enzyme deficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes that pancreatic enzyme supplements can aid absorption and mentions malabsorption, but does not explicitly state pancreatic enzyme deficiency as a cause of weight loss or explicitly frame multiple causes."
      }
    ],
    "question_number": 35,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:42:46.061729",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a symptom of pancreatic cancer can include unintentional weight loss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions \"Unexplained Weight Loss\" and also ties weight loss to loss of appetite."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a symptom of pancreatic cancer can include jaundice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists \"Jaundice\" as a symptom and describes it clearly."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a symptom of pancreatic cancer can include new onset diabetes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes \"New-Onset Diabetes\" with an explanation of mechanism."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a symptom of pancreatic cancer can include abdominal pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions \"Abdominal or Back Pain\" and describes upper abdominal pain radiating to the back."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pancreatic cancer can be difficult to detect early.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes symptom overlap causing delays in diagnosis and states early-stage disease may be asymptomatic, implying difficulty with early detection."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer does not cause symptoms until the disease is advanced.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States \"Early-stage pancreatic cancer may be asymptomatic, while advanced stages are more likely to exhibit noticeable symptoms,\" conveying that symptoms often appear when disease is advanced."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reason for jaundice is the blockade of bile ducts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains jaundice occurs \"due to a tumor blocking bile ducts.\""
      },
      {
        "criterion_number": 8,
        "description": "The response should state that loss of appetite can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists \"Loss of Appetite\" explicitly as a symptom."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that abdominal bloating or indigestion can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes \"Bloating or Abdominal Discomfort,\" which satisfies this criterion."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that foul-smelling stools or steatorrhea can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions \"Steatorrhea\" and describes \"greasy, foul-smelling, pale, or oily stools.\""
      },
      {
        "criterion_number": 11,
        "description": "The response should reference the American Cancer Society information page on symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to the American Cancer Society information page is provided."
      }
    ],
    "question_number": 36,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:43:02.359779",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that most pancreatic cancer cases are sporadic and not hereditary.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states pancreatic cancer is primarily sporadic and notes that over 90% of cases are not hereditary."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that there are hereditary conditions that can lead to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly acknowledges a hereditary component (5\u201310%) and links it to inherited genetic mutations and familial syndromes."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a strong family history is a significant risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes increased risk with first-degree relatives and greater risk with multiple affected relatives, indicating strong family history as a significant risk factor."
      },
      {
        "criterion_number": 4,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including familial pancreatic cancer syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists Familial Pancreatic Cancer Syndrome and describes criteria and associated risk."
      },
      {
        "criterion_number": 5,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including BRCA1/BRCA2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes BRCA1/BRCA2 with associated pancreatic cancer risk."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Lynch syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions Lynch syndrome (mismatch repair defects) and its association with pancreatic cancer risk."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Peutz-Jeghers syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists STK11 (Peutz-Jeghers syndrome) and notes elevated pancreatic cancer risk."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Familial atypical multiple mole melanoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes Familial atypical multiple mole melanoma (FAMMM) among rare syndromes; minor spelling variant noted but content is correct."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including hereditary pancreatitis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention hereditary pancreatitis (e.g., PRSS1) as a risk syndrome."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises consulting a genetic counselor/medical geneticist but does not specifically recommend consulting an oncologist."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends consulting a genetic counselor or medical geneticist for personalized assessment and testing."
      }
    ],
    "question_number": 37,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:43:21.845464",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that routine screening is not recommended for the general population.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses surveillance in high-risk groups and post-treatment settings but does not explicitly state that routine screening is not recommended for the general population."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention MRI as a surveillance modality for high-risk individuals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "MRI is listed as a surveillance imaging modality, and the response links surveillance to high-risk individuals (e.g., IPMN and hereditary risk), including annual EUS or MRI for precancerous lesions."
      },
      {
        "criterion_number": 3,
        "description": "The response must specify that surveillance typically starts around age 50 and continues annually.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of a typical start age around 50 or an explicit statement that surveillance continues annually for high-risk individuals; instead, it mentions starting in 30s\u201340s for hereditary syndromes and varying intervals."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that the evidence for screening/surveillance is not well established and mention the risk of overdiagnosis leading to unnecessary stress and procedures.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses over-surveillance, anxiety, false positives/negatives, and unnecessary procedures, it does not explicitly state that the evidence for screening/surveillance is not well established, nor does it explicitly use the concept of overdiagnosis."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that people at high risk may benefit from screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response indicates that high-risk individuals may require earlier and more intensive surveillance, implying benefit."
      },
      {
        "criterion_number": 6,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a significant family history of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions a strong family history (e.g., first-degree relatives) as a reason for genetic testing and counseling."
      },
      {
        "criterion_number": 7,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a known genetic syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists hereditary syndromes such as BRCA1/2 and Lynch syndrome as indications for genetic testing and tailored surveillance."
      },
      {
        "criterion_number": 8,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a history of chronic pancreatitis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chronic pancreatitis is not identified as a high-risk category; pancreatitis is only mentioned in the context of elevating CA 19-9."
      },
      {
        "criterion_number": 9,
        "description": "The response should include EUS as a screening modality to detect pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "EUS is highlighted as highly sensitive for detecting small tumors and for monitoring cystic lesions, fulfilling its role as a screening/surveillance modality."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend people discuss the risks and benefits of screening with a doctor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises patients to consult with a healthcare provider to determine the most appropriate surveillance strategy and discusses potential harms such as anxiety and unnecessary procedures."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend people discuss the risks and benefits of screening with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Genetic testing and counseling are recommended for those with strong family history or hereditary syndromes, and genetic counselors are included in the multidisciplinary team, implying discussion of risks and benefits."
      }
    ],
    "question_number": 38,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:43:50.459899",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Include surgery as a potential treatment modality for resectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly discusses surgical options (Whipple, distal pancreatectomy, total pancreatectomy) with curative intent for early-stage/localized (resectable) disease and notes eligibility limitations."
      },
      {
        "criterion_number": 2,
        "description": "Specify that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer, with main regimens being FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While chemotherapy is discussed and FOLFIRINOX is named, the response does not mention gemcitabine + nab-paclitaxel specifically and does not clearly state chemotherapy as the backbone for metastatic/unresectable disease."
      },
      {
        "criterion_number": 3,
        "description": "Include radiation as a potential treatment option for localized pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Radiation therapy is described, including neoadjuvant/adjuvant use and SBRT for localized, inoperable tumors."
      },
      {
        "criterion_number": 4,
        "description": "State that the treatment of pancreatic cancer depends on the stage of the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states treatment depends on tumor stage and reiterates staging as a key consideration."
      },
      {
        "criterion_number": 5,
        "description": "State that the treatment of pancreatic cancer depends on the co-morbidities of the patient.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions \"overall health\" but does not explicitly reference co-morbidities influencing treatment decisions."
      },
      {
        "criterion_number": 6,
        "description": "State that the treatment of pancreatic cancer depends on the functional status of the patient.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly mention functional or performance status as a determinant; tolerance to side effects is noted but not framed as performance status guiding therapy."
      },
      {
        "criterion_number": 7,
        "description": "Include immunotherapy, noting its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 0,
        "max_points": 15,
        "justification": "Immunotherapy is discussed, but the response does not restrict its role to MSI-H/dMMR cases and suggests broader approvals (including nivolumab), which is inaccurate for pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "Include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Correctly mentions PARP inhibitors (e.g., olaparib) for BRCA-mutated tumors."
      },
      {
        "criterion_number": 9,
        "description": "Introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear section on clinical trials, emphasizing their importance and examples of investigational approaches."
      }
    ],
    "question_number": 39,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:44:09.996560",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that stage 0 is a pre-cancer state, also known as pancreatic intraepithelial neoplasia or carcinoma in situ.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes Tis as 'tumor in situ' and non-invasive but does not explicitly state that stage 0 is a pre-cancer state nor mention pancreatic intraepithelial neoplasia (PanIN) or 'carcinoma in situ' by name; it also refers to it as 'cancer,' which is imprecise for Stage 0."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that stage 1 cancer is when the cancer is confined to the pancreas and has not spread to lymph nodes or distant sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stage I is described as T1 N0 M0, confined to the pancreas with no lymph node or distant spread, meeting the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should note that stage 1a is when the tumor is 2cm or smaller.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention Stage IA or specify that IA corresponds to a tumor 2 cm or smaller."
      },
      {
        "criterion_number": 4,
        "description": "The response should note that stage 1b is when the tumor is larger than 2cm.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention Stage IB; it instead places T2 (>2 cm) in Stage II, which does not satisfy the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that stage II is when the cancer is growing into nearby tissues and into lymph nodes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While lymph node involvement is mentioned for Stage II, the response does not state that Stage II involves growth into nearby tissues; it characterizes T2 as still confined to the pancreas."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that stage III is when the cancer is locally advanced and involves surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response characterizes Stage III as locally advanced with extension beyond the pancreas into adjacent tissues and involving surrounding structures, satisfying the criterion despite some staging inaccuracies."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that stage IV is when the cancer has spread to other organs or sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that Stage IV includes distant metastasis (M1) to organs such as liver, lungs, and peritoneum."
      },
      {
        "criterion_number": 8,
        "description": "The response should include a description of the T, N, M staging system.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response introduces the AJCC TNM system and describes T, N, and M categories across stages, fulfilling the requirement."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that pancreatic cancer is categorized by resectability.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that pancreatic cancer is categorized by resectability (resectable, borderline resectable, locally advanced/unresectable, metastatic). It only mentions resectability incidentally without presenting this categorization."
      }
    ],
    "question_number": 40,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:44:51.122034",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that neuropathy is a common side effect from the oxaliplatin in FOLFIRINOX.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states neuropathy is a known side effect of oxaliplatin, a component of FOLFIRINOX."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that the oncologist can \u2018hold\u2019 or temporarily stop oxaliplatin to manage neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly mention holding or temporarily stopping oxaliplatin; discusses adjusting/removing or switching regimens instead."
      },
      {
        "criterion_number": 3,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by dose reduction.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of dose reduction of oxaliplatin for neuropathy management."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No discussion of schedule modification strategies (e.g., omitting oxaliplatin cycles or altering infusion intervals)."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends switching to regimens without oxaliplatin (e.g., FOLFIRI, gemcitabine-based, CAPIRI)."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen, including gemcitabine-based therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions gemcitabine alone and gemcitabine plus nab-paclitaxel as alternatives."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including gabapentin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Supportive medications listed include pregabalin, duloxetine, and amitriptyline; gabapentin is not mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Duloxetine (an SNRI) is listed as a supportive option."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Pregabalin is explicitly mentioned as a supportive medication."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly urges consultation with the oncologist regarding neuropathy and treatment changes."
      }
    ],
    "question_number": 41,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:45:27.649001",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should be informed about the aim of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises clarifying endpoints (what the trial measures, e.g., survival, QoL, tumor response) and explains trial phases, both of which convey the trial\u2019s purpose/aim."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they should understand the potential benefits of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Benefits are explicitly listed (access to new therapies, potential better outcomes, contributing to research)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that they should understand the potential risks of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Risks are clearly outlined (unknown/severe side effects, no benefit, delay in receiving standard treatment)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they should be aware of the inclusion and exclusion criteria for the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "There is a dedicated section on Inclusion/Exclusion Criteria with examples (biomarkers, prior treatments)."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that they should be aware of the time commitments associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions duration, frequency of visits/procedures, and a specific 'Time Commitment' section discussing adherence and energy levels."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that they should be aware of the costs associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a 'Costs and Insurance' section covering coverage of treatment, travel, lodging, insurance, and financial assistance."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the phase of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear explanation of trial phases I\u2013IV and their implications."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding if there are crossover options.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While trial design and control groups are discussed, there is no mention of crossover options between arms."
      }
    ],
    "question_number": 42,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:45:45.770254",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Radiation can be used before surgery to help shrink borderline resectable tumors, with the goal of increasing the likelihood of achieving a complete resection in the localized setting.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly describes neoadjuvant radiation for borderline resectable tumors to shrink them, make them operable, and improve chances of surgical removal."
      },
      {
        "criterion_number": 2,
        "description": "Radiation can be used for locally advanced or unresectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "There is a dedicated section on unresectable/locally advanced disease detailing chemoradiation and common regimens."
      },
      {
        "criterion_number": 3,
        "description": "Radiation can be used in the palliative setting to relieve symptoms in patients with advanced or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a palliative radiation section covering pain relief, relief of obstruction, quality-of-life improvement, and techniques such as SBRT and hypofractionation."
      },
      {
        "criterion_number": 5,
        "description": "Pancreatic cancer treatment plans are determined by the stage of the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The 'Key Considerations' explicitly stratify recommendations by stage (early-stage, locally advanced, metastatic)."
      },
      {
        "criterion_number": 6,
        "description": "Pancreatic cancer treatment plans are determined by the overall health of the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes that overall health and performance status influence treatment choices."
      },
      {
        "criterion_number": 7,
        "description": "The goal of radiation in the localized setting can be to sterilize vessel margins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although vessel involvement is mentioned for borderline resectable disease, the response does not explicitly state the goal of sterilizing vessel margins."
      },
      {
        "criterion_number": 8,
        "description": "The goal of radiation in the localized setting can be to delay disease progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "For locally advanced/unresectable disease, the response states radiation (with systemic therapy) aims to slow tumor growth and prolong survival, which aligns with delaying progression."
      },
      {
        "criterion_number": 9,
        "description": "The goal of radiation in the localized setting can be to prevent local recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The neoadjuvant and adjuvant sections mention reducing the risk of recurrence and targeting residual microscopic disease."
      }
    ],
    "question_number": 43,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:46:14.216411",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic cancer leads to enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that pancreatic cancer can impair pancreatic function, leading to pancreatic exocrine insufficiency and insufficient enzyme production."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how enzyme deficiency can lead to problems with digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that enzymes are needed to break down carbohydrates, fats, and proteins, and that deficiency leads to malabsorption with symptoms such as bloating, diarrhea, weight loss, and malnutrition."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme supplements are used to replace the enzymes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that enzyme supplements are designed to replace or supplement the digestive enzymes the pancreas is not producing adequately."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that pancreatic enzyme supplements can improve digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that supplements help digest food and absorb nutrients and explicitly notes they aim to improve digestion and reduce symptoms."
      }
    ],
    "question_number": 44,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:46:30.935232",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that cancer is associated with an increased risk of developing blood clots.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly describes cancer-associated hypercoagulability, mentions 'cancer-associated thrombosis,' and explains that tumors release procoagulant substances increasing clot risk. This clearly states the association between cancer and increased blood clot risk."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that patients with pancreatic cancer are at increased risk of developing a blood clot.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response directly notes that pancreatic cancer can increase the risk of blood clots and references Trousseau\u2019s syndrome in pancreatic cancer. It also ties the patient's DVT to the cancer as a likely related factor, satisfying the criterion."
      }
    ],
    "question_number": 45,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:46:43.725008",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explicitly state that second opinions can be obtained at any time, including after diagnosis, before starting treatment, during treatment, or when considering clinical trials.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response recommends seeking a second opinion soon after diagnosis and in complex/uncertain cases, but it does not explicitly say they can be obtained at any time, nor does it clearly include during treatment or when considering clinical trials as specific times."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly mention that second opinions are particularly helpful after the initial diagnosis and before starting treatment, as well as when the initial treatment is no longer effective.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It emphasizes seeking a second opinion after initial diagnosis and early in planning, but does not explicitly mention 'before starting treatment' nor does it mention the scenario when initial treatment is no longer effective."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Under 'Lack of Clarity or Trust' it states, 'If you\u2019re unsure about the diagnosis (e.g., conflicting test results)...' which explicitly addresses diagnostic uncertainty."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding staging.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes disagreement about stage ('if there\u2019s disagreement among doctors about the stage') and suggests asking, 'What is your interpretation of the test results and staging?' which explicitly covers staging uncertainty."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the treatment plan.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions seeking a second opinion when 'the diagnosis or recommended treatment feels unclear' and if the 'proposed treatment... seems risky or unclear.'"
      },
      {
        "criterion_number": 6,
        "description": "Explicitly state that second opinions can be obtained at specialized referral centers, such as cancer centers with expertise in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "In 'Identify a Qualified Specialist,' it directs patients to 'Academic medical centers or \"cancer centers of excellence\"' and to seek specialists with training in pancreatic cancer, indicating specialized referral centers for second opinions."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly state that they should look up NCI-designated cancer centers specifically.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response references ASCO, PanCAN, and NCCN, but does not mention NCI-designated cancer centers."
      },
      {
        "criterion_number": 8,
        "description": "Mention major academic hospitals as a resource for finding pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'Academic medical centers... often have specialists in this area,' which clearly points to major academic hospitals as resources."
      },
      {
        "criterion_number": 9,
        "description": "Mention that the NCCN guidelines for Pancreatic Adenocarcinoma recommend evaluation at high volume centers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While NCCN is referenced generally, the response does not specifically state that NCCN guidelines recommend evaluation at high-volume centers."
      }
    ],
    "question_number": 46,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:47:15.842702",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that immunotherapy is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention mismatch repair deficiency (dMMR) or high microsatellite instability (MSI-H) as the key subgroup for which immunotherapy is effective/approved in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that immunotherapy is an ongoing area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly emphasizes that immunotherapy is an evolving option, that research is advancing, and that combination strategies are under investigation."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that there may be clinical trial options exploring novel immunotherapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly discusses clinical trials, including CAR-T, vaccines, and bispecific antibodies, and advises how to find trials."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that immune checkpoint blockade is only approved for patients with metastatic disease in certain situations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not specify the approval context (e.g., metastatic disease) or that approval is limited to specific situations; it speaks generally about use in advanced disease without clarifying approval status."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pembrolizumab is approved for patients whose tumors are TMB high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While TMB testing is mentioned, the response does not state that pembrolizumab has a tissue-agnostic approval for TMB-high tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend asking their oncology team about testing for eligibility for immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends consulting the oncology team, highlights biomarker testing (e.g., TMB), and encourages asking whether immunotherapy is appropriate for the specific cancer profile, which implies testing for eligibility."
      }
    ],
    "question_number": 47,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:47:56.715570",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should consult with their oncologist on the potential next steps.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises consulting the oncologist again and even suggests seeking a second opinion and involving a multidisciplinary team."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the oncologist may suggest alternative standard of care therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions the oncologist may suggest different chemotherapy regimens and radiation therapy, which are standard options after progression. While some targeted therapy examples (e.g., ivosidenib) are not standard for pancreatic cancer, the criterion of noting alternative standard-of-care therapies is fulfilled."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that the oncologist may suggest clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A dedicated section recommends exploring clinical trials, advises discussing them with the oncologist, and provides reputable resources."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that re-biopsy of the disease could reveal targetable mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it recommends tumor genomic profiling, it does not explicitly mention re-biopsy at progression as a means to identify new targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supportive care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends palliative/supportive care, hospice when appropriate, and specific symptom management strategies."
      }
    ],
    "question_number": 48,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:48:24.308682",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no approved CAR-T cell therapy for pancreatic cancer at this time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that CAR-T therapy is not yet FDA-approved for pancreatic cancer and is not standard practice, clearly conveying the lack of approved indication."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe CAR-T cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It accurately describes CAR-T therapy as genetically modifying a patient\u2019s own T cells to target and destroy cancer cells, which is a clear and correct description."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CAR-T cells are being studied in clinical trials for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly notes ongoing clinical trials for pancreatic cancer, lists example targets (mesothelin, EGFR, CLDN18), and cites an NCT trial number, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CAR-T cells are approved for the treatment of other types of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that CAR-T therapy is primarily approved for blood cancers and mentions leukemia and lymphoma, fulfilling the requirement. Minor unrelated inaccuracy (calling gemcitabine a targeted therapy) does not affect this criterion."
      }
    ],
    "question_number": 49,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:48:37.324328",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that hospice is considered when the medical team estimates a life expectancy of 6 months or less.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states hospice is typically considered when prognosis is 6 months or less based on medical evaluation."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the aim of hospice is to maximize quality of life and focus on addressing symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly emphasizes comfort, quality of life, and relief from pain and symptoms over curative treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that hospice can take place in the home, a nursing home, or in a dedicated hospice facility.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes care can be provided at home, in a nursing home, hospital, or hospice facility."
      },
      {
        "criterion_number": 4,
        "description": "The answer should start with an expression of sympathy and support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response begins with a descriptive definition of hospice without an initial expression of sympathy or support."
      },
      {
        "criterion_number": 5,
        "description": "The response should define hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Hospice is defined as specialized support focusing on comfort, dignity, and quality of life when curative treatments are no longer effective or desired."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what hospice care covers, including emotional and spiritual support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly includes counseling, spiritual guidance, and emotional support for patients and families."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe what hospice care covers, including bereavement support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions bereavement support and grief counseling for families."
      }
    ],
    "question_number": 50,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:48:59.258610",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that fatigue is a common side effect of chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response discusses 'chemotherapy-induced fatigue,' it does not explicitly state that fatigue is a common side effect of chemotherapy or mention its prevalence."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises discussing fatigue with the oncologist or nurse, considering treatment adjustments, and involving palliative care."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention that optimizing nutrition and hydration can help manage fatigue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "There is a dedicated section on 'Nutrition and Hydration' recommending nutrient-dense foods, small frequent meals, hydration, and potential supplements."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend good sleep hygiene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides specific sleep hygiene strategies, including consistent schedules, bedtime routines, limiting screens, and optimizing the sleep environment."
      },
      {
        "criterion_number": 5,
        "description": "The response should discuss potential causes for fatigue, including the effect of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions possible contributors such as anemia, infection, medication side effects, depression, and pain, but does not state that the cancer itself can cause fatigue."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that light physical activity can improve fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends light exercise (e.g., short walks, stretching) to boost energy and suggests involving a physical therapist."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend medication review.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing medication side effects with the medical team and mentions potential pharmacologic options, consistent with a medication review."
      }
    ],
    "question_number": 51,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:49:26.181093",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that alternative treatments like cannabis oil have not been proven to help patients with pancreatic cancer live longer or cure them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states cannabis oil is 'not a proven cure' and that 'its efficacy for treating the disease itself remains unproven,' which addresses lack of evidence for cure or survival benefit."
      },
      {
        "criterion_number": 2,
        "description": "State that cannabis oil is sometimes used to manage cancer-related symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly notes most research focuses on 'symptom management' and lists pain, nausea, and appetite stimulation as potential benefits."
      },
      {
        "criterion_number": 3,
        "description": "Recommend discussing the use of cannabis oil with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises consulting the oncology team and discussing cannabis use with the oncologist, including potential drug interactions and integrative medicine programs."
      },
      {
        "criterion_number": 4,
        "description": "Describe cannabis oil.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes cannabis oil/products as containing cannabinoids such as THC and CBD, and mentions forms (oils, tinctures, edibles) and CBD-dominant options, providing an adequate description."
      },
      {
        "criterion_number": 5,
        "description": "State that cannabis oil is not used as an anti-cancer treatment per guidelines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states cannabis oil is 'not a proven cure,' that it should 'not replace' surgery/chemotherapy/radiation, and emphasizes adhering to evidence-based treatments\u2014consistent with guideline-based use."
      },
      {
        "criterion_number": 6,
        "description": "Describe risks of using cannabis oil, including drug interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It warns about interactions with chemotherapy via CYP450 metabolism and urges consultation with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "Describe risks of using cannabis oil, including side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Side effects listed include dizziness, fatigue, dry mouth, anxiety/paranoia (with high THC), and potential long-term cognitive/mental health impacts."
      },
      {
        "criterion_number": 8,
        "description": "Describe risks of using cannabis oil, including variation in quality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights quality control concerns such as contaminants and inconsistent cannabinoid levels, recommending lab-tested reputable products."
      },
      {
        "criterion_number": 9,
        "description": "Describe risks of using cannabis oil, including legal concerns.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated legal section covers variability of laws by jurisdiction, access requirements, and caregiver responsibilities."
      }
    ],
    "question_number": 52,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:49:50.289712",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that lack of appetite is a common side effect of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response discusses appetite loss in pancreatic cancer, it does not explicitly state that it is a common side effect."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the patient should consult with their oncologist, who may refer them to a registered dietitian, oncology nutritionist, and/or palliative care physician to address symptoms and optimize supportive care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response recommends consulting the medical team and involves an oncology dietitian, but it does not explicitly mention consulting the oncologist or referral to palliative care."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme replacement can be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions pancreatic exocrine insufficiency and that enzyme supplements may be required, which is pancreatic enzyme replacement."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the patient can try smaller meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends small meals as part of 'Small, frequent meals'."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient can try more frequent meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises offering 5\u20136 small meals/snacks instead of 3 large ones, meeting the 'more frequent meals' criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the patient can try nutritional replacement shakes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It suggests smoothies/shakes and oral nutritional supplements like Ensure and Boost."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that appetite stimulants can also be considered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It names specific appetite stimulants (megestrol acetate, oxandrolone) as options."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that cancer itself can cause loss of appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It lists potential causes (nausea, pain, metabolic changes, medications, depression) but does not explicitly state that the cancer itself causes loss of appetite."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that chemotherapy can cause nausea and loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It notes medication side effects such as chemotherapy as contributors and addresses managing nausea."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that bloating can decrease appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Bloating is not mentioned; reduced fullness and other triggers are discussed but not bloating specifically."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that pancreatic enzyme deficiency can cause decreased appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Pancreatic exocrine insufficiency and enzyme supplements are mentioned, but it does not link enzyme deficiency explicitly to decreased appetite."
      }
    ],
    "question_number": 53,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:50:47.032036",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they can start with their primary doctor who can help refer to the most local community hospital with oncology services.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises engaging the primary care provider and the local hospital early (e.g., \u201cAsk your local hospital or primary care provider about telehealth options\u201d and \u201cyour loved one\u2019s primary care physician or a local oncologist can coordinate care\u201d), which directs starting with the PCP and implies referral/coordination with local oncology services."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that if they are able to travel, then major cancer centers offer consultations which can also be done as telehealth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions travel to the nearest academic/NCI centers and that many oncologists and cancer centers offer virtual consultations, satisfying both the travel and telehealth consultation components."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that patients can search for NCI-designated cancer centers to find the closest one to them, and explicitly mention that both oncologists and palliative care teams often offer virtual visits through telemedicine or telehealth consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it references the NCI Cancer Centers Directory to locate nearby centers and notes that oncologists and cancer centers offer virtual consultations, it does not explicitly state that palliative care teams offer virtual visits."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly recommend reaching out to regional cancer centers, including examples or resources for finding such centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends connecting with the nearest academic/tertiary centers and provides the NCI Cancer Centers Directory as a resource, clearly meeting this requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that specialists will often partner with local oncologists to coordinate care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it notes that local oncologists/PCPs can coordinate care and consult with specialists, it does not explicitly state that specialists will partner with local oncologists to coordinate care."
      }
    ],
    "question_number": 54,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:51:16.264317",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should offer sympathy for the stressful situation dealing with insurance coverage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens by acknowledging that dealing with insurance denials for cancer is overwhelming, demonstrating empathy and recognition of the stressful situation."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they can work with the hospital\u2019s financial counselor or social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends involving hospital oncology social workers and mentions the hospital billing department/financial aid, meeting the criterion to work with in-hospital support."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises involving the medical team/oncologist to submit evidence-based justifications and contact the insurer directly, clearly directing collaboration with the oncology team."
      },
      {
        "criterion_number": 4,
        "description": "The response should include contacting the insurance company to understand the reason for denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directs the reader to review the denial letter and to call the insurer to clarify the reasoning and request documentation, fulfilling the requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response should state one option for remedy is filing an appeal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a detailed section on appeals, including internal appeals and external review, explicitly naming appeals as a remedy."
      }
    ],
    "question_number": 55,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:51:28.098231",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define high-volume centers as those performing at least 40 or 50 Whipple procedures per year.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines high-volume as \u226520\u201330 surgeries per year, not the required \u226540\u201350 Whipple procedures per year."
      },
      {
        "criterion_number": 2,
        "description": "State that high-volume centers have significantly lower mortality rates and higher overall survival rates for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes lower mortality rates and better long-term survival at high-volume centers."
      },
      {
        "criterion_number": 3,
        "description": "State that high-volume centers have significantly lower complication rates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states significantly fewer complications at high-volume centers and provides examples."
      },
      {
        "criterion_number": 4,
        "description": "State that at a high-volume center, the surgeon is more likely to be a specialist in pancreas surgery.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions experienced surgeons and multidisciplinary teams but does not explicitly state that the surgeon is a pancreatic surgery specialist or more likely to be one."
      },
      {
        "criterion_number": 5,
        "description": "State that high-volume centers often have access to clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that high-volume centers often participate in clinical trials, offering access to experimental treatments."
      },
      {
        "criterion_number": 6,
        "description": "State that high-volume centers have access to the latest treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response cites access to cutting-edge technologies and advanced treatments, meeting the criterion."
      },
      {
        "criterion_number": 7,
        "description": "State disadvantages of going to a high-volume center, including travel time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Travel burden is explicitly discussed, including distance and associated stress/costs."
      },
      {
        "criterion_number": 8,
        "description": "State disadvantages of going to a high-volume center, including more complicated logistics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes logistical complexities such as travel arrangements, potential longer wait times, and insurance/cost issues."
      }
    ],
    "question_number": 56,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:51:50.223828",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the Pancreatic Cancer Action Network as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions Pancreatic Cancer Action Network (PCAN) and notes it provides resources and financial aid, with a link to pancan.org."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention CancerCare as a resource for financial assistance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "CancerCare is mentioned only as an online community/support group example, not as a financial assistance resource."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the American Cancer Society as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "American Cancer Society is identified with specific financial supports (grants, lodging, transportation assistance) and linked to cancer.org."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with a social worker.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of a social worker or recommendation to speak with one."
      },
      {
        "criterion_number": 5,
        "description": "The response should offer sympathy for the stressful situation dealing with financial burden during cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathetic language acknowledging the situation as overwhelming and stressful."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "References asking the oncologist about clinical trials and reviewing insurance with a provider, but does not explicitly recommend discussing financial concerns with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing financial concerns with a financial counselor.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions hospital financial assistance offices and a financial advisor, but does not recommend speaking with a financial counselor."
      }
    ],
    "question_number": 57,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:52:11.690945",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions that depression is common among patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States pancreatic cancer has a higher risk of depression and cites 30\u201350% prevalence in cancer patients, noting it may be higher in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing the patient\u2019s mood with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing mood with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions support groups as helpful for patients with cancer experiencing depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends support groups and provides ACS and PanCAN resources."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions seeking immediate evaluation by a medical professional if the patient is experiencing thoughts of harming themself or others.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to seek immediate help for suicidal thoughts and references seeking emergency care."
      },
      {
        "criterion_number": 5,
        "description": "The response offers the emergency department and calling 988 if the patient experiences thoughts of harming themself or others.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions calling 988 and seeking emergency care."
      },
      {
        "criterion_number": 6,
        "description": "The response points to published scientific studies describing the prevalence of depression in pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No published scientific studies or specific citations on pancreatic cancer depression prevalence are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists core depressive symptoms, including mood, anhedonia, sleep/appetite changes, fatigue, concentration issues, and suicidal thoughts."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing the patient\u2019s mood with a mental health professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends seeing a psychiatrist or psychologist for assessment and treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response states that there are various treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that depression is treatable and mentions therapy, antidepressants, or a combination."
      },
      {
        "criterion_number": 10,
        "description": "The response states that there are both pharmacologic and non-pharmacologic treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions therapy (non-pharmacologic) and antidepressants (pharmacologic)."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions lifestyle changes that support improvements in mental health.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests gentle physical activity, relaxation techniques, and maintaining routines."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that based on the ASCO guidelines, optimal care of depression should follow a stepped-care model.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of ASCO guidelines or the stepped-care model."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that CBT, behavior therapy (BT), and behavioral activation (BA) are the most effective treatments for managing depressive symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions CBT as an example but does not note BT/BA or that these are the most effective per guidelines."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that exercise both during and after treatment can significantly reduce depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests gentle activity may help mood but does not state that exercise during and after treatment significantly reduces depression."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that pharmacotherapy is not recommended as a first-line treatment for depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that pharmacotherapy is not first-line; instead lists antidepressants as an option without prioritization guidance."
      }
    ],
    "question_number": 58,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:52:51.617636",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises asking the oncologist specific questions and states that oncologists can provide individualized estimates."
      },
      {
        "criterion_number": 2,
        "description": "The response states that many aspects of a patient\u2019s health impact their prognosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple factors including overall fitness, age, and comorbidities, as well as stage, tumor biology, and treatment response."
      },
      {
        "criterion_number": 3,
        "description": "The response defines overall survival as it is used in clinical research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines overall survival as the percentage of people who survive a certain period after diagnosis, which aligns with the clinical concept of survival over time."
      },
      {
        "criterion_number": 4,
        "description": "The response defines progression-free survival as it is used in clinical research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not define progression-free survival; discusses disease-free survival instead."
      },
      {
        "criterion_number": 5,
        "description": "The response explains that overall survival and progression-free survival are typically reported as medians.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Explains the concept of median survival and provides an example for OS but does not state that OS and PFS are typically reported as medians, nor mention PFS."
      },
      {
        "criterion_number": 6,
        "description": "The response explains the above biostatistics terms (overall survival, progression-free survival, and median) in laymen\u2019s terms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Explains overall survival and median in lay terms but omits progression-free survival."
      },
      {
        "criterion_number": 7,
        "description": "The response explains that survival data is best reported in terms of the stage of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides stage-specific survival figures and emphasizes the importance of stage in prognosis."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the limitations of applying reported statistics to patients\u2019 individual cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that statistics are based on historical data, may not reflect newer treatments, and that individual outcomes vary ('Statistics \u2260 Destiny')."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions the difference between overall survival and progression-free survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention progression-free survival or contrast it with overall survival."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that survival is influenced by tumor characteristics such as genetic mutations (BRCA, KRAS), size, and location.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions genetic mutations (BRCA1/2, KRAS) and resectability/location (confined to pancreas), fulfilling the criterion."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that survival depends on treatments received (chemotherapy, surgery, targeted therapy, no treatment, etc.) and treatment response.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that treatment response affects outcomes and lists therapies including surgery, chemotherapy, targeted therapy, immunotherapy, and clinical trials."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that new treatments and advancements are being developed all the time, and these could potentially improve outcomes in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Highlights newer therapies, clinical trials, and accelerating advances that may improve outcomes."
      }
    ],
    "question_number": 59,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:53:17.948756",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing results with the medical team and explicitly mentions checking with the father's oncology team about access and insurance coverage."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that a liquid biopsy is a blood test.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that a liquid biopsy typically involves a simple blood draw."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that liquid biopsies involve analyzing circulating tumor DNA (ctDNA) from blood samples.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines ctDNA as DNA fragments shed by tumor cells into the blood and explains analysis with NGS/PCR."
      },
      {
        "criterion_number": 4,
        "description": "The response explains there are many different tests which evaluate various things including circulating tumor DNA, circulating tumor cells, and proteins in the blood.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions ctDNA and CTCs but does not mention proteins in the blood."
      },
      {
        "criterion_number": 5,
        "description": "The response says that liquid biopsies do not replace tissue biopsies in the diagnosis of cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states liquid biopsies are not a replacement for tissue biopsy and cannot definitively diagnose cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response says the results of liquid biopsies must be interpreted by a medical professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states that results should be discussed with the medical team and interpreted in context with other tests."
      },
      {
        "criterion_number": 7,
        "description": "The response says the results of liquid biopsies may be helpful when combined with imaging and pathology results.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions combining with imaging and clinical exams, but does not specify pathology results."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions there are liquid biopsies in various stages of development for different kinds of cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It discusses research and use in pancreatic cancer and generally in oncology, but does not mention various stages of development across different cancer types."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the limitations of liquid biopsies, including sensitivity, false positives, and cost.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly lists sensitivity issues, potential for false positives and false negatives, and addresses cost/availability concerns."
      },
      {
        "criterion_number": 10,
        "description": "The response says there are currently no FDA approved liquid biopsies for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not mention FDA approval status for pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response says health insurance may not pay for these tests.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests checking insurance coverage but does not state that insurance may not pay."
      },
      {
        "criterion_number": 12,
        "description": "The response says liquid biopsies may be able to identify genetic mutations present in the cancer which can help to guide treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that identifying genetic mutations can tailor therapies, supporting treatment guidance."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that liquid biopsies are noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes the test is less invasive and avoids repeated biopsies, but does not mention expediting testing due to no need for archival blocks or arranging a new biopsy."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not address limitations specific to copy-number changes or fusion detection in cfDNA assays."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that this is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states research is ongoing and the field is still evolving, and notes not all centers offer liquid biopsies, implying it is not yet standard of care."
      }
    ],
    "question_number": 60,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:53:56.381145",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response considers the costs of travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly includes travel costs in cost analysis (treatment, travel, accommodation, follow-up) and mentions logistics that impact travel expenses."
      },
      {
        "criterion_number": 2,
        "description": "The response considers the costs of healthcare abroad.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It discusses total treatment costs, potential upfront payments, and lack of international coverage by most plans."
      },
      {
        "criterion_number": 3,
        "description": "The response considers logistics of travel, including the need for passports and/or visas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It covers visa requirements, potential medical visas, residency permits, and practical travel logistics."
      },
      {
        "criterion_number": 4,
        "description": "The response considers language and cultural barriers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It addresses interpreter availability, multilingual staff, cultural comfort, dietary and religious needs."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions that patients receiving treatment for pancreatic cancer often require significant support from their family and friends.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises identifying companions (family/friends) to assist during treatment and recovery and emphasizes support services."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering if the patient is medically safe for travel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends consulting the oncologist to assess medical advisability and mentions risks during transit and need for medical clearance for air travel."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends researching the quality of healthcare in the intended destination.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises researching hospitals/specialists, accreditations (JCI, ISO), success rates, survival statistics, technology, and multidisciplinary teams."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing all travel plans with a medical professional prior to leaving.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends consulting the current oncologist, obtaining second opinions, and involving a travel medicine specialist."
      },
      {
        "criterion_number": 10,
        "description": "The response says that delaying the start of treatment for pancreatic cancer can be harmful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states to evaluate urgency and whether waiting for overseas care poses risks, conveying that delay can be harmful."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends researching pancreatic cancer outcomes in the intended destination as compared to her home country.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it suggests checking success rates and survival statistics, it does not explicitly recommend comparing outcomes to those in the home country."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends understanding the patient\u2019s treatment options, including clinical trials, which may be available in her home country before making travel plans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions clinical trials available at the destination and advanced treatments not available locally, but does not advise researching clinical trials or options available in the home country prior to travel."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention considerations related to insurance funding.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It covers reviewing existing insurance for international coverage, exploring medical travel insurance, expatriate plans, and potential upfront payment requirements."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to consider local accommodations when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It specifically advises arranging accommodations near the hospital."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention to consider challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It discusses planning for post-treatment monitoring, possible return visits, remote consultations, and continuity of care with the local team."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that immunizations and infection prevention are important, especially for immunosuppressed patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention immunizations, infection prevention, or special considerations for immunosuppressed patients undergoing chemotherapy."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that telemedicine and remote support can be leveraged for follow-up, symptom management, and multidisciplinary care, reducing the need for frequent travel and facilitating access to expertise at high-volume centers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes remote consultations, virtual evaluations, and using telemedicine for follow-up, which reduces travel and facilitates access to expertise."
      }
    ],
    "question_number": 61,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:54:28.895915",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that bowel changes, including diarrhea, nausea, and constipation, are common among patients undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes many chemotherapy drugs can cause diarrhea, nausea, or constipation, indicating these bowel changes are common during treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response mentions that chemotherapy, radiation therapy, surgery, and other treatments such as pain medications can impact the bowels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Chemotherapy, radiation enteritis, surgery (Whipple), and opioids causing constipation are all mentioned."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that bowel changes can also be due to infections.",
        "score_given": 2,
        "max_points": 2,
        "justification": "C. difficile and infection risk are explicitly cited as causes of diarrhea."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing specific concerns with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting the medical team and specifically encourages discussing changes with their oncologist or gastroenterologist."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping a log of events related to food intake, fluid intake, and bowel symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests tracking stool-related symptoms but does not recommend logging food or fluid intake."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the above log with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No suggestion to bring or discuss a symptom/food/fluid log with the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends if the patient has not had a bowel movement in more than 24 hours and is not passing gas, their bowels may be obstructed, which is a medical emergency and requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Bowel obstruction is mentioned, but no specific red-flag guidance about >24 hours without BM and no gas or ED urgency."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends if the patient is nauseous and unable to keep any food or drink down without vomiting, this can quickly lead to severe dehydration, which requires urgent evaluation by a medical professional and potentially intravenous fluids and medicines.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit advice regarding inability to keep fluids down, dehydration risk, or need for urgent evaluation/IV fluids."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends if the patient is experiencing severe abdominal pain, this may represent a medical emergency which requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Severe abdominal pain as an emergency/ED indication is not addressed."
      },
      {
        "criterion_number": 10,
        "description": "The response says patients with pancreatic cancer may experience pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Pancreatic insufficiency is explicitly named as a potential cause due to ductal blockage."
      },
      {
        "criterion_number": 11,
        "description": "The response explains pancreatic insufficiency is related to a deficiency in the pancreatic enzymes which break down food and can cause diarrhea and bloating.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explains that inadequate enzyme release leads to malabsorption causing steatorrhea and diarrhea; mechanism of enzyme deficiency is clearly described."
      },
      {
        "criterion_number": 12,
        "description": "The response explains there are supplementary pancreatic enzymes that can be taken to alleviate the symptoms of pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions enzyme supplements for pancreatic insufficiency to help manage symptoms."
      },
      {
        "criterion_number": 13,
        "description": "The response explains if the bowel changes are due to chemotherapy, the treating oncologist can often prescribe additional medications to control these side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While medications like anti-diarrheals are mentioned, it does not specifically state that the oncologist can prescribe additional medications for chemo-related side effects."
      },
      {
        "criterion_number": 14,
        "description": "The response says proper nutrition is an important part of cancer care outcomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Nutrition is referenced for symptom management, but it does not state its importance for overall cancer care outcomes."
      },
      {
        "criterion_number": 15,
        "description": "The response says it is important to remain hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Hydration is recommended as part of supportive care."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that it is important to determine the cause of the bowel changes to manage them effectively.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes evaluation to determine the exact cause and appropriate care, including testing to pinpoint the cause."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that gastric outlet/duodenal obstruction can occur in up to 10% of patients with pancreatic cancer, leading to symptoms like early satiety, nausea, postprandial vomiting, and weight loss.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of gastric outlet/duodenal obstruction prevalence or its characteristic symptoms."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that patients with malignant ascites from pancreatic cancer may experience abdominal discomfort, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Malignant ascites is not discussed."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that diet/nutrition changes can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It does not explicitly state that diet changes unrelated to cancer/treatment can alter bowel habits."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that stress/anxiety can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Stress/anxiety as a cause of bowel changes is not mentioned."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that pre-existing conditions can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Pre-existing GI conditions or other comorbidities are not cited as potential causes."
      }
    ],
    "question_number": 62,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:55:17.569132",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting the oncologist/medical team and emphasizes it as critical."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pancreatic cancer and its treatments may affect the patient\u2019s ability to drive safely.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses chemotherapy/treatment effects on driving but does not state that pancreatic cancer itself may affect driving ability."
      },
      {
        "criterion_number": 3,
        "description": "The response states that pain medications may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly notes pain medications can cause drowsiness/impaired judgment affecting driving."
      },
      {
        "criterion_number": 4,
        "description": "The response states that symptoms such as fatigue, drowsiness, nausea, and vomiting may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions fatigue, nausea/vomiting, and drowsiness (from medications) as impacting driving."
      },
      {
        "criterion_number": 5,
        "description": "The response states that the patient\u2019s healthcare team may have resources to assist with transportation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests alternative transportation and external organizations but does not state that the healthcare team can provide transportation resources (e.g., social work services)."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that chemotherapy can cause fatigue that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly states chemotherapy-related fatigue can slow reaction times and reduce alertness."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that chemotherapy can cause vision changes that may impair driving abilities.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions monitoring for blurred vision but does not attribute vision changes to chemotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chemotherapy can cause neuropathy that may impair driving abilities.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of neuropathy or its impact on pedal control/sensation."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that chemotherapy can cause cognitive changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Clearly references 'chemo brain' affecting concentration, memory, and decision-making."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to avoid driving after the first chemotherapy session to see how your husband tolerates it.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specifically advise avoiding driving after the first chemotherapy session."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to plan for backup transportation, such as a taxi, friends/family, or public transportation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends rideshare, friends/family, and public transit as alternatives."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the National Highway Traffic Safety Administration (NHTSA) provides information on medical conditions and driving safety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References the American Cancer Society and CancerCare but not NHTSA."
      }
    ],
    "question_number": 63,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:55:49.720254",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that the ability to work depends on individual circumstances such as the stage of cancer, overall health, and comorbidities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says working during treatment depends on individual factors and details stage/type (early vs advanced). While it does not explicitly name comorbidities, it clearly frames the decision as individualized and tied to cancer stage and personal factors."
      },
      {
        "criterion_number": 2,
        "description": "The response states that the ability to work depends on the type of treatment (chemotherapy, radiation, surgery, targeted therapy) and related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses surgery recovery and side effects from chemotherapy and radiation (fatigue, nausea, weakened immunity), linking these to impact on stamina and work capacity."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the ability to work depends on the support available from friends, family, and caregivers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions workplace support and emotional support resources but does not state that support from friends, family, or personal caregivers influences the ability to work."
      },
      {
        "criterion_number": 4,
        "description": "The response states that the ability to work depends on job type and flexibility (working from home, reduced hours, workplace accommodations, scheduled breaks).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly addresses job demands and flexibility and lists accommodations such as remote work, part-time hours, flexible start/end times, modified duties, and ADA accommodations including breaks."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pancreatic cancer and its treatment can cause symptoms which may make working challenging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes fatigue, pain, digestive issues, and treatment-related effects (e.g., nausea, weakened immunity) that can vary day-to-day and affect work."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly advises consulting the oncologist and a nurse navigator, and mentions referrals to a social worker or occupational therapist for strategies."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends workplace accommodations which may make working possible during treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It proposes specific accommodations (reduced hours, flexible scheduling, telecommuting, modified duties) and cites ADA reasonable accommodations including breaks."
      },
      {
        "criterion_number": 9,
        "description": "The response states the patient\u2019s ability to continue working should be continually reassessed as their medical condition changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes that every case is unique, encourages adjusting plans as needed, and acknowledges that treatment may become too taxing, prompting a leave of absence\u2014implying ongoing reassessment."
      },
      {
        "criterion_number": 10,
        "description": "The response states that self-care is important while undergoing cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly prioritizes health, recommends rest and avoiding overexertion, and suggests planning for low-energy days and seeking emotional support."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient may qualify for paid leave through their employer, the government, or both.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions FMLA (unpaid) and suggests disability benefits/insurance generally, but does not explicitly state eligibility for paid leave through employer or government programs."
      },
      {
        "criterion_number": 12,
        "description": "The response states many patients with pancreatic cancer take time off of work during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It says some people need to step back or take leave, but does not state that many patients take time off during treatment."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that it is important for patients with pancreatic cancer to maintain their quality of life, and that work during treatment may be possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It affirms that working during treatment is often possible and highlights maintaining normalcy and emotional well-being, aligning with quality-of-life considerations."
      }
    ],
    "question_number": 64,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:56:40.275664",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing the use of medical marijuana with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states 'Consult His Oncologist' and 'Work closely with your father\u2019s healthcare team' and emphasizes reviewing interactions and dosing with clinicians."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that medical marijuana is not an effective alternative treatment for pancreatic cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states 'It is not a cure for cancer but may improve quality of life.'"
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions risks and side effects associated with medical marijuana, including psychoactive effects and potential interactions with other medications.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Side effects listed include dizziness, drowsiness, impaired memory/concentration, dependency, and mental health concerns; it also advises reviewing drug interactions with chemotherapy, painkillers, and blood thinners. THC is identified as psychoactive."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly states that medical marijuana comes in various forms, such as oils, edibles, tinctures, and vaporizers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Forms listed include vaporizers, oils/tinctures, capsules, edibles, topicals, sublingual drops, and suppositories."
      },
      {
        "criterion_number": 5,
        "description": "The response specifically mentions the risk of inhaled medical marijuana exposing patients to infectious organisms like fungi, particularly for those receiving certain chemotherapy treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of infectious risks (e.g., fungal contamination) associated with inhaled products or special risks for immunocompromised/chemotherapy patients."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that medical marijuana may be used to control symptoms associated with pancreatic cancer and its treatments, such as nausea, vomiting, loss of appetite, and pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Benefits listed include pain relief, chemotherapy-induced nausea/vomiting, appetite stimulation, sleep, and mood."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that there is mixed data on the benefit of medical marijuana for managing symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes 'Research is ongoing, and effectiveness varies by individual' and that 'some studies show benefits... but evidence... is limited,' indicating mixed evidence."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses potential legal challenges with obtaining and using medical marijuana, noting that these may vary based on the patient\u2019s location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed location-specific legal considerations (state vs. federal discrepancies, requirements for medical cards, and employment/travel implications)."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends not driving or making important decisions while under the influence of marijuana.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While cognitive side effects are mentioned, there is no explicit advice to avoid driving or important decision-making."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly recommends obtaining medical marijuana only from professionals licensed to sell it.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends using licensed dispensaries for quality control and access."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that medical marijuana refers to products derived from the cannabis plant or its extracts that contain active compounds such as THC (tetrahydrocannabinol), CBD (cannabidiol), or combinations thereof.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains key components (THC and CBD, with full names), their effects, and notes products vary in THC:CBD ratios, effectively describing medical cannabis as products containing these compounds."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that preliminary data reports poor clinical outcomes in adults receiving immunotherapy while using cannabis and/or cannabinoids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of immunotherapy outcomes or the potential for poorer outcomes with concurrent cannabis use."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that CBD presents risks for hepatotoxicity, with a meta-analysis reporting a nearly 6-fold increase in liver enzyme elevation and drug-induced liver injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hepatotoxicity and liver enzyme elevation risks with CBD are not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cannabis and/or cannabinoids are one of several pharmacologic options for adults with cancer experiencing refractory nausea and vomiting despite optimal prophylaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although chemotherapy-induced nausea is mentioned and dronabinol noted, it does not specify use for refractory symptoms after optimal prophylaxis among several options."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce polypharmacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of polypharmacy reduction or research needs related to it."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce opioid requirements for cancer-related pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address opioid-sparing effects or the need for research in this area."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of chemotherapy-induced peripheral neuropathy or cannabis effects on it."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that further research is needed to determine the effects of cannabis on pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While pain relief is listed as a potential benefit, it does not explicitly state that further research is needed regarding cannabis\u2019s effects on pain."
      }
    ],
    "question_number": 65,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:57:29.073499",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends consulting with the patient\u2019s oncologist or healthcare team, including specific roles such as nurse practitioner or palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises, \u201cRequest a meeting with the oncologist or care team,\u201d and outlines topics to clarify (prognosis, options, expectations, timeline). While it does not explicitly name a nurse practitioner or palliative care specialist, it clearly recommends consultation with the oncologist/healthcare team, satisfying the core requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that the healthcare team may have a social worker available to assist with family discussions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly suggests using \u201ca social worker from the hospital\u201d to guide the family conversation, indicating availability through the care setting to assist with family discussions."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends involving a neutral third party, such as a social worker, spiritual care worker, counselor, or patient advocate, to facilitate family discussions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends a neutral facilitator and lists examples (trusted friend, therapist, hospital social worker) and separately mentions family mediation with a therapist or conflict resolution specialist."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly provides online resources for cancer patients and their families, including specific organizations like PANCAN, NCI, or ACS.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides specific online resources, including Pancreatic Cancer Action Network (PANCAN) and the American Cancer Society (ACS), as well as CancerCare and Cancer Support Community."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend scheduling a family meeting to discuss goals of care and important treatment decisions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends hosting a family meeting, with structure and goals focused on shared understanding and decision-making."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that understanding your mother\u2019s specific goals should shape conversations about goals of care and treatment recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly centers the mother\u2019s priorities (e.g., \u201cWhat does your mother value most?\u201d) and advises using her advance directives and values (substituted judgment/best interest) to guide decisions, aligning care with her goals."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that your mother\u2019s wishes related to treatment, belief systems, and personal ways of coping should be respected by their families, cancer care team, and others who support them through the cancer experience.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it emphasizes honoring the mother\u2019s values and humanity, it does not explicitly state that her treatment wishes, beliefs, and coping styles should be respected by both family and the cancer care team and other supporters."
      }
    ],
    "question_number": 66,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:58:11.053539",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response refers broadly to the healthcare team but does not explicitly recommend discussing concerns with the patient's oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual care worker, palliative care professional, or counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends professional counseling, involving a spiritual advisor, and consulting a hospital social worker."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends support groups and other online resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups and provides links to PanCAN and the American Cancer Society."
      },
      {
        "criterion_number": 4,
        "description": "The response states that depression is highly prevalent in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Depression is not mentioned as being highly prevalent in pancreatic cancer specifically."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No signs or symptoms of depression are described."
      },
      {
        "criterion_number": 6,
        "description": "The response states that if the patient is experiencing thoughts of harming themselves or others, they should seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of urgent evaluation for suicidal or homicidal thoughts."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that it\u2019s important to have open and honest conversations about their concerns, including feeling like a burden to their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes open and honest communication and specifically addresses validating concerns about feeling like a burden."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage the patient to express their fears and anxieties about the impact of their illness on their loved ones, and acknowledge and validate their feelings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises acknowledging feelings, encouraging expression of fears, and validating concerns."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to ask about the patient\u2019s preferences and personal goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests discussing and documenting healthcare preferences (advance directives) and creating a patient-centered care plan, aligning with goals-of-care discussions."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention it is important to emphasize working together to manage the challenges.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly emphasizes collaboration, shared task planning, family meetings, and that the journey is a shared effort."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention support networks such as PanCAN, CancerCare, ASCO.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions the Pancreatic Cancer Action Network (PanCAN); the criterion allows examples such as these."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that professional counseling can help process these emotions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends professional counseling to help process guilt, fear, and anxiety."
      }
    ],
    "question_number": 67,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:58:50.090443",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states targeted therapies work against cancer with specific genetic mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains targeted therapy \"focuses on specific molecules or pathways\" and emphasizes genetic testing for mutations (e.g., KRAS, BRAF, HER2, NTRK), indicating it works against cancers with specific genetic alterations."
      },
      {
        "criterion_number": 2,
        "description": "The response states that not all pancreatic cancers will have mutations for which targeted therapy can be used.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states \"Not all pancreatic cancers have the targeted mutations, so effectiveness varies.\""
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of targetable mutations in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists KRAS, BRAF, HER2, NTRK, and BRCA as potential targetable alterations."
      },
      {
        "criterion_number": 4,
        "description": "The response states targeted therapies can be given alone or sometimes in combination with chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response notes targeted therapy is \"often used alongside chemotherapy or immunotherapy\" but does not clearly state that targeted therapy can be given alone."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The \"Next Steps\" section explicitly advises asking the oncologist specific questions about mutations, targeted therapies, benefits/risks, and clinical trials."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that targeted therapy for pancreatic cancer involves using drugs to specifically target proteins, genes, or pathways of cancer cells, potentially causing less damage to normal cells compared to chemotherapy or radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states targeted therapy focuses on \"specific proteins, genes, or other molecules\" and contrasts with chemotherapy by noting \"often with fewer side effects,\" implying less damage to normal cells."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that while targeted therapy is an option, it is important to consider all potential treatment options, outcomes, and adverse events to make an informed decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends discussing expected benefits/risks with the oncologist and considering clinical trials, reflecting the need to weigh options, outcomes, and adverse events."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention examples of targeted therapies, such as Dabrafenib + trametinib (if BRAF V600E mutation-positive), Entrectinib, Larotrectinib, Repotrectinib (if NTRK gene fusion-positive), Selpercatinib (if RET gene fusion-positive), Rucaparib (for germline or somatic BRCA1/2 or PALB2 mutations), Olaparib (only for germline BRCA1/2 mutations), Adagrasib (if KRAS G12C mutation-positive), Sotorasib (if KRAS G12C mutation-positive), Erdafitinib (if FGFR genetic alterations), Fam-trastuzumab deruxtecan-nxki (if HER2 positive [IHC3+ or IHC2+ with FISH HER2 amplified]) Zenocutuzumab-zbco (if NRG1 gene fusion-positive).",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response includes examples from the list (e.g., olaparib and dabrafenib), satisfying the requirement to mention such agents."
      },
      {
        "criterion_number": 9,
        "description": "Negative points if targeted therapies are discussed that are not approved for pancreatic cancer, such as osimertinib, regorafenib, mTOR inhibitors.",
        "score_given": -10,
        "max_points": 0,
        "justification": "The response lists cetuximab and bevacizumab as examples in pancreatic cancer; these are not approved for pancreatic adenocarcinoma, constituting discussion of non-approved targeted therapies."
      }
    ],
    "question_number": 68,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T14:59:58.619636",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing integrative medicine with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises: \u201cDiscuss with the Oncologist\u2026 Inform your loved one\u2019s medical team about any integrative approaches being considered,\u201d and emphasizes coordination with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response states integrative medicine is not as effective as standard of care treatments for pancreatic cancer like chemotherapy, radiation, surgery, and targeted therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly frames integrative care as supportive for side effects and quality of life and states it should \u201cnever replace evidence-based cancer treatments,\u201d implying it is not as effective for treating the cancer itself as SOC."
      },
      {
        "criterion_number": 3,
        "description": "The response states integrative medicine can be a helpful adjunct to standard of care treatments for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States: \u201cIntegrative medicine can complement conventional care by addressing symptoms and enhancing quality of life,\u201d and repeatedly positions it alongside\u2014not instead of\u2014standard treatments."
      },
      {
        "criterion_number": 4,
        "description": "The response defines integrative medicine.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it describes how to use integrative therapies and that they complement conventional care, it does not provide a clear, explicit definition of integrative medicine as a coordinated approach combining evidence-based complementary therapies with conventional treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of integrative medicine interventions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple examples: acupuncture, meditation, yoga, nutrition/dietary modifications, supplements (omega-3, vitamin D), physical activity, art therapy, and support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends telling the patient\u2019s oncologist if they plan to include integrative medicine interventions into their care plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly instructs to inform the oncology team about any integrative approaches being considered and to coordinate care."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends telling the patient\u2019s oncologist about all supplements they are taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically says to discuss supplements with the oncology team, to disclose use to the medical team, and to document all supplements for the care team."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with the treatments being prescribed for their pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that certain herbs/supplements (e.g., turmeric/curcumin, garlic, ginger) may interfere with chemotherapy or blood thinners, highlighting interaction risks."
      },
      {
        "criterion_number": 9,
        "description": "The response states there is data to support some integrative medicine interventions for specific uses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies evidence-supported uses (e.g., acupuncture for pain/nausea/stress; meditation/yoga for anxiety and mood) and advises checking peer-reviewed sources."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that safety concerns and risks related to integrative medicine approaches are heightened with self-prescription or use of non-standardized products.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Warns against unregulated products and advises choosing third-party\u2013certified supplements (USP, NSF), discourages \u201ccure-all\u201d claims, and emphasizes coordination with clinicians\u2014addressing risks of self-prescribing and non-standardized products."
      }
    ],
    "question_number": 69,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:00:33.239184",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the skin changes with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to 'Consult the Medical Team Immediately' and to 'always involve the oncology team,' emphasizing discussion with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states that skin changes are a common side effect of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States, 'Skin changes during chemotherapy for pancreatic cancer are relatively common.'"
      },
      {
        "criterion_number": 3,
        "description": "The response states that skin changes related to treatment for pancreatic cancer can range from mild to life-threatening.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses mild to severe reactions and urgent care, but does not explicitly state that changes can be life-threatening."
      },
      {
        "criterion_number": 4,
        "description": "The response provides at least two examples of skin changes, including hand-foot syndrome, allergic reactions, or infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple examples including dryness/itchiness, rashes/redness, hand-foot syndrome, hyperpigmentation, and mentions allergic reactions and infections."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate evaluation by a healthcare provider if the patient shows signs of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists signs of infection under 'When to Be Concerned' and advises 'Consult the Medical Team Immediately,' implying immediate evaluation for those signs."
      },
      {
        "criterion_number": 6,
        "description": "The response provides at least one example of signs and symptoms of infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Gives examples: 'Redness, warmth, swelling, or open sores' as potential signs of infection."
      },
      {
        "criterion_number": 7,
        "description": "The response states that skin changes related to treatment for pancreatic cancer should be treated by a healthcare professional experienced in caring for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifies involvement of the 'oncologist' and 'oncology team' as best equipped to address the case, indicating experienced cancer-care professionals."
      },
      {
        "criterion_number": 8,
        "description": "The response states that skin changes related to treatment for pancreatic cancer often require specific interventions or escalation of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes potential dose reduction, switching medications, topical corticosteroids, and indicates severe reactions may require urgent attention\u2014demonstrating need for specific interventions/escalation."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions at least three specific manifestations of skin changes related to chemotherapy, such as new or worsening skin lesions, itch, acne-like symptoms, bullous dermatoses, allergic reactions, hand-foot syndrome, nail changes, or inflammatory dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple manifestations: dryness/itchiness, rashes/redness, hand-foot syndrome, hyperpigmentation, and allergic reactions (\u22653)."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that skin changes could also be due to other conditions, such as infection, other medications, or unrelated skin disorders.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States changes can arise from 'treatment itself or other factors' and specifically mentions infection and allergic reactions as alternative causes."
      },
      {
        "criterion_number": 12,
        "description": "The response states the importance of correctly identifying skin changes to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Emphasizes identification and management by the oncologist but does not explicitly state avoiding unnecessary discontinuation of effective therapy."
      }
    ],
    "question_number": 70,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:01:09.727186",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response suggests asking about the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: \u201cStaging: What stage is the cancer, and how was this determined?\u201d and resectability status."
      },
      {
        "criterion_number": 2,
        "description": "The response suggests asking about available treatment options.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists surgery, chemotherapy, radiation, targeted therapy, immunotherapy and asks, \u201cWhat are the recommended treatments?\u201d"
      },
      {
        "criterion_number": 3,
        "description": "The response suggests asking about prognosis if the patient wants to know this information.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit suggestion to ask about prognosis or expected outcomes/survival; focuses on goals and effectiveness but not prognosis."
      },
      {
        "criterion_number": 4,
        "description": "The response suggests asking about potential side effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes short-term and long-term side effects and management strategies under \u201cSide Effects & Management.\u201d"
      },
      {
        "criterion_number": 5,
        "description": "The response suggests asking about when the patient should follow up next.",
        "score_given": 5,
        "max_points": 5,
        "justification": "\u201cFollow-up Schedule: How often will we need scans or check-ups?\u201d and \u201cFollow Up: Schedule a follow-up call or meeting\u2026\u201d"
      },
      {
        "criterion_number": 6,
        "description": "The response recommends writing down questions ahead of time and bringing them to the appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "\u201cPrepare: Write down questions and bring medical records\u2026\u201d Clearly advises writing questions in advance in the appointment prep context."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests asking about symptoms affecting the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses pain management, digestive issues, weight loss, and emotional distress under side effects and palliative/supportive care."
      },
      {
        "criterion_number": 8,
        "description": "The response suggests asking about clinical trial availability.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicit \u201cClinical Trials: Are there any promising clinical trials she might qualify for?\u201d plus eligibility/process."
      },
      {
        "criterion_number": 9,
        "description": "The response suggests asking about how palliative care can help with the patient\u2019s care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "\u201cWhen should palliative care be involved? How can it help with symptoms like pain or fatigue?\u201d"
      },
      {
        "criterion_number": 10,
        "description": "The response suggests asking if genetic testing is available for germline inheritable cancer predisposition syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "\u201cGenetic Testing: Should we test for hereditary cancer syndromes (e.g., BRCA, Lynch)?\u201d"
      },
      {
        "criterion_number": 11,
        "description": "The response suggests asking about nutrition and if a nutritionist is available to help with dietary recommendations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions enzyme supplements and dietary changes but does not explicitly suggest asking for a nutritionist/dietitian."
      },
      {
        "criterion_number": 12,
        "description": "The response suggests asking about support groups for patients with pancreatic cancer and their families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "\u201cAre there therapists or support groups for patients and families?\u201d"
      },
      {
        "criterion_number": 13,
        "description": "The response suggests asking about how to contact the oncology team in case of questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "\u201cCare Team\u2026 How do we contact them in emergencies?\u201d and an emergency plan."
      },
      {
        "criterion_number": 14,
        "description": "The response suggests asking if lifestyle changes need to be made.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests asking about \u201cdietary changes,\u201d which are lifestyle modifications affecting day-to-day living."
      },
      {
        "criterion_number": 15,
        "description": "The response suggests asking about mental health and resources for mental health support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions therapists, coping strategies, and resources for emotional support."
      },
      {
        "criterion_number": 16,
        "description": "The response recommends writing down important information during the appointment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises taking detailed notes or audio recording; also suggests a companion to help take notes."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention to ask questions related to goals of treatment (palliative, curative, etc).",
        "score_given": 5,
        "max_points": 5,
        "justification": "\u201cGoals: Is the goal to cure, control symptoms, or improve quality of life? Are there curative options?\u201d"
      },
      {
        "criterion_number": 18,
        "description": "The response should mention bringing a family member or a friend to help listen and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States: \u201cconsider bringing a family member or friend to help take notes or ask additional questions.\u201d"
      }
    ],
    "question_number": 71,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:02:15.302171",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with 'Consult the Medical Team' and explicitly says 'Ask the oncologist...' about prognosis, goals, and impacts of stopping treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response states quality of life is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a section 'Quality of Life vs. Quantity of Life' emphasizing priorities and improving comfort."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends considering the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing treatment goals with the oncologist and aligning care with patient priorities, noting palliative care specialists can help align goals."
      },
      {
        "criterion_number": 4,
        "description": "The response states pancreatic cancer is an aggressive cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses advanced/metastatic disease, it does not explicitly state that pancreatic cancer is an aggressive cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response states stopping treatment without consulting the treating oncologist is dangerous.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It strongly recommends consulting the medical team but does not explicitly state that stopping treatment without consulting the oncologist is dangerous."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering access to emergency care at the travel destination.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says to ensure there are hospitals or clinics nearby in case of emergencies."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends refilling all prescription medications prior to travel.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions managing medications and feasibility of oral medications on the go but does not specifically recommend refilling all prescriptions prior to travel."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends considering if travel is safe.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It advises assessing health considerations and notes that shorter, low-stress trips may be more manageable, and to consider modified plans if travel is risky."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends considering if the patient is strong enough to travel.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly recommends assessing physical stamina and ability to travel."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly clarify what \u201cstopping treatment\u201d means, such as stopping all therapies, only chemotherapy, or supportive care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clarifies that some treatments may be paused rather than discontinued, discusses switching to less intensive therapies, and continuing palliative/supportive care while stopping more aggressive therapy."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly discuss the effects of a (temporary) treatment break on the prognosis of the cancer, symptoms, and other risks involved.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists risks of stopping including disease progression, symptom worsening, and reduced future treatment options, and notes stopping could reduce survival chances, implying impact on prognosis."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that stopping treatment may affect the patient\u2019s medical stability, ability to travel safely, and access to care and support while away.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it addresses risks (progression, symptom worsening) and advises ensuring access to care while traveling, it does not explicitly link stopping treatment to effects on medical stability, travel safety, and access to care/support while away in a single explicit statement."
      }
    ],
    "question_number": 72,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:03:10.923430",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises consulting the oncology team/oncologist and a vascular access specialist."
      },
      {
        "criterion_number": 2,
        "description": "The response states that if there are signs or symptoms of infection at the port site, to seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While infection is mentioned, there is no explicit instruction to seek immediate evaluation if infection signs occur."
      },
      {
        "criterion_number": 3,
        "description": "The response offers examples of signs or symptoms of infection, including fever, chills, redness or pain at the port site, and pus coming from the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific signs or symptoms of infection are listed."
      },
      {
        "criterion_number": 4,
        "description": "The response states many chemotherapy drugs must be given through central venous catheters.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that many chemotherapies require central venous access."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of central venous catheters.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Examples provided include PICC lines and tunneled catheters (Hickman, Broviac)."
      },
      {
        "criterion_number": 6,
        "description": "The response states different central venous catheters have pros and cons.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Pros and cons are listed for PICC lines, tunneled catheters, and ports."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends asking the patient\u2019s oncologist about alternative treatment regimens that may not require administration through a central venous catheter.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests oral options to avoid IV access and advises consulting the oncology team regarding suitability."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends avoiding touching, rubbing, and bumping the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No such precautionary advice is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include peripherally inserted central catheters (PICC lines).",
        "score_given": 5,
        "max_points": 5,
        "justification": "PICC lines are explicitly presented as an alternative."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a tunneled central venous catheter (Hickman, Broviac, Groshong).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Tunneled catheters are included with examples (Hickman, Broviac)."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a non-tunneled central venous catheter (jugular or subclavian line).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Non-tunneled central venous catheters (e.g., jugular or subclavian lines) are not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include oral chemotherapy such as capecitabine.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Oral options are mentioned, but capecitabine is not specified."
      },
      {
        "criterion_number": 14,
        "description": "The response should not mention that chemotherapy for pancreatic cancer can be given via subcutaneous injection.",
        "score_given": -10,
        "max_points": 0,
        "justification": "The response explicitly mentions subcutaneous injection as an alternative route for chemotherapy in this context."
      }
    ],
    "question_number": 73,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:04:08.323200",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises to 'Consult the Medical Team' and to 'Discuss with the oncologist' about vaccinations and tailoring steps to treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends avoiding people who have signs or symptoms of an infectious illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Avoid Crowds and Sick Contacts' and 'Visitors with symptoms (fever, cough) should avoid close contact,' which clearly advises avoiding symptomatic individuals."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends frequent hand washing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically instructs to 'Wash hands thoroughly with soap and water frequently' and requires visitor hand hygiene."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends wearing a face mask while in crowds.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions visitors with respiratory symptoms should wear masks but does not advise the patient to wear a mask while in crowds."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing asking the patient\u2019s healthcare team about which vaccinations are recommended.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises 'Discuss with the oncologist whether vaccines (e.g., flu, pneumonia, COVID-19) are safe.'"
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reporting signs and symptoms of infection to the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Instructs to monitor for signs of infection and 'Report these immediately' to the healthcare team."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of signs and symptoms of infection, including fever, chills, cough, runny nose, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides fever, chills, cough, sore throat, urinary symptoms, and wound redness, but does not include runny nose, nausea, or vomiting as examples."
      },
      {
        "criterion_number": 8,
        "description": "The response states the patient\u2019s oncologist may prescribe antibiotics, antivirals, and antifungals to prevent infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions prophylactic antibiotics 'if recommended' but does not state that oncologists may prescribe antivirals and antifungals."
      },
      {
        "criterion_number": 9,
        "description": "The response instructs the patient to take all medications as prescribed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states 'Take prescribed medications ... as directed.'"
      },
      {
        "criterion_number": 10,
        "description": "The response states some treatments for pancreatic cancer can lower white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References neutropenia and variable risk periods with chemotherapy but does not explicitly state that treatments can lower white blood cell counts."
      },
      {
        "criterion_number": 11,
        "description": "The response states white blood cells fight off infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not explain the function of white blood cells in fighting infection."
      },
      {
        "criterion_number": 12,
        "description": "The response states a low white blood cell count can increase the risk of infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that low white blood cell count increases infection risk, only mentions neutropenia-specific precautions."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that prevention includes vaccination for COVID-19 and flu for the patient and household members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions discussing flu and COVID-19 vaccination for the patient but does not address vaccination of household members."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention includes avoiding exposure to fungal spores. Patients with neutropenia should avoid prolonged contact with environments that have high concentrations of airborne fungal spores, such as construction and demolition sites, intensive exposure to soil through gardening or digging, and household renovation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises avoiding gardening/soil and mold growth but does not mention fungal spores, neutropenia-specific risk, or environments like construction/demolition or renovations."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state the lack of need for antimicrobial prophylaxis in most solid tumors with short-duration neutropenia; instead references antibiotics for prophylaxis if recommended."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state these interventions lack evidence; suggests safe food handling and does not address footwear exchange, protected environments, or the evidence regarding neutropenic diets."
      }
    ],
    "question_number": 74,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:05:08.925937",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines precision medicine as tailoring cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes precision medicine as tailoring treatment using genetic/molecular features of the tumor to choose more effective therapies and avoid a one-size-fits-all approach."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises asking his doctors specific questions about testing, biomarkers, and clinical trials."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions testing the patient\u2019s tumor for genetic mutations which can be targeted with certain therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes tumor genetic testing/NGS to find mutations (e.g., BRCA1/2, NTRK, KRAS) that can inform targeted therapies."
      },
      {
        "criterion_number": 4,
        "description": "The response states PARP inhibitors may be used in patients with mutations in the BRCA gene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes that BRCA1/2 mutations may confer sensitivity to PARP inhibitors such as olaparib."
      },
      {
        "criterion_number": 5,
        "description": "The response states immunotherapy may be used in patients if their tumors have high microsatellite instability (MSI-high).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions PD-L1 and TMB for immunotherapy selection but does not mention MSI-high/dMMR as an indication."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions testing the patient\u2019s tumor for expression of certain proteins which can be targeted with certain therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes testing for PD-L1 expression to help determine suitability for checkpoint inhibitors."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples such as PARP inhibitors (olaparib), TRK inhibitors (entrectinib), RET inhibitors (selpercatinib), and BRAF-targeted therapy (dabrafenib). Note: includes an inaccuracy stating sotorasib for KRAS G12D (sotorasib targets KRAS G12C), but still provides multiple correct examples."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of therapies targeting protein expression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not give explicit examples like HER2-directed therapy; while PD-L1 testing is mentioned, it does not provide concrete protein expression\u2013targeted therapy examples beyond immunotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions that not every patient will have genetic mutations or protein expression which can be targeted with precision medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that not all tumors have identifiable targets and that targeted treatments may not always work."
      },
      {
        "criterion_number": 10,
        "description": "The response states precision medicine helps the patient\u2019s oncologist identify treatments which will not be helpful.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses selecting effective options but does not explicitly state that it helps identify ineffective treatments to avoid."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that comprehensive genomic profiling using next-generation sequencing (NGS) is now standard for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions NGS but does not state that comprehensive genomic profiling is standard for pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that both germline and somatic testing are recommended for all patients regardless of family history; only suggests genetic counseling if hereditary mutations are suspected."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions NTRK fusions and TRK inhibitors but does not state the histology-agnostic (regardless of tumor type) indication."
      }
    ],
    "question_number": 75,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:06:08.291297",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises informing the oncologist and care team and consulting dentist/oral specialist."
      },
      {
        "criterion_number": 2,
        "description": "The response states mouth sores are a common side effect of some chemotherapy drugs.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes mucositis is caused by chemotherapy but does not state it is a common side effect."
      },
      {
        "criterion_number": 3,
        "description": "The response states drugs like 5-FU and capecitabine can cause mouth sores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No chemotherapy agents are named; 5-FU or capecitabine are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response states these are sometimes related to having low white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neutropenia or low white blood cell counts."
      },
      {
        "criterion_number": 5,
        "description": "The response states that having low white blood cell counts can increase the likelihood of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not link low white blood cell counts to higher infection risk."
      },
      {
        "criterion_number": 6,
        "description": "The response states mouth sores in patients on chemotherapy can also be related to infections from viruses or bacteria.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses signs of infection but does not state that mouth sores may be caused by viral or bacterial infections."
      },
      {
        "criterion_number": 7,
        "description": "The response states the patient\u2019s healthcare team may swab the mouth sores to test them for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of swabbing or testing the sores for infection."
      },
      {
        "criterion_number": 8,
        "description": "The response states there are medications which can help prevent and improve mouth sores in the form of both topical drugs and specialized mouthwashes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions topical anesthetics and 'magic mouthwash' for symptom control but does not state that medications can prevent mucositis."
      },
      {
        "criterion_number": 9,
        "description": "The response states there are medications which can improve symptoms related to mouth sores, like pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends topical anesthetics (e.g., benzocaine/Orajel) and other analgesic approaches for pain relief."
      },
      {
        "criterion_number": 10,
        "description": "The response instructs the patient to immediately seek evaluation by a healthcare provider if they are experiencing a fever or other signs or symptoms of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises urgent contact for fever, pus, worsening redness, difficulty breathing/swallowing, or uncontrolled bleeding."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends gentle oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides detailed guidance on soft toothbrush, gentle technique, and gentle rinses."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations due to lack of efficacy and potential for adverse effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests chlorhexidine as an option if prescribed and does not state it is generally not recommended for prevention."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical anesthetics (lidocaine viscous, 2% solution) and mixed medication mouthwashes (\u201cmagic mouthwash\u201d) may be used for pain control, though evidence for specific formulations is variable.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'magic mouthwash' and topical anesthetics but not lidocaine viscous 2% specifically or the variability of evidence for formulations."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Gabapentin may be considered for mucositis-related pain, often in combination with other analgesics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of gabapentin."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that topical and systemic antifungals (e.g., clotrimazole troches, systemic fluconazole) are indicated for secondary candidiasis, which is common in the setting of mucositis and xerostomia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Antifungals for secondary candidiasis are not discussed."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States that signs of infection may require antibiotics but does not specify they are reserved for documented bacterial infections."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen, but that stronger prescription medicines may be indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends acetaminophen and notes that the doctor may recommend additional analgesics, meeting both OTC and prescription aspects."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages coordination with oncologist, dentist/oral specialist, dietitian, and emphasizes supportive/emotional care."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, nutritional support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides specific dietary guidance (soft/cool foods, avoid irritants, small frequent meals, hydration) and suggests dietitian referral."
      }
    ],
    "question_number": 76,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:07:01.745068",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises: 'Discuss with the Oncologist: Your loved one\u2019s doctor can explain the specific trial\u2019s design and help weigh the pros and cons.'"
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the design of clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains randomization, double-blind design, control groups, crossover, and ethical safeguards; describes comparison to standard therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the four phases of clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly outlines Phases 1\u20134, including purpose and typical placebo use in each phase."
      },
      {
        "criterion_number": 4,
        "description": "The response defines placebo.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines placebo as an 'inactive substance' and clarifies its use in trial contexts."
      },
      {
        "criterion_number": 5,
        "description": "The response states that patients in clinical trials for cancer are seldom given a placebo, as this may cause harm.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States placebos are uncommon when effective treatments exist and that withholding treatment in serious illnesses like pancreatic cancer is ethically challenging, implying potential harm."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews informed consent.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to 'Review the Informed Consent' and understand goals, risks, and alternatives, which constitutes a review of the informed consent process."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the placebo effect.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not define or describe the placebo effect (psychological/physiological response due to expectation)."
      },
      {
        "criterion_number": 8,
        "description": "The response states that patients in the control arm of clinical trials often receive the standard of care treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes the control group typically receives standard treatment and that in pancreatic cancer the control arm is almost always standard of care."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to discover new, effective treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains trials assess effectiveness and compare to standard therapy; mentions access to cutting-edge treatments and advancing science."
      },
      {
        "criterion_number": 10,
        "description": "The response states clinical trials are designed to minimize patient harm.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States trials follow strict ethical guidelines, balance benefits and risks, and include ethical safeguards discouraging harmful placebo use."
      },
      {
        "criterion_number": 11,
        "description": "The response states that patients participating in clinical trials are monitored closely for side effects from the disease and the treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes 'Close monitoring by a research team, including frequent scans and check-ins,' indicating close surveillance for effects."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends researching clinical trials before participating.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages discussing with the oncologist, reviewing informed consent, and asking for clarity\u2014all recommendations to research/understand a trial beforehand."
      },
      {
        "criterion_number": 13,
        "description": "The response offers resources for researching clinical trials, including ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No external resources are provided; ClinicalTrials.gov is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response states clinical trials are designed to be ethical and are monitored closely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States trials follow strict ethical guidelines and mentions close monitoring (by the research team), also references FDA and ethics boards."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights that trials compare new treatments to standard care, assess effectiveness, and contribute to advancing science for future patients, implying their essential role in improving current and future therapies."
      }
    ],
    "question_number": 77,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:07:45.675431",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under 'Next Steps' it explicitly says 'Discuss with the Oncologist: Ask for details about the proposed combination, its goals, potential side effects, and alternatives.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states there are many different types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes multiple modalities and combinations (chemotherapy combinations, chemotherapy + targeted therapy, chemoradiation, chemotherapy + immunotherapy, and mentions surgery in early-stage settings), indicating many different types."
      },
      {
        "criterion_number": 3,
        "description": "The response includes surgery, chemotherapy, immunotherapy, targeted therapy, and radiation therapy as types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Chemotherapy is discussed extensively; immunotherapy is mentioned (e.g., pembrolizumab); targeted therapy is discussed (PARP, BRAF/MEK, HER2 agents); radiation is included via 'Chemotherapy + Radiation (Chemoradiation)'; surgery is referenced for early-stage tumors using 'surgery plus chemo/radiation.'"
      },
      {
        "criterion_number": 4,
        "description": "The response states combination therapy may mean two or more different types of treatment or two or more chemotherapy medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines combination therapy as using 'two or more treatments simultaneously or sequentially' and provides 'Chemotherapy Combinations' such as FOLFIRINOX, satisfying both aspects."
      },
      {
        "criterion_number": 5,
        "description": "The response gives the example of FOLFIRINOX.",
        "score_given": 5,
        "max_points": 5,
        "justification": "FOLFIRINOX is explicitly named and described as a widely used regimen."
      },
      {
        "criterion_number": 6,
        "description": "The response states that FOLFIRINOX is a combination chemotherapy regimen which contains 5-FU, leucovorin, irinotecan, and oxaliplatin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists the components 'leucovorin, fluorouracil, irinotecan, and oxaliplatin,' which corresponds to 5-FU, leucovorin, irinotecan, and oxaliplatin, and identifies it as a regimen."
      },
      {
        "criterion_number": 7,
        "description": "The response states the treatment plan for patients with pancreatic cancer is individualized to their overall health and the cancer\u2019s type, stage, and genetic signature.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states the approach is tailored to the cancer\u2019s characteristics and stage and the patient\u2019s overall health, and explicitly mentions tumor genetics/molecular profiling guiding targeted therapies."
      },
      {
        "criterion_number": 8,
        "description": "The response states the decision to use any cancer treatment weighs the likelihood of benefit with the risk of side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that side effects are more likely with combinations and that the oncologist will 'balance effectiveness with tolerability,' reflecting the benefit-risk assessment."
      },
      {
        "criterion_number": 9,
        "description": "The response states the goal of combination therapy is to achieve the best anti-cancer effect.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states combination therapy aims to 'enhance effectiveness,' 'overcome resistance,' and 'improve survival,' which conveys achieving the best anti-cancer effect."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that examples of combination therapy include chemoradiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists 'Chemotherapy + Radiation (Chemoradiation)' as an example."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that examples of combination therapy include chemotherapy and surgery, with neoadjuvant chemotherapy given before surgery and adjuvant chemotherapy given after surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While surgery is mentioned and neoadjuvant chemoradiation is referenced, the response does not explicitly state chemotherapy + surgery as an example nor specify neoadjuvant chemotherapy before surgery and adjuvant chemotherapy after surgery."
      }
    ],
    "question_number": 78,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:08:31.482792",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple sections advise involving the healthcare team: contacting the provider, working with the medical team on letters of medical necessity, involving the provider in appeals, and discussing treatment timing with the medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response states oncology practices often have team members who help patients with insurance issues.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests asking the medical team to assist, it does not explicitly state that oncology practices often have dedicated staff (e.g., financial counselors, navigators) for insurance issues."
      },
      {
        "criterion_number": 3,
        "description": "The response states pre-authorization issues are not uncommon in oncology care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It acknowledges the process is overwhelming but does not state that pre-authorization issues are common/not uncommon in oncology."
      },
      {
        "criterion_number": 4,
        "description": "The response states that denials should be appealed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly advises submitting an appeal within deadlines and pursuing external review if needed."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends contacting the insurance company.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly instructs to contact the insurer, confirm receipt, ask about timelines, and request a written denial."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends understanding the patient\u2019s insurance plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises understanding the insurer\u2019s requirements, ensuring in-network use to avoid unexpected costs, and notes consulting professionals to review the policy\u2014collectively encouraging understanding of the plan."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends understanding the insurance company\u2019s denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends requesting a written denial and using it for appeals, which implies understanding the denial rationale."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends contacting patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends connecting with patient advocacy groups and assistance programs for guidance and support."
      },
      {
        "criterion_number": 9,
        "description": "The response offers examples of patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides specific examples: PanCAN, CancerCare, Patient Advocate Foundation, American Cancer Society, and the Cancer Financial Assistance Coalition."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends clearly documenting all communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly instructs to document all calls, emails, and mailed documents and to keep copies."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends obtaining written documentation for all approved pre-authorizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises requesting written denials and keeping copies of submissions but does not instruct obtaining written approval documentation for approved pre-authorizations."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that prior authorization is a process in which payers require clinicians to obtain approval before a medication is covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit definition of prior authorization or mention of payer-required approval before medication coverage is provided."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that the appeal process involves submitting a formal appeal with supporting evidence, such as clinical guidelines, published trial data, and, for targeted or off-label therapies, molecular profiling results.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions including additional evidence like second opinions or updated data, it does not reference clinical guidelines, published trial data, or molecular profiling."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention that if appeals are unsuccessful or delays persist, alternative access strategies should be pursued, including patient assistance programs, manufacturer co-pay cards, and foundation grants, which require application and documentation of financial need.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions assistance programs and copay assistance but does not specifically mention manufacturer co-pay cards or the need for applications with documentation of financial need."
      },
      {
        "criterion_number": 15,
        "description": "The response must specifically mention patient advocacy organizations such as PanCAN and CancerCare as resources.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Both PanCAN and CancerCare are explicitly listed as resources."
      }
    ],
    "question_number": 79,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:09:15.525882",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to share the changes with his oncologist and medical team and seek prompt evaluation."
      },
      {
        "criterion_number": 2,
        "description": "The response states that infections can cause cognitive changes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States that infections (e.g., UTIs, pneumonia) can affect cognition."
      },
      {
        "criterion_number": 3,
        "description": "The response states that cancer and its treatments may cause symptoms that can mimic cognitive changes, including fatigue, pain, poor sleep, dehydration, and depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions fatigue, pain-related poor sleep, and dehydration/electrolyte imbalance, but does not mention depression."
      },
      {
        "criterion_number": 4,
        "description": "The response states sudden changes in cognition may be a medical emergency and to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends prompt evaluation generally but does not specify that sudden cognitive changes constitute a medical emergency."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate medical evaluation if the patient has stroke symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of stroke symptoms or the need for urgent evaluation if they occur."
      },
      {
        "criterion_number": 6,
        "description": "The response states if the patient has a fever or other signs or symptoms of infection, to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While infections are mentioned as a cause, there is no instruction to seek immediate evaluation for fever or infection signs."
      },
      {
        "criterion_number": 7,
        "description": "The response states patients commonly experience mental fogginess, or \u201cchemo brain.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions chemotherapy-related cognitive issues and uses the term \u201cchemo brain.\u201d"
      },
      {
        "criterion_number": 8,
        "description": "The response states that cognitive changes from cancer treatment may improve if the treatment is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that effects can be temporary but does not state that stopping treatment may lead to improvement."
      },
      {
        "criterion_number": 9,
        "description": "The response states that if treatment side effects are severe enough, the patient\u2019s oncologist may choose to decrease the dose of the treatment so it is better tolerated or switch to a different therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions adjusting the treatment plan generally but does not specify dose reduction or switching therapies."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends tracking the cognitive changes and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises tracking onset, severity, and patterns and sharing with the care team."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that cancer treatment (including radiation, chemotherapy, and pain medications such as opioids) can affect a person\u2019s cognitive functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically cites chemotherapy, radiation, and opioids (and steroids) as potential contributors to cognitive changes."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that other factors unrelated to treatment could also cause cognitive changes, such as cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes tumor progression (including possible brain metastasis) and infections/complications as non-treatment causes."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that stress/anxiety can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies anxiety as a factor contributing to poor sleep and impaired cognition, indicating stress/anxiety can affect cognition."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pre-existing conditions can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address pre-existing conditions (e.g., dementia, prior stroke, thyroid disease) as potential causes."
      }
    ],
    "question_number": 80,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:09:59.795184",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises discussion with the healthcare team and explicitly includes oncologists: 'consulting your mother\u2019s healthcare team' and 'Involve oncologists, gastroenterologists, dietitians, and palliative care specialists.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states feeding tubes can help patients get the nutrition and hydration they need when they are unable to eat or drink on their own.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions inadequate oral intake and nutrition support, it does not explicitly state that feeding tubes provide hydration; it focuses on calories/nutrients without mentioning fluids."
      },
      {
        "criterion_number": 3,
        "description": "The response states the most common types of feeding tubes are placed through the skin of the abdomen and into the stomach or small bowel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It describes NG (through the nose) and PEG (through the abdominal wall into the stomach) but does not state that the most common types are placed through the skin into the stomach or small bowel, nor does it mention small-bowel tubes (e.g., jejunostomy/PEG-J)."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the patient is not eating or drinking enough because they do not want to, this may be the body\u2019s way of signaling that the patient is nearing the end of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses end-of-life considerations and potential lack of survival benefit but does not state that decreased desire to eat/drink may be a natural end-of-life signal."
      },
      {
        "criterion_number": 6,
        "description": "The response states studies have shown that in the absence of a bowel obstruction, feeding tubes do not typically increase survival in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes feeding tubes may not improve survival near end of life but does not reference evidence or specify the 'absence of bowel obstruction' context."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends considering hospice care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Palliative care is mentioned, but hospice is not explicitly recommended."
      },
      {
        "criterion_number": 8,
        "description": "The response states that malnutrition is common in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Malnutrition is discussed generally, but it does not state that malnutrition is common specifically in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of feeding tubes, including discomfort and infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Risks listed include 'Infection' and 'Diarrhea or abdominal discomfort' plus aspiration and psychological impact."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends discussing the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a dedicated section on 'Prognosis and Goals of Care' and advises to 'Inquire about goals of care (curative vs. palliative)'."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked bile duct.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of bile duct obstruction or related symptoms (e.g., jaundice)."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked stomach.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly notes obstruction 'blocking the stomach outlet or intestines.'"
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to low levels of digestive enzymes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of pancreatic exocrine insufficiency or low digestive enzymes."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to loss of appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Loss of appetite/anorexia is not discussed."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to cancer-related pain.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Cancer-related pain as a contributor to poor intake or digestive issues is not mentioned."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that nutritional counseling is recommended for patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises involving dietitians and discusses dietary modifications and oral supplements, effectively recommending nutritional counseling in this pancreatic cancer context."
      }
    ],
    "question_number": 81,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:10:41.122084",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not advise consulting the patient\u2019s oncologist for guidance on these conversations."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends involving a professional who can help with these challenging conversations, like a social worker or spiritual counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends seeking family counseling and support groups, which involves professional support appropriate for these conversations."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends online resources for patients with cancer, including cancer.org.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists American Cancer Society (cancer.org), CancerCare, and PanCAN as resources."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends clear and honest language.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes being honest but reassuring and avoiding euphemisms, providing examples of clear, direct wording."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tailoring the conversation to the children\u2019s ages.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides detailed guidance for under 7, 7\u201312, and teens, explicitly tailoring content to developmental stages."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention to avoid overwhelming the child with too much information at once; provide information in small doses, stopping frequently to check for comprehension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes not to overload school-age children and to encourage questions, it does not explicitly advise giving information in small pieces or stopping to check for understanding."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention to arrange for an appropriate location for the conversation and ensure there is enough time to give the information and answer questions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses creating a safe emotional space but does not address choosing a suitable physical location or ensuring adequate time for the conversation."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention to provide information that is relevant to what the child wants to know.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages children to ask questions and invites answering what they want to know, implying tailoring information to their interests and needs."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to respond empathically to the child\u2019s emotions and acknowledge their feelings throughout the conversation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises normalizing feelings, validating grief, creating a safe space, and using empathic statements."
      }
    ],
    "question_number": 82,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:11:03.582598",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that sleep patterns can be disturbed by cancer and its treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that cancer and its treatments can affect sleep (\u201chow cancer and its treatments might affect sleep\u201d) and lists related factors."
      },
      {
        "criterion_number": 2,
        "description": "The response states that sleep patterns can be disturbed by symptoms like fatigue, pain, and nausea.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly mentions pain, fatigue, and nausea (under Pain or Discomfort; Fatigue; and Gastrointestinal Issues) as contributors to sleep disruption."
      },
      {
        "criterion_number": 3,
        "description": "The response states that sleep patterns can be a symptom of anxiety and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes \u201cAnxiety or Depression\u2026 that disrupt sleep,\u201d linking mental health conditions to sleep disturbances."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises consultation with the oncologist/medical team about sleep issues."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tracking the sleep disturbances and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a sleep diary and encourages discussing symptoms with the healthcare team, implying sharing tracked information."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends sleep hygiene techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides specific sleep hygiene tips such as consistent schedule, screen avoidance, and optimizing the sleep environment."
      },
      {
        "criterion_number": 7,
        "description": "The response states other options for treatment may include supplements like melatonin, cognitive behavioral therapy, or prescribed medications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention melatonin, cognitive behavioral therapy for insomnia, or prescribed sleep medications as potential options."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends seeking immediate medical evaluation if the changes in sleep patterns are sudden or severe.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit recommendation to seek urgent or immediate evaluation for sudden or severe sleep changes."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that non-pharmacological interventions like relaxation techniques, cognitive behavioral therapy for insomnia, and mindfulness can be beneficial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention relaxation techniques, mindfulness, or CBT-I; only general sleep hygiene and emotional support are discussed."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that addressing underlying causes of sleep disruption, such as pain management or treatment of anxiety/depression, is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages evaluation of underlying causes (e.g., unmanaged pain, medication adjustments) and suggests emotional support/therapy, indicating the importance of addressing root causes."
      }
    ],
    "question_number": 83,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:11:24.151396",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing complementary therapies with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to 'Always inform your loved one\u2019s oncologist' before starting acupuncture and includes a 'Talk to the Oncologist' step."
      },
      {
        "criterion_number": 2,
        "description": "The response states complementary therapies like acupuncture may improve symptoms related to cancer and its treatments and may improve cancer patients\u2019 quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes acupuncture can help with nausea/vomiting, pain, fatigue, stress, and may improve quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response states complementary therapies are not a safe alternative to standard cancer treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states acupuncture should complement, not replace, evidence-based treatments."
      },
      {
        "criterion_number": 4,
        "description": "The response states complementary therapies are not as effective as standard of care cancer treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly compare effectiveness to standard of care treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response defines complementary therapies and provides examples, including acupuncture.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Refers to 'complementary' as adjunctive but does not explicitly define the term nor provide multiple examples beyond acupuncture."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends informing the patient\u2019s oncologist of any supplements the patient starts taking.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Supplements are not addressed; only acupuncture is discussed."
      },
      {
        "criterion_number": 7,
        "description": "The response states supplements are not regulated by the FDA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of supplement regulation."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with certain treatments for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss supplement-drug interactions."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of acupuncture, including bleeding and infection, which may be increased in patients receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses increased bleeding with low platelets/blood thinners and infection risk with chemo-related immunosuppression; emphasizes sterile, single-use needles."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends utilizing a practitioner licensed in acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a licensed acupuncturist and references credentialing bodies (NCCAOM)."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that acupuncture is generally safe for cancer patients, with no increased risk of serious adverse events compared to sham or standard care, though mild side effects such as bruising, soreness, or transient discomfort may occur.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States acupuncture is generally safe with minor bruising/soreness, but does not specify 'no increased risk of serious adverse events compared to sham or standard care.'"
      }
    ],
    "question_number": 84,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:11:57.201509",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing balance problems with the patient\u2019s oncologist or healthcare team immediately.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises consulting the medical team and emphasizes early assessment but does not explicitly recommend contacting the oncologist or healthcare team immediately."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that symptoms from pancreatic cancer and its treatment, such as fatigue, headache, muscle weakness, and peripheral neuropathy, may contribute to sensations of imbalance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response links peripheral neuropathy to loss of balance and notes fatigue and muscle weakness affecting stability; it also mentions headache as a red flag. This adequately conveys that such symptoms can contribute to imbalance."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that chemotherapy can cause peripheral neuropathy, fatigue, anemia, and generalized weakness, which can all cause instability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes chemotherapy can cause peripheral neuropathy and fatigue, it does not mention anemia and does not clearly attribute generalized weakness specifically to chemotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that pancreatic cancer itself increases the risk of thromboembolic events, including cerebral ischemic strokes, which may present with acute balance disturbances or ataxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of thromboembolic events or ischemic strokes as a cause of acute balance disturbance."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly instructs seeking immediate medical evaluation if symptoms are abrupt, severe, or accompanied by other neurologic deficits.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although red flags (headache, seizures, mental status changes) are listed, the response does not explicitly instruct seeking immediate medical evaluation for abrupt or severe symptoms or additional neurologic deficits."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that balance problems can lead to falls.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions ensuring safety but does not explicitly state that balance problems can lead to falls."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends ensuring the patient drinks plenty of fluids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hydration is mentioned broadly, but there is no explicit recommendation to ensure the patient drinks plenty of fluids."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends the patient stand and walk with assistance until they can be evaluated by their healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation is made to use assistance when standing or walking prior to evaluation."
      }
    ],
    "question_number": 85,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:12:38.972098",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends reviewing the pathology report with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing findings with the oncology team multiple times, including a 'Next Steps' section focused on talking with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pathology reports are written by doctors called pathologists who view tissue under the microscope to diagnose diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'Comments from the Pathologist' but does not explain that pathologists write the report or that they diagnose by examining tissue under the microscope."
      },
      {
        "criterion_number": 3,
        "description": "The response states the pathology report will contain a tumor type.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly includes 'Tumor Type and Histology' with examples such as pancreatic adenocarcinoma and other subtypes."
      },
      {
        "criterion_number": 4,
        "description": "The response states the pathology report may contain a stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes TNM staging and overall stage (I\u2013IV), implying this information is part of the report."
      },
      {
        "criterion_number": 5,
        "description": "The response states the pathology report may contain a tumor size.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'Size' measured in centimeters as a key element of the report."
      },
      {
        "criterion_number": 6,
        "description": "The response states the pathology report may contain a tumor grade.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section on 'Grade (Differentiation)' with well/moderately/poorly differentiated examples."
      },
      {
        "criterion_number": 7,
        "description": "The response states the pathology report may mention vascular invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions 'Lymphovascular invasion' and its implications."
      },
      {
        "criterion_number": 8,
        "description": "The response states the pathology report may mention perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly cites 'Perineural invasion' and notes its association with aggressiveness."
      },
      {
        "criterion_number": 9,
        "description": "The response states the pathology report may contain special stains which can sometimes be used to determine additional treatment options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention special stains or immunohistochemistry; focuses on molecular/genetic testing and tumor markers instead."
      },
      {
        "criterion_number": 10,
        "description": "The response states the final stage ranges from I to IV and is a sum of a tumor (T) score, a node (N) score, and a metastasis (M) score.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that overall stage combines T, N, and M and gives the I\u2013IV range."
      },
      {
        "criterion_number": 11,
        "description": "The response states the pathology report helps the oncologist determine which treatment may be the most effective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Indicates that findings impact treatment options and encourages discussion with the oncologist about therapy choices."
      },
      {
        "criterion_number": 12,
        "description": "The response states the pathology report may include results from genetic testing of the tumor which may help in identifying targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a 'Molecular and Genetic Testing' section with BRCA1/2, MSI/MMR, KRAS, and notes targeted therapy and immunotherapy implications."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention margin status, including the presence of the tumor at or within 1 mm of any resection margin (R1), and its impact on prognosis and adjuvant therapy decisions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions negative vs positive margins and possible need for additional treatment but does not specify the within 1 mm (R1) definition or explicitly discuss prognosis/adjuvant therapy decisions using that terminology."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the importance of the number of lymph nodes examined and number positive, and explicitly link perineural and vascular invasion to higher recurrence risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes numbers of nodes examined and positive, and that PNI/LVI indicate aggressiveness or spread, but does not explicitly link PNI/LVI to higher recurrence risk."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention tumor location (head, body, tail) as required for accurate pathologic staging (pT), and reference the AJCC staging system using pT, pN, pM nomenclature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions tumor location (head/body/tail) and TNM but does not state that location is required for accurate pT staging or reference AJCC with pT/pN/pM nomenclature."
      }
    ],
    "question_number": 86,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:13:25.017739",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the case with an oncologist to review the trial details and discuss the pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises maintaining open dialogue with the oncologist, seeking their opinion on suitability, and obtaining a second opinion."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that there are no FDA-approved cancer vaccines for pancreatic cancer and that all vaccines for pancreatic cancer are experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that no pancreatic cancer vaccines are FDA-approved or that all pancreatic cancer vaccines are experimental."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how a cancer vaccine works.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes therapeutic vaccines as aiming to treat existing cancer by boosting the immune response, which explains the mechanism at a general level."
      },
      {
        "criterion_number": 4,
        "description": "The response states clinical trials are how treatments are tested for diseases like pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response outlines that Phase I focuses on safety and Phase II/III test effectiveness and compare to standard treatments, conveying that trials test treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Only Phase I and Phase II/III are described; Phase IV is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends researching clinical trials prior to enrolling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It encourages thorough research, provides key questions to ask, and points to resources for finding trials."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends ClinicalTrials.gov as a resource.",
        "score_given": 3,
        "max_points": 3,
        "justification": "ClinicalTrials.gov is explicitly recommended as a resource for searching trials."
      },
      {
        "criterion_number": 8,
        "description": "The response states patients should consider all of their treatment options prior to enrolling in a clinical trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It prompts comparison with current treatment options and alignment with overall health and goals, indicating consideration of all options."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to minimize patient harm and closely follow ethical standards.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response mentions IRB approval and ethical standards but does not explicitly state that trials are designed to minimize patient harm."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential benefits and risks of clinical trial participation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists potential risks (e.g., side effects, unknown long-term risks) and benefits (access to cutting-edge therapy, contribution to research)."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends discussing with the clinical trial research team about costs to the patient for participating in the trial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it addresses costs and coverage, it does not explicitly instruct discussing costs with the clinical trial research team."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention that vaccine clinical trials in pancreatic cancer are designed to address the poor response of this malignancy to standard immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention that pancreatic cancer responds poorly to standard immunotherapies or that vaccine trials are designed to address this issue."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that vaccine trials aim to stimulate tumor-specific T cell (immune cell) responses to enhance the immune system\u2019s effectiveness in killing cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response refers to boosting immune response generally but does not mention tumor-specific T cell responses."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention at least two of the following vaccine platforms: peptide-based vaccines targeting defined tumor antigens, dendritic cell vaccines loaded with tumor lysates, or personalized mRNA/neoantigen vaccines that encode patient-specific tumor mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific vaccine platforms (peptide, dendritic cell, or personalized mRNA/neoantigen) are mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention that safety data from recent trials indicate that most vaccine regimens are well-tolerated, with adverse events generally limited to mild-to-moderate injection site reactions, flu-like symptoms, or transient fever.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although side effects are listed, the response does not reference safety data from recent trials or state that regimens are generally well-tolerated."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that most data on vaccine trials in pancreatic cancer are derived from early-phase studies with small sample sizes and limited long-term follow-up.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of the evidence base being primarily early-phase with small sample sizes and limited follow-up."
      },
      {
        "criterion_number": 17,
        "description": "The response must explicitly define clinical trials as research studies that explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it describes what phases test, it does not explicitly define clinical trials as research studies to determine safety and efficacy for humans."
      },
      {
        "criterion_number": 18,
        "description": "The response must explicitly state that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that clinical trials are essential for optimizing current and future cancer therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response must mention that the patient will be informed, verbally and in writing, if a placebo is part of a clinical trial before they enroll.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Placebo is mentioned and consent is discussed, but it does not explicitly state that patients will be informed verbally and in writing about placebo prior to enrollment."
      }
    ],
    "question_number": 87,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:14:44.542657",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing care coordination concerns directly with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises, \u201cAsk your husband\u2019s oncologist \u2026 to act as the central point of contact,\u201d directly recommending discussing coordination with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that the medical oncologist typically serves as the coordinating physician among the different specialists on the healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests asking the oncologist or primary care physician to serve as the coordinator, it does not state that the medical oncologist typically serves this role."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a patient navigator or social worker.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends leveraging a patient navigator or social worker for logistical coordination and suggests asking the care team if one is available."
      },
      {
        "criterion_number": 4,
        "description": "The response states that most oncology clinics have nurses who specialize in helping patients coordinate care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit statement that most oncology clinics have nurses who specialize in care coordination; only a general mention of a nurse hotline."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends trying to schedule multiple appointments on one day to limit life interruptions.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It advises creating a master calendar and managing logistics but does not recommend clustering multiple appointments on one day."
      },
      {
        "criterion_number": 6,
        "description": "The response states that the different specialists will communicate with one another and document their assessments in the electronic medical record.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions using patient portals (e.g., MyChart/Epic) for shared access, it does not explicitly state that specialists will communicate with each other and document their assessments in the EMR."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends asking about a multidisciplinary meeting with the involved specialists, sometimes called a \u201cTumor Board.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states, \u201cRequest a multidisciplinary meeting,\u201d where all specialists review the case together, satisfying the recommendation (even though it does not use the term \u201cTumor Board\u201d)."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention a structured multidisciplinary approach for coordinating care among multiple specialists for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It frames a \u201cstructured approach\u201d and recommends a multidisciplinary meeting to align specialists, in the context of pancreatic cancer care."
      },
      {
        "criterion_number": 9,
        "description": "The response must list all required specialists: surgical oncology, medical oncology, radiation oncology, gastroenterology, genetics, nutrition, and palliative care, and mention their distinct roles in diagnosis, staging, treatment, and supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions surgeon, medical oncologist, radiation oncologist, and a dietitian, but omits gastroenterology, genetics, and palliative care and does not describe distinct roles in diagnosis, staging, treatment, and supportive care."
      },
      {
        "criterion_number": 11,
        "description": "The response must emphasize the necessity of clear patient-centered communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly emphasizes clear communication, proactive updates, clarifying roles, asking questions, and advocacy, highlighting patient-centered communication."
      }
    ],
    "question_number": 88,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:15:33.637750",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises working with the oncologist and primary care provider to create a personalized emergency plan in the 'Consult the Care Team' section."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews common medical emergencies experienced by patients with pancreatic cancer, including biliary obstruction and bowel obstruction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers multiple emergencies and specifically includes 'Bile Duct Obstruction/Jaundice' and 'Bowel Obstruction' with symptom descriptions."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends having an Advance Directive or Living Will in place to guide the patient\u2019s care if they are unable to speak for themselves.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States to ensure an 'advanced directive/living will' is in place under 'Medical Documents.'"
      },
      {
        "criterion_number": 4,
        "description": "The response recommends seeking help from a professional in talking about these challenging questions, like a social worker, spiritual worker, or palliative care professional.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends 'palliative care services' and 'counselors' in 'Psychological Support.'"
      },
      {
        "criterion_number": 5,
        "description": "The response recommends ensuring supportive care medications are refilled for symptoms like pain and nausea.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions having antiemetics on hand and a go-bag with medications but does not explicitly recommend ensuring refills for supportive medications (pain/nausea)."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that pancreatic cancer patients are at high risk for acute emergencies due to tumor progression, treatment effects, or comorbidities.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses complications and treatment effects but does not explicitly state that pancreatic cancer patients are at high risk for acute emergencies due to these factors."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that biliary obstruction presents with jaundice, dark urine, and pruritus.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'sudden yellowing of skin/eyes (jaundice), dark urine, severe itching (pruritus)' under biliary obstruction."
      },
      {
        "criterion_number": 9,
        "description": "The response must describe gastric outlet obstruction as persistent vomiting, inability to tolerate oral intake, and abdominal distension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes bowel obstruction but does not specifically describe gastric outlet obstruction or mention inability to tolerate oral intake/persistent vomiting as required."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention VTE and include symptoms like sudden leg swelling, pain, shortness of breath, or chest pain, and state that pulmonary embolism is a leading cause of death after cancer itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions VTE symptoms (leg pain/swelling, chest pain, shortness of breath) but does not state that pulmonary embolism is a leading cause of death after cancer itself."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention febrile neutropenia as a life-threatening complication of chemotherapy, characterized by fever and signs of infection in the context of neutropenia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References neutropenia and monitoring for fever but does not call out febrile neutropenia as life-threatening."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention metabolic derangements such as hypercalcemia (confusion, weakness, constipation) or hyponatremia (confusion, seizures).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of hypercalcemia, hyponatremia, or other metabolic derangements and their hallmark symptoms."
      },
      {
        "criterion_number": 13,
        "description": "The response must describe bowel obstruction as presenting with abdominal pain, vomiting, and constipation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'sudden, severe abdominal pain, vomiting, inability to pass stool' and abdominal distension, which aligns with abdominal pain, vomiting, and constipation/obstipation."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention spinal cord compression and its symptoms, such as new-onset weakness, sensory changes, or loss of bowel/bladder control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions neurologic symptoms (confusion, seizures, weakness) but does not identify spinal cord compression or note sensory changes or bowel/bladder dysfunction."
      }
    ],
    "question_number": 89,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:16:31.549519",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the hearing changes with his oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises to \"discuss his symptoms with his doctors immediately\" and to \"reach out to his oncologist or primary care physician as soon as possible.\""
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments, like oxaliplatin, which is frequently used in treating pancreatic cancer as part of combination chemotherapy, can cause hearing changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names oxaliplatin (noting use in FOLFIRINOX for pancreatic cancer) as a cause of ototoxicity leading to hearing loss/tinnitus."
      },
      {
        "criterion_number": 3,
        "description": "The response states that platinum-based chemotherapy, such as cisplatin, is well-known to cause hearing loss (ototoxicity).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists platinum-based drugs \"like oxaliplatin or cisplatin\" as damaging inner-ear hair cells causing hearing loss."
      },
      {
        "criterion_number": 4,
        "description": "The response states the hearing changes may be related to other conditions like fatigue, infection, dehydration, malnutrition, or metabolic abnormalities from the cancer or its treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests an ENT evaluation for \"infections\" and mentions steroids affecting \"blood sugar or fluid balance,\" addressing infection and metabolic/fluid abnormalities as potential contributors."
      },
      {
        "criterion_number": 5,
        "description": "The response states it is important for the patient\u2019s oncologist to know about new symptoms because they may need to adjust the dose of the chemotherapy or consider a different treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states the team can \"consider adjusting doses, switching medications\" after reviewing the regimen and audiogram."
      },
      {
        "criterion_number": 6,
        "description": "The response states that treatment-related side effects may become worse or permanent if changes are not made to the treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes hearing loss can be permanent (mentioning hearing aids/cochlear implants), it does not explicitly state that side effects may worsen or become permanent if treatment is not changed."
      },
      {
        "criterion_number": 7,
        "description": "The response states hearing changes may be related to cancer spreading to the brain if there are other neurologic symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes cancer spread to the brain or cranial nerves could impact hearing and typically presents with more severe neurological symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response states the hearing changes may be related to normal age-related hearing loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes \"Age-related hearing loss\" as a possible explanation."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the risk of hearing loss increases with cumulative doses and patient age.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says effects may \"develop over time with repeated doses\" (cumulative exposure) and separately acknowledges age-related hearing loss, implying increased risk with age."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that other therapies, including aminoglycoside antibiotics, loop diuretics, and radiation to the head/neck, can also contribute to hearing loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions aminoglycoside antibiotics and radiation to the head/neck, but does not mention loop diuretics."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that referral for audiologic evaluation is advised.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends performing an audiogram and suggests ENT evaluation, both of which constitute audiologic assessment."
      }
    ],
    "question_number": 90,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:17:21.489827",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states proton therapy is a type of radiation therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, 'Proton therapy is a specialized form of radiation therapy.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states proton therapy uses protons rather than photons to deliver highly conformal radiation doses to tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it uses charged particles (protons) instead of traditional X-ray photons and explains Bragg peak/precision."
      },
      {
        "criterion_number": 3,
        "description": "The response states proton therapy may be more precise in its target field compared to traditional radiation therapy techniques, which may reduce treatment-related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes precision targeting and reduced exposure to surrounding tissues, noting potentially fewer side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response states proton therapy is a safe and feasible option for select patients with locally advanced or recurrent pancreatic cancer, especially when minimizing toxicity to surrounding organs is critical.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies use in 'recurrent or locally advanced cancers' and highlights benefit of minimizing toxicity to adjacent organs."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use proton therapy is influenced by the cancer\u2019s stage, location, size, proximity to other organs, among others.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends discussing factors including tumor location, stage, overall health, and goals of care; acknowledges individualized decision-making."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a Radiation Oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussion with 'her radiation oncologist.'"
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages consultation with 'her oncology team,' which includes the patient's oncologist."
      },
      {
        "criterion_number": 8,
        "description": "The response states proton therapy has proven benefit in some cancers, like head and neck cancer, though has unclear benefit over traditional radiation therapy and is considered experimental in most types of cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that evidence is limited and investigational in some settings for pancreatic cancer but does not mention proven benefit in specific cancers (e.g., head and neck) nor that it is experimental in most cancers."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all cancer centers have the capability to provide proton therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States proton centers are fewer and availability is limited; mentions variability in insurance coverage."
      },
      {
        "criterion_number": 10,
        "description": "The response states proton therapy still carries the risk of side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Emphasizes reduced toxicity and suggests discussing risks but does not clearly state that proton therapy still has side effects."
      },
      {
        "criterion_number": 11,
        "description": "The response states proton therapy is often used in combination with chemotherapy (such as gemcitabine) as part of concurrent chemoradiation protocols.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of concurrent chemotherapy or specific agents like gemcitabine."
      },
      {
        "criterion_number": 12,
        "description": "The response states proton therapy can be used for locally advanced, unresectable, or recurrent disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions use in 'recurrent or locally advanced cancers,' which satisfies the criterion."
      }
    ],
    "question_number": 91,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:17:45.905242",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist, as they likely have financial experts who are knowledgeable in this area.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises talking to the oncology team and hospital social worker, and reiterates in the 'Steps to Take' to consult the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends learning about the patient\u2019s insurance plan, including out-of-pocket costs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions insurance may affect eligibility and to gather insurance details, but does not explicitly recommend learning the insurance plan specifics or out-of-pocket costs."
      },
      {
        "criterion_number": 3,
        "description": "The response states pharmaceutical companies have programs to help patients cover the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes manufacturer patient assistance programs and lists examples such as Pfizer RxPathways, Bristol-Myers Squibb, and Novartis."
      },
      {
        "criterion_number": 4,
        "description": "The response states large hospital systems and cancer centers may have assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes hospitals/cancer centers offer sliding-scale fees, charity care, or grants and advises speaking with the oncology team or social worker."
      },
      {
        "criterion_number": 5,
        "description": "The response states patient assistance programs may cover all or most of the cost of medications for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States manufacturer programs may include free medication (covering all costs) or copay assistance, implying most costs could be covered."
      },
      {
        "criterion_number": 6,
        "description": "The response states government programs may offer assistance with the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists Medicaid, Medicare Part D Extra Help (LIS), and State Pharmaceutical Assistance Programs as government options."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of non-profit organizations with patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple nonprofits including RxAssist, NeedyMeds, HealthWell Foundation, Pancreatic Cancer Action Network, and American Cancer Society."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of pancreatic cancer-specific patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions the Pancreatic Cancer Action Network, which is disease-specific and connects to financial aid resources."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends applying for assistance early as the process may take time and delay treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to apply early and notes waiting periods/limited funds, acknowledging time-related delays."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention federal, state, manufacturer, and independent charity options for medication cost assistance for pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes federal (Medicare LIS), state (SPAPs), manufacturer programs, and independent charities (e.g., HealthWell)."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that Medicaid offers comprehensive prescription drug coverage with minimal co-payments and is the most effective public program for low-income patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions Medicaid but does not state comprehensive coverage, minimal co-pays, or that it is the most effective public program."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention that manufacturer-sponsored assistance programs provide free or discounted medications to eligible uninsured or underinsured patients, requiring proof of financial hardship and doctor certification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes free/discounted meds from manufacturers but does not specify uninsured/underinsured eligibility, proof of financial hardship, or doctor certification requirements."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that independent nonprofits like HealthWell and PAN Foundation offer co-pay and premium assistance to insured patients with incomes below 400-500% of the federal poverty level.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions HealthWell and copay aid but not PAN Foundation, premium assistance, or the 400\u2013500% FPL income thresholds."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the complexity of accessing assistance programs and disparities among non-English speakers and some ethnic groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address complexity in access or disparities affecting non-English speakers and certain ethnic groups."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention financial navigators and online tools such as NeedyMeds or RxAssist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Includes online tools (NeedyMeds, RxAssist) but does not mention financial navigators specifically."
      }
    ],
    "question_number": 92,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:18:23.481554",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises asking the oncologist specific questions about proposed maintenance therapy, benefits/risks, and monitoring."
      },
      {
        "criterion_number": 2,
        "description": "The response states maintenance therapy is typically used in pancreatic cancer after the initial induction therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines maintenance as continued treatment after first-line therapy and notes it typically starts after initial chemotherapy if there is response or stability."
      },
      {
        "criterion_number": 3,
        "description": "The response states maintenance therapy typically involves fewer anti-cancer drugs with the goal of limiting side effects.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions maintenance is less intense with fewer side effects, it does not state that it typically involves fewer drugs nor link de-escalation in number of agents explicitly to side-effect reduction."
      },
      {
        "criterion_number": 4,
        "description": "The response states the oncologist will continue to monitor the cancer closely while the patient is on maintenance therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes effectiveness will be monitored with scans and blood tests, indicating ongoing close monitoring."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the cancer grows while on maintenance therapy, combination therapy may be reintroduced to get the cancer back under control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention reintroducing combination therapy upon progression during maintenance."
      },
      {
        "criterion_number": 6,
        "description": "The response states chemotherapy side effects are typically cumulative, so using maintenance therapy may help the patient tolerate treatment for a longer period of time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss cumulative toxicity or the rationale that maintenance may allow longer tolerability."
      },
      {
        "criterion_number": 7,
        "description": "The response states maintenance therapy may involve chemotherapy, targeted therapy, or immunotherapy depending upon the characteristics of the patient\u2019s tumor.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions chemotherapy and targeted therapy but not immunotherapy, and does not clearly frame selection across these modalities based on tumor characteristics."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the decision to initiate maintenance therapy should be individualized, considering disease response, cumulative toxicities, patient preference, and goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it notes factors like response and overall health, it does not address cumulative toxicities, patient preferences, or goals of care explicitly."
      }
    ],
    "question_number": 93,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:19:03.814450",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states: 'Share concerns about anxiety with your loved one\u2019s oncologist. They may adjust treatment plans or refer you to specialists.'"
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a licensed mental health care provider.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends professional counseling, oncology social workers, and finding therapists via Psychology Today, which directs users to licensed mental health professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response instructs the patient to seek immediate medical evaluation if they are experiencing thoughts of harming themselves or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it lists Crisis Text Line and SAMHSA, it does not instruct to call emergency services or seek immediate medical evaluation for imminent risk or self-harm ideation."
      },
      {
        "criterion_number": 4,
        "description": "The response states anxiety is a common occurrence in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It acknowledges anxiety can be overwhelming but does not explicitly state that anxiety is common among patients with cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response states treatments like cognitive behavioral therapy may help to control anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "CBT is not mentioned; the response does not name evidence-based therapies like cognitive behavioral therapy."
      },
      {
        "criterion_number": 6,
        "description": "The response states medications may help to control anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention that medications (e.g., anxiolytics or antidepressants) may help manage anxiety."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention psychotherapy, psychoeducation, supportive therapy, and integrative modalities as available resources for treatment-related anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly use the terms psychotherapy, psychoeducation, supportive therapy, or integrative modalities; only general counseling and mindfulness/relaxation are mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention mindfulness-based interventions or mindfulness-based stress reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it recommends 'mindfulness & relaxation tools,' it does not explicitly mention 'mindfulness-based interventions' or 'mindfulness-based stress reduction (MBSR)'."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends mindfulness and relaxation techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends Headspace, Calm, Insight Timer, deep breathing, yoga, and tai chi."
      },
      {
        "criterion_number": 11,
        "description": "The response offers pancreatic cancer-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists Pancreatic Cancer Action Network (PanCAN) and a 'Pancreatic Cancer Resource Center,' which are pancreas-specific resources."
      },
      {
        "criterion_number": 12,
        "description": "The response offers mental health-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes CancerCare counseling, NAMI, Psychology Today therapist directory, Crisis Text Line, and SAMHSA helpline."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends participation in cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends support groups via PanCAN, ACS, and CancerCare."
      }
    ],
    "question_number": 94,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:19:57.282405",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to consult his oncologist, ask specific questions, and seek multidisciplinary input."
      },
      {
        "criterion_number": 3,
        "description": "The response states cryotherapy is a procedure that uses metal instruments cooled to subzero temperatures in order to kill tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes freezing with liquid nitrogen/argon and mentions a probe, but does not explicitly state metal instruments cooled to subzero temperatures."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that cryotherapy (also called cryoablation) is a minimally invasive locoregional treatment that destroys tumor tissue by freezing it, typically using probes inserted through the skin (percutaneously) or intraoperatively under imaging guidance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Uses the term cryoablation and notes probe insertion, but does not explicitly describe it as minimally invasive/locoregional or mention percutaneous/intraoperative use under imaging guidance."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use cryotherapy involves the cancer\u2019s size, location, proximity to other organs, among other things.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes evaluation based on tumor size, location, stage, overall health, and proximity to critical organs."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the benefits and risks of this procedure with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically suggests asking about risks and benefits and discussing options with the oncologist."
      },
      {
        "criterion_number": 7,
        "description": "The response states cryotherapy may be used in conjunction with other treatment modalities like chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists other modalities as alternatives but does not state that cryotherapy may be combined with chemotherapy or other treatments."
      },
      {
        "criterion_number": 8,
        "description": "The response states cryotherapy is not typically used to cure cancer but may be used to debulk tumors that are not operable.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states it is not a cure and discusses use for unresectable tumors to reduce symptoms/slow growth and shrink tumors, consistent with debulking non-operable disease."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all patients benefit from cryotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes that cryotherapy has a limited, non-routine role and may play a role only in specific scenarios, indicating not all patients benefit."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in pancreatic cancer, cryotherapy is not a standard first-line therapy but is considered for patients with unresectable, locally advanced, or metastatic disease who are not candidates for surgical resection or have failed systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is not a standard therapy and discusses consideration for unresectable localized tumors and palliative use in advanced stages, aligning with unresectable/advanced settings and non-surgical candidacy."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that its primary role is palliative, aiming to reduce tumor burden, alleviate pain, and potentially improve quality of life and local disease control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes a palliative role in advanced disease focusing on symptom relief (pain/bleeding) and reduction of tumor effects, consistent with improving quality of life and local control."
      }
    ],
    "question_number": 95,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:21:15.823724",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: 'Consult the Oncology Team' and to share results with the mother's doctors, fulfilling the recommendation to discuss with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states CA 19-9 is the tumor marker most commonly used to track disease status in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses markers beyond CA 19-9 but does not state that CA 19-9 is the most commonly used marker for tracking pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response states other tumor markers, like CEA and CA 125, are less reliable than CA 19-9 for disease monitoring in pancreatic cancer and are used more frequently in other gastrointestinal or genitourinary cancers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes CEA is commonly used in colorectal cancer and CA 125 in ovarian cancer and mentions limitations, but does not explicitly state they are less reliable than CA 19-9 for pancreatic cancer monitoring."
      },
      {
        "criterion_number": 4,
        "description": "The response states tumor markers may be used to monitor the course of disease in patients with pancreatic cancer, along with imaging studies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States markers can help monitor treatment response or detect recurrence and emphasizes interpretation alongside imaging, biopsies, and clinical evaluation."
      },
      {
        "criterion_number": 5,
        "description": "The response states tumor markers are not reliable markers of disease in all patients with pancreatic cancer, as not all tumors secrete the markers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes no single marker is definitive and mentions false positives, it does not state that not all tumors secrete markers or that some patients are non-secretors; the brief mention of Lewis antigen is inaccurate and not tied to tumor secretion."
      },
      {
        "criterion_number": 6,
        "description": "The response states circulating tumor DNA (ctDNA) is an emerging technology aimed at detecting early cancer progression and recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes ctDNA as helpful to monitor treatment response or detect recurrence and notes it is an advanced technique still in research, consistent with an emerging technology."
      },
      {
        "criterion_number": 7,
        "description": "The response states circulating tumor DNA (ctDNA) is not FDA approved for disease monitoring in pancreatic cancer and remains experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes ctDNA is still in research and not widely used, but does not explicitly state lack of FDA approval or that it remains experimental for pancreatic cancer monitoring."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that CEA is elevated in 30-60% of pancreatic cancer cases and is particularly useful in Lewis-negative patients who do not secrete CA19-9.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No prevalence range (30\u201360%) is provided, and it does not correctly identify Lewis-negative non-secretors; instead it incorrectly links low CA 19-9 to ABO blood type."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that both CEA and CA125 have demonstrated value for diagnosis, prognosis, and monitoring, especially when CA19-9 is not informative. CA125, when combined with CA19-9, improves diagnostic accuracy and is associated with tumor burden and metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes potential uses of CEA and CA125, it does not state their specific value when CA19-9 is not informative, does not mention that CA125 combined with CA19-9 improves diagnostic accuracy, and does not link CA125 to tumor burden or metastatic disease."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that emerging markers such as LAMC2, POSTN are not yet standard in routine clinical practice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions other emerging markers (mesothelin, MUC1) are not standard, but does not mention LAMC2 or POSTN specifically."
      }
    ],
    "question_number": 96,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:22:05.309284",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that hand-foot syndrome is a common side effect of some chemotherapy drugs used to treat pancreatic cancer, including capecitabine and 5-FU.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response calls HFS a common side effect and mentions capecitabine, but does not mention 5-FU."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist and healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes close communication with the oncology team and instructs to contact the oncology team urgently for concerning symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the patient\u2019s oncologist may recommend reducing the chemotherapy dose.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes dose reduction or schedule changes (e.g., for capecitabine)."
      },
      {
        "criterion_number": 4,
        "description": "The response instructs the patient to seek immediate medical evaluation if the patient experiences fever, chills, blisters, or pus draining from the affected area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises seeking prompt medical care for signs of infection (fever, pus) and contacting the oncology team urgently for blistering/ulcers. Chills are not named, but immediate evaluation for key symptoms is clearly recommended."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s oncology team will grade the severity of the hand-foot syndrome, which will determine the recommended treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of grading severity or using a grading scale to guide management."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends hand hygiene with a gentle soap.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends cleaning broken skin with mild soap and water, implying gentle soap use for hygiene."
      },
      {
        "criterion_number": 7,
        "description": "The response states pain may be controlled with over-the-counter medications like Tylenol or ibuprofen, though the patient should check with their healthcare team first.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions acetaminophen and NSAIDs for pain but does not instruct to check with the healthcare team first."
      },
      {
        "criterion_number": 8,
        "description": "The response states oral or topical prescription pain medications may be needed if pain is severe.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It includes topical lidocaine patches and OTC analgesics but does not state that prescription pain medications may be needed for severe pain."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends utilizing topical moisturizers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises frequent use of fragrance-free, alcohol-free lotions or emollients."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends skin protection with loose clothing and soft shoe soles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends loose/soft breathable clothing and avoiding tight shoes but does not mention soft shoe soles."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends cooling the skin with cold compresses.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends applying cool (not cold) compresses to reduce discomfort, fulfilling the intent to cool the skin."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends avoiding hot showers and activities that cause rubbing on the skin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises keeping hands/feet away from hot water and avoiding friction (tight clothing/shoes, gloves for chores)."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention strategies include celecoxib and urea cream.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of celecoxib or urea cream as prevention strategies."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cooling procedures, such as frozen gloves or socks applied during taxane infusions, may prevent or reduce HFS severity and are recommended by the Oncology Nursing Society for taxane-based regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of frozen gloves/socks during taxane infusions or ONS recommendations."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that prevention strategies such as Pyridoxine (vitamin B6) and lactic acid have not shown consistent benefit for prevention or treatment of HFS in randomized trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of pyridoxine or lactic acid efficacy in trials."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that omeprazole (a proton pump inhibitor) and tipiracil (a thymidine phosphorylase inhibitor) may have prophylactic effects, but these are not yet standard practice.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of omeprazole or tipiracil for prophylaxis."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that management of established HFS includes topical urea and corticosteroids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Topical corticosteroids are mentioned (hydrocortisone), but topical urea is not included."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Photobiomodulation (low-level laser therapy) has shown promise as an adjunct for pain and symptom control.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of photobiomodulation or low-level laser therapy."
      }
    ],
    "question_number": 97,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:23:34.566069",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The decision between a cancer center and community oncology is often based on the type and stage of cancer, the patient\u2019s insurance, location, and preference.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly addresses stage/complexity, insurance coverage, travel/location logistics, and personal preferences/practical constraints as decision factors."
      },
      {
        "criterion_number": 2,
        "description": "Cancer centers may have access to more advanced therapies and clinical trials than community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes access to cutting-edge therapies and clinical trials at cancer centers multiple times."
      },
      {
        "criterion_number": 3,
        "description": "Pancreatic cancer requires multidisciplinary care involving medical oncology, radiation oncology, and surgical oncology, which may be more readily available at a large cancer center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes multidisciplinary teams, multidisciplinary rounds, and coordinated sequencing of surgery/chemotherapy/radiation at cancer centers, specifically in the context of pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "Cancer centers may be more equipped to handle complex care for advanced disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States cancer centers have higher volumes, specialized expertise, and are critical for advanced/metastatic or complex cases."
      },
      {
        "criterion_number": 5,
        "description": "Community oncology programs may be more convenient and closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions convenience, closer to home, and reduced travel burden for community practices."
      },
      {
        "criterion_number": 6,
        "description": "There may be differences in cost between cancer centers and community oncology programs based on the patient\u2019s insurance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses potential higher costs at cancer centers, need to check insurance coverage, financial aid, and notes lower overhead at community practices."
      },
      {
        "criterion_number": 7,
        "description": "Cancer centers may offer more support services to patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists robust support services at cancer centers (nutritionists, social workers, genetic counselors, navigators) compared with fewer services in community settings."
      },
      {
        "criterion_number": 8,
        "description": "Most standard cancer care can be delivered at community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes community oncologists provide excellent care for common scenarios and may suffice for early-stage disease, implying standard care delivery locally."
      },
      {
        "criterion_number": 9,
        "description": "Cancer centers include NCI-designated comprehensive cancer centers and academic medical centers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly references NCI-designated/comprehensive cancer centers and separately mentions academic or research centers in the context of clinical trials."
      },
      {
        "criterion_number": 10,
        "description": "Cancer centers are often located in major cities, which can mean longer travel times, more complex scheduling, and larger, busier environments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights travel burden and distance to cancer centers; while it does not state 'major cities' or 'busy environments' explicitly, it captures the key logistical challenge of longer travel."
      },
      {
        "criterion_number": 11,
        "description": "In some cases, initial treatment planning can be done at a cancer center, and follow-up care can be done at a community center closer to home.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes collaboration and a hybrid approach but does not explicitly state the model of initial planning at a cancer center with follow-up at a community site."
      }
    ],
    "question_number": 98,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:24:18.806964",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says, 'Discuss with Their Healthcare Team: Share concerns with their oncologist or a nurse' and suggests asking about side effects, medications, and referrals."
      },
      {
        "criterion_number": 2,
        "description": "The response states patients undergoing treatment for pancreatic cancer may experience a decrease in libido related to symptoms from treatment or the cancer itself, like fatigue, nausea, pain, malnutrition, anxiety, and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes 'medications that might affect libido' and lists treatment side effects such as fatigue, pain, and nausea, linking treatment factors to libido/sexual function changes."
      },
      {
        "criterion_number": 3,
        "description": "The response specifically mentions at least one of the following changes in intimacy: decreased desire, arousal disorders, pain, erectile dysfunction, altered body image, or emotional distress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions 'pain,' 'medications that might affect libido' (decreased desire), 'changes in body image,' and 'fears of rejection' (emotional distress)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Section 'Open and Honest Communication' advises using 'I feel' statements and encouraging expression of fears, desires, and boundaries."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends seeking input from a professional trained in intimacy problems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 'referrals to specialists (e.g., a sexual health therapist or counselor)' and 'individual or couples therapy with a therapist experienced in cancer.'"
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends 'Support Groups' and references CancerCare and local cancer centers."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly mentions at least one of the following interventions: psychosocial therapy, psychosexual therapy, or couples-based therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 'individual or couples therapy,' which satisfies couples-based therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least one of the following referral options: medical sexologist, psycho-sexologist, social worker, or psychologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions a 'sexual health therapist or counselor' and 'therapist,' but does not explicitly name a medical sexologist, psycho-sexologist, social worker, or psychologist."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly states that concerns about intimacy during treatment for a loved one with pancreatic cancer are common.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states 'you\u2019re not alone\u2014many others have walked this path,' indicating such concerns are common."
      }
    ],
    "question_number": 99,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:25:03.275351",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines radiofrequency ablation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains RFA as using radiofrequency energy via a needle to generate heat to destroy cancer cells, with imaging guidance."
      },
      {
        "criterion_number": 2,
        "description": "The response states radiofrequency ablation is minimally invasive and typically does not require surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes RFA as minimally invasive, with no large incisions, and notes the goal is to treat tumors without surgery."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated 'Next Steps' section urging discussion with the medical team and suggesting specific questions."
      },
      {
        "criterion_number": 4,
        "description": "The response states not all patients with pancreatic cancer benefit from radiofrequency ablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'Not for all cases' and emphasizes case selection and limitations."
      },
      {
        "criterion_number": 5,
        "description": "The response considers the potential risks and benefits of radiofrequency ablation for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists benefits (less pain, scarring) and risks/side effects (pain, bleeding, injury to nearby organs) and notes limited curative potential in advanced disease."
      },
      {
        "criterion_number": 6,
        "description": "The response states radiofrequency ablation is typically used in a multidisciplinary treatment plan along with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that RFA is typically part of a multidisciplinary plan with chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response states radiofrequency ablation is a procedure performed by specially trained Interventional Radiologists.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not identify the type of specialists who perform RFA (e.g., Interventional Radiologists)."
      },
      {
        "criterion_number": 8,
        "description": "The response states this is typically an outpatient procedure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions discharge in 1\u20133 days but does not state that it is typically outpatient."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that in pancreatic cancer, RFA is most commonly delivered via endoscopic ultrasound guidance (EUS-RFA), allowing precise targeting of the tumor while minimizing injury to surrounding structures.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention EUS-RFA or its advantages for pancreatic tumors."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that radiofrequency ablation is used in pancreatic cancer primarily for unresectable or inoperable tumors as a palliative or adjunctive therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is often used for tumors difficult to remove surgically and as palliative treatment in advanced cases, aligning with primary use in unresectable/inoperable disease."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA is not a substitute for surgery or systemic therapy in resectable disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state that RFA is not a substitute for surgery or systemic therapy in resectable pancreatic cancer."
      }
    ],
    "question_number": 100,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:25:55.818076",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises contacting and regularly reviewing with the oncology team, primary care provider, and pharmacist; also states to contact the oncology team immediately for concerns."
      },
      {
        "criterion_number": 2,
        "description": "The response states it is normal for patients with pancreatic cancer to be on multiple medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states it is common for pancreatic cancer patients to be on several medications."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may need medications for symptom control, including acid reflux, nausea, pain, diarrhea, and enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions nausea, pain, diarrhea, and enzyme replacement, but does not explicitly mention acid reflux."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends utilizing a pill organizer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends using a weekly pill organizer to sort doses by day/time."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping an updated medication list with administration times.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises keeping a written or digital list including name, dose, purpose, and time taken."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reviewing the patient\u2019s medication list with the healthcare team to identify strategies to make handling the medications easier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends medication review with oncologist/PCP at each visit and consulting the pharmacist for reconciliation; also suggests simplifying regimens (combining meds or once-daily options)."
      }
    ],
    "question_number": 101,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:26:22.007866",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing yoga with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises consulting the oncologist/surgeon and coordinating with the medical team before starting yoga."
      },
      {
        "criterion_number": 2,
        "description": "The response states yoga may improve a cancer patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a dedicated 'Quality of Life' section and explains benefits like sense of control, normalcy, and connection."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends gentle and slow yoga practice to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends gentle styles (restorative, chair, yoga nidra), starting slowly, and listening to the body."
      },
      {
        "criterion_number": 4,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions fatigue and pain and advises hydration/nutrition, but does not explicitly link increased injury risk to fatigue, malnutrition, dehydration, and pain collectively."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not recommend cancer support groups; only notes possible connection in group yoga settings."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References 'some studies' but provides no citations or sources."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are yoga classes specifically for cancer patients and provides resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests finding an instructor experienced with cancer patients but does not mention oncology-specific classes or provide any resources."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that yoga is generally safe for people with cancer, including those undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States yoga is generally safe and beneficial as a complement when approached thoughtfully, including during treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that yoga may help reduce cancer-related fatigue, anxiety, and depression, and improve emotional well-being during and after treatment, though effects are typically small to moderate and the certainty of evidence is low to moderate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes potential benefits for fatigue and anxiety but does not mention depression or qualify effect sizes and evidence certainty."
      }
    ],
    "question_number": 102,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:27:03.105926",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussion with his medical team and oncologist (e.g., 'it\u2019s crucial to discuss these with his medical team' and 'Please reach out to his oncologist')."
      },
      {
        "criterion_number": 2,
        "description": "The response states many side effects from cancer treatment improve and disappear once treatment stops.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes some immunotherapy toxicities may improve after stopping, it does not broadly state that many side effects improve or disappear after treatment stops."
      },
      {
        "criterion_number": 3,
        "description": "The response states some side effects like peripheral neuropathy may become permanent.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes neuropathy may persist even after treatment ends, implying potential permanence."
      },
      {
        "criterion_number": 4,
        "description": "The response states some side effects from treatment may take time to improve or disappear, as long as many months.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit mention of a prolonged time course (e.g., many months) for improvement."
      },
      {
        "criterion_number": 5,
        "description": "The response states many side effects from treatment can be controlled with medications, for example pancreatic enzyme supplementation for pancreatic insufficiency or vitamins for malabsorption after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear example: malabsorption often requires lifelong pancreatic enzyme supplements; also discusses symptom management and dietitian support."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews potential side effects of surgery for pancreatic cancer (e.g., Whipple procedure).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers digestive issues, malabsorption, diabetes risk, weight loss, bowel changes, and infection risk after Whipple/other surgeries."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews potential side effects of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple chemo-related long-term effects: cardiotoxicity, neuropathy, fatigue, kidney/liver damage, secondary cancers, fertility issues, and cognitive changes."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the potential for long-term heart or kidney damage and fertility issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions cardiotoxicity (heart damage), kidney/liver damage, and fertility issues."
      },
      {
        "criterion_number": 9,
        "description": "The response states the treating team will work within the patient\u2019s goals of care to maximize treatment efficacy while limiting side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages communication and palliative care but does not explicitly state alignment with patient goals of care to balance efficacy and toxicity."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential side effects of radiation therapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses skin/tissue changes, digestive issues, low risk of secondary cancers, and potential lung/heart damage if nearby areas are irradiated."
      },
      {
        "criterion_number": 11,
        "description": "The response states some cancer treatments can increase the likelihood of developing second cancers in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes secondary cancer risk with certain chemotherapy agents and low risk over time with radiation."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends open communication with the patient\u2019s healthcare team about symptoms and symptom control to limit the long-term effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides 'Open Communication' as a key step and recommends documenting side effects to share with doctors."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that long-term side effects are common in patients treated for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that long-term side effects are common; it only notes that treatments can have long-term effects."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the cumulative impact of surgery, chemotherapy, radiation, and the underlying disease as sources of long-term side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists modalities and their effects separately but does not mention the cumulative impact or explicitly include the underlying disease as a contributor."
      }
    ],
    "question_number": 103,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:28:04.705657",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response offers recommendations for organizations and includes key initiatives of the organizations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists multiple organizations (PanCAN, Lustgarten Foundation, American Cancer Society, NCI, PCRF, Basser Center) and provides focus areas and/or key programs for most (e.g., research funding, patient services, advocacy). While there are factual concerns (e.g., PCRF link appears to be Pediatric Cancer Research Foundation, and the Basser Center is at Penn, not MSK), the response does provide recommendations and describes initiatives as required by the rubric."
      },
      {
        "criterion_number": 2,
        "description": "The response includes Charity Navigator ratings for the mentioned organizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response advises checking Charity Navigator but does not provide any actual Charity Navigator ratings for the listed organizations."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly state that nonprofit organizations are vital for supporting innovative research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly state that nonprofit organizations are vital for supporting innovative research in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that donations to nonprofit organizations can support research, clinical trials, and patient support initiatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although the response mentions donations supporting research and patient services, it does not mention clinical trials. The criterion requires explicit mention of research, clinical trials, and patient support initiatives."
      }
    ],
    "question_number": 104,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:28:31.578611",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s oncologist immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting the oncology team and states prompt evaluation by oncology is essential; also urges contacting the healthcare provider immediately."
      },
      {
        "criterion_number": 2,
        "description": "The response instructs the patient to seek immediate medical evaluation if the vision changes are abrupt in onset, severe, or accompanied by other symptoms including dizziness, pain, confusion, fever, or other neurologic symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directs immediate medical attention for sudden/progressive vision changes and identifies red flags; mentions associated symptoms such as headaches, dizziness, confusion, and neurologic emergencies."
      },
      {
        "criterion_number": 3,
        "description": "The response states vision changes related to treatment are not typical, though can be related to dry eyes or peripheral neuropathy from chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes gemcitabine/5-FU are less commonly linked to vision issues and mentions dehydration causing dry eyes; conveys that treatment-related vision changes are not typical but possible."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that chemotherapy can cause vision changes (ocular toxicity). For example, gemcitabine and 5-fluorouracil have been associated with retinal findings including cotton-wool spots and other visual disturbances.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it states chemotherapy can cause vision changes, it does not mention ocular toxicity or the specific association of gemcitabine/5-FU with retinal findings such as cotton-wool spots."
      },
      {
        "criterion_number": 5,
        "description": "The response states the oncologist may recommend dose reducing treatment or changing to a different treatment if the vision changes are felt to be treatment-related.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of dose reduction or switching therapy as management for treatment-related vision changes."
      },
      {
        "criterion_number": 6,
        "description": "The response states vision changes may be related to metastasis to the brain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes brain metastases as a cause of vision changes and emphasizes urgency."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that ocular metastases may cause vision changes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention ocular (intraocular) metastases as a cause of vision changes."
      },
      {
        "criterion_number": 8,
        "description": "The response states vision changes may be related to paraneoplastic processes and explains what this is.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of paraneoplastic processes or explanation provided."
      },
      {
        "criterion_number": 10,
        "description": "The response states the patient\u2019s oncologist may prescribe medications to improve the vision changes, including eye drops, steroids, or antibiotics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention that the oncologist may prescribe eye drops, steroids, or antibiotics to address vision changes."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient\u2019s vision changes may be due to infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies infections (e.g., meningitis) in immunocompromised patients as potential causes of vision changes."
      },
      {
        "criterion_number": 12,
        "description": "The response states the patient\u2019s vision changes may be due to age-related vision changes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of age-related vision changes."
      }
    ],
    "question_number": 105,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:29:37.050155",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that telehealth appointments are generally as effective as in-person visits for many aspects of care for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response emphasizes that effectiveness depends on several factors and that telehealth is a complement rather than a complete substitute; it does not state that telehealth is generally as effective for many aspects of care."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the potential benefits of telehealth appointments, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly notes convenience/reduced travel, cost and time savings, reduced infection exposure, and improved access to specialized care (e.g., for rural patients)."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the potential downsides of telehealth appointments, including potential differences in insurance reimbursement and challenges with physical examination.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights the inability to perform hands-on exams and advises confirming insurance coverage for telehealth, addressing reimbursement/coverage concerns."
      },
      {
        "criterion_number": 4,
        "description": "The response states it can be challenging for a doctor to fully evaluate a patient via telehealth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states virtual visits cannot replace hands-on assessments and notes difficulty conveying nonverbal cues, implying challenges in full evaluation."
      },
      {
        "criterion_number": 5,
        "description": "The response states telehealth can be a convenient alternative to in-office visits and may be helpful if the patient has mobility or transportation issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes convenience, reduced travel burden, and notes particular usefulness if the patient is fatigued or has mobility issues."
      },
      {
        "criterion_number": 6,
        "description": "The response states in-office visits may be more appropriate in certain situations, including for initial visits or when there are big changes to the patient\u2019s health or treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises in-person visits for new/worsening symptoms, complex decisions, and active treatment monitoring, addressing situations with significant changes."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing telehealth options with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends consulting her oncologist about telehealth policies and how virtual visits fit into the care plan."
      },
      {
        "criterion_number": 8,
        "description": "The response states not all oncologists offer telehealth appointments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests checking the medical team\u2019s telehealth policies, it does not explicitly state that not all oncologists offer telehealth."
      },
      {
        "criterion_number": 9,
        "description": "The response offers tips for making the most out of a telehealth appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides concrete tips: prepare records and questions, keep symptom logs, and ensure a quiet, well-lit environment."
      },
      {
        "criterion_number": 10,
        "description": "The response states medical emergencies are not appropriate for telehealth evaluations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that emergency situations require immediate in-person evaluation and provides examples (e.g., breathing difficulties)."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that telehealth may be less suitable for sensitive discussions, such as new diagnosis or end-of-life care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends prioritizing in-person visits for complex decisions and emotional support, indicating sensitivity-related limitations of telehealth."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that limitations of telehealth include technology barriers and occasional concerns about reduced personal connection or quality of interaction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses technology barriers (internet/device comfort) and reduced rapport due to fewer nonverbal cues."
      }
    ],
    "question_number": 106,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:31:03.310030",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises consultation with the oncology team multiple times (e.g., under Cold caps: 'discuss with the oncology team' and in 'Consult the Oncologist' section)."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments for pancreatic cancer can cause hair loss, for example, FOLFIRINOX or gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response discusses FOLFIRINOX and gemcitabine and links them to hair loss risk, noting FOLFIRINOX may pose higher risk and that gemcitabine is associated with less hair loss."
      },
      {
        "criterion_number": 3,
        "description": "The response provides reported estimates of hair loss with FOLFIRINOX and gemcitabine and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No numerical estimates or statistics for alopecia rates with FOLFIRINOX or gemcitabine are provided, and no specific citations supporting such estimates are included."
      },
      {
        "criterion_number": 4,
        "description": "The response states hair typically grows back once the causative treatment is stopped.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states hair usually starts regrowing 1\u20133 months after treatment ends and that hair loss is usually reversible."
      },
      {
        "criterion_number": 5,
        "description": "The response states cold caps are sometimes used to reduce hair loss but they can be expensive.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cold caps are mentioned as an option, but there is no mention of cost or that they can be expensive."
      },
      {
        "criterion_number": 6,
        "description": "The response states hair loss from chemotherapy is a common and distressing side effect in patients undergoing treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response acknowledges hair loss can be distressing, it does not state that it is a common side effect."
      },
      {
        "criterion_number": 7,
        "description": "The response states other chemotherapy regimens or immunotherapy or targeted therapy cause hair loss at lower rates or not at all.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes gemcitabine is generally associated with less hair loss compared to FOLFIRINOX, fulfilling the criterion of indicating lower rates with other regimens."
      },
      {
        "criterion_number": 8,
        "description": "The response states many cancer patients wear hats or wigs to help with appearances and self-esteem.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises using wigs, scarves, or hats to help manage physical and emotional comfort and provides practical tips to keep a wig or scarf handy."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Support groups are explicitly recommended, with examples (e.g., American Cancer Society\u2019s Reach to Recovery, online communities)."
      },
      {
        "criterion_number": 10,
        "description": "The response reports expected timelines for hair loss after starting chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states hair loss typically begins 2\u20134 weeks after starting chemotherapy."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the severity and risk of hair loss is higher with multi-agent and taxane-containing protocols, and female patients are at increased risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it implies higher risk with multi-agent FOLFIRINOX versus gemcitabine, it does not explicitly mention taxane-containing protocols as higher risk nor that female patients are at increased risk."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that most cases of hair loss are reversible, with regrowth expected within 3-6 months after cessation of chemotherapy, but persistent or permanent alopecia can occur, especially after repeated or high-dose regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes reversibility and provides regrowth timelines but does not mention the possibility of persistent or permanent alopecia."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that eyebrow and eyelash loss may also be seen.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of eyebrow or eyelash loss."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that topical minoxidil may aid regrowth post-chemotherapy, though evidence for prevention is limited.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Topical minoxidil is not discussed."
      }
    ],
    "question_number": 107,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:32:03.507222",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines oligometastatic disease in pancreatic cancer as limited spread, typically a single organ and a small number of lesions (\u22643 to \u22645).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines oligometastatic disease as a limited number of metastases (typically 1\u20133, up to 5) and notes limited number and location with examples (liver, lung, peritoneum). This meets the definition\u2019s key elements, including lesion count thresholds."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly encourages asking the oncologist questions, working closely with the medical team, and seeking a multidisciplinary team, fulfilling the criterion."
      },
      {
        "criterion_number": 3,
        "description": "Discusses impact on treatment options, including possibility of aggressive multimodal therapy (systemic chemotherapy plus local treatments such as surgery, ablation, SBRT), potentially following response to initial therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response outlines systemic therapy alongside local modalities (surgery, SBRT, ablation) as options for oligometastatic disease, addressing aggressive multimodal treatment. While it does not explicitly state sequencing after good response, it adequately presents the multimodal approach."
      },
      {
        "criterion_number": 4,
        "description": "Contrasts oligometastatic disease to localized disease and widespread metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response contrasts oligometastatic with widespread metastatic disease but does not explicitly contrast it with localized (confined to the pancreas) disease."
      },
      {
        "criterion_number": 5,
        "description": "Mentions potential for improved prognosis compared to widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that patients with oligometastatic disease often have a better prognosis than those with widespread metastases and notes potential survival benefit with aggressive local treatment."
      }
    ],
    "question_number": 108,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:32:34.114808",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states it is common for patients to have low blood counts due to chemotherapy used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that low blood counts and related treatment delays are common in pancreatic cancer, particularly during chemotherapy, and explains chemotherapy-induced myelosuppression."
      },
      {
        "criterion_number": 2,
        "description": "The response states treatment delays due to low blood counts are enacted to ensure the patient\u2019s safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that delays or dose reductions occur when counts fall below safe thresholds as a routine safety measure to prevent serious complications."
      },
      {
        "criterion_number": 3,
        "description": "The response states the oncologist may recommend dose reducing the chemotherapy or changing to a different treatment if the blood counts remain low.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly mentions dose adjustments and the possibility of switching to a different chemotherapy regimen or other therapies if delays are prolonged."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of chemotherapy known to cause low blood counts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Gemcitabine is specifically cited as a regimen associated with myelosuppression, meeting the requirement for examples."
      },
      {
        "criterion_number": 5,
        "description": "The response lists the different types of low blood counts that may impact treatment, including anemia, neutropenia, thrombocytopenia, and low total white blood cell count, and explains why these cells are important in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists neutropenia (low white blood cells), anemia (fatigue), and thrombocytopenia (bleeding risk), explaining each in lay terms; low WBC is referenced under neutropenia."
      },
      {
        "criterion_number": 6,
        "description": "The response states the oncologist may prescribe an injection medication (e.g., G-CSF) to help increase the neutrophil count.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions growth factors (e.g., G-CSF) may be used to stimulate white blood cell production, which implies increasing neutrophils with an injectable medication."
      },
      {
        "criterion_number": 7,
        "description": "The response states if the red blood cell or platelet counts get too low, the oncologist may order a transfusion of red blood cells or platelets to keep these at safe levels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions transfusion support with red blood cells or platelets when counts are critically low."
      },
      {
        "criterion_number": 8,
        "description": "The response instructs the patient to seek immediate medical evaluation if they have low blood counts and experience fever, chest pain, shortness of breath, leg swelling, blood in the urine, blood in the stool, or other uncontrollable bleeding.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No red-flag symptom guidance or instructions to seek urgent evaluation are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends ensuring good nutrition to ensure the bone marrow can produce the required blood cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises ensuring proper nutrition as part of supportive care."
      },
      {
        "criterion_number": 10,
        "description": "The response must strongly recommend consulting with an oncologist or care team, providing specific questions or topics to discuss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It urges communication with the medical team, suggests asking about reasons for delay, timeline, alternatives, and discusses strategies like dose adjustments and growth factors, and ends with a recommendation to consult their oncologist."
      }
    ],
    "question_number": 109,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:33:21.486031",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consultation with the father's oncologist and medical team multiple times."
      },
      {
        "criterion_number": 2,
        "description": "The response explains hyperthermia treatment for cancer in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear, accessible explanation of what hyperthermia is, how it works, types, uses, benefits, and risks."
      },
      {
        "criterion_number": 3,
        "description": "The response specifies that hyperthermia treatment involves heating tumor tissue to a temperature range of 39-43\u00b0C to enhance the cytotoxic effects of chemotherapy and/or radiotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States a temperature range of 40\u201344\u00b0C and explains sensitization to radiation and chemotherapy, covering the intended concept despite a slightly wider range."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions all three delivery methods: regional (including \u2018deep regional\u2019), intraoperative, and whole-body hyperthermia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions local, regional, and whole-body hyperthermia but does not mention intraoperative hyperthermia or specifically \u2018deep regional\u2019."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews potential benefits and risks of hyperthermia treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists potential benefits (tumor shrinkage, pain reduction, enhancing other therapies) and risks (burns, tissue damage, dehydration, hypotension, rare clots)."
      },
      {
        "criterion_number": 6,
        "description": "The response states hyperthermia is not an effective alternative to standard of care treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Says it is not a standard first-line treatment but does not explicitly state it is not an effective alternative to standard of care."
      },
      {
        "criterion_number": 7,
        "description": "The response states hyperthermia is not a standard first-line therapy for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states hyperthermia is not a standard first-line treatment for pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response states there is not robust evidence for the use of hyperthermia treatment in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Implies ongoing research and evolving role but does not explicitly state that evidence is not robust."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that hyperthermia is used in pancreatic cancer as an adjunct to standard chemoradiotherapy for patients with locally advanced, unresectable, or metastatic disease, especially when conventional therapies have limited efficacy or are refractory.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention use specifically as an adjunct in locally advanced, unresectable, or metastatic settings or refractory disease."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that adding hyperthermia to chemoradiotherapy may improve overall response rates and median survival compared to standard therapy alone, with acceptable safety profiles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss response rates, median survival, or comparative safety profiles when added to chemoradiotherapy."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that the quality of evidence for hyperthermia is limited, it remains investigational, and there are ongoing trials evaluating its efficacy and optimal integration into multimodal treatment regimens.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions clinical trials and that its role is evolving, but does not explicitly state limited quality of evidence, investigational status, or ongoing trials evaluating efficacy and optimal integration."
      }
    ],
    "question_number": 110,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:34:13.952529",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises starting with the treating oncologist (and gastroenterologist) to review results and relate findings to diagnosis, treatment, and prognosis."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends a certified genetic counselor, details their role, and provides a directory link (NSGC) for finding one."
      },
      {
        "criterion_number": 4,
        "description": "The response explains genetic testing and why it is done in cancer treatment, using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains in accessible language that genetic findings can inform treatment options (e.g., targeted therapies), prognosis, and family risk, and mentions test limitations."
      },
      {
        "criterion_number": 5,
        "description": "The response includes in its explanation that certain genetic mutations like BRCA2 may be targets for targeted cancer therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions that mutations in BRCA1/2 and PALB2 may influence treatment choices and references targeted therapies explicitly."
      },
      {
        "criterion_number": 6,
        "description": "The response states that certain genetic mutations are associated with inherited cancer predisposition syndromes which may affect the patient\u2019s relatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes hereditary cancer syndromes (e.g., Lynch, hereditary pancreatitis) and discusses implications for relatives and family testing."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that board-certified genetic counselors, medical geneticists, and oncologists can help determine the clinical significance of identified variants, discuss implications for surveillance, prevention, and treatment, and provide guidance for at-risk family members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions oncologists, genetic counselors, and medical geneticists and their roles in interpreting results, treatment implications, and family guidance, it does not mention surveillance or prevention specifically; therefore the criterion is not fully met under the binary scoring."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that pathogenic variants in genes such as BRCA1, BRCA2, PALB2, ATM, CDKN2A, and others may influence both therapeutic decisions and recommendations for family screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically cites BRCA1/2 and PALB2 as influencing treatment choices and discusses implications for family testing; conveys the dual impact on therapy and family screening even though not all listed genes are named."
      }
    ],
    "question_number": 111,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:35:06.507417",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises asking the oncologist to review medications and consulting a registered dietitian specializing in oncology."
      },
      {
        "criterion_number": 2,
        "description": "The response states changes in taste are a common side effect of some chemotherapies used in the treatment of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes chemotherapy can alter taste but does not state it is a common side effect or tie it specifically to pancreatic cancer regimens."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends trying different foods and drinks to identify flavor profiles that are appealing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages trial and error with flavors, keeping a food journal, and adjusting seasonings and textures."
      },
      {
        "criterion_number": 4,
        "description": "The response states cold intolerance is a common side effect of oxaliplatin, so patients should avoid cold foods and drinks.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention oxaliplatin or cold intolerance; in fact suggests cold foods may be more appealing."
      },
      {
        "criterion_number": 5,
        "description": "The response states changes in taste typically improve or disappear entirely when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement about taste changes resolving after discontinuation of the causative medication."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of maintaining proper nutrition and hydration while undergoing treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Stresses hydration strategies, small frequent meals, nutritional support, and flags dehydration/weight loss as reasons to seek help."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends nutritional supplements to ensure the patient is achieving their needs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically mentions protein shakes and multivitamins as supplements if needed."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that improved oral hygiene and active swallowing exercises may also promote taste recovery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Covers oral hygiene thoroughly but does not mention active swallowing exercises."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that a referral to a registered dietitian is recommended for tailored nutritional strategies, as taste changes often lead to reduced appetite, altered food preferences, and risk of malnutrition.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Recommends a registered dietitian for a personalized plan but does not explicitly link taste changes to reduced appetite, altered preferences, or malnutrition risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that dietitians can assist with food texture modification, flavor enhancement, and strategies to maintain adequate caloric and protein intake.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not specify these particular roles; only notes personalized meal plans and possible supplements."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pharmacological and supplement-based interventions have been explored with mixed results. Further research is needed to establish standardized, effective interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of pharmacologic or supplement-based interventions for dysgeusia or evidence quality."
      }
    ],
    "question_number": 112,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:36:21.384814",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the exercise plan with the patient\u2019s oncologist or healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly advises consulting the oncologist and a physical therapist, and checking with the primary care physician to rule out contraindications."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends gentle and slow exercise to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends starting with low-to-moderate intensity activities such as walking, gentle stretching/yoga, and chair exercises, and advises avoiding high-intensity workouts or activities causing pain."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it discusses fatigue, nutrition, hydration, and pain, it does not explicitly state that these factors increase injury risk during treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends support groups and specifically mentions the American Cancer Society and the Pancreatic Cancer Action Network as sources of support."
      },
      {
        "criterion_number": 5,
        "description": "The response states gentle exercise participation may improve a cancer patient\u2019s quality of life and offers published research studies as evidence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It claims studies suggest benefits including improved quality of life but does not provide published research studies or specific references to support the claim."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific studies or citations are provided; the response uses general statements such as 'studies suggest' without references."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are exercise classes specifically for cancer patients and provides resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention cancer-specific exercise classes or provide resources for such classes."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention that The American Society of Clinical Oncology recommends both aerobic and resistance exercise as safe and beneficial for patients with pancreatic cancer during chemotherapy, chemoradiotherapy, or neoadjuvant therapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no explicit mention of ASCO or its recommendations regarding aerobic and resistance exercise during specific pancreatic cancer treatments."
      },
      {
        "criterion_number": 9,
        "description": "The response must clearly state that physical activity should be tailored to individual capacity and comorbidities, using terms like \u201cindividual capacity,\u201d \u201cpersonalized,\u201d or \u201ctailored.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response repeatedly emphasizes tailoring/personalizing the plan to the patient\u2019s specific condition and states 'Personalization is critical.'"
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that aerobic exercise (e.g., walking, cycling, swimming) and resistance training (e.g., weights, resistance bands) improve cardiorespiratory fitness, physical function, and reduce symptoms like fatigue and mood disturbances.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions walking and general benefits such as reduced fatigue and stress, it does not explicitly include resistance training (weights/resistance bands) nor state improvements in cardiorespiratory fitness as required."
      }
    ],
    "question_number": 113,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:37:08.146921",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises, \"Always consult their oncologist or healthcare provider for personalized guidance\" and encourages communication with the medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends reporting any new symptoms to the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states, \"Report any new or worsening symptoms promptly,\" meeting the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response states it is important to separate side effects of treatment from progression of disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly address distinguishing treatment side effects from disease progression."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of new or worsening pain, jaundice, unintentional weight loss, and appetite changes as symptoms that may signify progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists worsening abdominal pain (radiating to the back), jaundice, rapid/unexplained weight loss, and loss of appetite as concerning signs."
      },
      {
        "criterion_number": 5,
        "description": "The response states metastases to other sites in the body can have various symptoms and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides a section on possible metastasis with examples (bone pain; liver involvement with right-sided pain and worsening jaundice; lung symptoms; ascites)."
      },
      {
        "criterion_number": 6,
        "description": "The response instructs the patient to seek immediate medical evaluation if they experience severe pain, jaundice, severe constipation, confusion, or neurologic changes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it mentions severe symptoms (e.g., severe abdominal pain, constipation from bowel obstruction, confusion), it does not explicitly instruct to seek immediate medical evaluation or emergency care."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention at least 10 of the following signs and symptoms indicating disease progression in pancreatic cancer: jaundice, dark urine, pale stools, pruritus, abdominal pain, back pain, weight loss, anorexia, fatigue, nausea/vomiting, constipation, diarrhea, new or worsening diabetes, bloating, belching, cachexia, or blood clots.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions at least 11 items: jaundice, pruritus, abdominal pain, back pain, weight loss, anorexia (loss of appetite), fatigue/weakness, nausea/vomiting, constipation, new/worsening diabetes, and blood clots."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention gastrointestinal bleeding or rapidly declining performance status as alarm symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of gastrointestinal bleeding or rapidly declining performance status."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state the importance of close monitoring of symptoms for timely intervention and supportive care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes close monitoring by advising a symptom journal and to report new/worsening symptoms promptly; it also references palliative care (supportive care), aligning with timely intervention and support."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention early integration of supportive care to optimize quality of life and address complications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends involving palliative care to manage symptoms and improve quality of life, it does not explicitly emphasize early integration or addressing complications."
      }
    ],
    "question_number": 114,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:38:26.524029",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoadjuvant therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly defines neoadjuvant therapy as treatment given before the primary treatment to improve effectiveness."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that neoadjuvant treatment is given before the main treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states it is treatment given before the primary/main treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that neoadjuvant therapy usually occurs before surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States it is usually before surgery and outlines sequence: neoadjuvant \u2192 surgery \u2192 adjuvant."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that neoadjuvant therapy is usually chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes chemotherapy is the most common approach and provides common regimens."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that radiation therapy can sometimes be used for neoadjuvant therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States radiation is less common alone but sometimes combined with chemotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that oncologists often evaluate the response of a person\u2019s cancer after neoadjuvant therapy to determine the next steps.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions assessing treatment response and using it to guide future treatment decisions."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the main goals of neoadjuvant therapy are to treat micrometastases early, improve chances of margin-negative (R0) resection, downstage advanced tumors, and ensure patients receive systemic therapy, as many can\u2019t complete adjuvant treatment after surgery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions shrinking/downstaging tumors and improving surgical outcomes, it does not explicitly mention treating micrometastases, improving R0 margin rates, or ensuring systemic therapy due to post-op adjuvant attrition."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that patient selection, multidisciplinary coordination, and management of therapy-related toxicities are critical, as attrition during neoadjuvant therapy can preclude surgery.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Highlights multidisciplinary care, notes not all are candidates (patient selection), and discusses side effects/tolerance that can delay or stop treatment, implying attrition risk affecting surgery."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises asking the medical team about specifics and earlier identifies the team as including oncologists, effectively recommending discussion with an oncologist."
      }
    ],
    "question_number": 115,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:39:17.544224",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that music therapy can help with symptoms associated with pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response repeatedly notes symptom benefits during cancer treatment (e.g., stress, anxiety, pain, physical comfort) and explicitly mentions managing chronic pain associated with pancreatic cancer and overall symptom management."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that music therapy can help with anxiety.",
        "score_given": 4,
        "max_points": 4,
        "justification": "There is a dedicated section on Stress and Anxiety Reduction and multiple mentions of reducing anxiety during treatment and procedures."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that music therapy can improve quality of life.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The conclusion explicitly states that music therapy may enhance quality of life during pancreatic cancer treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that music therapy can help with depression.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It states music can uplift mood and combat feelings of depression."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that music therapy can help with pain.",
        "score_given": 4,
        "max_points": 4,
        "justification": "There is a specific Pain Management section describing reduced perceived pain and distraction during procedures."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that music therapy can help with fatigue.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Fatigue is mentioned only as a potential limitation to participation; the response does not claim music therapy helps reduce fatigue."
      },
      {
        "criterion_number": 7,
        "description": "The response states that music therapy is anti-cancer therapy.",
        "score_given": 0,
        "max_points": 0,
        "justification": "It does not claim disease-modifying or anti-cancer effects and clearly states music therapy should complement, not replace, standard treatments."
      },
      {
        "criterion_number": 8,
        "description": "The response should cite peer-reviewed publications with links.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No peer-reviewed citations or links are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the American Society of Clinical Oncology and the Society for Integrative Oncology recommend music therapy as a safe, non-invasive adjunct for managing anxiety and depression in adults with cancer, including those undergoing active treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of ASCO or SIO recommendations is included."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that emerging evidence suggests music therapy may also modulate immune responses and support overall treatment outcomes, but further research is needed to clarify its biological effects and optimal use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response does not discuss immune modulation or emerging biological effects; it only notes limited evidence in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises consulting the mother\u2019s oncologist and care team to integrate music therapy into the care plan."
      }
    ],
    "question_number": 116,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:40:02.207112",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that pancreatic cancer is not contagious.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that pancreatic cancer itself doesn\u2019t directly pose a health risk to pets, effectively conveying that it is not contagious to pets."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that chemotherapy can weaken the immune system and make someone at increased risk of infection.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention that chemotherapy causes immunosuppression or increases infection risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pets can carry infections that could be harmful to immunocompromised persons.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not discuss infection risks from pets to immunocompromised patients."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient discuss precautions related to chemotherapy excretion with a pharmacist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to consult a pharmacist about chemotherapy excretion precautions."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some chemotherapy drugs are excreted in urine.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of chemotherapy excretion in urine."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that some chemotherapy drugs are excreted in stool.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of chemotherapy excretion in stool."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that some chemotherapy drugs are excreted in saliva.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of chemotherapy excretion in saliva."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some chemotherapy drugs are excreted in vomit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of chemotherapy excretion in vomit."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that pets should avoid contact with excreted medications.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No guidance given about pets avoiding contact with chemotherapy residues in bodily fluids."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that pets should avoid contact with chemotherapy medications.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explicitly advises keeping all medications, including chemotherapy, out of reach of pets."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that pets should avoid contact with all medications.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Advises keeping all medications out of pets\u2019 reach."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pets provide significant emotional and psychological benefits to cancer patients.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States pets provide emotional support and comfort, emphasizing psychological benefits."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that to reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on their pets.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of precautions related to chemotherapy or radiation residues around pets."
      },
      {
        "criterion_number": 14,
        "description": "After chemotherapy, surfaces\u2014especially in bathrooms\u2014can remain contaminated for at least 48 hours, so thorough cleaning is advised.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No information about surface contamination timelines or bathroom cleaning post-chemotherapy."
      },
      {
        "criterion_number": 15,
        "description": "Hand hygiene is essential after contact with patient waste or contaminated areas.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not address hand hygiene after exposure to patient waste or contaminated areas."
      },
      {
        "criterion_number": 16,
        "description": "Immunocompromised patients should practice good hand hygiene after handling pets.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No recommendation for hand hygiene specifically after handling pets by immunocompromised patients."
      },
      {
        "criterion_number": 17,
        "description": "Immunocompromised patients should avoid contact with pet waste.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not advise immunocompromised patients to avoid contact with pet waste."
      },
      {
        "criterion_number": 18,
        "description": "Immunocompromised patients should prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of avoiding pet licking of open wounds."
      },
      {
        "criterion_number": 19,
        "description": "There is no strong evidence that pet ownership increases cancer risk or that pets need to be removed from the home during treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly state there is no evidence to remove pets or that pet ownership does not increase cancer risk."
      },
      {
        "criterion_number": 20,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets, and seek assistance with pet care.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No guidance about avoiding specific animal types or seeking help when severely immunosuppressed."
      },
      {
        "criterion_number": 21,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Suggests consulting the healthcare team or a vet, but does not specifically recommend discussing with an oncologist."
      }
    ],
    "question_number": 117,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:41:03.153509",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define adjuvant therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines adjuvant therapy as additional treatment given after the primary treatment to eliminate remaining cancer cells."
      },
      {
        "criterion_number": 2,
        "description": "The response should state the goal of adjuvant therapy is to prevent cancer recurrence.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states the goal is to reduce the risk of cancer recurrence and improve long-term outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that adjuvant therapy usually occurs after surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that adjuvant therapy is given after the primary treatment such as surgery and references the postoperative context."
      },
      {
        "criterion_number": 4,
        "description": "The response should include adjuvant therapy can be chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States chemotherapy is commonly used and provides examples (gemcitabine, FOLFIRINOX)."
      },
      {
        "criterion_number": 5,
        "description": "The response should include adjuvant therapy can be radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions radiation therapy as a possible adjuvant option in select cases."
      },
      {
        "criterion_number": 6,
        "description": "The response states that guidelines recommend all patients with resected pancreatic adenocarcinoma who did not receive preoperative therapy should be offered 6 months of adjuvant chemotherapy, unless there are medical or surgical contraindications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it references NCCN guidelines recommending adjuvant chemotherapy for eligible patients, it does not specify the 6-month duration or the explicit recommendation for all resected patients who did not receive preoperative therapy, nor the unless-contraindicated clause."
      },
      {
        "criterion_number": 7,
        "description": "The response states that adjuvant systemic therapy significantly improves survival compared to surgery alone.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Cites the CONKO-001 trial showing improved survival with adjuvant gemcitabine versus surgery alone, indicating a survival benefit."
      },
      {
        "criterion_number": 8,
        "description": "The response states that the choice of adjuvant regimen should be individualized based on patient fitness and risk of toxicity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Emphasizes personalization of regimen based on overall health, cancer biology, preferences, and tolerance/side effects."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends that the user discuss this case with an oncologist or cancer specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends discussing details with his oncologist and provides a list of discussion points."
      }
    ],
    "question_number": 118,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:41:36.165840",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing constipation with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises consultation with the healthcare team/oncologist (e.g., \"Consult the Healthcare Team Immediately,\" \"Discuss with the oncologist or pain specialist,\" and \"Never self-prescribe... consult the care team\")."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing pain medications with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically recommends discussing adjustment of pain medications with the oncologist or pain specialist, including switching opioids and adjusting schedules."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that constipation is a side effect of opioid pain medications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that opioids (e.g., morphine, oxycodone) can cause constipation."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stimulant laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A bowel regimen is outlined and includes stimulant options (bisacodyl suppositories) under medical guidance."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of osmotic laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends osmotic agents including polyethylene glycol (PEG), lactulose, and magnesium citrate."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stool softeners.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Docusate sodium (a stool softener) is recommended as part of the laxative options."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that a combination of these treatments is sometimes needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While multiple options are listed and prophylactic laxative use is suggested, it does not explicitly state that a combination of laxative classes may be needed."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there are prescription medications that can directly target opioid-associated constipation.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It mentions methylnaltrexone and naloxegol, noting they target opioid receptors in the gut without affecting analgesia."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend hydration to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "There is a dedicated Hydration section with practical recommendations (sips of water, ORS/electrolyte drinks)."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend physical activity to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It encourages gentle movement such as short walks and chair exercises to stimulate motility."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that opioid-induced constipation is primarily due to reduced gut motility, and agents that increase water content or stimulate peristalsis directly address the underlying pathophysiology.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explanation of the pathophysiology (reduced gut motility) is provided, nor is there linkage of osmotic/stimulant mechanisms to addressing this."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that the American Gastroenterological Association recommends polyethylene glycol (PEG) and lactulose as effective osmotic agents, both of which significantly improve stool consistency and frequency compared to placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although PEG and lactulose are mentioned, there is no reference to AGA recommendations or efficacy versus placebo."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that soluble fiber may be considered only for patients with fiber-deficient diets, as it has limited efficacy in opioid-induced constipation due to its lack of effect on colonic motility.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It suggests soluble fiber may help and to avoid excessive insoluble fiber but does not note limited efficacy in OIC or the motility-related rationale, nor restrict use to fiber-deficient diets."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that enemas are reserved for rescue therapy and not for regular use.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It positions enemas/suppositories as options when oral laxatives fail, which aligns with rescue use rather than routine use."
      }
    ],
    "question_number": 119,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:42:40.800869",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that meditation and mindfulness can improve quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that mindfulness-based interventions improve quality of life during cancer treatment and discusses multiple QoL-related benefits (e.g., sleep, focus, coping)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that meditation and mindfulness are not anti-cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly notes they should not replace medical care, labels them as 'Not a Cure,' and states there is no evidence they alter tumor growth or treatment efficacy."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that meditation and mindfulness can help emotional well-being.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response emphasizes improvements in emotional well-being, stress/anxiety reduction, and emotional resilience."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that meditation and mindfulness demonstrate moderate improvements in anxiety, depression, cancer-related fatigue, and overall quality of life in oncology populations, with effects maintained for at least several months post-intervention.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions improvements in anxiety, depression, and quality of life, it does not address cancer-related fatigue or the durability of effects for several months post-intervention."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that meditation and mindfulness are safe, feasible, and can be integrated alongside standard cancer care to help manage both physical and psychological symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It frames mindfulness as a complementary practice alongside standard care, provides practical steps demonstrating feasibility, and notes benefits for physical symptoms (e.g., pain) and psychological symptoms (e.g., stress, anxiety)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises discussing mindfulness with the medical team/healthcare providers to align with the treatment plan, which encompasses the oncologist."
      }
    ],
    "question_number": 120,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:43:20.338426",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing their concerns with an oncology nutritionist or dietitian.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises working with a Registered Dietitian (RD) for a personalized plan and monitoring."
      },
      {
        "criterion_number": 2,
        "description": "State that pancreatic enzyme supplements can help with digesting food when there is pancreatic enzyme deficiency.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains that pancreatic cancer can impair enzyme production and that prescribed enzyme supplements (e.g., Creon, Pancreaze) help break down fats, proteins, and carbs."
      },
      {
        "criterion_number": 3,
        "description": "State that nutrition is important for maintaining strength or energy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions increased energy needs and in the final note states nutrition can support strength during treatment."
      },
      {
        "criterion_number": 4,
        "description": "State that nutrition is important for supporting the immune system.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No explicit reference to immune system support through nutrition."
      },
      {
        "criterion_number": 5,
        "description": "State that nutrition is important for maintaining weight.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes high-calorie intake to address unintentional weight loss and preserve muscle mass, implying weight maintenance."
      },
      {
        "criterion_number": 6,
        "description": "State the reasons for challenges with nutrition in patients with pancreatic cancer, including poor appetite.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes chemotherapy can reduce appetite and provides strategies like small, frequent meals."
      },
      {
        "criterion_number": 7,
        "description": "State the reasons for challenges with nutrition in patients with pancreatic cancer, including digestion difficulties.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes digestive issues (bloating, diarrhea, steatorrhea) and enzyme insufficiency leading to malabsorption."
      },
      {
        "criterion_number": 8,
        "description": "State the reasons for challenges with nutrition in patients with pancreatic cancer, including side effects of treatment like nausea.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention nausea as a treatment side effect; vomiting is mentioned but not linked to treatment side effects like nausea."
      },
      {
        "criterion_number": 9,
        "description": "State they should focus on protein intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicit 'High-Calorie, High-Protein Focus' with protein food examples."
      },
      {
        "criterion_number": 10,
        "description": "State they should focus on calorie intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Emphasizes high-calorie intake and nutrient-dense options."
      },
      {
        "criterion_number": 11,
        "description": "Recommend trying to manage nausea.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No specific advice on nausea management (e.g., antiemetics, ginger, small sips) is provided."
      },
      {
        "criterion_number": 12,
        "description": "Recommend hydration.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a dedicated hydration section recommending frequent fluids and oral rehydration solutions."
      },
      {
        "criterion_number": 13,
        "description": "Mention that patients with pancreatic cancer undergoing treatment are at high risk of malnutrition, cachexia, and weight loss, necessitating early and ongoing nutritional assessment and intervention.",
        "score_given": 0,
        "max_points": 9,
        "justification": "Notes unintentional weight loss and RD involvement but does not explicitly state high risk of malnutrition/cachexia or the need for early and ongoing assessment."
      },
      {
        "criterion_number": 14,
        "description": "Mention that dietary strategies should prioritize enteral nutrition over parenteral nutrition when oral intake is inadequate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of enteral versus parenteral nutrition."
      },
      {
        "criterion_number": 15,
        "description": "Mention that oral nutritional supplements, especially those enriched with omega-3 fatty acids, are beneficial for supporting body weight and lean body mass.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Recommends supplements like Ensure/Boost but does not note omega-3 enrichment or benefits for lean body mass."
      },
      {
        "criterion_number": 16,
        "description": "Mention that diet composition should emphasize a plant-enriched diet for overall health and cancer risk reduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not emphasize a plant-enriched diet or link it to overall health/cancer risk reduction."
      },
      {
        "criterion_number": 17,
        "description": "Mention that current evidence does not support ketogenic diets for treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No discussion of ketogenic diets or evidence regarding their use."
      }
    ],
    "question_number": 121,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:44:08.910432",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that memory issues can be associated with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions chemotherapy-induced cognitive impairment (\"chemo brain\") and names drugs (gemcitabine, 5-FU) as causes of memory lapses and brain fog."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing memory concerns with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear recommendation to consult the medical team (oncologist/neurologist), review treatment history, and perform assessments; emphasizes open communication with doctors."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that memory issues can be associated with pain medications.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically notes opioids (e.g., morphine) can cause drowsiness, confusion, or cognitive slowing."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that memory issues can be associated with poor nutrition.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States malnutrition and vitamin deficiencies (e.g., B12, folate) can impact cognition."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that memory issues can be associated with dehydration.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly mentions dehydration as a factor that can impact cognition."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that memory issues can be associated with anxiety.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists anxiety as a contributor to cognitive challenges and recommends psychological support."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that memory issues can be associated with depression.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists depression alongside anxiety as contributing to cognitive challenges."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that memory issues can be associated with fatigue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention fatigue as a cause; discusses sleep disturbance and drowsiness but not fatigue per se."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that memory issues can be associated with stress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends stress reduction as part of cognitive rehabilitation, implying stress contributes to cognitive/memory issues; references emotional toll affecting cognition."
      },
      {
        "criterion_number": 10,
        "description": "The response should cite peer-reviewed articles with links.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No citations or links to peer-reviewed literature are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that memory issues in pancreatic cancer patients are frequently related to cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that memory problems are more commonly linked to treatments or related health issues, emphasizing treatment-related causation."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention biological mechanisms underlying chemotherapy-induced cognitive changes (neurotoxicity, neuroinflammation, brain structure/connectivity changes, biomarkers/genetic predispositions).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss mechanistic pathways such as neuroinflammation, neurotoxicity, brain connectivity changes, or biomarkers/genetics."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that cognitive impairment may also be influenced by the cancer itself, paraneoplastic effects, and other factors such as age, comorbidities, and emotional distress.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions cancer-related factors and emotional distress but does not mention paraneoplastic effects, age, or comorbidities specifically."
      }
    ],
    "question_number": 122,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:44:49.634924",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ablative techniques in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines ablation as minimally invasive procedures that destroy cancer tissue and applies this to pancreatic cancer with imaging guidance and examples."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that ablative techniques in pancreatic cancer are used when surgery isn\u2019t possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes ablation as an alternative when surgery isn\u2019t feasible and for unresectable tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including radiofrequency ablation (RFA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "RFA is described with mechanism (heat via radio waves) and pancreatic cancer applications."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including microwave ablation (MWA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "MWA is described with mechanism (microwave heating) and comparative uses."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that ablative techniques are not curative.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Says 'not a cure for all cases' and 'may not eliminate all cancer cells,' but does not clearly state that ablation is not curative in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that ablative techniques in pancreatic cancer are used to manage symptoms.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions palliative use to reduce pain or obstruction."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including cryoablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cryoablation is described with mechanism (freezing) and contextual use."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these techniques are typically considered after or in conjunction with systemic chemotherapy, which remains the first-line treatment for locally advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes combination therapy with chemotherapy/radiation but does not state chemotherapy is first-line for locally advanced disease or that ablation is typically considered after it."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including irreversible electroporation (IRE).",
        "score_given": 5,
        "max_points": 5,
        "justification": "IRE is described with a basic mechanism and rationale for use near vessels/nerves."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including high-intensity focused ultrasound (HIFU).",
        "score_given": 0,
        "max_points": 5,
        "justification": "HIFU is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA delivers thermal energy via a probe to induce coagulative necrosis of tumor cells. RFA can be performed percutaneously, surgically, or via endoscopic ultrasound (EUS) guidance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mechanism of heat delivery is described but not coagulative necrosis or procedural approaches (percutaneous/surgical/EUS)."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that RFA is the most studied thermal technique and has demonstrated feasibility and safety, with some evidence of improved survival and immune modulation.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No mention of RFA being the most studied, feasibility/safety data, survival, or immune modulation."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that MWA uses electromagnetic waves to generate heat and destroy tumor tissue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States that microwaves heat tumor tissue to high temperatures, implying EM waves and tissue destruction."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that MWA is emerging as an alternative to RFA, with potential advantages in speed and ablation volume, but clinical data remain limited.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not discuss speed/ablation volume advantages or limited clinical data."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that IRE is a non-thermal technique that uses high-voltage electrical pulses to create permanent nanopores in cell membranes, leading to apoptosis.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions electric pulses and pore formation but not non-thermal nature, high-voltage, permanent nanopores, or apoptosis."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that IRE is particularly attractive for tumors near critical structures, as it spares connective tissue and vessels. It is increasingly used in locally advanced pancreatic cancer and is under investigation in randomized trials.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Notes usefulness near vessels/nerves but does not mention sparing connective tissue/vessels or its increasing use in LAPC/ongoing randomized trials."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that HIFU delivers focused ultrasound waves to induce thermal and mechanical destruction of tumor cells.",
        "score_given": 0,
        "max_points": 4,
        "justification": "HIFU mechanism is not addressed."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that HIFU is less commonly used but has shown feasibility in clinical studies.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of HIFU feasibility or usage frequency."
      },
      {
        "criterion_number": 19,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly encourages discussion with the medical team and suggests consulting another oncologist or specialist."
      }
    ],
    "question_number": 123,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:46:00.768875",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Discuss goals of care with oncology team",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends open dialogue with the medical team to ensure the care plan aligns with the patient\u2019s values and goals and mentions advance directives, indicating goals-of-care discussions."
      },
      {
        "criterion_number": 2,
        "description": "Discuss symptom management with oncology team",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises working with the medical team on pain, nausea, fatigue, digestive issues, and nutrition, clearly directing symptom management discussions to clinicians."
      },
      {
        "criterion_number": 3,
        "description": "Include information about palliative care",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends early integration of palliative care to manage symptoms and align care with goals."
      },
      {
        "criterion_number": 4,
        "description": "State that mental health professionals can help",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages professional counseling/therapy to address anxiety, depression, or grief and mentions support groups."
      },
      {
        "criterion_number": 5,
        "description": "Recommend discussing side effect management with oncology team",
        "score_given": 5,
        "max_points": 5,
        "justification": "States to discuss potential chemotherapy/surgery side effects and mitigation strategies, within the broader context of working with the medical team."
      },
      {
        "criterion_number": 6,
        "description": "Mention pancreatic cancer\u2019s aggressive nature and high symptom burden",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly state that pancreatic cancer is an aggressive malignancy with high symptom burden; focuses on management strategies without this characterization."
      },
      {
        "criterion_number": 7,
        "description": "Clarify palliative care is not hospice and can be provided at any stage",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly notes palliative care is not limited to end-of-life and recommends early integration, indicating availability alongside active treatment."
      },
      {
        "criterion_number": 8,
        "description": "Mention multidisciplinary collaboration\u2019s impact on quality of life",
        "score_given": 4,
        "max_points": 4,
        "justification": "Emphasizes a holistic approach and collaboration with a medical team; involves dietitians, palliative care, counselors, spiritual advisors, and home care services, reflecting multidisciplinary support to improve quality of life."
      },
      {
        "criterion_number": 9,
        "description": "Mention advance care planning\u2019s impact on quality of life",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends discussing advance directives/living wills to clarify preferences, aligning care with values and thereby supporting quality of life."
      }
    ],
    "question_number": 124,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:46:46.882079",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the Pancreatic Cancer Action Network (PanCAN) as a major pancreatic cancer advocacy organization.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Pancreatic Cancer Action Network is listed first under National Organizations, with description and link to pancan.org (though abbreviated as PCAN)."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing advocacy options with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises asking the medical team for referrals and explicitly includes a section to consult the healthcare team (oncologists/social workers)."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that PanCAN is a leading national organization dedicated to patient advocacy, support, research funding, and public policy initiatives for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists PanCAN\u2019s focus on patient support, advocacy, and research funding, it does not explicitly characterize PanCAN as a leading national organization nor clearly reference public policy initiatives."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that PanCAN offers structured opportunities for patients and families to engage in advocacy, including legislative outreach, awareness campaigns, and peer support programs such as the Patient and Liaison Services (PALS) program.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions advocacy training, events, PurpleStride, and contacting legislators using PCAN templates, but does not mention PALS or peer support programs, nor clearly describe PanCAN\u2019s structured advocacy programs."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the American Society of Clinical Oncology\u2019s patient-facing website, Cancer.Net, provides information on advocacy opportunities and connects patients to broader cancer advocacy networks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cancer.Net is linked, but the response does not state that it provides advocacy opportunity information or connects patients to broader advocacy networks."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that both PanCAN and Cancer.Net are specifically recommended by the American Society of Clinical Oncology in its clinical practice guidelines as key resources for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention that ASCO clinical practice guidelines specifically recommend PanCAN and Cancer.Net as key resources."
      }
    ],
    "question_number": 125,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:47:31.974285",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes that early-stage (localized) tumors are more likely operable and that advanced/metastatic disease may not qualify for surgery."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include surgery.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It presents multiple treatment modalities (surgery, chemotherapy, radiation, targeted therapy) and discusses surgical options in detail."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include chemotherapy.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Chemotherapy is discussed as preoperative (neoadjuvant), postoperative (adjuvant), and as a non-surgical option."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include radiation.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Radiation is mentioned as part of preoperative therapy and as a non-surgical option."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that chemotherapy can be used before or after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states preoperative (neoadjuvant) chemotherapy and postoperative (adjuvant) chemotherapy recommendations."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer management should involve a multidisciplinary team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends involvement of a multidisciplinary team including oncologists, surgeons, radiologists, and dietitians."
      },
      {
        "criterion_number": 7,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe the Whipple procedure.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The Whipple procedure is described with indications, organs removed, and risks/recovery."
      },
      {
        "criterion_number": 8,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe distal pancreatectomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Distal pancreatectomy is described with indications, extent of resection, and implications for glucose/digestion."
      },
      {
        "criterion_number": 9,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe total pancreatectomy.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Total pancreatectomy is described including spleen removal and the need for lifelong insulin and enzyme replacement."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that surgical resection is the only potentially curative option for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While it says surgery offers potential for cure if fully removed, it does not explicitly state that surgery is the only potentially curative option."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that deciding on surgery requires multidisciplinary evaluation and mention anatomical, biological, or patient factors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It emphasizes multidisciplinary evaluation and details anatomical (size/location, vascular invasion), biological (genetic markers), and patient factors (overall fitness)."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises involving oncologists as part of a multidisciplinary team and recommends obtaining a second opinion from a pancreatic cancer specialist."
      }
    ],
    "question_number": 126,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:48:13.284369",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes that surgery is only possible in early stages and that survival varies by stage, indicating treatment decisions depend on stage."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention that treatment depends on tumor location (e.g., head vs body/tail)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes surgery.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it lists multiple treatment options including surgery, it does not explicitly state that treatment is multimodality or combined."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Chemotherapy is listed, but the response does not explicitly state that treatment is multimodality."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes radiation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Radiation is mentioned among options, but the response does not state that treatment is multimodality."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that early, multidisciplinary management is essential to optimize outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit mention of early multidisciplinary management or coordinated team care to optimize outcomes."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that care is best coordinated at high-volume centers with expertise in pancreatic malignancies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation to seek care at high-volume or expert centers."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that symptom management is an important part of the care of patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes early palliative care, pain/symptom management, and medications for nausea, pain, and fatigue."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the basics of pancreatic cancer, including that the most common type is pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides general basics (symptoms, risk factors) but does not state that adenocarcinoma is the most common type."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how pancreatic cancer is staged based on the NCCN guidelines (version 2.2025) using AJCC 8th edition TNM staging and prognostic groups.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No TNM staging detail or AJCC/NCCN staging groups are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy with a poor prognosis, often presenting at an advanced stage.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes that pancreatic cancer is often diagnosed at later stages, but does not explicitly state it is aggressive or has a poor prognosis."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend writing down questions in advance to ensure that all concerns are addressed during consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it lists key questions and suggests bringing support to take notes, it does not explicitly recommend writing questions down in advance."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that advocacy for comprehensive testing is important, including somatic and germline genetic testing.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit recommendation for somatic and germline genetic testing is made."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to inquire about clinical trial opportunities, as participation may provide access to novel therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking the oncologist about clinical trials and includes it as a key question."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information, support services, and advocacy opportunities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "PanCAN is cited, but Cancer.Net is not mentioned."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises discussing specifics and treatment goals with an oncologist and to ask the oncologist about clinical trials."
      }
    ],
    "question_number": 127,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:49:20.290414",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic neuroendocrine tumors (pNETs) are usually sporadic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, 'Many PNETs occur sporadically (not inherited),' indicating that most are sporadic."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that pancreatic neuroendocrine tumors (pNETs) do tend to have a genetic component in a significant minority of cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes 'Approximately 10\u201330% of PNETs are associated with inherited genetic syndromes,' indicating a significant minority."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that some cases of pancreatic neuroendocrine tumors (pNETs) are associated with hereditary syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists multiple hereditary syndromes associated with PNETs."
      },
      {
        "criterion_number": 4,
        "description": "The response should include multiple endocrine neoplasia type 1 (MEN1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "MEN1 is explicitly mentioned with gene details."
      },
      {
        "criterion_number": 5,
        "description": "The response should include von Hippel-Lindau disease (VHL).",
        "score_given": 3,
        "max_points": 3,
        "justification": "VHL is explicitly mentioned with gene details."
      },
      {
        "criterion_number": 6,
        "description": "The response should include neurofibromatosis type 1 (NF1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "NF1 is explicitly mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should include tuberous sclerosis complex (TSC).",
        "score_given": 3,
        "max_points": 3,
        "justification": "TSC (TSC1/TSC2) is explicitly mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that genetic testing is available for pancreatic neuroendocrine tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated section 'Genetic Testing Availability' describes types of tests and the process."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that they have concerns about the risk of cancer, they should talk with a genetic counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends speaking with a genetic counselor and notes their role in interpreting results."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 10\u201317% of pancreatic neuroendocrine tumors (pNETs) are associated with inherited syndromes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It cites a range of 10\u201330% rather than approximately 10\u201317%."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that these inherited syndromes often present at a younger age.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states testing may be recommended if diagnosed at a young age (<50), implying earlier presentation."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that germline mutations are also found in sporadic-appearing pancreatic neuroendocrine tumors (pNETs), including mutations in DNA repair genes such as MUTYH, CHEK2, and BRCA2, as well as MEN1 and VHL.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention germline findings in sporadic-appearing cases or specific genes like MUTYH, CHEK2, or BRCA2."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that multigene panel testing is recommended, as it can identify both syndromic and non-syndromic germline variants relevant for familial risk assessment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While multi-gene panels are described, it does not explicitly recommend them for identifying both syndromic and non-syndromic germline variants for familial risk assessment."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the user discuss this case with a medical professional.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It advises consulting an oncologist or genetic counselor for review and discussion of options."
      }
    ],
    "question_number": 128,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:49:56.946275",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions the Pancreatic Cancer Action Network (PanCAN) as a source for survivor stories.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly names the Pancreatic Cancer Action Network and states their website features survivor stories, resources, and a community forum, meeting the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends asking the oncology team for additional support group recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises: 'Ask your oncologist or hospital about in-person or virtual groups for pancreatic cancer patients,' directly fulfilling this requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions Cancer Support Community (CSC) as a resource for support or survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions Gilda\u2019s Club and MyLifeLine (which are affiliated with CSC), it does not explicitly name 'Cancer Support Community' or 'CSC.'"
      },
      {
        "criterion_number": 4,
        "description": "The response mentions Let\u2019s Win! Pancreatic Cancer survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of Let\u2019s Win! Pancreatic Cancer or its survivor stories."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the American Society of Clinical Oncology\u2019s patient-facing website (www.cancer.net) as a source for stories of hope.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references the American Cancer Society but does not mention ASCO\u2019s Cancer.Net."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that organizations provide patient and survivor stories, peer support networks, and opportunities to connect with others who have faced similar diagnoses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes that PanCAN features survivor stories and a community forum, Inspire hosts survivor stories and advice, and various support groups/online platforms provide forums for sharing experiences\u2014clearly stating these organizational supports."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that peer support and shared experiences are recognized as powerful tools for maintaining motivation and a sense of hope during the cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes that 'Many people find strength in stories of resilience,' recommends support groups and moderated forums for sharing experiences, and states that feeling empowered can foster hope\u2014conveying the role of peer support/shared experiences in maintaining hope."
      }
    ],
    "question_number": 129,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:50:37.713851",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define stage IV pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response references stage IV repeatedly but does not define it as metastatic disease with spread to distant organs (e.g., liver, lungs, peritoneum)."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that the disease is not curable.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response never states that stage IV pancreatic cancer is incurable; it even mentions 'curative' treatments alongside disease-controlling care, which is not accurate for stage IV."
      },
      {
        "criterion_number": 3,
        "description": "The response should include the goal of treatment is to control the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions 'disease-controlling treatments' and focuses on extending survival, which conveys cancer control as a primary goal."
      },
      {
        "criterion_number": 4,
        "description": "The response should include the goal of treatment to improve symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Symptom improvement is emphasized through early palliative care, pain, nausea, fatigue, and GI symptom management, and overall quality-of-life focus."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the cornerstone of treatment for stage IV pancreatic cancer is systemic chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although systemic chemotherapy options are discussed first, the response does not explicitly state that systemic chemotherapy is the cornerstone/mainstay of treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response should include chemotherapy regimens listed in NCCN guidelines (version 2.2025) for treatment of metastatic pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists FOLFIRINOX and gemcitabine monotherapy, both of which are NCCN-supported regimens for metastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response should discuss that clinical trials are another option.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are clearly recommended, with examples of novel therapies and a link to ClinicalTrials.gov."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there may be targeted treatments based on genetic mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions PARP inhibitors for BRCA1/2 and immunotherapy for MSI-H, indicating treatments based on molecular alterations."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the tumor have genetic testing.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it references that mutations may be identified via genomic testing, it does not explicitly recommend tumor and/or germline genetic testing be performed."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that early palliative care referral is recommended at diagnosis to optimize symptom management, psychological support, and advance care planning.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends early integration of palliative care with details on symptom management, psychosocial support, and advance care planning."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that aggressive symptom management, such as management of pain, fatigue, nausea, and gastrointestinal symptoms is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It thoroughly addresses pain control, antiemetics, fatigue strategies, GI symptoms, and other supportive measures."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic enzyme replacement therapy should be considered for exocrine insufficiency, and nutritional support is important for maintaining weight and strength.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends pancreatic enzyme replacement (Creon/Viokase) and emphasizes working with an oncology dietitian on high-calorie/high-protein nutrition."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that psychosocial support, including counseling and peer support, is critical for both patients and families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It highlights support groups (PanCAN, ACS), family counseling, and mental health resources as important supports."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting her medical team/oncologist, including asking about clinical trials and seeking second opinions."
      }
    ],
    "question_number": 130,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:51:42.347166",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that management of pancreatic tumors involves a multidisciplinary team of surgeons, medical oncologists, and radiation oncologists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly emphasizes multidisciplinary teams and lists surgical oncologists, medical oncologists, and radiation oncologists among team members."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that outcomes are significantly improved when care is delivered by a multidisciplinary team at high-volume centers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions multidisciplinary teams and that the right team can impact outcomes, but does not reference high-volume centers or tie improved outcomes to them."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides PanCAN as a resource with description and correct link (pancan.org)."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide information for the American Cancer Society (ACS).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions the American Cancer Society as a resource for support/financial assistance, satisfying the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes a link to the NCI website (cancer.gov) and states it can be used to search for treatment centers, which meets the requirement."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that high-volume centers\u2014defined as institutions performing at least 15 pancreatic resections annually\u2014demonstrate superior survival rates, lower postoperative morbidity, improved lymphadenectomy, shorter hospital stays, and better access to adjuvant therapies.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of high-volume centers, the \u226515 resections/year definition, or the specific outcome advantages listed."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that high-volume centers are typically academic medical centers, National Cancer Institute-designated cancer centers, or hospitals with established pancreatic cancer programs.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it references NCI-designated centers, it does not tie them to the concept of high-volume centers or state the typical types of high-volume institutions."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to request referrals from local oncologists or primary care providers, who can direct patients to high-volume centers and experienced teams.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises asking PCP/oncologist for referrals, but does not state that they can direct patients specifically to high-volume centers; the high-volume element is absent."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends starting with the current oncologist and seeking second opinions, meeting the requirement."
      }
    ],
    "question_number": 131,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:52:34.863845",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly states that some chemotherapy can have negative effects on the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states, 'certain therapies (chemotherapy, radiation, targeted drugs) can impact cardiac health' and details cardiotoxic effects under 'Chemotherapy.'"
      },
      {
        "criterion_number": 2,
        "description": "The response specifically mentions that 5-fluorouracil (or \u201c5-FU\u201d) can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It lists '5-FU, capecitabine: May cause arrhythmias or hypertension.'"
      },
      {
        "criterion_number": 3,
        "description": "The response recommends monitoring for shortness of breath.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Under 'Key Symptoms to Watch For' it includes 'Shortness of breath (especially during activity or at rest).'"
      },
      {
        "criterion_number": 4,
        "description": "The response recommends monitoring for chest pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Under 'Key Symptoms to Watch For' it includes 'Chest discomfort or pain (angina-like symptoms).' "
      },
      {
        "criterion_number": 5,
        "description": "The response recommends monitoring for fast heart rate.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Under 'Key Symptoms to Watch For' it lists 'Rapid or irregular heartbeat (palpitations).'"
      },
      {
        "criterion_number": 6,
        "description": "The response recommends monitoring for dizziness.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Under 'Key Symptoms to Watch For' it includes 'Dizziness, lightheadedness, or fainting.'"
      },
      {
        "criterion_number": 7,
        "description": "The response recommends monitoring for unusual fatigue.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Under 'Key Symptoms to Watch For' it lists 'Fatigue or weakness that\u2019s sudden or worsening.'"
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends discussing any new symptom with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises 'Report symptoms immediately,' but does not explicitly state to discuss new symptoms with the oncology team specifically."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends discussing any concerning symptom with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it urges reporting symptoms promptly, it does not explicitly say to discuss concerning symptoms with the oncology team."
      },
      {
        "criterion_number": 10,
        "description": "The response states that electrocardiograms can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends a baseline 'Electrocardiogram (ECG) ... to assess heart rhythm and detect early issues.'"
      },
      {
        "criterion_number": 11,
        "description": "The response states that echocardiogram can be used to monitor heart function.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends an 'Echocardiogram: Measures heart function (ejection fraction) and structure' and repeats during therapy if high-risk drugs are used."
      },
      {
        "criterion_number": 12,
        "description": "The response states that blood pressure can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises 'Regular blood pressure checks and monitoring for hypertension' and home tracking of blood pressure."
      },
      {
        "criterion_number": 13,
        "description": "The response specifically mentions that capecitabine can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It states '5-FU, capecitabine: May cause arrhythmias or hypertension.'"
      },
      {
        "criterion_number": 14,
        "description": "The response specifically mentions that some targeted therapies can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It lists targeted therapies (bevacizumab, everolimus, sunitinib) and notes hypertension, heart failure, or heart strain."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly states that pancreatic cancer treatments can cause at least three cardiac issues: heart failure, arrhythmias, hypertension, ischemia, or cardiomyopathy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions cardiomyopathy (anthracyclines), arrhythmias and hypertension (5-FU/capecitabine), and heart failure (bevacizumab)."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly states that the risk of cardiac side effects is higher in patients with preexisting cardiovascular conditions or those receiving specific agents such as anthracyclines or fluoropyrimidines.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It indicates higher risk with specific agents, e.g., 'anthracyclines: High risk of cardiomyopathy' and fluoropyrimidines causing arrhythmias/hypertension."
      },
      {
        "criterion_number": 17,
        "description": "The response explicitly recommends baseline cardiac risk assessment and regular monitoring with echocardiography, cardiac biomarkers, and clinical evaluation for early/asymptomatic cardiac dysfunction.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It recommends baseline ECG, echocardiogram, and cardiac biomarkers (troponin, BNP/NT-proBNP), with repeat echocardiograms during/after treatment and ongoing clinical monitoring."
      },
      {
        "criterion_number": 18,
        "description": "The response explicitly references recommendations from the American College of Cardiology and/or the American Society of Clinical Oncology, stating that pretherapy evaluation and ongoing surveillance are recommended for patients with cardiovascular risk factors or those receiving cardiotoxic agents.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of ACC or ASCO guidelines or their specific recommendations."
      },
      {
        "criterion_number": 19,
        "description": "The response explicitly recommends that the user discuss the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states 'Work closely with her oncologist and cardiologist' and 'Involve a cardio-oncologist,' which explicitly encourages discussion with oncology."
      }
    ],
    "question_number": 132,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:53:35.629278",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that treatment decisions are personal decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States \"the decision is theirs alone\" and emphasizes respecting their agency; also notes the journey is deeply personal."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend listening to their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly recommends active listening and creating a safe space for feelings and fears."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend validating their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a section titled \"Validate Their Feelings\" with example validating statements."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend respecting their autonomy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises to honor their wishes and avoid pressure or guilt-tripping; emphasizes their decision."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supporting their quality of life.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Focuses on comfort, symptom relief, aligning care with personal values, and practical/psychosocial support\u2014core quality-of-life elements."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend offering reassurance.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Reassures that stopping treatment is not \"giving up\" and emphasizes unwavering support and dignity."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that clear, compassionate communication about prognosis, treatment options, and goals of care is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Promotes open, non-judgmental dialogue; suggests discussing goals of treatment with the medical team; mentions terminal prognosis and planning for what's next."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that transitioning to hospice care may be appropriate when the focus shifts entirely to comfort and dignity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Discusses hospice as an option when stopping treatment/terminal prognosis and frames care around comfort and dignity."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that hospice provides intensive symptom management, psychosocial and spiritual support, and home-based care, while avoiding non-beneficial interventions such as hospitalization or aggressive procedures.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions hospice can provide comprehensive care at home or in a facility, but does not explicitly state intensive symptom management, psychosocial/spiritual support as hospice services, nor avoidance of hospitalization/aggressive procedures."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention addressing practical issues related to end-of-life decision-making, such as managing costs and accessing resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses advance directives, offers specific organizations/resources, and explicitly mentions financial planning and assistance for palliative/hospice care and bills."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussing the decision with their oncologist and palliative care specialist."
      }
    ],
    "question_number": 133,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:54:02.729201",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing legal planning with a qualified professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple recommendations to consult professionals are present, including 'Consult an attorney' for the will, 'Work with an estate planning or elder law attorney,' and 'Consult a financial advisor or elder law attorney.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should include that laws can vary state to state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly notes 'varies by state' for will execution, instructs to 'check your state\u2019s requirements' for advance directives, mentions 'state-specific form' for healthcare proxy, and that 'Medicaid rules vary by state.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should include a description of an advance healthcare directive or living will.",
        "score_given": 5,
        "max_points": 5,
        "justification": "An 'Advance Directive (Living Will)' section explains it outlines preferences for medical care when incapacitated, including life-sustaining treatment, pain management, and organ donation."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of a medical power of attorney.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The 'Healthcare Proxy (Durable Power of Attorney for Healthcare)' section describes appointing someone to make medical decisions if the patient cannot do so and emphasizes choosing a trusted person."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of a durable power of attorney for finances.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The 'Financial Power of Attorney (POA)' section explains authorizing someone to manage financial affairs and notes that a durable POA remains effective if incapacitated."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of a last will and testament.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The 'Last Will and Testament' section clearly states its purpose for asset distribution, naming an executor, and guardianship for minors."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that POLST forms translate preferences into actionable medical orders for emergency settings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of POLST/MOLST or that preferences are converted into clinician orders for emergency/acute settings."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these documents ensure that care aligns with the patient\u2019s values and preferences, especially if the patient loses decision-making capacity due to disease progression or treatment effects.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response repeatedly emphasizes ensuring wishes are respected and appointing a proxy who understands values, and specifies use when incapacitated or unable to communicate."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that it is essential to have ongoing, structured conversations about goals of care, as patient preferences may change over time.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it suggests 'Communicate Openly' with family and to update a letter of intent periodically, it does not explicitly call for ongoing, structured goals-of-care conversations or note that preferences may change over time."
      }
    ],
    "question_number": 134,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:54:27.966049",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises to \"ask the oncology team\" about clinical trials and includes a general prompt to seek guidance from healthcare providers, which encompasses discussing concerns with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states: \"don\u2019t hesitate to ask healthcare providers or social workers for guidance,\" directly recommending consultation with a social worker."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend discussing their concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a dedicated step: \"Work with a Financial Counselor\" and references the Patient Advocate Foundation for free guidance."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that patient advocacy organizations can help and include information on the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Under Non-Profit Organizations, it names the Pancreatic Cancer Action Network with URL (pancan.org) and phone number, and frames it as offering financial navigation services and grants."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that patient advocacy organizations can help and include information on CancerCare.org.",
        "score_given": 0,
        "max_points": 3,
        "justification": "CancerCare.org is not mentioned anywhere in the response."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that patient advocacy organizations can help and include information for the American Cancer Society.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The American Cancer Society is included with a description of assistance and the URL (cancer.org)."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that patients with pancreatic cancer who are facing significant medical bills have access to several financial assistance options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "The opening sentence explicitly states there are \"several financial assistance options\" for those dealing with medical bills related to pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that financial assistance options include patient assistance programs (PAPs) from independent charity foundations, pharmaceutical company programs, and direct grants from nonprofit organizations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists manufacturer PAPs, independent charity foundations (e.g., HealthWell Foundation), and nonprofit grants (e.g., PanCAN), covering all specified categories."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that these programs may provide co-payment assistance, help with insurance premiums, and sometimes support for non-medical expenses such as transportation or housing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While co-pay assistance and non-medical support (transportation and lodging via ACS) are mentioned, help with insurance premiums is not referenced."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that eligibility is generally based on annual household income (often up to 400\u2013500% of the federal poverty level), insurance status, and physician endorsement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No eligibility criteria such as FPL thresholds, insurance status requirements, or physician endorsement are discussed for assistance programs."
      }
    ],
    "question_number": 135,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:55:06.489278",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe PARP inhibitors as targeted agents that block the PARP enzyme involved in repairing single-strand DNA breaks.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response accurately describes PARP inhibitors as targeted therapies that block PARP enzymes involved in DNA repair and explains synthetic lethality. Although it does not explicitly say 'single-strand DNA breaks,' the mechanism and role in DNA repair are correctly conveyed."
      },
      {
        "criterion_number": 2,
        "description": "Mention use in advanced pancreatic cancer when there is a germline BRCA mutation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions BRCA1/2 mutations but does not specify germline mutations as the indication for use in pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "Mention use as maintenance therapy in metastatic pancreatic cancer with germline BRCA1/2 mutation and no progression after at least 16 weeks of first-line platinum-based chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not discuss maintenance therapy, the requirement for non-progression after \u226516 weeks of platinum-based chemotherapy, or the germline BRCA1/2 context. It also incorrectly states PARP inhibitors are not FDA-approved for pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "Mention that comprehensive germline testing for BRCA mutations is recommended for all patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it recommends genetic testing, it focuses on tumor profiling and does not specifically recommend comprehensive germline testing for all pancreatic cancer patients."
      },
      {
        "criterion_number": 5,
        "description": "Mention that ASCO specifically recommends olaparib based on the POLO trial showing improved PFS without compromising quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references the POLO trial incorrectly as an ovarian cancer study and does not mention ASCO recommendations, progression-free survival benefit, or quality-of-life findings."
      },
      {
        "criterion_number": 6,
        "description": "Mention other PARP inhibitors and combinations are investigational, and reference NCCN V2.2025 first-line systemic therapy principles across performance status groups.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Although it notes ongoing studies and off-label use, it does not state that other PARP inhibitors/combos remain investigational per guidelines, nor does it reference NCCN first-line therapy recommendations across performance status groups."
      },
      {
        "criterion_number": 7,
        "description": "Recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises discussing the case with his oncologist and suggests specific questions to ask."
      }
    ],
    "question_number": 136,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:55:47.033885",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend considering proximity to the treatment center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions considering proximity to medical facilities and distance to the center."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend considering housing options near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly advises looking into patient housing and short-term rentals near the center, and evaluating renting vs. buying."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend considering transportation to and from the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses transportation, including public transit, parking, distance, and hospital transport services."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering financial considerations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a full section on financial considerations, including cost of living, employment/income, grants, and assistance."
      },
      {
        "criterion_number": 5,
        "description": "The response should include insurance coverage.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically discusses insurance coverage, out-of-network coverage, payment plans, and financial assistance programs."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend considering the social support system near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages identifying local support groups and considering proximity to family/friends for emotional support."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN) Patient services.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions PanCAN and notes they offer resources, support groups, and financial aid, which constitutes providing information."
      },
      {
        "criterion_number": 8,
        "description": "The response should provide information for the American Cancer Society (ACS) page on finding a doctor.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions the American Cancer Society generally but does not reference or provide information about the ACS page on finding a doctor."
      },
      {
        "criterion_number": 9,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No link or reference to the NCI website for locating NCI-designated cancer centers."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not reference NCCN, version 2.2025, or the specific recommendation about high-volume centers and imaging."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly mentions patient preferences, goals of care, or quality of life as central to the decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a 'Quality of Life' section and emphasizes prioritizing needs based on the patient's condition and balancing emotional well-being."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly addresses open communication about expectations, prognosis, or the impact of relocation on daily life.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advises staying in communication with the medical team but does not explicitly address discussing expectations, prognosis, or daily-life impacts."
      },
      {
        "criterion_number": 13,
        "description": "The response explicitly mentions continuity of care, transferring medical records, coordinating with the current care team, or ensuring uninterrupted access to medications/supportive services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Directly addresses continuity of care and discussing transfer plans with the current healthcare team."
      },
      {
        "criterion_number": 14,
        "description": "The response explicitly mentions access to multidisciplinary care and/or clinical trials as important factors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights multidisciplinary teams and participation in clinical trials as important considerations."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly recommends discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends involving her oncologist in planning and decision-making."
      }
    ],
    "question_number": 137,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:56:16.408998",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the anxiety with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises: \"Discuss anxiety with their oncologist\" and to collaborate with the medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response should include considering relaxation techniques prior to the scan.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes deep breathing, mindfulness/meditation, progressive muscle relaxation, grounding exercises, and distraction before the scan."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend asking the oncology team about what will happen during the scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to \"Discuss what the scan entails\" and to \"Ask their medical team for clear, written information\" about the procedure."
      },
      {
        "criterion_number": 4,
        "description": "The response should include talking to a mental health professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages seeing a therapist, especially one specializing in cancer or medical anxiety; specifically mentions CBT."
      },
      {
        "criterion_number": 5,
        "description": "The response should include talking to a social worker.",
        "score_given": 0,
        "max_points": 1,
        "justification": "No mention of a social worker."
      },
      {
        "criterion_number": 6,
        "description": "The response should discuss medical interventions to help with anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that oncologists may offer sedation for scans, which is a medical intervention for anxiety."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that severe anxiety related to upcoming scans is highly prevalent or very common among patients with pancreatic cancer or cancer in general.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that \"anxiety in such situations is common and okay,\" normalizing scan-related anxiety."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least two of the following resource types for managing treatment-related anxiety: psychotherapy, psychoeducation, supportive therapy, or integrative modalities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions psychotherapy (CBT) and integrative modalities (mindfulness/meditation, progressive muscle relaxation)."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly identifies Cognitive Behavioral Therapy (CBT) as the first-line or primary intervention for treatment-related anxiety in pancreatic cancer or cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While CBT is described as effective, it is not labeled as first-line nor attributed to any oncology guideline."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions mindfulness-based interventions (MBIs) or mindfulness-based stress reduction (MBSR) as recommended for anxiety in cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mindfulness is mentioned, but there is no reference to MBIs/MBSR being guideline-recommended or any attribution to a major guideline."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that pharmacologic therapy may be considered for severe anxiety or when first-line psychological interventions are insufficient, and that this is a secondary option with weaker evidence, as per a major oncology guideline.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions possible sedation for scans but does not frame pharmacotherapy as a secondary, weaker-evidence option nor attribute to a guideline."
      }
    ],
    "question_number": 138,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:57:03.199383",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include open communication with the family.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises holding age-appropriate family conversations, regular emotional check-ins, and setting boundaries, directly addressing open communication."
      },
      {
        "criterion_number": 2,
        "description": "The response should include maintaining daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends keeping daily structure (mealtimes, bedtime, activities) and adapting traditions, clearly meeting the routine criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should include continuing to do activities that bring enjoyment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Encourages enjoyable activities for the patient (music, reading) and family (movie nights, small celebrations, new traditions), fulfilling the enjoyment criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should include letting the support system help.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Promotes delegating tasks, using support networks, leveraging tools like Meal Train/Lotsa Helping Hands, and considering professional help, fully addressing reliance on support systems."
      },
      {
        "criterion_number": 5,
        "description": "The response should include ensuring self-care for the patient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically encourages the patient to engage in enjoyable activities and emotional support (therapy/support groups), meeting patient self-care."
      },
      {
        "criterion_number": 6,
        "description": "The response should include ensuring self-care for the support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises the caregiver to prioritize rest, exercise, reflection, and consider therapy/support groups, meeting caregiver self-care."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that pancreatic cancer imposes profound emotional, social, and practical upheaval on both the patient and family, disrupting established routines, roles, and relationships.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Acknowledges shifting routines, role changes (sharing responsibilities), and emotional strain across the family in the context of pancreatic cancer, sufficiently conveying the disruption and upheaval."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that early integration of supportive and palliative care is recommended.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of palliative care or early integration of supportive care teams."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that referrals to registered dietitians and symptom management specialists can help minimize disruptions to family life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to dietitians, nutrition, or symptom management specialists."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that caregiver and family support resources can provide education, emotional support, and practical assistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cites PanCAN and CancerCare for counseling, education, financial/practical help, and support groups, meeting the criterion."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the literature notes persistent gaps in support for caregivers and families affected by pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention evidence or literature about persistent gaps in caregiver/family support."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit recommendation to discuss the case with an oncologist."
      }
    ],
    "question_number": 139,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:57:45.064947",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing genetic counseling with the oncology team or healthcare provider in the context of pancreatic cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises asking the loved one\u2019s oncologist for a referral to a genetic counselor, linking the process to the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "Accurately describe the role of a genetic counselor as a trained professional who helps with understanding genetic aspects, provides guidance/support, and assists with risk assessment and testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly outlines counselors\u2019 roles in risk assessment, education, informed decision-making, testing coordination, and emotional support."
      },
      {
        "criterion_number": 3,
        "description": "Mention that genetic counseling involves a structured evaluation of personal and family cancer history.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit section on reviewing personal diagnosis details and detailed family cancer history, including ages and relationships."
      },
      {
        "criterion_number": 4,
        "description": "Mention that genetic counseling involves education about hereditary cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses hereditary risk, inheritance patterns, and examples such as BRCA-related hereditary breast-ovarian syndrome."
      },
      {
        "criterion_number": 5,
        "description": "Mention that genetic counseling involves a discussion of the risks, benefits, and limitations of genetic testing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated informed consent section with benefits, risks (including VUS and insurance concerns), and limitations."
      },
      {
        "criterion_number": 6,
        "description": "Mention that genetic counseling addresses psychological and ethical aspects, including communication of results to family and consideration of reproductive implications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses psychological support, confidentiality/ethical guidelines, family implications and cascade testing, communication to relatives, and acknowledges issues affecting children; also notes risk-reducing surgeries with reproductive implications."
      },
      {
        "criterion_number": 7,
        "description": "Mention that the American Society of Clinical Oncology recommends that this process be conducted with providers experienced in hereditary cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ASCO or its recommendation about using providers experienced in hereditary cancer syndromes."
      },
      {
        "criterion_number": 8,
        "description": "Mention that ASCO recommends germline genetic testing early in the disease course, ideally using a multigene panel including BRCA1/2 and other pancreatic cancer risk genes.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not cite ASCO, does not recommend early testing or multigene panel; additionally suggests testing only if family history indicates, which conflicts with current ASCO guidance for PDAC."
      }
    ],
    "question_number": 140,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:58:09.798926",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that neuropathy is a common side effect from certain chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that many chemotherapy drugs (e.g., paclitaxel, cisplatin, vincristine) can damage nerves, indicating chemo-induced neuropathy is common."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises consulting the oncologist and medical team to review treatments and side effects."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that neuropathy from chemotherapy can be managed by dose reduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions adjusting the treatment plan by reducing dosage."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that neuropathy from chemotherapy can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of schedule modification (e.g., changing intervals, treatment breaks)."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that neuropathy from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the oncologist might switch to a less neurotoxic regimen."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that neuropathy from chemotherapy can be managed using supportive medications, including gabapentin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Lists gabapentin as a supportive medication for neuropathic pain."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Does not specifically link oxaliplatin-induced neuropathy to supportive medications like SNRIs; oxaliplatin is mentioned inaccurately as a pre-medication."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Pregabalin is mentioned generally but not specifically for oxaliplatin-induced neuropathy."
      },
      {
        "criterion_number": 10,
        "description": "The response should include physical therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends physical therapy or light stretching to improve strength and reduce discomfort."
      },
      {
        "criterion_number": 11,
        "description": "The response should include occupational therapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Occupational therapy is not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that peripheral neuropathy could arise from chemotherapy (notably platinum agents), direct tumor involvement, or paraneoplastic syndromes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions chemotherapy and tumor compression/spread; includes a platinum agent example (cisplatin), but does not mention paraneoplastic syndromes."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that peripheral neuropathy significantly impairs quality of life and functional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state the impact of neuropathy on quality of life or functional status."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that management should be individualized, balancing efficacy, side effects, and patient-specific factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Uses phrases like 'tailored approach' and 'individual variability'; discusses balancing treatment efficacy and side effects."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that Duloxetine is the only agent with moderate evidence-based recommendation for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions duloxetine as an option but does not state it is the only agent with moderate evidence for CIPN."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that the typical starting dose of duloxetine is 30 mg daily, titrated to 60 mg daily as tolerated, with slow tapering recommended to avoid withdrawal symptoms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No dosing or tapering guidance for duloxetine is provided."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that other pharmacologic options include tricyclic antidepressants (nortriptyline, amitriptyline), gabapentin, and pregabalin, which are supported by guidelines for cancer-related neuropathic pain but have inconclusive evidence.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Lists amitriptyline, gabapentin, and pregabalin but does not note guideline context or that evidence is inconclusive."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical agents such as lidocaine and capsaicin patches may be considered for localized neuropathic pain, though evidence is limited.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Includes lidocaine and capsaicin for localized pain but does not state that evidence is limited."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that opioids are not preferred for chronic neuropathic pain due to risk of tolerance, dependence, and adverse effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Advises caution with opioids but does not state they are not preferred for chronic neuropathic pain."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that interventional approaches, notably neurolytic celiac plexus block, are effective for refractory pain in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No interventional pain approaches, such as celiac plexus block, are mentioned."
      }
    ],
    "question_number": 141,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:59:04.327160",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define curative treatment as interventions with the intent to eradicate the disease and achieve long-term survival.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states curative treatment aims to eliminate/eradicate the cancer with hope of a cure or long-term remission, adequately conveying intent to eradicate and long-term survival."
      },
      {
        "criterion_number": 2,
        "description": "Include that curative treatment can include surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Surgery (e.g., Whipple procedure) is explicitly listed under curative treatment."
      },
      {
        "criterion_number": 3,
        "description": "Mention that in curative treatment, surgery is often followed by adjuvant chemotherapy to reduce recurrence risk.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes chemotherapy/radiation used after surgery to destroy remaining cancer cells or reduce recurrence risk, which aligns with adjuvant therapy."
      },
      {
        "criterion_number": 4,
        "description": "Define palliative treatment as focusing on improving quality of life when cure is not possible.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly states the goal is to manage symptoms, improve quality of life, and provide comfort\u2014not to cure."
      },
      {
        "criterion_number": 5,
        "description": "Mention that palliative treatment is the case for the majority of patients with locally advanced unresectable or metastatic disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes pancreatic cancer is often advanced and curative treatment is challenging, it does not explicitly state that the majority with locally advanced unresectable or metastatic disease receive palliative treatment."
      },
      {
        "criterion_number": 6,
        "description": "Include that the primary goal of palliative treatment is to prolong survival, control symptoms, and maintain quality of life.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes symptom control and quality of life and adds that palliative care can extend life, thereby covering all three elements."
      },
      {
        "criterion_number": 7,
        "description": "Include that palliative treatment can include chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Chemotherapy is discussed under curative intent and as concurrent with pain management, but it is not explicitly identified as a palliative treatment option."
      },
      {
        "criterion_number": 8,
        "description": "Include that palliative treatment can include radiation for local control or pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Radiation is mentioned only in the curative context; palliative radiation for local control or pain is not specified."
      },
      {
        "criterion_number": 9,
        "description": "Include that palliative treatment can include pain management.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Pain management is explicitly listed under palliative treatment (medications or nerve blocks)."
      },
      {
        "criterion_number": 10,
        "description": "Mention that palliative approaches include endoscopic or surgical procedures to relieve biliary or gastric outlet obstruction, and comprehensive supportive care for pain, nutrition, and psychosocial needs.",
        "score_given": 0,
        "max_points": 4,
        "justification": "While supportive care for pain, nutrition, and emotional/spiritual needs is included, there is no mention of endoscopic or surgical procedures to relieve biliary or gastric outlet obstruction."
      },
      {
        "criterion_number": 11,
        "description": "Mention that ASCO emphasizes early integration of palliative care for all patients with advanced disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ASCO and early integration recommendations are not referenced."
      },
      {
        "criterion_number": 12,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises talking to her oncologist and suggests coordinated care with palliative specialists."
      }
    ],
    "question_number": 142,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T15:59:38.932991",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a detailed Cost and Financial Planning section covering treatment fees, travel, accommodation, follow-up care, comparisons, and funding options."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment decisions with your oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises consulting the current oncologist about options and sharing results with the local oncologist; reiterated in final recommendations."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the stage of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention assessing or confirming the disease stage or how stage affects eligibility or benefit."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the type of cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not explicitly recommend confirming histologic type (e.g., adenocarcinoma vs neuroendocrine) or subtype; mentions mutations but not cancer type."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding the reputation of the clinic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes identifying reputable centers, JCI accreditation, and affiliations with leading institutions."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the qualifications of the providers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends inquiring about the center\u2019s experience with pancreatic cancer and verifying accreditation and affiliations, which reflect provider qualifications."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the details of the experimental treatments, including types of drugs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists specific experimental modalities and drugs (e.g., checkpoint inhibitors pembrolizumab, nivolumab) and describes investigational approaches."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the evidence supporting the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises reviewing published studies, evidence basis, survival/benefit data, and checking peer-reviewed publications and trial registries."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the potential side effects of the experimental treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directs readers to review potential side effects and plan for emergency care if complications arise."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend understanding the safety of the drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses safety through discussion of risks, liability, emergency care protocols, and ethical oversight/IRB."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding the legal protections of the country.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers regulatory status, IRB/ethical oversight, informed consent, liability, and documentation language."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the availability of medical records.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises ensuring documentation is in a language you understand, to document everything, and to plan how results will be shared with the local oncologist."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the logistics of traveling abroad for treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Provides guidance on visas, travel, accommodations, interpreters, and scheduling."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention considering your loved one\u2019s health and travel suitability, as long travel can be taxing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address whether the patient\u2019s health status allows for long-distance travel or the strain of travel."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention considering if the other country has specialized high-quality pancreatic cancer care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Highlights seeking reputable, specialized centers and cites leading institutions and countries known for high standards."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention considering visa barriers when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly instructs to ensure necessary visas and travel documents."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention considering local accommodations when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises planning for accommodations near the treatment center."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention considering cultural barriers when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses language and communication barriers, including need for interpreters and language proficiency."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention considering challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Directly discusses post-treatment monitoring, sharing results with local oncologist, and emergency care planning."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention considering social support challenges when traveling abroad for treatment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions general emotional support resources but does not address the specific challenge of reduced social support due to traveling abroad."
      }
    ],
    "question_number": 143,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:00:56.834271",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe why treatments for pancreatic cancer can increase infection risk, including immunosuppression due to chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that treatment can cause low white blood cell counts (neutropenia) and links this to infection risk; references chemotherapy (e.g., mouth sores common with chemotherapy) and immune suppression."
      },
      {
        "criterion_number": 2,
        "description": "Recommend hand hygiene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends frequent, thorough handwashing with soap and water for at least 20 seconds."
      },
      {
        "criterion_number": 3,
        "description": "Recommend avoiding sick contacts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises avoiding crowds but does not specifically recommend avoiding contact with sick individuals."
      },
      {
        "criterion_number": 4,
        "description": "Recommend being up to date on age-appropriate vaccinations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises ensuring up-to-date inactivated vaccines (flu, pneumonia) and avoiding live vaccines while immunosuppressed."
      },
      {
        "criterion_number": 5,
        "description": "Recommend discussing the infections with the oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages regular follow-ups, reporting symptoms early (including any fever), and consulting the oncologist for personalized advice."
      },
      {
        "criterion_number": 6,
        "description": "Recommend food safety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed food safety guidance (cook thoroughly, avoid high-risk foods, proper storage, avoid unpasteurized products)."
      },
      {
        "criterion_number": 7,
        "description": "Recommend adherence with prophylactic medications if prescribed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that prophylactic antibiotics may be prescribed during neutropenia and to follow the oncologist\u2019s advice closely, implying adherence when prescribed."
      },
      {
        "criterion_number": 8,
        "description": "Mention avoiding exposure to fungal spores, especially for neutropenic patients, by avoiding high-spore environments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises avoiding fresh flowers, plants, and moldy items that can harbor fungi, aligning with avoiding fungal spore exposure."
      },
      {
        "criterion_number": 9,
        "description": "Mention that antimicrobial prophylaxis is not needed for most solid tumors if risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not state that prophylaxis is generally unnecessary for most solid tumors with short-duration neutropenia."
      },
      {
        "criterion_number": 10,
        "description": "Mention that footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to lack of benefit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address that these specific interventions lack evidence and are not recommended."
      }
    ],
    "question_number": 144,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:01:27.314565",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes the combination of immune checkpoint blockade with chemotherapy as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit section on 'Immunotherapy + Chemotherapy' cites pembrolizumab combined with standard regimens (e.g., FOLFIRINOX, gemcitabine/nab-paclitaxel) and related trials."
      },
      {
        "criterion_number": 2,
        "description": "The response describes the combination of immune checkpoint blockade with radiation as a current research strategy in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Radiation is mentioned as being paired with 'immunotherapy' but checkpoint inhibitors are not explicitly specified; the criterion requires explicit immune checkpoint blockade with radiation."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the combination of immune checkpoint blockade with other novel agents (e.g., targeted therapies, immune modulators, or agents targeting the tumor microenvironment) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple examples provided: KRAS inhibitors with pembrolizumab, CD40 agonists with checkpoint inhibitors, CSF-1R inhibitors, VEGF and hedgehog pathway agents paired with immunotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly defines immunotherapy as a treatment that uses the body\u2019s immune system to attack cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit definition stating that immunotherapy uses the body's immune system to attack cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with MSI-high tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of pembrolizumab approval for MSI-high pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with dMMR (deficient mismatch repair) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of pembrolizumab approval for dMMR pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with TMB-high (tumor mutational burden-high) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of pembrolizumab approval for TMB-high tumors."
      },
      {
        "criterion_number": 8,
        "description": "The response specifically mentions clinicaltrials.gov as a resource for finding immunotherapy clinical trials.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly references ClinicalTrials.gov as a platform to identify trials."
      },
      {
        "criterion_number": 9,
        "description": "The response specifically mentions the PanCan clinical trial finder as a resource for finding immunotherapy clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions the Pancreatic Cancer Action Network (PanCAN) generally but does not specifically cite the PanCAN Clinical Trial Finder."
      },
      {
        "criterion_number": 10,
        "description": "The response describes immune checkpoint blockade as a current strategy for studying immunotherapy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details multiple checkpoint inhibitors (PD-1/PD-L1, CTLA-4) and their combinations under investigation."
      },
      {
        "criterion_number": 11,
        "description": "The response describes adoptive cellular therapy (e.g., CAR-T cell therapy or modified T-cells) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly mentions CAR-T cell therapy targeting mesothelin/EGFR and combinations with checkpoint inhibitors."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that current research on immunotherapy combinations for patients with pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment (TME) and enhancing antitumor immune responses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States the TME suppresses immune responses and discusses strategies (e.g., CD40, CSF-1R, stromal targeting) to overcome this and enhance immunity."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery, with early results suggesting potential improvements in disease-free and overall survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neoadjuvant use before surgery or outcomes like disease-free/overall survival."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cancer vaccines are under investigation as an immunotherapy approach for pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses neoantigen vaccines and mRNA-based personalized vaccines under investigation."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting an oncologist and discussing eligibility for clinical trials."
      }
    ],
    "question_number": 145,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:02:09.859164",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the goal of the study.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly asks, 'What is the primary goal of this study?' under Purpose & Design."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the phase of the trial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks, 'What phase is the trial in?' and notes implications for safety, efficacy, and risks."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the eligibility requirements of the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a section on 'Eligibility & Exclusion Criteria' with specific questions about inclusion/exclusion, current treatments, and requirements."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the potential side effects of the treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under 'Risks & Benefits' asks about potential risks/side effects and serious risks, and comparison to standard treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding if there are additional tests required to participate in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks, 'How often will follow-up appointments or tests be required?' and addresses treatments/procedures, implying additional study-related testing."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding if there are travel costs associated with the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically asks about costs including transportation and lodging; also mentions travel reimbursement."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the evidence supporting the trial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not directly prompt asking about existing evidence, prior data, or rationale supporting the trial."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the kind of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks, 'What treatments or procedures will my father receive?' with examples (drug, surgery, radiation, placebo, standard care)."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the visit schedule of the trial.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Addresses duration, time commitment, clinic visits, follow-ups, and how often appointments/tests are required."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly states that research studies are designed to determine if a new medical strategy, treatment, or device is safe and/or effective for humans.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit statement defining research studies as determining safety and/or efficacy."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that clinical trials are essential for improving, optimizing, or advancing current and/or future cancer therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not explicitly state the essential role of clinical trials in advancing therapies."
      },
      {
        "criterion_number": 12,
        "description": "The response includes the question: \u201cHow will participation impact current treatment and care?\u201d",
        "score_given": 6,
        "max_points": 6,
        "justification": "Addresses this concept with questions like 'Will his standard care be adjusted?' and 'Could his current treatments interfere with the study?'"
      },
      {
        "criterion_number": 13,
        "description": "The response includes the question: \u201cWhat are the implications for family members, especially if genetic testing is involved?\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions family involvement and genetic eligibility requirements but does not ask about implications for family members if genetic testing is involved."
      },
      {
        "criterion_number": 14,
        "description": "The response recommends discussing the case with an oncologist or relevant healthcare professional to review trial details and discuss pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting the father\u2019s oncologist to review credibility, risks, and alignment with the treatment plan."
      }
    ],
    "question_number": 146,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:02:55.973774",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe non-opioid medications for pain control, including acetaminophen.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly lists acetaminophen as a non-opioid option and notes its role for mild to moderate pain with liver monitoring."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe non-opioid medications for pain control, including NSAIDs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Names NSAIDs (ibuprofen, naproxen) and provides considerations for use in pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe non-opioid medications for neuropathic pain, including gabapentin.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions gabapentin (and pregabalin) specifically for neuropathic pain modulation."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe non-opioid medications for neuropathic pain, including anti-depressants.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists antidepressants for neuropathic pain (duloxetine and amitriptyline) with rationale."
      },
      {
        "criterion_number": 5,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including nerve blocks.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Identifies interventional procedures including nerve blocks and celiac plexus blocks for abdominal pain."
      },
      {
        "criterion_number": 6,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including radiation therapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Radiation therapy is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should include non-pharmacologic therapies, including acupuncture.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Acupuncture is specifically listed as a non-pharmacologic approach with potential benefit."
      },
      {
        "criterion_number": 8,
        "description": "The response should include non-pharmacologic therapies, including psychological support.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes CBT, mindfulness/relaxation, and support groups, addressing psychological support."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing symptom management with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes coordination with the healthcare team, explicitly including oncologists, and advises requesting an oncology-led pain management plan."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe non-opioid medications for neuropathic pain, including pregabalin, duloxetine, nortriptyline, and amitriptyline.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pregabalin, duloxetine, and amitriptyline but does not include nortriptyline."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical agents, including lidocaine and capsaicin patches, can be considered for localized neuropathic pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists topical agents (lidocaine patches and capsaicin) for localized pain; while capsaicin is noted as a cream rather than a patch, both agents are included for localized pain management."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that corticosteroids are reserved for specific indications such as spinal cord compression or inflammatory pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Corticosteroids and their specific indications are not discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that antioxidant supplementation may reduce painful attacks in select cases, though evidence is limited and should be considered adjunctive.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Antioxidant supplementation is not addressed; turmeric is mentioned but without discussing antioxidant use for painful attacks or evidence limitations."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that interventional and procedural approaches are particularly relevant in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights interventional procedures including celiac plexus blocks within a pancreatic cancer context, underscoring their relevance."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that neurolytic celiac plexus block is supported by randomized trials for opioid-sparing pain relief.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Celiac plexus block is mentioned, but there is no reference to neurolytic technique, randomized trial support, or opioid-sparing outcomes."
      },
      {
        "criterion_number": 16,
        "description": "The response should include non-pharmacologic therapies, including physical therapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Physical therapy is explicitly recommended with examples of gentle exercise and tailored plans."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend discussing symptom management with a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises consulting a palliative care specialist and explains their role in non-opioid pain management."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that cognitive-behavioral therapy and stress management are effective adjuncts.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Specifically mentions CBT and mindfulness/relaxation techniques as helpful strategies to manage pain and distress."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that areas that need further research include the long-term comparative effectiveness of nonopioid and integrative modalities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of research gaps or the long-term comparative effectiveness of nonopioid and integrative approaches."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that effective pain management in pancreatic cancer requires regular assessment and individualized planning.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes individualized care, regular communication, dynamic adjustments, and a formal pain management plan."
      }
    ],
    "question_number": 147,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:03:58.818196",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing psychological concerns about the children with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises starting with the loved one\u2019s healthcare team for referrals and mentions hospital social workers, but it does not explicitly recommend discussing the children\u2019s psychological concerns with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends professional counseling and mentions mental health professionals (e.g., therapist, counselor, psychologist, psychiatrist).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends counseling and therapy, mentions school counselors, referrals to therapists, and family therapy, fulfilling the requirement to reference mental health professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends support groups and cites ACS and CancerCare offering groups for children, teens, and families, which applies to teens with a parent with cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends involving school counselors for support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises consulting school counselors for referrals and emphasizes school support, including access to a counselor."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions cancersupportcommunity.org as a resource.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions the Cancer Support Community helpline, it does not reference cancersupportcommunity.org nor tie CSC specifically to teen support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions PanCAN (Pancreatic Cancer Action Network) patient services as a resource.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions PanCAN and links to pancan.org, but does not specifically reference PanCAN Patient Services as a resource."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that informal support from family, friends, and teachers is highly valued by adolescents.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Although it encourages open communication and school involvement, it does not state that adolescents highly value informal support from family, friends, and teachers."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that technology-based resources, such as online support communities and apps, can supplement in-person support and are increasingly used by adolescents for connection and information.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists online communities (e.g., MyCancerCircle, PatientsLikeMe, Reddit) and apps (Calm, Headspace) and recommends a mix of in-person groups and online communities, indicating supplementation and adolescent use."
      }
    ],
    "question_number": 148,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:05:06.720752",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines ctDNA as DNA from cancer cells in blood and as a biomarker for diagnosis, monitoring, or recurrence.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines ctDNA as fragments of DNA shed by cancer cells into the bloodstream and describes its use for monitoring and tracking progression/recurrence."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly states ctDNA can be used for mutation testing in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that the blood is sequenced to identify mutations and discusses tailoring therapies based on mutations (e.g., BRCA)."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly states ctDNA can provide prognostic information about recurrence risk or detect minimal residual disease after treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It notes ctDNA can detect tiny amounts of cancer DNA and track recurrence even before scans show changes, which aligns with MRD/early recurrence detection concepts."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly states ctDNA can be used to monitor response to treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It explicitly mentions monitoring treatment response and detecting resistance during targeted therapy."
      },
      {
        "criterion_number": 5,
        "description": "States that per NCCN guidelines, ctDNA is only recommended for mutation testing in pancreatic cancer if a biopsy sample is not available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of NCCN guidance or the specific recommendation about using ctDNA only when tissue is not available."
      },
      {
        "criterion_number": 6,
        "description": "Mentions ctDNA is noninvasive and can expedite testing because no need to retrieve archival blocks or arrange for new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes ctDNA is less invasive and avoids repeated biopsies, but does not state that testing is expedited nor mention archival blocks."
      },
      {
        "criterion_number": 7,
        "description": "Mentions copy-number changes are harder to assess in cfDNA and fusion testing may be limited in current cfDNA tests.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of copy-number variant detection challenges or fusion testing limitations."
      },
      {
        "criterion_number": 8,
        "description": "Mentions ctDNA may miss low-level cancers or not detect all mutations, and there may be false negative or false positive results.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions sensitivity issues and low shedding, but does not explicitly address false negatives or false positives."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that not all hospitals offer ctDNA testing and that not all insurances cover them.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of availability across hospitals or insurance coverage."
      },
      {
        "criterion_number": 10,
        "description": "Mentions ctDNA testing is under active research and not yet standard of care for all cancer patients.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes the role in pancreatic cancer is evolving and may be used in research, but does not explicitly state it is not standard of care for all cancer patients."
      },
      {
        "criterion_number": 11,
        "description": "Recommends discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directly advises discussing the rationale and implications with the oncologist and includes a 'Discuss with the Oncologist' section."
      }
    ],
    "question_number": 149,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:06:02.481180",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends designating a single point person (e.g., care coordinator, family member, or friend) to coordinate care and serve as the primary contact for health-related matters.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It states: \"Assign a central point of contact (e.g., the primary oncologist or a family member) to facilitate communication between hospitals.\""
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies the lead oncologist at the primary treating hospital as the coordinator and recommends multidisciplinary team meetings involving oncologists and other specialists."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends keeping an organized, centralized medical record of all relevant documents (e.g., test results, treatment plans, medication lists, doctor notes).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises keeping a centralized digital or physical file with test results, treatment plans, medications, and provider contacts."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends discussing or arranging the transfer of medical records with each hospital involved.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to use HIPAA authorization forms and to contact each hospital\u2019s medical records department to request and transfer records."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends carrying or maintaining an up-to-date medication list.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends maintaining a medication log (doses, times, side effects) and ensuring all providers are aware of current medications."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly mentions nurse navigators or patient navigators as resources for care coordination.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It mentions nurse navigators and patient navigators as contacts who can streamline care and help with scheduling."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that effective coordination of care between multiple hospitals for a patient with pancreatic cancer requires addressing several systemic and logistical challenges.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It frames the process as complex and emphasizes addressing communication and logistics explicitly (e.g., scheduling, insurance, transport), highlighting logistical/system-level challenges."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the lack of shared electronic health records is a significant barrier.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it suggests using patient portals and HIPAA forms, it does not explicitly state that lack of shared EHRs is a significant barrier."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the lack of shared electronic health records impedes seamless information exchange, and the risk of inconsistent recommendations when care is split between high-volume centers and community hospitals.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It does not mention EHR-related impediments or the specific risk of inconsistent recommendations between high-volume centers and community hospitals."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention to facilitate doctor-to-doctor communication.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It recommends multidisciplinary team meetings and real-time updates via secure platforms, which facilitate direct clinician-to-clinician communication."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention to ask for a summary note after every visit and share it with all the providers.",
        "score_given": 0,
        "max_points": 8,
        "justification": "It advises bringing a notebook to take personal notes but does not instruct asking for after-visit summaries to share with all providers."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to use PanCAN or NCI for personalized advice on coordinating care, finding specialists, and accessing clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions PanCAN as a resource for support and navigating care but does not explicitly recommend using PanCAN/NCI for finding specialists or clinical trials."
      }
    ],
    "question_number": 150,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:07:13.451778",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that weight loss can occur due to impaired absorption due to pancreatic enzyme deficiency.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly states weight loss can occur due to impaired digestion from reduced pancreatic enzyme production (malabsorption)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic exocrine insufficiency leads to deficiencies in fat-soluble vitamins or micronutrients and explicitly recommends pancreatic enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While PERT is explicitly recommended and vitamin deficiencies are mentioned, the response does not explicitly state that pancreatic exocrine insufficiency leads to deficiencies in fat-soluble vitamins or micronutrients."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that appetite stimulants can sometimes be helpful.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of appetite stimulants (e.g., megestrol, mirtazapine, dronabinol) or that they can be helpful."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that appetite stimulants may be considered for refractory cases or due to potential side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of considering appetite stimulants in refractory cases or potential side effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to consult the medical/oncology team and to report weight changes to the care team, satisfying the requirement."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there can be many causes of losing weight in patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes multiple causes including malabsorption, metabolic changes, obstruction, and treatment-related factors."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that losing weight can be due to the cancer itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions cancer-related metabolic changes as a cause of weight loss."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that weight loss can occur as a side effect of chemotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not state that chemotherapy can cause weight loss; instead suggests it may help with weight maintenance."
      },
      {
        "criterion_number": 9,
        "description": "The response should state the patient should try and get sufficient protein intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends smoothies/shakes with added protein and highlights protein in nutrient-dense options."
      },
      {
        "criterion_number": 10,
        "description": "The response should state the patient should try and get sufficient calorie intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Advises high-calorie, nutrient-dense foods and small frequent meals."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that nutrition/protein supplements can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests oral supplements and protein-enriched shakes as helpful options."
      },
      {
        "criterion_number": 12,
        "description": "The response does not explicitly state the patient should discuss changes to their diet with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response recommends working with a dietitian and consulting doctors but does not explicitly instruct discussing dietary changes with the oncology team."
      },
      {
        "criterion_number": 13,
        "description": "The response should discuss concerns with a palliative care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages involvement of palliative care for supportive needs."
      },
      {
        "criterion_number": 14,
        "description": "States that patients with pancreatic cancer are at high risk of malnutrition, cachexia, and weight loss, and explicitly mentions the need for early and ongoing nutritional assessment/intervention.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state high risk of malnutrition/cachexia or the need for early and ongoing nutritional assessment/intervention."
      },
      {
        "criterion_number": 15,
        "description": "Explicitly recommends prompt referral to a registered dietitian or nutritionist for individualized evaluation/counseling, or states that nutritional support is a cornerstone of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends working with a registered dietitian for tailored planning and includes RD in the multidisciplinary team."
      },
      {
        "criterion_number": 16,
        "description": "Clearly states that early and aggressive nutritional intervention is essential to reduce further weight/muscle loss, improve tolerance to oncologic therapies, and optimize survival or quality of life.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not clearly state that early and aggressive nutritional intervention is essential or detail benefits to therapy tolerance/survival."
      },
      {
        "criterion_number": 17,
        "description": "Explicitly states that enteral nutrition (tube feeding) should be prioritized over parenteral nutrition (IV feeding) when oral intake is inadequate, and mentions at least one benefit of enteral nutrition.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions enteral and parenteral options but does not explicitly prioritize enteral feeding or state a specific benefit of enteral nutrition."
      },
      {
        "criterion_number": 18,
        "description": "Recommends oral nutritional supplements and specifically mentions omega-3 fatty acids as beneficial for supporting body weight or lean body mass.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of omega-3 fatty acids."
      },
      {
        "criterion_number": 19,
        "description": "Recommends discussing the case with an oncologist or dietitian/nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends consulting the oncology team and working with a registered dietitian."
      }
    ],
    "question_number": 151,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:09:11.914269",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing massage therapy with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises discussing massage therapy with the oncologist/care team and repeats this in 'Next Steps' and 'Final Note'."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using a massage therapist who has experience with oncology patients.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Recommends a licensed therapist with oncology experience and specifically references 'oncology massage'."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding massage if the person has a fever.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States to avoid massage during fever and lists fever under 'Red Flags'."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend avoiding massage if the person has an infection.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises avoiding massage with active infections in both considerations and 'Red Flags'."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend avoiding massage if the person has excessive pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists 'Uncontrolled pain' as a red flag requiring avoidance of massage."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend avoiding massage if the person has a clot or deep vein thrombosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions increased clotting risk and avoiding prolonged pressure on legs but does not explicitly advise avoiding massage in the presence of a known clot/DVT."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend avoiding massage over the tumor.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises avoiding areas near tumors and avoiding pressure on tumors."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend avoiding massage over sensitive areas.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Recommends avoiding pressure on swollen lymph nodes and avoiding recently operated or radiated areas, which are sensitive."
      },
      {
        "criterion_number": 9,
        "description": "States that massage therapy is generally considered safe for patients undergoing treatment for pancreatic cancer when performed by trained professionals, and explicitly mentions that serious adverse events are extremely rare.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not state that massage is generally safe when performed by trained professionals, nor that serious adverse events are extremely rare."
      },
      {
        "criterion_number": 10,
        "description": "States that evidence from randomized controlled trials or meta-analyses shows massage therapy can reduce pain, anxiety, and fatigue, and may improve quality of life in cancer patients, and explicitly mentions that the certainty of evidence is low and benefits are typically moderate.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No reference to RCTs/meta-analyses, evidence certainty, or magnitude of benefit."
      },
      {
        "criterion_number": 11,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions bleeding risk (e.g., low platelets) as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends consulting oncology team and lists low platelet counts (bleeding/bruising risk) as a red flag."
      },
      {
        "criterion_number": 12,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions unstable bone lesions as a specific safety concern.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention unstable bone lesions."
      }
    ],
    "question_number": 152,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:10:03.844445",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe personalized medicine approaches in pancreatic cancer, including tumor genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains personalized medicine and details genomic testing/molecular profiling of the tumor, including methods like NGS and liquid biopsy."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that precision medicine, or personalized oncology, tailors cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opening paragraph explicitly states tailoring treatment to tumor genetic makeup to improve effectiveness and reduce side effects."
      },
      {
        "criterion_number": 3,
        "description": "The response should include somatic testing for patients with locally advanced pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specifically address locally advanced disease or indicate somatic testing for this group."
      },
      {
        "criterion_number": 4,
        "description": "The response should include somatic testing for patients with metastatic pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention metastatic disease or recommend somatic testing specifically for metastatic candidates."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit recommendation that all patients receive both germline and somatic testing regardless of family history."
      },
      {
        "criterion_number": 6,
        "description": "The response should include germline testing for inherited pancreatic cancer syndromes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Germline testing and inherited syndromes are not discussed."
      },
      {
        "criterion_number": 7,
        "description": "The response should include germline testing is recommended for all patients with confirmed pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not recommend germline testing for all confirmed pancreatic cancer patients."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that mutations found by somatic testing can sometimes be targeted with medications.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States targeted therapies can be selected based on genomic profiling results and provides examples, indicating somatic alterations can be targeted."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that based on genetic testing and molecular profiles, targeted therapies can be given.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly connects molecular profiling to targeted therapy choices and lists specific classes/agents."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that patients with certain germline mutations are candidates for targeted therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions BRCA1/2 mutations and PARP inhibitors but does not specify germline mutations as the basis for candidacy."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that FDA-approved targeted therapies include PARP inhibitors (e.g., olaparib) for patients with germline BRCA1/2 mutations, typically as maintenance therapy following platinum-based chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Lists PARP inhibitors for BRCA1/2 but omits the FDA-approved indication specifying germline status and platinum-based maintenance context."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of NTRK fusions or larotrectinib/entrectinib."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that immune checkpoint inhibitors (pembrolizumab, dostarlimab) are approved for dMMR/MSI-H PDAC, a rare but important subset.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions checkpoint inhibitors generally and biomarkers like PD-L1/TMB, but does not specify the dMMR/MSI-H indication or name dostarlimab."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that sotorasib is an emerging agent for KRAS G12C-mutated pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not reference sotorasib or KRAS G12C."
      },
      {
        "criterion_number": 15,
        "description": "The response should include that clinical trials may be testing drugs targeting certain mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights clinical trials, basket trials, and precision medicine trials targeting specific molecular alterations."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises asking the oncologist about molecular profiling and working with a multidisciplinary team."
      }
    ],
    "question_number": 153,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:11:13.397155",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that diarrhea is a common side effect from certain chemotherapy drugs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that diarrhea can stem from chemotherapy but does not explicitly state it is a common side effect of certain chemotherapy drugs."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that diarrhea can be managed with anti-motility agents such as loperamide.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response recommends loperamide as a first-line anti-diarrheal, meeting the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that dietary modifications include the elimination of lactose-containing products and high-osmolar supplements.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It advises avoiding dairy if lactose intolerance is suspected but does not clearly recommend eliminating lactose-containing products broadly, nor does it mention eliminating high-osmolar supplements."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that loperamide is given starting at 4 mg followed by 2 mg every 4 hours or after each unformed stool, not exceeding 16 mg per day.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Although it gives a starting dose of 4 mg then 2 mg after each loose stool, it incorrectly lists a maximum of 8 mg/day and omits the every-4-hours option; it does not state the 16 mg/day maximum."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that diarrhea from chemotherapy can be managed by dose reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit mention of chemotherapy dose reduction as a management strategy for diarrhea."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that diarrhea from chemotherapy can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of modifying the chemotherapy schedule as a management strategy."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that diarrhea from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of switching to an alternate chemotherapy regimen to manage diarrhea."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that diarrhea can be associated with pancreatic enzyme deficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It identifies malabsorption due to insufficient pancreatic enzymes as a relevant issue in this context, implying association with diarrhea."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that diarrhea associated with pancreatic enzyme deficiency can be improved with pancreatic enzyme supplementation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly suggests pancreatic enzyme supplements (e.g., Creon) may help when pancreatic enzymes are insufficient."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in patients with exocrine pancreatic insufficiency, pancreatic enzyme replacement therapy (PERT) should be initiated and titrated to symptom control, as this can significantly reduce steatorrhea and improve nutritional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "PERT titration, impact on steatorrhea, and improvement in nutritional status are not discussed."
      },
      {
        "criterion_number": 11,
        "description": "The response should discuss symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly emphasizes consulting the medical/oncology team, including discussing symptoms and management adjustments."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that if diarrhea progresses to grade 3 or 4 or persists after 24\u201348 hours of loperamide, aggressive management is recommended.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to CTCAE grading or persistence after 24\u201348 hours of loperamide as a trigger for aggressive management."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that aggressive management includes intravenous fluids for dehydration, octreotide, and empiric antibiotics if infection is suspected.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It mentions intravenous fluids but does not mention octreotide or empiric antibiotics as part of aggressive management."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that octreotide is initially given as 100\u2013150 \u03bcg subcutaneously three times daily, with escalation up to 500 \u03bcg if needed.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Octreotide and its dosing are not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that stool studies and laboratory evaluation for infectious etiologies should be performed in severe cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises stool tests for infectious etiologies such as C. difficile, aligning with this criterion."
      }
    ],
    "question_number": 154,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:12:02.483652",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the treatment plan with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting the oncologist to discuss stage, prognosis, and the treatment plan, and how it affects ability to work."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the prognosis.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Directly mentions discussing prognosis with the oncologist and using it to guide decisions (e.g., end-of-life planning if poor prognosis)."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the goals of treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Addresses treatment goals by discussing palliative/supportive care and focusing on quality of life when appropriate, implying consideration of curative vs palliative aims."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering the impact of stopping work on health insurance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically discusses health insurance implications including COBRA, Medicaid/Medicare, and affordability considerations if leaving employment."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering the impact of stopping work on income.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights income replacement options (SSDI, short-term disability), budgeting, and emergency funds, directly addressing income impact."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the expected physical effects of treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Notes side effects like fatigue, nausea, and pain, and discusses effects on energy levels and physical capacity."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the expected mental effects of treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions cognitive function impacts and recommends counseling/support groups for anxiety, depression, and identity changes."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend considering employer-sponsored medical leave.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly references FMLA, workplace accommodations, unpaid leave, and phased retirement as alternatives to resignation."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly mentions at least two common symptoms of pancreatic cancer, such as pain, fatigue, dietary issues, or weight loss, and states that these symptoms can impair daily functioning and/or the ability to work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists fatigue, nausea, and pain and states these may make working difficult, linking symptoms to work impairment."
      },
      {
        "criterion_number": 10,
        "description": "The response states that multiple factors should be systematically evaluated to support informed, patient-centered decision-making when considering stopping work for pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with the need to evaluate multiple factors and provides a structured, comprehensive framework for decision-making."
      },
      {
        "criterion_number": 11,
        "description": "The response states that discussions should elicit or consider the patient\u2019s personal values, goals, and/or preferences, including the importance of quality of life versus life extension.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Addresses personal values by emphasizing quality of life, purpose/identity, and tailoring decisions to the patient's goals; contrasts quality of life considerations especially in poor prognosis."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions that financial and practical considerations are critical in the decision to stop working.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Multiple sections emphasize financial planning, insurance, budgeting, and practical supports as central to the decision."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends referral to, or consultation with, financial counselors or social workers to help navigate financial challenges, access resources, or manage cancer care costs.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends consulting financial planners and social workers specializing in cancer care."
      },
      {
        "criterion_number": 14,
        "description": "The response states that patients should be informed about disability benefits, workplace accommodations, and/or community support programs that may help with financial or practical challenges.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifies disability benefits (SSDI), workplace accommodations (ADA), FMLA, and support groups, covering practical/financial assistance options."
      }
    ],
    "question_number": 155,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:12:46.154026",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor profiling as involving comprehensive molecular analysis of tumor tissue and often blood to identify genetic, transcriptomic, and proteomic alterations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes profiling of tumor and blood (biopsy and liquid biopsy) and lab methods (NGS for genetic/DNA, IHC for proteins/proteomics). It also references subtyping based on gene expression, indicating transcriptomic analysis. Note: there is a separate inaccuracy about KRAS G12D inhibitors, but it does not negate meeting this criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a tumor biopsy can be used for tumor profiling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that a biopsy (tissue sample) is typically taken from the tumor."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that circulating tumor DNA can be used for tumor profiling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that a liquid biopsy (blood test analyzing circulating tumor DNA) is used as a less invasive alternative."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that tumor biopsies can be tested for mutations in the DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes NGS and gene panels identifying mutations in tumor DNA and mentions detecting genetic changes (mutations)."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that tumor biopsies can be tested for mutations in the RNA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not state RNA mutation testing; only mentions gene expression subtyping without referring to RNA mutation assays."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that tumor biopsies can be tested for the presence of certain proteins.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifies immunohistochemistry to detect protein markers such as HER2 and mismatch repair proteins."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that circulating tumor DNA can be tested for mutations in DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions liquid biopsy analyzing circulating tumor DNA in the context of mutation profiling, implying mutation testing of ctDNA."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that tumor profiling helps identify alterations that may be actionable for therapy selection or clinical trial enrollment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that profiling can guide targeted therapies and facilitate clinical trial eligibility."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that routine molecular tumor profiling is now feasible and recommended for all patients with pancreatic cancer, regardless of stage or surgical eligibility, and include NCCN v2.2025 workup details.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not reference NCCN v2.2025, universal profiling recommendations, or the detailed imaging/staging and workup pathway."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 20\u201328% of patients have actionable findings, and those who receive matched therapies based on tumor profiling have significantly improved progression-free and overall survival compared to those who do not.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No mention of the 20\u201328% actionable rate or survival benefits with matched therapy."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that actionable alterations include BRCA1/2 mutations, NTRK, BRAF, FGFR2, RET, NRG1, and ALK fusions, and mismatch repair deficiency (dMMR/MSI-H).",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions BRCA1/2 and dMMR/MSI-H, but omits NTRK, BRAF, FGFR2, RET, NRG1, and ALK fusions."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises discussing results with his oncologist and mentions multidisciplinary review."
      }
    ],
    "question_number": 156,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:13:38.439229",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the connection between chronic inflammation of the pancreas and the risk of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly links chronic pancreatitis to increased pancreatic cancer risk: 'Chronic Inflammation Links: Conditions like chronic pancreatitis or obesity-related inflammation may elevate pancreatic cancer risk.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that inflammation plays a central or significant role in pancreatic cancer pathogenesis, progression, or clinical outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states inflammation contributes to 'tumor growth, progression, and treatment resistance' and describes a pro-cancer tumor microenvironment driven by inflammatory factors."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that there is no treatment for targeting inflammation in pancreatic cancer per NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not mention NCCN guidelines or state that there is no NCCN-recommended treatment specifically targeting inflammation in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that inflammation is implicated in many cancers and include symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes inflammation's role in pancreatic cancer and touches on symptom management (pain, cachexia), it does not explicitly state that inflammation is implicated in many cancers nor does it list general inflammation symptoms."
      },
      {
        "criterion_number": 5,
        "description": "The response should explicitly mention that strategies to manage inflammation in pancreatic cancer are being researched or investigated in clinical or translational research.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It references 'Emerging Therapies,' 'Ongoing Studies,' and 'clinical trials targeting inflammation' with mention of checking NCT databases, clearly indicating active research."
      },
      {
        "criterion_number": 6,
        "description": "The response should explicitly mention that strategies involving cytokine signaling are being researched, investigated, or studied for managing inflammation in pancreatic cancer.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It specifically cites 'Cytokine Inhibitors: Drugs blocking TNF-\u03b1 or IL-6 (e.g., certolizumab) are under investigation,' directly addressing cytokine signaling strategies."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly recommend that the user discuss this case with an oncologist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises to consult the oncology team and includes 'Oncologist Input: Treatment plans must be personalized,' meeting the criterion."
      }
    ],
    "question_number": 157,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:14:08.031650",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes at least three specific benefits of art therapy for cancer patients, such as emotional expression, stress reduction, coping skills, mood improvement, self-esteem, social connection, or mindfulness/relaxation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response lists multiple specific benefits: emotional expression/communication, stress and anxiety reduction (including mindfulness/relaxation), distraction from pain, sense of control/empowerment, social connection/support, and enhanced quality of life with mood improvement and reduced depression. This clearly exceeds three distinct benefits."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that art therapy is not an anti-cancer therapy, does not treat cancer itself, or is not a substitute for medical cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states, \"Complementary, Not Replacement: Art therapy should support medical treatment, not replace it,\" clearly indicating it is not a substitute for cancer treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response provides the name \u201cAmerican Art Therapy Association\u201d and states or implies that this organization can be used to find a qualified art therapist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response mentions the \"American Art Therapy Association\" and notes that such organizations \"can provide referrals,\" directly implying it can be used to find a qualified therapist."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly recommends that the user discuss the use of art therapy with an oncologist or healthcare provider involved in the cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises to \"Consult the Medical Team\" and to share the interest with \"the oncologist or care coordinator\" and also encourages discussing it with the healthcare team to align with the care plan."
      }
    ],
    "question_number": 158,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:14:27.944907",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The person should contact the insurance company to understand the reason for the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly instructs to contact the insurance company for a detailed explanation of the denial and to review the plan\u2019s formulary and coverage criteria."
      },
      {
        "criterion_number": 2,
        "description": "The person should file an appeal as an option to remedy the denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises filing an internal appeal, requesting expedited review, and pursuing an external review if needed."
      },
      {
        "criterion_number": 3,
        "description": "The person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends asking the oncologist to help with appeals, write letters of medical necessity, and request formulary exceptions."
      },
      {
        "criterion_number": 4,
        "description": "The person should work with their oncology team to understand the denial.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests engaging the healthcare team for advocacy and appeals, it does not explicitly state working with the oncology team to understand the denial reasons."
      },
      {
        "criterion_number": 5,
        "description": "Patient assistance programs should be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically recommends patient assistance programs and names resources such as RxAssist, NeedyMeds, and manufacturer programs."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly defines prior authorization as a process in which insurers require approval before a medication is covered.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Prior authorization is not mentioned or defined."
      },
      {
        "criterion_number": 7,
        "description": "The response states that prior authorization denials or delays are common in oncology care and mentions at least one impact.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss prior authorization denials/delays or their prevalence/impact in oncology."
      },
      {
        "criterion_number": 8,
        "description": "The person should contact the oncologist to request a referral to a financial navigator or social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the doctor to connect them with patient navigators and notes that hospitals have social workers or case managers to help with insurance and financial issues."
      },
      {
        "criterion_number": 9,
        "description": "The appeal process involves submitting a formal appeal with supporting evidence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response describes gathering medical records and letters of medical necessity and submitting an appeal, meeting the requirement."
      },
      {
        "criterion_number": 10,
        "description": "If appeals are unsuccessful, alternative access strategies should be pursued, such as patient assistance programs or manufacturer co-pay cards.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It presents alternative access strategies (patient assistance programs, manufacturer programs, nonprofits). While not explicitly conditional on failed appeals, the alternatives are clearly offered."
      },
      {
        "criterion_number": 11,
        "description": "The response names at least one patient advocacy organization that can help connect the user with resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names the Patient Advocate Foundation, American Cancer Society, Pancreatic Cancer Action Network, and CancerCare."
      }
    ],
    "question_number": 159,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:15:23.133692",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly advises consulting the oncology team for evaluation, management decisions, and before trying new products."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe common chemotherapy-related side effects, including dry skin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists chemo-related rashes, dryness, and hand-foot syndrome explicitly."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe management of dry skin, including using thick emollient creams.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends fragrance-free moisturizers including petroleum jelly and ceramide-based creams; also mentions thick emollients."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe management of dry skin, including avoiding hot water.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises avoiding hot water (in the context of HFS and cooling); applicable to dry skin care."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe management of dry skin, including avoiding scrubbing the skin.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly advise avoiding scrubbing; only mentions gentle cleansers and patting dry."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe common chemotherapy-related side effects, including hand-foot syndrome associated with certain chemotherapy drugs like capecitabine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly identifies HFS and specifically names capecitabine as a culprit."
      },
      {
        "criterion_number": 7,
        "description": "The response should include management of hand-foot syndrome, including the use of urea-based creams.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly recommends urea-based creams (e.g., Eucerin 10% urea)."
      },
      {
        "criterion_number": 8,
        "description": "The response should include management of hand-foot syndrome, including the use of lanolin-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention lanolin-based creams."
      },
      {
        "criterion_number": 9,
        "description": "The response should include management of hand-foot syndrome, including the use of supportive footwear.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions loose, breathable socks but not supportive footwear or cushioned shoes."
      },
      {
        "criterion_number": 10,
        "description": "The response should include management of hand-foot syndrome, including the use of gloves at night.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests gloves but not specifically wearing them at night."
      },
      {
        "criterion_number": 11,
        "description": "The response should include management of hand-foot syndrome, including avoiding friction on affected areas.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly advise avoiding friction; focuses on cooling and loose clothing."
      },
      {
        "criterion_number": 12,
        "description": "The response should include management of hand-foot syndrome, including dose reduction of chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States severe reactions may require dose reduction, drug substitution, or interruption; also mentions pausing treatment for severe HFS."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe radiation dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines radiation dermatitis with redness, dryness, tenderness, peeling in the treated area."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe management of radiation dermatitis, including the use of creams approved by the radiation team.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides examples of topical agents but does not specify using only creams approved by the radiation team."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe management of radiation dermatitis, including avoiding sun exposure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises sunscreen use and avoiding sun exposure in the treated area."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly names at least one chemotherapy agent as a cause of skin changes, such as gemcitabine, FOLFIRINOX, or nab-paclitaxel.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Names 5-FU, capecitabine, and taxanes as causes of skin reactions."
      },
      {
        "criterion_number": 17,
        "description": "The response lists at least four distinct manifestations of chemotherapy-related skin changes, with at least two from the specified list.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions dryness, rashes, hand-foot syndrome, itching, peeling, redness, and blistering\u2014at least four distinct manifestations."
      },
      {
        "criterion_number": 18,
        "description": "The response states that skin changes may also be due to other causes such as infection, other medications, or unrelated skin disorders/systemic diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state alternative causes beyond cancer treatments; infection is mentioned as a complication of broken skin, not as an alternative cause of skin changes."
      },
      {
        "criterion_number": 19,
        "description": "The response states that prevention of skin problems is important and should begin at or before therapy initiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages early intervention but does not state starting preventive measures at or before therapy initiation."
      },
      {
        "criterion_number": 20,
        "description": "The response recommends using gentle, pH-balanced cleansers, regular moisturization, and broad-spectrum sun protection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends gentle (mild, fragrance-free) cleansers, regular moisturization, and broad-spectrum SPF 30+ sun protection."
      },
      {
        "criterion_number": 21,
        "description": "The response mentions prophylactic cooling measures during taxane infusions for hand-foot syndrome, supported by guidelines or evidence.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests cooling for symptom relief but does not mention prophylactic cooling during taxane infusions."
      },
      {
        "criterion_number": 22,
        "description": "The response states that correct identification of skin changes is important to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Emphasizes identifying the cause but does not explicitly link correct identification to avoiding unnecessary discontinuation of effective therapy."
      },
      {
        "criterion_number": 23,
        "description": "The response recommends hydration with emollients, topical corticosteroids, antihistamines, and oatmeal baths for dry skin and itch.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions emollients, antihistamines, and topical steroids but not oatmeal baths."
      },
      {
        "criterion_number": 24,
        "description": "The response states that for acne-like rash, oral tetracyclines and topical steroids are effective treatments.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention acneiform rash or oral tetracyclines."
      },
      {
        "criterion_number": 25,
        "description": "The response states that for hand-foot syndrome, urea creams, topical steroids, and cooling procedures are beneficial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Recommends urea creams and cooling but does not include topical steroids specifically for HFS."
      },
      {
        "criterion_number": 26,
        "description": "The response states that mild immune-related rashes can be managed with topical corticosteroids, urea-containing creams, and antihistamines for pruritus.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes that immunotherapy can cause rashes but does not provide specific management with topical steroids, urea creams, and antihistamines for mild immune-related rashes."
      },
      {
        "criterion_number": 27,
        "description": "The response states that severe immune-related rashes can be managed with systemic corticosteroids and, if refractory, immunomodulators, and that therapy interruption may be necessary for severe reactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address systemic corticosteroids or immunomodulators for severe immune-related rashes; only mentions potential dose reduction or interruption generally."
      }
    ],
    "question_number": 160,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:16:41.782814",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a structured overview of the TME including stroma, immune contexture, hypoxia/angiogenesis, and metabolic alterations, and explains their roles."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the tumor microenvironment in pancreatic cancer critically influences both treatment options and outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States TME plays a critical role in aggressiveness and treatment resistance, limits drug penetration and immunotherapy efficacy, and guides therapeutic strategies."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that the pancreatic cancer tumor microenvironment has a dense desmoplastic stroma which can act as a physical barrier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions a dense, fibrous stroma (desmoplastic reaction) acting as a physical barrier that limits drug penetration."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of stromal cells, including fibroblasts.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention fibroblasts or cancer-associated fibroblasts."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of stromal cells, including pancreatic stellate cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Pancreatic stellate cells are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of immune cells within the tumor microenvironment of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies Tregs, MDSCs, and TAMs and their immunosuppressive roles."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer can be immunosuppressive.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Labels the TME as an immunosuppressive environment that suppresses anti-tumor immunity and limits checkpoint inhibitor effectiveness."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the tumor microenvironment architecture creates physical and biochemical barriers that limit drug delivery, promote immune evasion, and drive resistance to chemotherapy, targeted therapy, and immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Describes the stroma limiting drug delivery, immunosuppressive cells promoting immune evasion, and resistance to chemotherapy and immunotherapy; notes limited benefit/resistance to targeted agents (e.g., Hedgehog inhibitors)."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Repeatedly links TME features (stroma, hypoxia, immune suppression) to treatment resistance and reduced efficacy."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in metastasis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions CXCL12\u2013CXCR4 inhibitors disrupting tumor\u2013stroma interactions to potentially reduce metastasis, implying TME involvement in metastatic behavior."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in relapse.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Relapse is not explicitly discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that drugs targeting the tumor microenvironment in pancreatic cancer have not yet shown benefit to patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes hyaluronidase with mixed results, anti-angiogenic agents with modest efficacy, and Hedgehog inhibitors with limited benefit, indicating lack of clear patient benefit to date."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that many studies are underway evaluating the role of tumor microenvironment-targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States many TME-targeted strategies are in early-phase trials and encourages discussion of clinical trials."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that current and emerging treatment strategies increasingly focus on remodeling the tumor microenvironment to improve therapeutic efficacy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Highlights current and emerging TME-targeted combinations and stroma/immune-modifying approaches to enhance efficacy."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that locoregional therapies such as radiation and ablation may also alter the tumor microenvironment, increasing antigen presentation and immune response.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of radiation, ablation, or locoregional therapy effects on the TME."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages consulting the oncology team and maintaining open dialogue with the medical team, including about clinical trials."
      }
    ],
    "question_number": 161,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:17:29.426950",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Pet therapy can offer emotional benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes emotional benefits such as reduced stress/anxiety, mood enhancement, comfort, and reduced isolation."
      },
      {
        "criterion_number": 2,
        "description": "Pet therapy can offer psychological benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes psychological benefits including reduced anxiety, improved mood, and distraction from pain/symptoms."
      },
      {
        "criterion_number": 3,
        "description": "Treatment of cancer can cause immune suppression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States chemotherapy can weaken the immune system and references neutropenia."
      },
      {
        "criterion_number": 4,
        "description": "Pets can carry diseases that can harm immunosuppressed people.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights infection risk and emphasizes vaccinated, healthy animals screened for parasites and illnesses."
      },
      {
        "criterion_number": 5,
        "description": "Patients should avoid exposing open wounds to pets or animals.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise patients to protect their own open wounds from animal contact; only mentions avoiding animals with open sores."
      },
      {
        "criterion_number": 6,
        "description": "Patients should avoid exposing port sites to animals.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of protecting port or central line sites from animal exposure."
      },
      {
        "criterion_number": 7,
        "description": "Patients should discuss the safety of pet therapy with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises consultation with the oncologist and care team about risks, timing, and hospital policies."
      },
      {
        "criterion_number": 8,
        "description": "Pet therapy visits are beneficial and generally safe for patients undergoing treatment for pancreatic cancer when conducted with certified therapy animals under appropriate infection control protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States pet therapy can be valuable and recommends certified programs, screening, grooming, and hygiene protocols."
      },
      {
        "criterion_number": 9,
        "description": "To reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on pets.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention precautions to protect pets from chemotherapy or radiation residues."
      },
      {
        "criterion_number": 10,
        "description": "Immunocompromised patients with pancreatic cancer receiving chemotherapy or radiation therapy should practice good hand hygiene after handling pets, avoid contact with pet waste, and prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not instruct the patient to wash hands after handling pets, avoid pet waste, or prevent pets from licking wounds."
      },
      {
        "criterion_number": 11,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No guidance provided about avoiding young animals, reptiles, or exotic pets for severely immunosuppressed patients."
      }
    ],
    "question_number": 162,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:18:06.180667",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing financial concerns with a social worker associated with their oncology team.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions hospital social workers as connectors to resources but does not explicitly recommend discussing financial concerns with them or tie them to the oncology team for financial issues."
      },
      {
        "criterion_number": 2,
        "description": "The response should include information for the American Cancer Society Road to Recovery program.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly lists American Cancer Society Road to Recovery with description and contact (phone and website)."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including the Pancreatic Cancer Action Network.",
        "score_given": 0,
        "max_points": 3,
        "justification": "PanCAN is mentioned as a resource/navigation support, but travel grants through PanCAN are not described; no explicit link of PanCAN to travel grants."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests reaching out to the oncology team for logistics and partnerships but does not explicitly recommend discussing financial concerns with them."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing financial concerns with a financial counselor associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises contacting the treatment center\u2019s financial assistance office about programs, which constitutes engaging financial counselors at the oncology center regarding financial needs."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing lodging assistance programs with their oncology team.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions lodging resources and to leverage hospital resources, but does not explicitly recommend discussing lodging assistance with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including Cancer Care.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Specifically cites CancerCare providing financial support for transportation and lodging, fulfilling the travel grant information criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that resources include hospital-based transportation programs.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No explicit mention of hospital-based transportation programs; transportation resources listed are external (ACS, Angel Flight, etc.)."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that resources include philanthropic or grant-funded travel assistance.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists philanthropic organizations (CancerCare, Patient Advocate Foundation, HealthWell) that support travel/lodging; also mentions travel grants (LLS), indicating grant-funded assistance."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that telemedicine is increasingly used to reduce the need for travel, allowing for virtual visits, remote symptom monitoring, and tele-rehabilitation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Telemedicine/telehealth is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that telehealth appointments are generally as effective as in-person visits for many aspects of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No content on the effectiveness of telehealth."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that telehealth offers benefits, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Telehealth benefits are not discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that telehealth may be less suitable for initial diagnosis, physical examinations, or sensitive discussions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No discussion of scenarios where telehealth is less suitable."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention limitations of telehealth, including challenges with physical examination, technology barriers, and occasional concerns about reduced personal connection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No telehealth limitations are mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the CDC recommends developing a personal travel health plan, ensuring adequate medication supply, and considering supplemental medical or evacuation insurance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No CDC travel health planning recommendations included."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises asking the oncologist and reaching out to the oncology team, satisfying the recommendation to discuss the case with an oncologist."
      }
    ],
    "question_number": 163,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:19:39.358748",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapies together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly defines combination immunotherapy as using two or more immunotherapies (e.g., PD-1/PD-L1 or CTLA-4 inhibitors)."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states combination immunotherapy may involve combining immunotherapy with chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes targeted therapies as a combination partner with immunotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with other new agents.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions radiation and targeted therapies, it does not clearly specify 'other new agents' (e.g., novel TME-modifying agents, oncolytic viruses) as a category."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the definition of immunotherapy per the NCI definition of cancer terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No NCI-based definition of immunotherapy is provided; it gives a general goal but not the NCI definition."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are MSI high.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Pembrolizumab and MSI-H approval are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are mismatch repair deficient.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of pembrolizumab approval for dMMR tumors."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors have a high tumor mutational burden.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of pembrolizumab approval for TMB-high tumors."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that other immunotherapies are investigational.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Although it notes limited data and early-phase trials, it does not clearly state that other immunotherapies for pancreatic cancer are investigational."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information for clinicaltrial.gov for current trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically recommends ClinicalTrials.gov with search guidance and provides the link."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding what type of combination immunotherapy is being tested.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It advises asking 'What is being tested?' and lists examples like specific drugs and combination partners."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the evidence behind the combination immunotherapy in the trial.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It discusses trial phase and endpoints but does not advise assessing the evidence or rationale behind the combination."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the potential side effects of the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It lists immunotherapy side effects and advises asking about toxicity management and emergency protocols."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe eligibility criteria for clinical trials, including the stage of disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It includes 'stage' under eligibility criteria."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe eligibility criteria for clinical trials, including the site of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It does not mention site of disease as part of eligibility."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe eligibility criteria for clinical trials, including prior treatments.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists 'prior treatments' under eligibility criteria."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe eligibility criteria for clinical trials, including required testing.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It mentions tumor biomarkers and a dedicated section on genetic testing (BRCA1/2, KRAS, TMB)."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that research trials explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explains Phase 1 focuses on safety and later phases assess efficacy, conveying that trials test safety and effectiveness in humans."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 4,
        "justification": "It highlights potential benefits and access but does not state that trials are essential for optimizing therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that trials are divided into phases (phase I - phase IV).",
        "score_given": 0,
        "max_points": 8,
        "justification": "It mentions 'Phase 1' and 'later phases' but does not explicitly note phases I\u2013IV."
      },
      {
        "criterion_number": 21,
        "description": "The response should explain the different phases of clinical trials.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Only Phase 1 (safety) is described; phases II\u2013IV are not explained."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that current research on immunotherapy combinations for pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment and enhancing antitumor immune responses.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No discussion of the immunosuppressive tumor microenvironment or strategies to overcome it."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention promising strategies include combining immunotherapy with chemotherapy, TME-modifying agents, and other immune stimulants.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While chemotherapy is mentioned, TME-modifying agents and other immune stimulants are not discussed."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neoadjuvant immunotherapy or pre-surgical immune priming."
      },
      {
        "criterion_number": 25,
        "description": "The response should mention that cancer vaccines are under investigation as an approach for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer vaccines are not mentioned."
      },
      {
        "criterion_number": 26,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly encourages discussing with the oncologist, getting detailed trial information, and seeking a second opinion."
      }
    ],
    "question_number": 164,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:20:46.264756",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the current treatment plan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response emphasizes organization and adapting to changes, it does not explicitly advise understanding or reviewing the current treatment plan (e.g., regimen, cycle timing, goals of therapy)."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing the treatment schedule with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests keeping communication open with the healthcare team in general, but does not explicitly recommend discussing or optimizing the treatment schedule with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend open communication with the care team about work, family, and personal goals.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it encourages open dialogue with the healthcare team, it does not specifically advise sharing work, family obligations, or personal goals with the care team to tailor care."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend open communication with work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly recommends communicating with employers about flexible hours, remote work, and FMLA, and obtaining documentation from the healthcare team."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding side effects of treatments.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Side effects are mentioned only in the context of unexpected changes; there is no guidance to learn or understand expected treatment side effects."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the timing of side effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no recommendation to understand when side effects are likely to occur (e.g., post-infusion days), which is key for scheduling."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend utilizing a support system, including talking with a social worker.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly recommends engaging hospital social workers for coordination, financial aid, and emotional support."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend utilizing a support system, including talking with a patient navigator.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly mentions patient navigators as part of the professional support team."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that early referral to palliative care is recommended for symptom management, emotional support, and caregiver assistance, and is not synonymous with hospice.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Palliative care is not mentioned; hospice is referenced without clarifying the distinction or recommending early palliative care for comprehensive support."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that practical strategies for managing treatment schedules include leveraging telehealth, app-based, and telephone support to increase flexibility and reduce travel burden.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it mentions apps like MyChart/CaringBridge and provides helpline numbers, it does not recommend telehealth or frame app/phone support as strategies to increase flexibility and reduce travel burden."
      }
    ],
    "question_number": 165,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:21:37.034139",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Mention that treatment-related mouth problems, particularly oral mucositis, are common in patients with pancreatic cancer receiving chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response discusses mucositis and treatment-related mouth problems, it does not state that these issues, particularly oral mucositis, are common among pancreatic cancer patients receiving chemotherapy."
      },
      {
        "criterion_number": 2,
        "description": "Recommend discussing their mouth problems with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly advises informing the oncology team about mouth issues and contacting the healthcare team promptly for severe symptoms."
      },
      {
        "criterion_number": 3,
        "description": "Recommend maintaining good oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specific oral hygiene measures are provided, including soft-bristled toothbrush use, alcohol-free toothpaste, and frequent saline/baking soda rinses."
      },
      {
        "criterion_number": 4,
        "description": "Include that meeting with an oral medicine provider can be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response explicitly mentions consulting a dentist or oral medicine specialist for tailored care."
      },
      {
        "criterion_number": 5,
        "description": "Recommend staying hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Hydration strategies are included, such as frequent sips of water, using a humidifier, and artificial saliva products."
      },
      {
        "criterion_number": 6,
        "description": "Recommend getting regular dental care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Regular dental check-ups are recommended to monitor and treat infections early."
      },
      {
        "criterion_number": 7,
        "description": "Mention that oral cryotherapy is effective for prevention of mucositis for select chemotherapy regimens.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of oral cryotherapy (e.g., ice chips during 5-FU) for mucositis prevention."
      },
      {
        "criterion_number": 8,
        "description": "Mention that benzydamine mouthwash is supported for prevention, especially in patients receiving radiotherapy or chemoradiotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Benzydamine mouthwash is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "Mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations.",
        "score_given": 0,
        "max_points": 4,
        "justification": "The response suggests chlorhexidine rinses in certain contexts but does not note that chlorhexidine is not recommended for prevention in most adult cancer populations."
      },
      {
        "criterion_number": 10,
        "description": "Mention that bland mouth rinses (e.g., sodium bicarbonate or saline) are preferred for routine care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Bland rinses with saline and baking soda are recommended multiple times for routine care and symptom relief."
      },
      {
        "criterion_number": 11,
        "description": "Mention that topical anesthetics and mixed medication mouthwashes may be used for pain control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Topical anesthetics (e.g., benzocaine) are mentioned, but mixed medication mouthwashes (e.g., compounded 'magic mouthwash') are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "Mention that gabapentin may be considered for mucositis-related pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gabapentin is not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "Mention that topical and systemic antifungals are indicated for secondary candidiasis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Topical antifungals (e.g., nystatin) are mentioned, but systemic antifungals are not addressed."
      },
      {
        "criterion_number": 14,
        "description": "Mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response states antibiotics may be needed if bacterial infections develop, aligning with reserving antibiotics for documented infections."
      },
      {
        "criterion_number": 15,
        "description": "Mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Acetaminophen is recommended for pain relief, satisfying the criterion."
      },
      {
        "criterion_number": 16,
        "description": "Mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response emphasizes involvement of the oncology team, dentist/oral medicine specialist, dietitian, and support networks."
      },
      {
        "criterion_number": 17,
        "description": "Mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, and nutritional support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Dietary adjustments including soft foods, small frequent meals, smoothies, and nutritional supplements are discussed."
      }
    ],
    "question_number": 166,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:22:43.449125",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define minimal residual disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines MRD as detecting tiny traces of cancer remaining after treatment and explains mechanisms (ctDNA, rare cancer cells/proteins) and methods (PCR, NGS)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that minimal residual disease testing in pancreatic cancer is investigational.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states 'Not Yet Standard: MRD testing is still emerging, especially for solid tumors like pancreatic cancer. It\u2019s often used in research or specialized centers,' which conveys its investigational status."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing minimal residual disease testing with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "The 'What You Can Do' section explicitly advises: 'Ask Your Oncologist' and 'Results should always be discussed with your oncologist.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should include that NCCN guidelines do not recommend minimal residual disease testing in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of NCCN guidelines or that they do not recommend MRD testing in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that insurance may not cover minimal residual disease testing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes 'Availability and cost vary by location/insurance,' indicating potential variability in insurance coverage, which implies that insurance may not cover MRD in some cases."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that postoperative ctDNA positivity is associated with a higher risk of early recurrence and worse survival in resected pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it generally states MRD positivity may mean a higher chance of return, it does not specifically mention postoperative ctDNA positivity in resected pancreatic cancer or its association with early recurrence and worse survival."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that serial minimal residual disease testing can provide dynamic risk stratification.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it mentions 'closer monitoring with frequent scans or MRD tests,' it does not state that serial MRD testing provides dynamic risk stratification."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that minimal residual disease testing may identify patients who could benefit from intensified surveillance or additional therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states that if MRD is found, the oncologist might recommend 'more aggressive treatments' and 'closer monitoring,' meeting the criterion."
      }
    ],
    "question_number": 167,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:23:54.914376",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking the oncology team for spiritual care professionals.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises asking the loved one\u2019s medical team about chaplaincy services and mentions oncology social workers as connectors to spiritual resources, satisfying the intent to involve the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend reaching out to local places of worship.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly recommends reaching out to local religious institutions (churches, synagogues, mosques, temples)."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend reaching out to community support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends cancer-specific support groups, online communities, and local community center groups addressing spiritual and emotional needs."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national cancer support organizations, including the American Cancer Society.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names the American Cancer Society as a resource among national organizations."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend national cancer support organizations, including Cancer Care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends CancerCare and notes its support groups and online resources."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that spiritual counseling and support can be accessed through hospital-based chaplaincy services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It clearly highlights hospital chaplaincy services, available regardless of religious affiliation, and suggests asking the medical team about them."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that spiritual counseling and support can be accessed through interdisciplinary palliative care teams.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of palliative care teams or interdisciplinary palliative services."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that interventions such as prayer, mindfulness/meditation, and facilitated sessions with trained providers, including both individual and group formats, have demonstrated benefits for spiritual well-being, hope, and meaning in cancer care.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions prayer, mindfulness/meditation, counselors, and support groups, it does not state that these interventions have demonstrated benefits for spiritual well-being, hope, and meaning in cancer care."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information and support services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention Cancer.Net or the Pancreatic Cancer Action Network (PanCAN)."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests asking the medical team and oncology social workers about chaplaincy services but does not explicitly recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 168,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:24:32.459094",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend learning about pancreatic cancer, including diagnosis.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It directs the reader to reliable educational resources (e.g., National Cancer Institute, PanCAN) and encourages asking questions to understand care, implying learning about the condition and diagnosis."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend learning about pancreatic cancer, including staging.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Staging is not mentioned or recommended for the reader to learn about."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend learning about pancreatic cancer, including treatment options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises to clarify the treatment plan, potential side effects, and to discuss palliative or hospice care options, which constitutes learning about treatment options."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national patient support resources, including information for the Pancreatic Cancer Action Network.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly references and links to the Pancreatic Cancer Action Network, as well as other national resources (American Cancer Society, NCI, CancerCare)."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend open communication within the couple and with the care team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It explicitly recommends talking openly with the husband and the healthcare team about fears, hopes, and needs."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend building a support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups, counseling, leaning on loved ones, and using community resources\u2014clearly advocating building a support system."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly state that significant lifestyle changes are common for both patients and spouses/partners after a pancreatic cancer diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses lifestyle changes and notes fatigue can affect both patients and caregivers, it does not explicitly state that significant lifestyle changes are common for both patients and spouses/partners."
      },
      {
        "criterion_number": 8,
        "description": "The response should explicitly mention at least two of the following: uncertainty about the future, role changes, emotional upheaval, or altered daily routines.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It explicitly addresses emotional upheaval (overwhelmed, anxious, grieving) but does not explicitly mention a second required element such as uncertainty about the future, role changes, or altered daily routines."
      },
      {
        "criterion_number": 9,
        "description": "The response should explicitly recommend early integration of supportive and/or palliative care for symptom management, psychosocial support, or advance care planning.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It clearly advises to discuss palliative or hospice care options early, satisfying the recommendation for early consideration/integration of palliative care."
      },
      {
        "criterion_number": 10,
        "description": "The response should explicitly state that palliative and/or supportive care should be offered to all patients with pancreatic cancer, regardless of stage or prognosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that palliative/supportive care should be offered to all patients regardless of stage or prognosis."
      },
      {
        "criterion_number": 11,
        "description": "The response should explicitly state that both dietary and exercise interventions are important for maintaining quality of life and optimizing outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it provides diet and gentle exercise guidance, it does not explicitly connect both interventions to maintaining quality of life and optimizing outcomes."
      },
      {
        "criterion_number": 12,
        "description": "The response should explicitly state that regular exercise and healthy lifestyle changes are associated with improved physical and psychological outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that gentle movement (short walks or light stretching) can improve mood and energy, directly linking exercise to psychological and physical benefits."
      },
      {
        "criterion_number": 13,
        "description": "The response should explicitly recommend discussing the case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It encourages asking questions of the healthcare team but does not explicitly recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 169,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:25:37.562338",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe tumor heterogeneity, including diverse genetic, epigenetic, transcriptomic, and microenvironmental features both between patients (inter-tumoral) and within a single tumor (intra-tumoral).",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response covers intra-tumoral genetic and microenvironmental heterogeneity and mentions epigenetic therapies, but does not explicitly address transcriptomic heterogeneity or inter-patient (inter-tumoral) heterogeneity."
      },
      {
        "criterion_number": 2,
        "description": "Include that tumor heterogeneity can include differences in genetic mutations within a tumor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states cells within a single tumor can have different genetic mutations and notes a single biopsy may not capture the full genetic makeup."
      },
      {
        "criterion_number": 3,
        "description": "Include that tumor heterogeneity can include differences in genetic mutations between tumor sites.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that distant metastases may have different genetic traits than the primary tumor."
      },
      {
        "criterion_number": 4,
        "description": "Include that tumor heterogeneity can include differences in cellular growth between cancer sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions differing growth patterns within a tumor but does not explicitly state differences in cellular growth between distinct cancer sites."
      },
      {
        "criterion_number": 5,
        "description": "Include that tumor heterogeneity can include differences in microenvironment between tumor sites.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that the immune microenvironment can differ across regions, affecting treatment response, which addresses microenvironmental variation across tumor regions/sites."
      },
      {
        "criterion_number": 6,
        "description": "Mention that tumor heterogeneity is a major driver of variable treatment response, therapy resistance, and clinical outcomes in pancreatic ductal adenocarcinoma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links heterogeneity in PDAC to aggressiveness, treatment resistance, and variable responses to therapy (e.g., immunotherapy)."
      },
      {
        "criterion_number": 7,
        "description": "Include that tumor heterogeneity is thought to contribute to drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Clearly states that subpopulations can be resistant and lead to recurrence and regrowth after therapy."
      },
      {
        "criterion_number": 8,
        "description": "Include that tumor heterogeneity is thought to contribute to the use of multiple chemotherapy agents.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Discusses combining therapies (chemo, immunotherapy, targeted agents) but does not specifically tie heterogeneity to the use of multiple chemotherapy agents."
      },
      {
        "criterion_number": 9,
        "description": "Mention that phenotypic plasticity allows tumor cells to shift between subtypes, especially under therapeutic or microenvironmental stress, contributing to acquired resistance and disease progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention phenotypic plasticity, subtype switching, or stress-induced transitions."
      },
      {
        "criterion_number": 10,
        "description": "Mention that tumor heterogeneity limits the effectiveness of one-size-fits-all approaches and underlies the need for molecular profiling and personalized treatment strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes genomic profiling, tailored combinations, and personalized approaches due to heterogeneity."
      },
      {
        "criterion_number": 11,
        "description": "Recommend discussing genetic testing with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises ensuring the oncology team uses genomic testing to guide treatment."
      },
      {
        "criterion_number": 12,
        "description": "Mention that research efforts focus on integrating genomic, transcriptomic, and single-cell analyses to better classify tumors and guide therapy selection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions single-cell and spatial genomics and liquid biopsies but does not mention transcriptomic analyses or integration of genomic, transcriptomic, and single-cell data."
      },
      {
        "criterion_number": 13,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages working closely with the oncology team and having open conversations with the medical team."
      }
    ],
    "question_number": 170,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:26:32.440690",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the definitions of different types of research studies, including randomized clinical trials and observational studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines multiple study types and observational studies, but does not explicitly define randomized clinical trials or describe randomization."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain that not all research studies are clinical trials, and some explore ancillary aspects of cancer care such as symptom control or mental health.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It clearly distinguishes non-interventional observational studies and highlights quality-of-life/supportive care trials focusing on symptoms and psychological support."
      },
      {
        "criterion_number": 3,
        "description": "The response should include links and references to informational websites about clinical trials being held across the United States, such as the National Cancer Institute (NCI).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It references ClinicalTrials.gov, WHO registry, advocacy organizations (PanCAN, ACS), major centers, and cooperative groups. Although NCI is not named specifically and URLs are not provided, the referenced resources meet the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient ask their oncologist about locations where clinical trials are being held and consider a referral to institutions where trial participation is possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises consulting his oncologist, asking for referrals to trials or centers, and considering major cancer centers."
      },
      {
        "criterion_number": 8,
        "description": "The response should include definitions of phases 1, 2, and 3 clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It correctly defines Phases I\u2013III (safety/dose, efficacy/side effects, comparison to standard therapy) and also mentions Phase IV."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that clinical trials are most commonly done at academic medicine institutions.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it lists major cancer centers and notes travel to specialized centers, it does not explicitly state that trials are most commonly done at academic medicine institutions."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that clinical trials may include an experimental treatment or placebo, and the efficacy may not be known as compared to standard of care treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions risks and benefits generically but does not state that trials may include placebo or that efficacy relative to standard of care may be unknown."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention clinical trials as a research opportunity.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are explicitly and repeatedly discussed as a key research opportunity."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention patient registries or biorepositories as opportunities for further studies.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions genomic/biomarker studies and liquid biopsies, it does not explicitly reference patient registries or biorepositories."
      }
    ],
    "question_number": 171,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:27:15.268100",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe how mutated cells that can form cancer evade the immune system",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains multiple evasion mechanisms specific to pancreatic cancer: immunosuppressive cytokines (TGF-\u03b2, IL-10), PD-L1/PD-1 braking, dense fibrotic stroma blocking immune infiltration, accumulation of Tregs/MDSCs, and low neoantigen load reducing visibility to immune cells."
      },
      {
        "criterion_number": 2,
        "description": "Describe the immune system\u2019s role in protecting the body from mutated cells with oncogenic potential",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that the immune system identifies and destroys abnormal cells including early cancer cells and lists relevant cell types (cytotoxic and helper T cells, B cells, NK cells, dendritic cells) and their roles."
      },
      {
        "criterion_number": 3,
        "description": "Include a definition of immunotherapy",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a functional definition by explaining immunotherapy as therapies that harness the body\u2019s defenses (immune system) to fight cancer, then elaborates with examples."
      },
      {
        "criterion_number": 4,
        "description": "Describe the mechanism of action of immunotherapies in cancer",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains mechanisms: checkpoint inhibitors block PD-1/PD-L1 to restore T-cell activity; CAR-T engineering to target tumor antigens; vaccines stimulate immune responses to tumor antigens/neoantigens; cytokines boost immune activity; TME-targeting and combination strategies to overcome immunosuppression. Despite a minor inaccuracy elsewhere, mechanisms are described correctly."
      },
      {
        "criterion_number": 6,
        "description": "Describe features of pancreatic cancer that make it difficult to treat with immunotherapy",
        "score_given": 6,
        "max_points": 6,
        "justification": "Details key barriers: dense desmoplastic stroma, immunosuppressive microenvironment (Tregs, MDSCs), low immunogenicity/neoantigen load, variable/low PD-L1 expression, late diagnosis, and genetic drivers that can interfere with immune signaling."
      },
      {
        "criterion_number": 7,
        "description": "Mention that there is research being done on the role of the immune system in pancreatic cancer treatment",
        "score_given": 6,
        "max_points": 6,
        "justification": "Repeatedly emphasizes ongoing research and clinical trials, including emerging strategies (microbiome, neoantigen vaccines, combination therapies), and labels many approaches as under investigation."
      },
      {
        "criterion_number": 8,
        "description": "Recommend speaking with the oncologist about clinical trials or referral to a center that does clinical trials",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing options with the oncologist and provides resources (ClinicalTrials.gov, PanCAN) to find trials."
      },
      {
        "criterion_number": 9,
        "description": "State that a limited number of pancreatic cancer cases respond to immunotherapy due to features such as MSI-H or mismatch repair deficiency",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention MSI-H or mismatch repair deficiency or that this subset can respond to checkpoint inhibitors; only references tumor mutational burden generally."
      },
      {
        "criterion_number": 10,
        "description": "State that they should ask the oncologist if the tumor has MSI-H or mismatch repair deficiency",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation to ask specifically about MSI-H or mismatch repair deficiency testing."
      }
    ],
    "question_number": 172,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:27:55.322894",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define caregiver burnout as physical, emotional, and mental exhaustion, and normalize it as common.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response normalizes caregiver burnout as common and valid but does not explicitly define it as physical, emotional, and mental exhaustion."
      },
      {
        "criterion_number": 2,
        "description": "Link to no-cost support services for caregivers (e.g., support groups or online groups).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes multiple no-cost options: CancerCare (free counseling/support groups), PanCAN, ACS, Cancer Support Community, and online communities, with websites provided."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly mention insurance-covered caregiver assistance and advise inquiring with the insurance carrier about coverage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit mention of caregiver assistance covered by insurance or advice to contact the insurance carrier about coverage."
      },
      {
        "criterion_number": 5,
        "description": "Provide resources for mental wellbeing, specifically mentioning therapists through Psychology Today\u2019s website.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly references Psychology Today\u2019s therapist directory for counseling."
      },
      {
        "criterion_number": 6,
        "description": "Describe the use of family members and friends to help with caretaking responsibilities.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages asking loved ones for help and suggests using CaringBridge to coordinate practical support."
      },
      {
        "criterion_number": 7,
        "description": "Recommend reaching out to the oncology team to inquire if social work resources are available to assist in determining if any in-home support or respite services are financially covered by the patient\u2019s insurance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises contacting the oncology team/social worker for resources and palliative care options, but does not specify evaluating insurance coverage for in-home or respite services."
      },
      {
        "criterion_number": 8,
        "description": "Mention that Hospice services offer varying degrees of in-home support and caregiver support, if/when appropriate.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions contacting hospice services for respite care (even when not end-of-life), indicating caregiver support consistent with hospice services."
      },
      {
        "criterion_number": 9,
        "description": "State that there are options for professional caregiver support to give a break to family members/loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes respite care and home care agencies providing assistance, which offers breaks to caregivers."
      },
      {
        "criterion_number": 10,
        "description": "State that palliative care involvement can help with optimizing symptom management which may help reduce caregiver burden.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References palliative care options but does not state the role in optimizing symptom management or reducing caregiver burden."
      },
      {
        "criterion_number": 11,
        "description": "State they should make sure to take time for self-care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated self-care section and explicitly reminds that self-care is important and not selfish."
      }
    ],
    "question_number": 173,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:28:35.984290",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should explain what liquid biopsies are and how they are different from traditional biopsies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines liquid biopsy and explicitly contrasts it with traditional tissue biopsy, explaining it analyzes tumor-derived material in blood rather than tissue."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that \u201cliquid biopsy\u201d involves taking a sample of blood to analyze either circulating tumor DNA or circulating tumor cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states a simple blood draw is performed and analyzes ctDNA and CTCs (and also mentions exosomes/proteins)."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain the different uses of liquid biopsies in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple uses are described: monitoring treatment response, detecting resistance and recurrence, informing personalized treatment, early detection of progression, and use in clinical trials."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention if liquid biopsy is FDA approved for any uses in pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not address FDA approval status or whether there are FDA-approved liquid biopsy uses specific to pancreatic adenocarcinoma."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe that liquid biopsies are used as an adjunct to traditional cancer monitoring techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states clearly that liquid biopsy is not a standalone test and complements imaging and clinical evaluation."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is not sufficient to establish whether or not the cancer is responding to treatment and that it has to be used in addition to imaging tests.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes that liquid biopsy does not replace imaging and must be interpreted in context, fulfilling the requirement."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe advantages of liquid biopsy over traditional biopsy, but should state that liquid biopsy cannot be used to diagnose cancer at this time.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advantages are well described, but the response does not state that liquid biopsy cannot be used to diagnose cancer; it even opens by calling it a 'diagnostic tool,' which may be misleading."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe that liquid biopsies can provide information about the genetic mutations in a cancer which can impact treatment options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that identifying mutations (e.g., KRAS, TP53) may guide targeted therapies, indicating mutation profiling can inform treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the role of liquid biopsy in cancer care is being heavily studied.",
        "score_given": 11,
        "max_points": 11,
        "justification": "The response notes the field is evolving, not yet standard of care, and references clinical trials, conveying that it is under active study."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that liquid biopsy meaningfulness is different across cancer types and sometimes among patients with the same cancers, as some tumors do not shed material as much as others.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions low ctDNA in early-stage disease and if tumors are not shedding, but does not state that utility varies across cancer types; the cross-cancer variability component is missing."
      },
      {
        "criterion_number": 14,
        "description": "The response should also state that the approach is not established as standard of care and would likely be offered in the context of a research study.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It states the approach is not standard of care and mentions possible use in trials, but does not assert that it would likely be offered in the context of a research study."
      }
    ],
    "question_number": 174,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:29:33.197779",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should emphasize the importance of managing treatment and disease-related side effects to preserve independence and quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly emphasizes symptom management (pain, fatigue, nutrition) and explicitly advises discussing treatment side effects and prioritizing quality of life, including early palliative care involvement."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the expected side effects of pancreatic cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not describe typical treatment-related side effects (e.g., chemotherapy/radiation-induced nausea, vomiting, diarrhea, neuropathy, cytopenias). It only generally mentions side effects without specifics."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe common symptoms that patients experience from pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses common disease-related symptoms including pain, fatigue, digestive challenges, and weight loss."
      },
      {
        "criterion_number": 4,
        "description": "The response should suggest ways to use technology to help with everyday tasks in the home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends assistive technology such as medical alert systems and medication apps, and suggests video calls to maintain connection, supporting daily functioning and safety."
      },
      {
        "criterion_number": 5,
        "description": "The response should suggest ways to make modifications in the home to allow the patient to traverse and use their home independently.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides specific home modification strategies: grab bars, shower chairs, raised toilet seats, ramps, non-slip mats, and improved lighting."
      },
      {
        "criterion_number": 6,
        "description": "The response should emphasize the importance of maintaining autonomy and some control for the patient regarding their everyday tasks and life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly encourages letting the patient lead activities, avoiding overprotection, and involving the patient in care decisions to foster autonomy."
      },
      {
        "criterion_number": 7,
        "description": "The response should make recommendations for how to assist an individual suffering from pancreatic cancer treatment or disease-related side effects on their activities of daily living.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Gives concrete ADL support strategies: adaptive equipment for bathing/toileting, mobility aids and transfers, pacing for fatigue, nutrition support/meal services for feeding, transportation assistance, and caregiver support."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining good mental health by the patient and caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses mental health with counseling/therapy, mindfulness, stress management, and highlights caregiver self-care and respite to prevent burnout."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention resources for in-home assistance such as paid caregivers or Hospice services.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions hiring part-time help (paid caregivers), respite programs, palliative care teams, and community/nonprofit supports; while hospice is not named, paid caregiver resources are included."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest asking the oncology team if there is social work support available, and/or if anyone can assist in determining if the patient\u2019s insurance will cover the cost of an in-home paid caregiver.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises requesting referrals to social workers through the healthcare team, satisfying the 'ask about social work support' component (the criterion allows 'and/or')."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that physical independence can be promoted by maintaining strength with rehab and exercises.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends gentle exercise (walking, stretching) and specifically suggests referral to physical therapists, supporting strength and functional independence."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that assistance devices and equipment such as shower chairs and grabbing bars can be used to help maintain independence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly lists shower chairs and grab bars among assistive devices to maintain safety and independence."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that emotional support including participating in patient groups is another good way of maintaining independence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages participation in pancreatic cancer support groups (e.g., PanCAN) and emphasizes emotional support as part of maintaining well-being and independence."
      }
    ],
    "question_number": 175,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:30:32.072111",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include a definition of genetic testing for heritable cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses consulting a genetic counselor and which genes might be tested, but it does not define genetic testing for heritable cancer syndromes (e.g., analyzing blood/saliva for inherited pathogenic variants)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that genetic testing for inherited mutations is recommended for all patients with pancreatic adenocarcinoma at diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not state universal germline testing for all patients with pancreatic adenocarcinoma at diagnosis. It instead frames testing as typical after diagnosis and if hereditary cancer is suspected, without the universal recommendation."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss genetic testing for inherited cancer syndromes and molecular testing of tumor tissue with their oncologist and oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises consulting a genetic counselor and collaborating with healthcare providers, it does not recommend discussion with the oncologist/oncology team specifically, nor does it mention molecular testing of tumor tissue."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why family members at risk of inheriting a genetic mutation should be aware if they have it.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that if a mutation is found, at-risk relatives can pursue increased surveillance and consider risk-reducing strategies, explaining the utility of knowing mutation status."
      },
      {
        "criterion_number": 7,
        "description": "The response should list cancer syndromes and mutated genes that are associated with an increased risk of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it lists genes (BRCA1/2, PALB2, CDKN2A, STK11) and mentions a syndrome, it contains inaccuracies (e.g., linking STK11 to FAMM/FAMMM instead of Peutz-Jeghers). Due to medical inaccuracy in the syndromic associations, full credit cannot be awarded."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention that BRCA1 and BRCA2 testing can be considered, particularly if there are other first-degree relatives with malignancies such as breast or prostate cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While BRCA1/2 are mentioned and their associated cancer risks are listed, the response does not explicitly state that BRCA1/2 testing should be considered particularly when there are first-degree relatives with breast or prostate cancer."
      },
      {
        "criterion_number": 11,
        "description": "If a patient\u2019s genetic testing for inherited mutations returns positive for a pathogenic mutation or they have a strong family history for cancer (regardless of mutation status), they should be referred to a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises consulting a genetic counselor first and emphasizes counseling before and after testing, which satisfies the referral recommendation for positive results or strong family history."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that some family members of a patient with a positive pathogenic mutation may be at increased risk for certain cancers and should consider genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that if the father tests positive, first-degree relatives should be tested and second-degree relatives may be considered, clearly indicating increased risk and consideration of testing for family members."
      }
    ],
    "question_number": 176,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:31:40.257869",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the phenomenon known as \u201cchemo-brain,\u201d or cognitive issues experienced by individuals undergoing chemotherapy treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly names 'chemo brain' and describes cognitive issues such as memory lapses and difficulty concentrating associated with treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment-related cognitive changes are a known side effect of treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States these changes 'can indeed occur' with chemotherapy, surgery, or radiation for pancreatic cancer, indicating they are recognized treatment-related effects."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about impaired cognition related to chemotherapy treatment and how long it is expected to last once treatment is completed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that many issues are temporary and improve after treatment ends, with potential improvement over months to years, and attributes effects to chemotherapy drugs."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the cognitive changes can be from the chemotherapy drugs or from the cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions chemotherapy affecting brain function and includes metastasis to the brain as a cancer-related cause."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that some medications, such as opioids, used for symptom management can cause depressed cognition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies medication side effects including 'steroids or pain medications' as contributors; this reasonably encompasses opioids used for symptom management."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that other etiologies of impaired cognition may also be present, such as organ dysfunction, age-related cognitive decline, poor nutritional status, or medication side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions infections, nutritional deficiencies, and medication side effects as alternative/reversible contributors, satisfying the requirement to cite other etiologies."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that depression is related to cognitive impairment, especially in the elderly population.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention depression or its relationship to cognitive impairment."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some causes of cognitive impairment are reversible, while others are not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly distinguishes temporary vs long-lasting effects and notes some resolve while others need ongoing management."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient or family member discuss cognitive impairment with the patient\u2019s oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages a comprehensive assessment with the oncologist/neurologist and ongoing dialogue with the care team."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that symptoms can be managed with \u201ccognitive rehabilitation,\u201d which can include exercises such as puzzles and word games.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends cognitive rehabilitation and gives examples including memory exercises and puzzles."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that optimizing lifestyle changes, such as good sleep and exercise, can help manage symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises on exercise, sleep, stress management, and nutrition to support cognitive function."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that in some cases, the treatment team may consider prescribing a stimulant such as methylphenidate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions donepezil as a potential medication but does not reference stimulants such as methylphenidate."
      }
    ],
    "question_number": 177,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:32:28.850854",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what cancer stem cells are.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines CSCs as a small subpopulation of cancer cells with stem-like properties, including self-renewal and differentiation within a tumor."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role that cancer stem cells play in tumorigenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States CSCs drive tumor initiation, progression, and recurrence, and may seed metastases in distant organs."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe what is known about cancer stem cells in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses aggressiveness, residual disease, recurrence, tumor microenvironment, and commonly cited markers (CD44, CD24, ESA) relevant to pancreatic CSCs."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference research on pancreatic cancer stem cells and include real citations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides general resources and lists trial IDs and drug names without verifiable, specific peer-reviewed citations or clearly validated trial references supporting the claims about CSC-targeting in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should clearly state what is known about how pancreatic cancer stem cells affect treatment efficacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly explains that CSCs survive chemotherapy and radiation, contribute to recurrence and treatment resistance, and may persist after surgery."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that cancer stem cells are a subpopulation of cancer cells within a tumor that possess the ability to self-renew and differentiate into various cell types, and the concept of persistence must be clearly mentioned.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes CSCs as a small subpopulation with self-renewal and differentiation capacity and clearly conveys persistence via survival after therapy, dormancy, and maintenance of residual disease."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that cancer stem cells are more resistant to conventional therapies like chemotherapy and radiation, and mention at least two mechanisms such as quiescence, efflux pumps, DNA repair, or microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states resistance to chemo/radiation and lists multiple mechanisms: quiescence, enhanced DNA repair, drug efflux via ABC transporters, and protective tumor microenvironment."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that there are currently no standard of care treatments that directly target cancer stem cells, but it is an active area of research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes therapies are experimental and early-stage but does not explicitly state that no standard-of-care treatments directly target CSCs."
      }
    ],
    "question_number": 178,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:33:16.983809",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe different types of support groups such as in-person, virtual, and telephone.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response clearly distinguishes online/telehealth (virtual) and in-person groups, but it does not mention telephone-based support groups or helplines as a modality."
      },
      {
        "criterion_number": 2,
        "description": "The response should list resources with website links that provide free or insurance-covered pancreatic cancer support group information such as PanCAN, NCI, and NCCN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes multiple resources with links that offer free support information, including PanCAN (https://www.pancan.org/support/), American Cancer Society (https://www.cancer.org/support.html), CancerCare (https://www.cancercare.org/), Cancer Support Community (https://www.cancersupportcommunity.org/), and MyLifeLine. Although NCI/NCCN are not mentioned, the criterion is satisfied by providing relevant linked resources (PanCAN is included)."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient and/or family inquire with the oncology team about support group resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises: \"Ask Your Medical Team: Oncologists or social workers can recommend local or virtual options.\""
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the importance of maintaining mental health support for patients and caregivers affected by pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response emphasizes emotional support, suggests counseling for caregivers, and highlights coping and mental health resources (e.g., CancerCare counseling), underscoring the importance of maintaining mental health support."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention websites for people to find support groups local to their home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It directs readers to Cancer Support Community, PanCAN\u2019s Resource Hub, Meetup, and Facebook Groups for locating local or virtual support options, with links provided for several."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention ways in which support groups for people affected by cancer can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes benefits including emotional support, shared understanding, help with coping strategies, navigating side effects, dietary changes, healthcare systems, and practical needs like financial/insurance assistance."
      },
      {
        "criterion_number": 7,
        "description": "The response should normalize the use of support groups for people affected by cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Statements such as \"Support groups can be invaluable\" and \"You\u2019re not alone\" normalize and validate participation."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that people can use support groups for different stages of cancer, and that mental health challenges can be faced even during the survivorship period.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While it mentions stage-specific and treatment-focused groups (e.g., newly diagnosed, metastatic), it does not state that mental health challenges can occur during survivorship."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize that support groups can help people affected by cancer feel less isolated or alone.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes camaraderie and shared understanding and concludes with \"You\u2019re not alone,\" directly addressing isolation."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that faith-based support groups exist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly notes cultural/religious groups and mentions local faith-based groups as options."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that support groups are not a substitute for seeking mental health services if you are suffering from depression, and should describe what depression is.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests counseling generally but does not state that support groups are not a substitute for treatment of depression, nor does it describe what depression is."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention other avenues for support including palliative medicine and Hospice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of palliative care or hospice services is included."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that virtual options include Facebook groups and PanCAN virtual support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists Facebook Groups as a place to find support and references PanCAN\u2019s online/virtual support communities, satisfying both components."
      }
    ],
    "question_number": 179,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:33:58.599285",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe how malignant cells evade the body\u2019s immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains immune evasion via an immunosuppressive tumor microenvironment, including low immune infiltration (\"cold\" tumors), presence of regulatory T cells and myeloid-derived suppressor cells, and PD-L1-mediated dampening of immune responses."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly describe the mechanisms of action for chemotherapy, immunotherapy, and radiation in killing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotherapy is described as damaging DNA (e.g., gemcitabine), but there is no explicit mechanism for how immunotherapy kills cancer (e.g., unleashing T cells via checkpoint blockade) and no mention of radiation\u2019s mechanism (DNA double-strand breaks and lethal damage)."
      },
      {
        "criterion_number": 4,
        "description": "The response must thoroughly cover multiple mechanisms of treatment resistance, including genetic mutations, tumor heterogeneity, drug efflux, alterations in drug targets, epigenetic changes, adaptive responses, and the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It comprehensively addresses genetic/molecular changes (KRAS, target mutations/amplifications), tumor heterogeneity, drug efflux pumps (P-glycoprotein), target modification, epigenetic changes, adaptive responses (alternative pathway activation, enhanced DNA repair, metabolic reprogramming), and tumor microenvironment factors (desmoplastic stroma, immunosuppression, pro-survival cytokines)."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention cancer stem cells and connect them to specific resistance mechanisms such as drug efflux pumps, enhanced DNA repair, or immune evasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cancer stem cells are explicitly mentioned and linked to resistance via dormancy, rapid self-renewal, and enhanced DNA repair; they are also noted as capable of repopulating the tumor."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that surviving resistant cells can repopulate the tumor after most cells are killed by treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states that spared subpopulations can repopulate the tumor and that CSCs can repopulate after therapy ends."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly describe that with every treatment, a selective pressure is applied to cancer cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While evolution and adaptation are implied, the response does not explicitly describe treatment as imposing selective pressure on cancer cell populations."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that this topic is being widely researched and cite at least one source from the literature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No statement about the breadth of ongoing research is made, and no literature citations are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly defines treatment resistance as the phenomenon where cancer cells over time no longer respond to therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response discusses mechanisms and consequences of resistance but does not provide an explicit definition that resistance is when cancer cells over time no longer respond to therapies."
      }
    ],
    "question_number": 180,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:34:34.167130",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe specific biomarkers for pancreatic cancer, explicitly mentioning both CA 19-9 and CEA.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response lists multiple genomic biomarkers (e.g., KRAS, BRAF, MSI/MMR, HER2) but does not mention CA 19-9 or CEA at all."
      },
      {
        "criterion_number": 2,
        "description": "The response must explain what circulating tumor DNA (ctDNA) is and how it is considered a cancer biomarker in some malignancies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ctDNA is not defined or explained. Although 'liquid biopsy' is briefly mentioned, there is no description of ctDNA as a biomarker."
      },
      {
        "criterion_number": 3,
        "description": "The response must summarize how ctDNA enters the bloodstream and is detected through blood tests.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explanation is provided for how ctDNA is shed into the bloodstream or how it is detected via blood tests."
      },
      {
        "criterion_number": 4,
        "description": "The response must include ways that ctDNA detection can enhance existing modalities for cancer monitoring, including detection of new and potentially targetable mutations in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not discuss ctDNA\u2019s role in monitoring, minimal residual disease, early relapse detection, or identification of emergent targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response must include at least one link to existing scientific literature regarding ctDNA use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or links to scientific literature are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must suggest that the patient discuss pancreatic cancer biomarker testing with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The 'Next Steps' section explicitly advises discussing biomarker testing with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response must define biomarkers for cancer in general terms, including at least one example of a measurable indicator (e.g., proteins, genes, or mutations).",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no general definition of biomarkers. While examples of genes and proteins are listed, the response does not provide a general definition of what a biomarker is."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how biomarkers are used in pancreatic cancer care and explicitly state that they are an adjunct to traditional imaging and biopsy interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response describes therapeutic implications of biomarkers but does not explicitly state that biomarkers are an adjunct to imaging and biopsy."
      },
      {
        "criterion_number": 9,
        "description": "The response must discuss that biomarker reliability varies between individuals with cancer and are not always interpretable, including a specific example of variability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion is provided about inter-individual variability or interpretability issues, and no example of variability is given."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that biomarkers can have false positives and false negatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of false positives or false negatives for biomarkers."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that BRCA and HRD genes are key biomarkers as they can predict response to platinum chemotherapy and PARP inhibitors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "BRCA and homologous recombination deficiency (HRD) are not mentioned, nor are their implications for platinum sensitivity or PARP inhibitors."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that MSI/MMR is an important biomarker as it can identify the small percentage of patients that may respond to immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "MSI/MMR and pembrolizumab eligibility are mentioned, but the response does not state that this applies to a small percentage of pancreatic cancer patients."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that testing can be done on a blood sample or from tumor tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that testing can be done on tumor biopsy tissue and that liquid biopsy (blood tests) may be used if tissue is unavailable."
      }
    ],
    "question_number": 181,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:35:23.982151",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe at least two management strategies for osteopenia and osteoporosis, such as bisphosphonates, denosumab, calcium, or vitamin D.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists multiple strategies for steroid-induced osteoporosis: calcium, vitamin D, bisphosphonates (e.g., zoledronic acid), and denosumab, plus lifestyle and monitoring."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe at least two types of bone and bone density problems that can arise during cancer treatment, such as osteopenia, osteoporosis, or bone metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions and describes several issues: osteoporosis, osteonecrosis, radiation-related bone damage, chemotherapy-induced bone loss, and hypercalcemia."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention bone metastases and at least two treatment options, such as systemic therapy, observation, radiation, or surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bone metastases are only mentioned as a cause of hypercalcemia; no metastasis-specific treatments (e.g., systemic therapy, radiation, surgery, observation) are described."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that bone metastases can be painful and/or asymptomatic.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not address symptoms of bone metastases, including pain or asymptomatic presentation."
      },
      {
        "criterion_number": 5,
        "description": "The response must mention the frequency or rarity of pancreatic cancer metastasizing to the bone.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement is made about how common or rare bone metastases are in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response must define or describe osteopenia and osteoporosis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Osteoporosis is mentioned but not defined; osteopenia is not discussed or defined."
      },
      {
        "criterion_number": 7,
        "description": "The response must identify at least one risk factor for osteopenia and osteoporosis and explain how these conditions are tested, such as with a DEXA scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies long-term corticosteroid use as a cause/risk for osteoporosis and recommends DEXA scans for monitoring."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention granulocyte colony stimulating factor and its potential side effect of temporary bone pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Granulocyte colony stimulating factor (G-CSF) and its bone pain side effect are not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response must emphasize that pain related to cancer or cancer-treatment is taken seriously and should be discussed with the patient\u2019s oncology team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It emphasizes communicating with the medical team, reporting bone pain promptly, and discusses tailored pain management options."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention that palliative medicine is a specialty for managing symptoms related to medical diagnoses and treatments, and that the patient can request a referral to this specialty if available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Palliative medicine as a specialty and referral option is not mentioned."
      }
    ],
    "question_number": 182,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:35:53.683118",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define epigenetics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines epigenetics as changes that alter gene expression without changing the DNA sequence."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how epigenetic changes can happen in normal cells, including gene silencing, activation, and DNA methylation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes mechanisms (DNA methylation, histone modifications, non-coding RNAs) and their roles in gene silencing and activation, including hypermethylation and hypomethylation. While focused on pancreatic cancer, it adequately covers how these mechanisms occur."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how epigenetic changes impact the cell\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains impacts on cell cycle regulation (p16, p21), apoptosis, adhesion (E-cadherin), EMT, and overall proliferation and invasiveness."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of epigenetic changes in cancer cells.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states roles in tumor development, progression, metastasis, and treatment resistance with pancreatic cancer\u2013specific examples."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that epigenetic changes can lead to inactivation of silencing tumor-suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly mentions hypermethylation leading to silencing of tumor suppressors such as CDKN2A (p16), APC, and RAR\u03b22."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that epigenetic changes can lead to activation of oncogenes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes hypomethylation may activate oncogenes and describes upregulation of oncogenic miRNAs (e.g., miR-21)."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that epigenetic changes can contribute to changes in the behavior of the tumor, such as increased propensity to spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes reduced cell adhesion via E-cadherin methylation and EMT promotion by miR-21, linking to increased invasiveness and metastasis."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that epigenetic changes can impact treatment response.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States epigenetic changes contribute to chemotherapy resistance and altered sensitivity to therapies; mentions strategies to overcome resistance."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that targeting epigenetic changes in pancreatic cancer is an experimental topic that is being actively researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Details ongoing research and trials of DNMT inhibitors, HDAC inhibitors, and miRNA-based therapies; emphasizes challenges and future directions."
      }
    ],
    "question_number": 183,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:36:26.683423",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that patients consider care agencies that are accredited and have a good reputation.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It explicitly advises checking accreditation (The Joint Commission, CHAP) and emphasizes reviews, references, and clinician referrals, addressing both accreditation and reputation."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that patients consider care agencies that provide a broad range of services, as the patient may have evolving needs as their treatment progresses.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It lists core and specialized services (skilled nursing, PT/OT, IV therapy, wound care) and notes adaptability/customization to changing needs, fulfilling the requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient inquire with his oncology team if there is social work support available to assist in seeking home health care that is covered by the patient\u2019s insurance carrier.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Although it mentions medical social work and suggests asking the oncologist for recommendations, it does not explicitly advise inquiring with the oncology team's social worker for assistance with insurance-covered home health care."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there is a broad range of types of in-home care and that the patient and family should consider what tasks they need assistance with.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It describes a broad range of in-home services but does not explicitly direct the family to consider and identify the specific tasks they need help with."
      },
      {
        "criterion_number": 5,
        "description": "The response should summarize common types of assistance that cancer patients benefit from such as cooking, cleaning, general home upkeep, shopping.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It covers clinical and personal care (bathing, medication reminders) but does not mention household support like cooking, cleaning, home upkeep, or shopping."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide links to websites where patients can learn more about the types of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No external links or websites are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention Hospice as a service that provides care in the home for patients with a prognosis of 6 months or less.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is mentioned but the specific eligibility criterion of a prognosis of 6 months or less is not stated."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that home health services include skilled nursing care and in-home therapies, such as physical and occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly lists skilled nursing and physical/occupational therapy under core services."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that they should seek agencies with experience in caring for cancer patients, specifically mentioning oncology-trained staff.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises ensuring staff trained in oncology and includes a question about experience with pancreatic cancer patients."
      }
    ],
    "question_number": 184,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:37:02.217071",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define angiogenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines angiogenesis as the process by which new blood vessels form, meeting the criterion directly."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the role of angiogenesis in solid tumors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains that tumors require blood supply for oxygen and nutrients, facilitating growth and metastasis\u2014an accurate description of angiogenesis in solid tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of angiogenesis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response discusses pancreatic tumors\u2019 reliance on angiogenesis, hypoxia-driven pathways (HIFs), and stromal influences, specifically contextualizing angiogenesis within pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should discuss how angiogenesis is a target for cancer treatment in some cancers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It details anti-angiogenic strategies (e.g., VEGF inhibitors like bevacizumab), mechanisms, and combination approaches, demonstrating how angiogenesis is targeted in oncology."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that anti-angiogenesis drugs are not used routinely in pancreatic cancer as they have not been shown to significantly improve outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response incorrectly suggests bevacizumab may improve survival and is sometimes used with chemotherapy in metastatic pancreatic cancer, and it does not state that anti-angiogenic agents are not routinely used due to lack of demonstrated benefit."
      },
      {
        "criterion_number": 6,
        "description": "The response should link to randomized control trials studying the effect of anti-angiogenic therapies in pancreatic cancer, with summaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No randomized controlled trials are cited or linked, and no trial results are summarized."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss treatment options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing treatment options with the medical team to tailor care, satisfying the criterion."
      }
    ],
    "question_number": 185,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:37:30.971968",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that liver function is routinely monitored during treatment using labs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions regular blood tests (ALT, AST, ALP, bilirubin, albumin, INR) to monitor liver function and states they are checked regularly."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe ways in which pancreatic cancer and pancreatic cancer treatment can affect the liver.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes liver metastases, biliary obstruction leading to jaundice, portal vein thrombosis, ascites, and treatment-induced liver injury from chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes in liver function labs will often be investigated further with imaging studies.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes imaging (ultrasound/CT/MRI/PET) as part of monitoring to evaluate liver structure and complications, implying further evaluation beyond labs."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe ways in which liver injury can be treated, such as dose reduction in systemic treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends dose reductions, switching agents (e.g., replace gemcitabine with capecitabine), and holding treatment when liver function deteriorates."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which liver injury can be treated, such as local therapy to tumors in the liver.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions surgery and localized therapies including SBRT/radiation for liver lesions."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways in which liver injury can be treated, such as biliary stenting.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that jaundice due to obstruction may require bile duct stenting."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe ways in which liver injury can be treated, such as elimination of offending medications or supplements.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises avoiding hepatotoxins like alcohol and acetaminophen and to discuss all medications; also suggests switching/holding offending drugs."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways in which liver injury can be treated, such as treatment of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention infection-related causes (e.g., cholangitis) or antibiotic treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that in rare cases, biopsy of liver tissue is needed to understand the cause of liver injury.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions biopsy only to characterize liver masses, not as a rare step to determine the cause of unexplained liver injury."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that many different medications and supplements can cause liver toxicity, and the patient should discuss all medications and supplements they take while undergoing cancer treatment to ensure no interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises discussing all medications, including over-the-counter, and avoiding hepatotoxic substances."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe red flag symptoms for liver injury.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists severe abdominal pain, confusion/mental changes, worsening jaundice, and vomiting as reasons to seek immediate help."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the patient discuss any new or worrisome symptoms with a member of their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages consulting the medical team for personalized guidance and contacting the healthcare team promptly for concerning symptoms."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of exercise, nutrition, and sleep in mitigating treatment-related toxicities and side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides nutritional guidance but does not emphasize exercise or sleep."
      }
    ],
    "question_number": 186,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:38:57.638477",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should discuss what tumor dormancy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor dormancy as a state where cancer cells temporarily stop dividing, can remain in the body without growing, and may later reactivate."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the implications of tumor cells that can enter dormancy, such as disease recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that dormant cells can 'awaken' and resume growth, emphasizes monitoring, and discusses potential reactivation, aligning with recurrence risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should outline that there is ongoing study on the subject of tumor dormancy, though it is not fully understood at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that scientists are studying dormancy and that treatments targeting dormancy are still evolving, implying incomplete understanding."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that dormancy can occur due to microenvironmental factors such as changes in the tumor microenvironment, lack of nutrients, or the presence of certain immune cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions microenvironment changes (oxygen, nutrients) and immune system activity as factors that can trigger dormancy."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that dormant cells are often less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that dormant cells are less susceptible to chemotherapy; only notes that treatment might force cells into dormancy and some may persist."
      },
      {
        "criterion_number": 6,
        "description": "The response should reference evidence from the scientific literature that discusses tumor dormancy in pancreatic cancer, and only references with a PubMed identification number (PMID) should be included.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No scientific literature or PMIDs are cited; only general support organizations are referenced."
      },
      {
        "criterion_number": 7,
        "description": "The response should indicate whether or not it is possible to detect dormant cancer cells in the body in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it says dormant cells may go undetected by standard tests, it does not directly address detectability of dormant pancreatic cancer cells specifically or provide a clear yes/no."
      }
    ],
    "question_number": 187,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:39:43.245359",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what an advance directive is and why people create them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines living will and healthcare proxy, and states reasons (ensure dignity/autonomy, align care with values, reduce stress)."
      },
      {
        "criterion_number": 2,
        "description": "Recommend asking the oncology team if there are resources available to assist (e.g., social work).",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions discussing documents with the medical team and external resources (ACS, hospice, attorneys) but does not advise asking the oncology team about resources or social work support."
      },
      {
        "criterion_number": 3,
        "description": "Direct the patient to consider acceptable medical treatments in emergencies or incapacity (CPR, dialysis, artificial nutrition, IV fluids/antibiotics); living will.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly covers living will content including CPR, mechanical ventilation, dialysis, tube feeding, IV fluids/hydration, and comfort-focused care."
      },
      {
        "criterion_number": 4,
        "description": "Recommend electing a specific durable power of attorney for healthcare.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises designating a healthcare proxy and outlines qualities of an appropriate surrogate."
      },
      {
        "criterion_number": 5,
        "description": "State that the patient should complete a POLST with their clinician and keep it visible at home.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of POLST or keeping clinician orders for life-sustaining treatment at home."
      },
      {
        "criterion_number": 6,
        "description": "State that advance directives should include a DNR order if desired.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically references code status with DNR/DNI in the living will section."
      },
      {
        "criterion_number": 7,
        "description": "Encourage completing advance directives as soon as possible, even if cancer is in remission or cured.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly encourage early completion or address doing so even if in remission/cured."
      },
      {
        "criterion_number": 8,
        "description": "Explain logistics of completing an advance directive and recommend submitting a copy to the oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers legal requirements (formatting, witnessing, notarization), updating, distribution, and specifically sharing copies with the oncologist and hospital."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize importance of future planning for pancreatic cancer due to aggressiveness/difficulty to cure.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes pancreatic cancer progresses unpredictably and links this to the importance of having clear directives, emphasizing proactive planning."
      }
    ],
    "question_number": 188,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:40:47.100628",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what targeted therapy is in oncologic treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines targeted therapy as treatments that target specific molecules/pathways involved in cancer growth and contrasts it with chemotherapy."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain what combination targeted therapy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that combination targeted therapy uses two or more targeted drugs together and provides reasons (multiple pathways, overcoming resistance, synergy)."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe what kinds of targeted therapy options exist in pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides examples relevant to pancreatic cancer such as BRAF/MEK inhibitor combinations and HER2-directed therapy; describes selection based on biomarkers."
      },
      {
        "criterion_number": 4,
        "description": "The response should illustrate why more than one targeted medication might be used at the same time to treat cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists clear rationales: targeting different pathways, overcoming resistance, and enhancing effectiveness/synergy."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain why the patient\u2019s tumor tissue needs to undergo molecular testing to understand what targeted therapies are indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that genomic testing identifies mutations/biomarkers to guide drug selection and gives specific examples (BRAF, HER2)."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain that some targeted therapies may not work on the patient\u2019s tumor due to lack of targetable mutations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it emphasizes personalization and biomarker-driven therapy, it does not explicitly state that therapies may not work if the tumor lacks the targetable mutation."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain that targeted therapies do not always work in pancreatic cancer due to tumor heterogeneity.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions resistance and cancers finding new ways to grow but does not specifically reference tumor heterogeneity as a reason."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe that targeted therapies are sometimes used at the same time as traditional chemotherapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state or give examples that targeted therapies may be combined with chemotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient discuss this further with their oncologist as targeted therapies are individualized to each patient\u2019s cancer, and not all targeted therapies are treatment options for all patients with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises asking the oncologist for details, considering clinical trials, and seeking a second opinion; emphasizes individualized treatment."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention KRAS inhibitors as a current area of research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "KRAS is mentioned as a gene, but KRAS inhibitors or their research status are not explicitly mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention PARP inhibitors are used in pancreatic cancer patients with BRCA1/2 mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of PARP inhibitors or their use in BRCA1/2-mutated pancreatic cancer."
      }
    ],
    "question_number": 189,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:41:38.696286",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States cancer 'spread (metastasize) to specific organs and tissues,' effectively defining metastasis as spread beyond the primary site."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer metastasizes, such as hematologic spread and lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions hematogenous spread to lungs and involvement of lymph nodes, and references the portal vein, covering key routes."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how pancreatic cancer metastasizes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes portal venous spread to liver, peritoneal seeding, hematogenous spread to lungs, and lymphatic spread to nodes."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that pancreatic cancer typically spreads locally first, involving surrounding lymph nodes, organs, and blood vessels.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly says 'Local Spread First' and notes early involvement of nearby lymph nodes and structures; discusses vascular involvement (portal vein)."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that metastatic spread can be influenced by the location of the primary tumor, for example whether it is located at the pancreatic head or the tail.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of differences in spread patterns by tumor location (head vs tail)."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that the liver is usually the first location for metastases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States the liver is the 'most frequent distant site' but does not explicitly say it is 'usually the first' site."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly state that pancreatic cancer can metastasize to the peritoneum or lining of the abdominal cavity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states spread to the peritoneal cavity and omentum (lining of the abdomen)."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that pancreatic cancer can spread to the lungs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists lungs as a site of metastasis via hematogenous spread."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer can spread to at least one of the following less common sites: bones, brain, or adrenal gland.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists adrenal glands, bones, and brain as less common metastatic sites."
      },
      {
        "criterion_number": 11,
        "description": "The response should explain what proportion of pancreatic cancers are metastatic at diagnosis and why.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides no proportion or percentage of metastatic cases at diagnosis."
      },
      {
        "criterion_number": 12,
        "description": "The response should discuss that pancreatic cancer commonly has already metastasized at the time of diagnosis because it often is asymptomatic at an early stage and only becomes symptomatic, prompting diagnostic investigation, once it has spread beyond its original site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that early disease is often asymptomatic leading to late diagnosis; only mentions early metastasis complicating detection."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that treatment options exist for all stages of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly state that there are treatments for all stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that options for treatment modalities, for example surgery or chemotherapy, depend on the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that stage and location of metastases guide treatment options such as surgery and chemotherapy."
      }
    ],
    "question_number": 190,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:42:59.411621",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how pancreatic cancer chemotherapy treatment can cause injury to the kidneys.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states that chemotherapy agents used in pancreatic cancer (e.g., gemcitabine, 5-fluorouracil) can be nephrotoxic and harm kidneys."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that platinum drugs (e.g., cisplatin, oxaliplatin) can directly injure the kidney.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No mention of platinum agents (cisplatin/oxaliplatin/carboplatin) or their nephrotoxicity."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how other pancreatic cancer treatments, such as surgery or radiation, can cause injury to the kidneys.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that abdominal radiation can impact kidney function, addressing non-chemotherapy treatment-related kidney injury."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that urinary tract infection should be ruled out, as some cancer treatments can put patients at increased risk for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention urinary tract infections or the need to rule out infection."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe that patients undergoing systemic treatment for pancreatic cancer should have their kidney function monitored frequently to evaluate for toxicity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends regular testing (creatinine, BUN, electrolytes, urinalysis) before, during, and after treatment, implying frequent monitoring."
      },
      {
        "criterion_number": 7,
        "description": "The response must clearly state that the first step is to identify the offending agent and reduce or hold the drug.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests dose reduction/substitution and avoiding nephrotoxic drugs but does not clearly state that the first step is to identify the offending agent and reduce or hold the drug."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is monitored and managed, such as serial lab tests of renal function to understand if it is improving over time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details serial monitoring with labs (creatinine, BUN, electrolytes, urinalysis) and notes adjustment based on results."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as dose reduction of systemic treatment, particularly the offending drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends dose reduction or substitution of chemotherapy and avoidance of nephrotoxic drugs."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as administration of intravenous fluids or other medications to support the kidneys.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides management strategies including medications addressing kidney-related complications (e.g., phosphate binders, vitamin D; antiemetics to maintain hydration), satisfying the 'such as' example."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention that IV fluids can be used to provide hydration.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Hydration is encouraged orally, but intravenous fluids are not explicitly mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as thorough evaluation of other medications or supplements a patient is taking to ensure there are no harmful interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises reviewing all medications, including over-the-counter drugs, for kidney safety and avoiding nephrotoxic agents, which addresses evaluation for harmful effects/interactions."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that alleviating obstruction (e.g., via stenting or nephrostomy) can help recover renal function.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of urinary tract obstruction, stenting, or nephrostomy."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that dehydration and obstruction (e.g., biliary or urinary) can lead to kidney injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions dehydration as a cause of kidney strain but does not mention obstruction."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consult with their oncology team and oncology pharmacist prior to starting new medications or supplements while undergoing pancreatic cancer treatment to avoid harmful interactions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages communication with the medical team and consulting healthcare providers, but does not specifically recommend consulting the oncology pharmacist or specify prior to starting new medications/supplements."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that sometimes dialysis may be indicated if there is a severe kidney injury related to cancer treatment.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Dialysis is not mentioned."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend staying well hydrated and with adequate nutrition intake while undergoing pancreatic cancer treatment to preserve energy and organ functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends adequate hydration and provides dietary guidance to maintain nutrition; discusses antiemetics to maintain hydration and nutrition."
      }
    ],
    "question_number": 191,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:44:25.320152",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the role of genetic mutations in cancer.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Clearly details driver mutations (KRAS, TP53, CDKN2A, SMAD4) and DNA repair genes (BRCA1/2, ATM), explaining how they initiate tumorigenesis, promote genomic instability, and drive growth."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer treatment applies selective pressure on cancer cells, allowing those that harbor certain characteristics that confer resistance to therapy a survival advantage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes therapy-driven selective pressure via clonal selection, noting that treatment eliminates sensitive subclones while resistant subclones gain a survival advantage and dominate."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that after certain treatments, tumor cells susceptible to that treatment will have died while those resistant to the treatment survive, making the residual cancer fundamentally different from the original cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that therapy removes sensitive subclones and allows resistant ones to dominate, leading to recurrence\u2014indicating the post-treatment tumor differs from the original."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how genetic mutations can cause cancer cells to resist certain treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples of resistance-conferring mutations (KRAS, PIK3CA, BRAF; EGFR/MET alterations) and notes genetic adaptations under therapy that render targeted treatments ineffective."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the heterogeneous cellular make-up of pancreatic cancer at baseline.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes intrinsic heterogeneity (subclones) and the complex tumor microenvironment typical of PDAC (dense stroma with fibroblasts, immune cells), indicating baseline cellular heterogeneity."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the mesenchymal-epithelial transition, including triggers for this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses epithelial-mesenchymal transition (EMT) and its drivers but does not address mesenchymal-epithelial transition (MET) or its triggers."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe methods for evaluating tumor evolution over time, including circulating tumor DNA and/or traditional biopsy of the primary tumor or metastatic lesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions liquid biopsies (ctDNA, CTCs) to monitor evolution and imaging/biomarkers; inclusion of ctDNA satisfies the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that tumor evolution is when the cancer changes and adapts over time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Conveys that pancreatic cancer evolves and adapts over time, including under treatment pressures (\u201cdynamic disease,\u201d \u201cevolves rapidly,\u201d clonal selection), satisfying the definition."
      }
    ],
    "question_number": 192,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:45:29.228347",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define complementary therapies, including supportive and integrative therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Complementary therapies are mentioned and integrative programs are referenced, but no explicit definition of complementary, supportive, or integrative therapy is provided."
      },
      {
        "criterion_number": 2,
        "description": "The response should define aromatherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Aromatherapy is discussed in terms of essential oils and routes of use, but the response does not explicitly define aromatherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that ingested/applied substances can cause reactions and it may be difficult to tell if reactions are from the complementary therapy or the cancer treatment; therefore use with caution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes possible allergic/skin/respiratory reactions and advises caution, it does not state the difficulty of distinguishing reactions from complementary therapy versus cancer treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response should inform patients that complementary therapies do not treat cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states aromatherapy is not proven to treat cancer and warns against cure claims; indicates complementary therapies do not replace conventional treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response should inform patients that some complementary therapies may help with symptoms related to their cancer diagnosis, such as stress or insomnia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states aromatherapy may help with symptoms like stress, nausea, and pain and suggests other supportive modalities for symptom management."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the patient inquire with their oncology team about trusted practitioners or referrals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises consulting the oncologist and a certified integrative medicine specialist and notes many centers have integrative programs, implying referral through the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide website links to informational pages from cancer societies such as NCI or PanCAN.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links are provided to the National Cancer Institute and MSKCC's About Herbs, satisfying the requirement via NCI."
      },
      {
        "criterion_number": 8,
        "description": "The response should strongly recommend discussing any complementary therapies with the oncology team to ensure no harmful interactions with cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes potential drug interactions and instructs to always consult the oncologist before using essential oils, meeting the strong recommendation criterion."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that aromatherapy is safest when used through inhalation and that oils must be appropriately prepared.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes inhalation is generally safer but does not explicitly state it is the safest, nor does it specify appropriate preparation (e.g., proper dilution) of oils."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that essential oils on the skin should be used with caution due to the risk of worsening skin irritation from chemotherapy or radiation.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions topical application can cause skin irritation and allergic reactions but does not explicitly link this to worsening skin irritation from chemotherapy or radiation."
      }
    ],
    "question_number": 193,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:46:37.858981",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metabolism in humans.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response discusses cancer metabolism concepts (glycolysis, oxidative phosphorylation, metabolic reprogramming) but does not provide a general definition of human metabolism as the sum of chemical reactions that convert nutrients into energy and building blocks."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the Warburg Effect.",
        "score_given": 9,
        "max_points": 9,
        "justification": "It clearly explains that many cancer cells preferentially use aerobic glycolysis despite oxygen availability, producing ATP quickly but less efficiently than oxidative phosphorylation, and links this to proliferation and survival."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about glucose, amino acid, and lipid metabolism in cancer cells, specifically in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It covers glucose metabolism (glycolysis, glucose deprivation), amino acid metabolism (glutamine usage), and lipid metabolism (fatty acid oxidation and synthesis, FASN), and ties these concepts to pancreatic cancer by noting its inclusion and KRAS-driven metabolic changes."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes in metabolism can alter sensitivity to cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that metabolic flexibility drives drug resistance and that metabolic inhibitors can enhance chemotherapy efficacy; it also notes effects on immunotherapy responses."
      },
      {
        "criterion_number": 5,
        "description": "The response should not recommend specific diets for the management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions ketogenic diets only as experimental with preliminary evidence and advises consultation; it does not recommend any specific diet."
      },
      {
        "criterion_number": 6,
        "description": "The response should not indicate that restrictive diets, such as the ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It does not instruct patients to start restrictive diets and emphasizes that efficacy is unproven and to consult the oncology team."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises discussing with the oncology team, it does not recommend requesting a referral to a nutritionist/dietitian."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there is not any current evidence for dietary interventions to alter the metabolism of the cancer and improve treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that evidence for dietary approaches like the ketogenic diet is preliminary and efficacy is unproven, indicating no current evidence for improved treatment outcomes via dietary metabolic interventions."
      }
    ],
    "question_number": 194,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:47:34.900288",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "List causes of eye problems related to cancer and/or treatment, including chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, dry eye, metastatic disease to the brain or eye, and infections.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions chemotherapy-related dry eye, conjunctivitis, and corneal damage, but it does not mention chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, metastatic disease to the brain/eye, or infections."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that chemotherapy can lead to eye dryness and irritations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states that chemotherapy drugs can cause dry eyes and describes associated irritation, redness, and blurred vision."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly state that the use of steroids can lead to an increase in cataracts or glaucoma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of steroid use or the associated risk of cataracts or glaucoma."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly state that immunosuppressed patients are more likely to have infections in their eyes.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not state that immunosuppressed patients are at increased risk of ocular infections."
      },
      {
        "criterion_number": 5,
        "description": "Mention that the patient\u2019s eye symptoms may not be related to cancer or treatment, and advise seeking an eye exam by a qualified practitioner.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests possible referral to an ophthalmologist via the oncology team, it does not state that symptoms may be unrelated to cancer/treatment. The criterion requires both elements."
      },
      {
        "criterion_number": 6,
        "description": "Recommend documenting characteristics of symptoms, such as severity and date of onset.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises tracking symptoms and noting when eye issues occur, which addresses documentation of timing/onset characteristics."
      },
      {
        "criterion_number": 7,
        "description": "List red flag eye symptoms that should prompt immediate medical care, such as vision loss or severe pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists multiple red flags including sudden or severe vision changes, loss of vision, flashes of light, eye pain, and double vision."
      },
      {
        "criterion_number": 8,
        "description": "Explicitly state that any eye symptoms should be discussed with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly instructs contacting the oncology team ASAP and sharing all symptoms with the oncologist."
      },
      {
        "criterion_number": 9,
        "description": "Recommend possibly requesting a referral to an ophthalmologist based on symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises consulting the medical team, who may refer to an ophthalmologist, effectively recommending possible referral."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly state that eye drops can be used to mitigate symptoms of dry eyes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends preservative-free artificial tears and lubricating ointments for dry eye symptoms."
      }
    ],
    "question_number": 195,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:48:21.918488",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define neoantigens in cancer as proteins expressed on the surface of cancer cells, used by the immune system to differentiate cancer from healthy tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that neoantigens arise from mutations, are presented on the cancer cell surface via MHC molecules, and are recognized by T cells, enabling immune differentiation from normal tissue."
      },
      {
        "criterion_number": 2,
        "description": "Mention ongoing research involving neoantigens in cancer, including cancer vaccines, immunotherapy, and CAR-T trials.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response covers immunotherapy (checkpoint inhibitors) and personalized cancer vaccines, and references clinical trials generally, but does not mention CAR-T trials. Because the criterion specifies inclusion of CAR-T, full credit cannot be awarded."
      },
      {
        "criterion_number": 3,
        "description": "State that there are no FDA-approved treatments targeting neoantigens at this time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly state that there are no FDA-approved neoantigen-targeted therapies. It notes vaccines are experimental but does not clearly make the FDA-approval status point."
      },
      {
        "criterion_number": 4,
        "description": "Recommend that the patient discuss the role of neoantigens in their cancer care with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing with the oncologist how the tumor\u2019s neoantigen profile influences treatment and prognosis."
      },
      {
        "criterion_number": 5,
        "description": "Recommend considering referral to be considered for clinical trials for pancreatic cancer treatment in their area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends considering participation in a clinical trial as an option, which aligns with advising referral for clinical trials."
      }
    ],
    "question_number": 196,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:48:53.609245",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define autophagy, including degradation/recycling and homeostasis via removal of damaged organelles and protein aggregates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines autophagy as a recycling mechanism involving autophagosomes and lysosomal degradation, and explains its role in maintaining cellular health/homeostasis by removing damaged organelles and proteins."
      },
      {
        "criterion_number": 2,
        "description": "Describe the dual role of autophagy in cancer (tumor suppression and promotion) with context on changes during progression.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly presents pro-tumor and anti-tumor roles and discusses context dependence, including early vs advanced stages."
      },
      {
        "criterion_number": 3,
        "description": "State that autophagy can be protective against cancer by removing damaged or dysregulated proteins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes autophagy clears mutated proteins and damaged organelles to prevent genomic instability, fulfilling this criterion."
      },
      {
        "criterion_number": 4,
        "description": "Describe autophagy in pancreatic adenocarcinoma, specifically its upregulation and contribution to cancer cell survival and treatment resistance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response states autophagy is upregulated in PDAC and supports survival, it does not explicitly connect autophagy to treatment resistance in PDAC."
      },
      {
        "criterion_number": 5,
        "description": "State that cancer cells can use autophagy to promote survival, growth, and therapy resistance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions survival support and metastasis, but does not explicitly state promotion of therapy resistance (nor clearly attribute growth) via autophagy."
      },
      {
        "criterion_number": 6,
        "description": "Explain whether autophagy can be targeted with treatment and provide at least one reference with a PMID.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Targeting autophagy is described (e.g., chloroquine/hydroxychloroquine), but no scientific reference or PMID is provided."
      },
      {
        "criterion_number": 7,
        "description": "State that blocking autophagy is under investigation and not standard of care in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response notes ongoing trials and that inhibition is under investigation but does not explicitly state there are no current standard-of-care treatments targeting autophagy in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "Mention specific autophagy-targeting drugs, cite evidence, and clearly state FDA approval status.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Specific drugs (chloroquine/hydroxychloroquine) are mentioned, but no literature citations are provided and FDA approval status is not clearly stated."
      },
      {
        "criterion_number": 10,
        "description": "Reference at least one scientific literature source with a PMID.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No PMIDs or scientific literature references are included."
      }
    ],
    "question_number": 197,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:49:47.110682",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the different types of support groups that exist for cancer patients and family members of cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While the response distinguishes telehealth versus in-person, synchronous versus asynchronous (forums), and mentions hybrid and disease-specific groups, it does not describe the broader range of group types (e.g., caregiver/family-only groups, bereavement, peer-led vs professionally facilitated) nor explicitly address family-member-focused groups."
      },
      {
        "criterion_number": 3,
        "description": "The response should address whether there is evidence that a telehealth support group is inferior to an in-person support group.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly states that studies suggest telehealth groups are comparable to in-person groups and cites a 2021 review reporting no significant differences in psychological outcomes, directly addressing inferiority."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide references and sources for evidence regarding the effectiveness of telehealth versus in-person support groups.",
        "score_given": 6,
        "max_points": 6,
        "justification": "A source is provided (2021 review in the Journal of Cancer Survivorship). Although not fully cited, it constitutes a reference supporting claims."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that in-person and telehealth groups each have their advantages and disadvantages and either may be as effective based on an individual\u2019s needs and preferences.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly outlines pros and cons of both formats and concludes that either may be equally effective depending on individual preferences and needs."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that telehealth groups can be more accessible and convenient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly highlights accessibility (geography, mobility) and convenience (no travel, flexible scheduling) as advantages of telehealth."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some may feel that in-person groups will lead to better emotional connection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes that in-person groups allow richer nonverbal cues and that some individuals prefer face-to-face interactions for a stronger emotional connection."
      },
      {
        "criterion_number": 9,
        "description": "The response should include a way for the patient or family member to input their location to generate a list of local support group resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No link, tool, or instruction is provided for entering a location to generate local resources."
      },
      {
        "criterion_number": 10,
        "description": "The response should list organizations to contact that might be able to provide support resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations (e.g., PanCAN, ACS, Cancer Support Community) are listed."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ask their oncology team for assistance in finding support groups.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends consulting healthcare providers, specifically oncologists and social workers, for tailored support group recommendations."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe that increased stress is normal when dealing with a cancer diagnosis and treatment, or as a family member of a cancer patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references emotional support and reducing distress, it does not explicitly state that increased stress is normal for patients or family members."
      }
    ],
    "question_number": 198,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:50:27.862312",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the effect of caffeine on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises limiting caffeine in the evening as part of sleep hygiene, indicating awareness of caffeine\u2019s negative impact on sleep."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention the effect of alcohol on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that alcohol can fragment sleep and recommends limiting alcohol in the evening."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the effect of illegal drugs on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of illegal/illicit drugs or their effects on sleep."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe strategies to improve sleep that are evidence-based.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends evidence-based strategies: consistent schedule, optimizing environment (dark/cool/quiet), CBT-I, limiting caffeine/alcohol, exercise and daytime light exposure, managing pain/side effects, and a sleep diary."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references for evidence-based sleep improvement interventions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No scientific references or citations are provided; listed organizations are resources, not references supporting specific interventions."
      },
      {
        "criterion_number": 6,
        "description": "The response should include insights into things in everyday life that may be interfering with a patient\u2019s ability to sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies everyday factors: screen use before bed, heavy meals, caffeine/alcohol in the evening, room light/noise/temperature, late fluid intake leading to bathroom trips, and nighttime disruptions."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide insights into how cancer-related symptoms can interfere with sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses pain, nausea, medication side effects (e.g., steroids, opioids), anxiety/depression, and urinary urgency as contributors to sleep disturbance."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of appropriate management of cancer-related or cancer-treatment related symptoms to prevent interference in everyday life, including sleep.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It emphasizes working with the medical team to adjust analgesics and manage side effects, and to review treatments/medications to address sleep disruption."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe common symptoms that people with pancreatic cancer might experience.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not list pancreatic cancer\u2013specific symptoms (e.g., jaundice, weight loss, steatorrhea, abdominal/back pain); it mentions general issues like pain and nausea without pancreatic-specific context."
      },
      {
        "criterion_number": 10,
        "description": "The response should direct the patient to discuss any symptoms of cancer or cancer treatment with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises consulting the healthcare provider/oncology team, reviewing treatments/medications, and discussing sleep aids with the oncology team."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize the importance of mental health and the impact of stress on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights anxiety/depression as common and impactful on sleep and suggests CBT-I, counseling, mindfulness, and journaling."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that sleep hygiene is an important first step.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it includes a section on sleep hygiene, it does not explicitly state that sleep hygiene is an important first step."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention a consistent relaxing bedtime routine starting 30 to 60 minutes before bedtime.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends a pre-bed routine and avoiding screens 1\u20132 hours before bed but does not specify starting a relaxing routine 30\u201360 minutes before bedtime."
      },
      {
        "criterion_number": 14,
        "description": "The response must clearly state that stimulant use, such as nicotine, should be avoided in the afternoon and evenings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention nicotine or stimulant avoidance in the afternoon/evening."
      },
      {
        "criterion_number": 15,
        "description": "The response must explicitly recommend optimizing the sleep environment by keeping the room dark, cool, and quiet.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends keeping the bedroom cool, dark, and quiet and suggests blackout curtains, earplugs, or white noise."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that supportive therapies, such as melatonin or other sleep aids, can be considered if deemed safe by the medical team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises considering melatonin and prescription sleep aids with medical guidance and discusses risks/benefits with the oncology team."
      }
    ],
    "question_number": 199,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:51:40.147883",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer-related cachexia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines cachexia as a complex, involuntary metabolic syndrome distinct from regular weight loss, characterized by progressive weight loss and metabolic dysfunction."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cachexia occurs in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains tumor-driven cytokines/hormones, chronic inflammation, and treatment side effects as drivers of cachexia and notes pancreatic cancer patients are particularly vulnerable, which addresses mechanisms relevant to pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should delineate cancer cachexia from regular weight loss.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides side-by-side distinctions in nature, symptoms, impact, causes, and reversibility between cachexia and regular weight loss."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that cachexia can occur independently of dietary changes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states that cachexia is not caused by reduced intake and can continue despite adequate eating; includes phrases such as 'even if someone eats well.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cachexia involves muscle loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly emphasizes muscle wasting and loss of lean body mass."
      },
      {
        "criterion_number": 6,
        "description": "The response should include information about prognosis in patients experiencing cancer cachexia.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States cachexia is linked to worse outcomes and increased mortality risk."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide evidence-based recommendations to patients experiencing cancer cachexia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Offers evidence-based strategies: nutritional support (high-calorie/high-protein), medications (megestrol acetate), tailored exercise, multidisciplinary and palliative care, and practical steps like small frequent meals."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss their concerns about cancer cachexia with their oncology team and/or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly advises discussion with the oncology team and includes dietitians; provides specific questions to ask the medical team."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that cachexia is difficult to manage.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Conveys difficulty by noting interventions often aren\u2019t sufficient alone and describing cachexia as 'deeply challenging.'"
      },
      {
        "criterion_number": 10,
        "description": "The response should state that cachexia can be mitigated by nutritional support, medications, and physical therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions nutritional support, medications (megestrol acetate), and exercise tailored to ability, which aligns with physical therapy approaches."
      }
    ],
    "question_number": 200,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:52:22.782444",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe epithelial-mesenchymal transition (EMT) as a transformation where epithelial cells acquire mesenchymal characteristics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines EMT as epithelial cells transforming into mesenchymal cells with increased motility and invasiveness."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention that EMT is a key feature of cancer progression, contributing to tumor progression, invasion, metastasis, and therapy resistance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States EMT is critical in cancer progression with invasion and metastasis, but does not mention therapy resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response must define epithelial cells as those forming the lining of glands, organs, and body surfaces, including the pancreas, and describe their tight connections and specific functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes epithelial cells line organs and form barriers/tight layers, but does not explicitly mention glands, body surfaces, or the pancreas."
      },
      {
        "criterion_number": 4,
        "description": "The response must define mesenchymal cells as those that can move, change shape, and are found in connective tissue, supporting organs and glands.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes mesenchymal cells as mobile and spindle-shaped but does not state they are found in connective tissue or that they support organs and glands."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that EMT enables cancer cells to migrate to distant sites, leading to metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states EMT facilitates escape from the primary tumor and colonization of distant organs."
      },
      {
        "criterion_number": 6,
        "description": "The response must mention that EMT is an area of current research and explicitly state that there are no treatments aimed at this process yet.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes EMT is an active research area and therapies are experimental, but does not explicitly state there are no treatments aimed at EMT yet."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that plasticity is a key factor in treatment resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions partial EMT but does not reference plasticity or its role in treatment resistance in pancreatic cancer."
      }
    ],
    "question_number": 201,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:53:00.647271",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define the microbiome as the microorganisms that live in the body and play roles in digestion, immune function, metabolism, and inflammation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses gut bacteria and dysbiosis but does not explicitly define the microbiome as the collection of microorganisms living in the body, nor does it clearly state its roles across digestion, immune function, metabolism, and inflammation in a definitional way."
      },
      {
        "criterion_number": 2,
        "description": "Mention that the microbiome is associated with cancer, specifically pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response directly addresses the role of the microbiome in pancreatic cancer development, progression, and treatment, satisfying this criterion."
      },
      {
        "criterion_number": 3,
        "description": "Describe how the microbiome is thought to affect pancreatic cancer treatment, including its influence on the efficacy of immunotherapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explains that gut microbiota can modulate immune responses and references evidence from other cancers (e.g., melanoma) linking microbiota profiles to immunotherapy outcomes, and notes microbiome effects on treatment tolerance."
      },
      {
        "criterion_number": 4,
        "description": "Describe how the microbiome can influence how the body metabolizes chemotherapy drugs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions that the microbiome might influence drug metabolism for targeted therapies and that chemotherapy can disrupt microbiota, it does not specifically state that the microbiome influences the metabolism of chemotherapy agents."
      },
      {
        "criterion_number": 5,
        "description": "Mention that modulating the microbiome to improve cancer outcomes is an active area of research with limited evidence and no standard of care options to date.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response notes active research and limited evidence and mentions clinical trials, but it does not explicitly state that there are no standard-of-care microbiome-targeted options at present."
      },
      {
        "criterion_number": 6,
        "description": "Mention the various roles the microbiome is postulated to play in the human body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response discusses immune modulation, inflammation, metabolite production (SCFAs), and effects on treatment tolerance and the tumor microenvironment, covering multiple roles attributed to the microbiome."
      },
      {
        "criterion_number": 7,
        "description": "Summarize the scientific research with references (PMID if available).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided to support the statements."
      },
      {
        "criterion_number": 8,
        "description": "Describe standard of care treatments for pancreatic cancer, including chemotherapy and immunotherapy, and mention that appropriate treatment selection depends on the stage of cancer and fitness of the patient.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not outline standard-of-care therapies by stage/fitness or name regimens; it only references chemotherapy and immunotherapy in the context of microbiome effects."
      },
      {
        "criterion_number": 9,
        "description": "Suggest that the patient discuss whether there are ways to support a healthy microbiome with a nutritionist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response advises discussing changes with the oncology team but does not suggest consultation with a nutritionist regarding microbiome-supportive strategies."
      }
    ],
    "question_number": 202,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:53:43.915919",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that mood changes are very common with the diagnosis of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that mood changes are common in loved ones with pancreatic cancer and normalizes this experience."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment-related mood changes with the oncology team to ensure they are provided with available local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends consulting the healthcare/oncology team for medication adjustments and emphasizes working with a multidisciplinary team, implying use of local resources through the care team."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend a referral to a mental health provider familiar with cancer patients and cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It suggests therapy and involvement of mental health professionals (psychiatrist, social worker) within a multidisciplinary cancer care team, meeting the referral criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe counseling as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends counseling/CBT to help process emotions and reduce anxiety."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe medications, such as antidepressants, as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states oncologists may prescribe antidepressants (e.g., SSRIs) for treatment-related mood changes."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe support group participation as an intervention that may help alleviate mood issues.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Support groups are recommended, with examples of organizations and benefits like reducing isolation."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide supportive language about mood changes during cancer treatment and attempt to normalize this phenomenon.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It uses supportive language and explicitly normalizes mood changes as a normal response, not a sign of weakness."
      },
      {
        "criterion_number": 8,
        "description": "The response should reference studies that quantify patients with cancer that suffer from mood changes after diagnosis and/or during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No studies or quantitative data are cited to quantify the prevalence of mood changes."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe different interventions that may help alleviate mood issues, such as psychiatric evaluation, exercise, nutrition, and cancer-related symptom control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends psychiatric involvement, exercise, nutrition guidance, sleep hygiene, mindfulness, and medical evaluation for symptom control and reversible causes."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that patients with suicidal thoughts consider presentation to medical care urgently or emergently.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs to seek immediate help for self-harm thoughts and provides crisis lines, satisfying the urgency requirement."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the role of palliative medicine in cancer care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Palliative care is not mentioned or described."
      },
      {
        "criterion_number": 12,
        "description": "The response should list common side effects of both pancreatic cancer and pancreatic cancer treatment, and suggest that feeling poorly can impact one\u2019s mood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists pain, fatigue, nausea, weight loss, weakness, and treatment-related effects (e.g., chemo, radiation, steroids) and links these to mood changes."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that some patients benefit from a mental health standpoint by having their affairs in order, as this can provide some peace of mind in the face of a serious illness.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no recommendation about getting affairs in order for peace of mind."
      },
      {
        "criterion_number": 14,
        "description": "The response should list online resources for support for patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides links to the American Cancer Society and the Pancreatic Cancer Action Network."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that mindfulness and relaxation techniques can be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends mindfulness, meditation, deep breathing, and yoga as relaxation techniques."
      }
    ],
    "question_number": 203,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:54:25.238515",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor suppressor genes and their function in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor suppressor genes as brakes on cell growth and details their functions: DNA repair, cell cycle regulation, apoptosis, and control of processes like angiogenesis and metastasis."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how defects in tumor suppressor genes can lead to cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that inactivation leads to loss of growth control, avoidance of apoptosis, unchecked division, invasiveness, and immune evasion."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how tumor suppressor genes gain defects or mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes multiple mechanisms: mutations, deletion/loss of both copies (two-hit hypothesis), and epigenetic silencing via DNA methylation."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that there are genetic syndromes inherited in families that affect tumor suppressor genes, leaving affected individuals at higher risk of developing cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes inherited BRCA1/2 mutations increasing pancreatic cancer risk in families and references Lynch syndrome (MLH1), satisfying the concept of hereditary cancer syndromes."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention tumor suppressor genes that are thought to play a role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists TP53, CDKN2A (p16), and SMAD4 as key tumor suppressors in pancreatic cancer; also mentions BRCA1/2."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is an active area of research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that therapies are under investigation, references ongoing research and updates, and discusses experimental treatments/clinical trials."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss whether there are clinical trials available in their area with their oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions clinical trials conceptually but does not explicitly recommend discussing trial availability in their area with the oncology team."
      }
    ],
    "question_number": 204,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:54:54.145779",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must recommend discussing mental health counseling with the oncology team to connect with local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the medical team (oncologists, nurses, social workers) at the cancer center for referrals to trusted counselors."
      },
      {
        "criterion_number": 3,
        "description": "The response must introduce palliative medicine as a specialty for managing symptoms or end-of-life care for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions palliative care and hospice teams, noting their specialization in end-of-life care and holistic support."
      },
      {
        "criterion_number": 4,
        "description": "The response must list at least three types of mental health care providers, including their credentials and any limitations in practice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It lists multiple provider types with credentials (e.g., LCSW, LPC, LMFT, PhD/PsyD, chaplains) but does not describe limitations in practice or scope (e.g., prescribing limitations, non-licensed status of chaplains), which the criterion requires."
      },
      {
        "criterion_number": 5,
        "description": "The response must mention at least one modality for delivery of mental health counseling, such as in-person or telehealth.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly recommends telehealth/virtual sessions as an option."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that choosing the best provider is individualized and cannot be recommended online.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it emphasizes the importance of fit and trying multiple options, it does not explicitly state that an individualized recommendation cannot be provided online."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention providers affiliated with religious denominations or faith-based counseling options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It references chaplains within palliative care teams, which are faith-based providers."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention mental health resources available for family members and caregivers of cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly includes family-focused options (family/couples therapists, grief/bereavement counselors) and support groups (e.g., Cancer Support Community, GriefShare) relevant to families and caregivers."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend seeking counseling proactively, not waiting for a crisis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not explicitly recommend proactive counseling or advise against waiting for a crisis."
      },
      {
        "criterion_number": 10,
        "description": "The response must recommend at least one additional way to improve overall wellbeing, such as nutrition, exercise, sleep, or symptom control.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit recommendations on nutrition, exercise, sleep, or other wellbeing strategies are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that a licensed clinical social worker would be a good resource to utilize for advice and to be connected to further resources such as financial or caregiver support.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although LCSWs are listed among licensed therapists and social workers are mentioned on care teams, it does not state that an LCSW can connect patients/families to financial or caregiver support resources."
      }
    ],
    "question_number": 205,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:55:37.551860",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what DNA damage repair pathways are in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines DDR as pathways that detect and repair DNA damage and explains their role in cell survival and response to chemo/radiation."
      },
      {
        "criterion_number": 2,
        "description": "The response should list examples of genes implicated in DNA repair pathways in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists multiple relevant genes/components (BRCA1/2, PALB2, RAD51, ATM, ATR, CHK1/2, PARP, TP53). While not all are commonly mutated, examples are provided."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain treatments in pancreatic cancer that are indicated for mutations in certain DNA repair pathway mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains PARP inhibitors for BRCA1/2-mutated pancreatic cancer with synthetic lethality rationale and mentions their use in trials/therapy contexts."
      },
      {
        "criterion_number": 4,
        "description": "The response should list DNA pathway repair targeted therapies in pancreatic cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists PARP inhibitors (olaparib, niraparib) and other DDR-targeted classes (ATM/ATR, CHK inhibitors) with examples. Some inaccuracies in specific inhibitor targets are present, but targeted therapies are listed."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how mutations in DNA damage repair pathways affect chemotherapy effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that defective DDR increases sensitivity to DNA-damaging agents and that functional/altered DDR can confer resistance; provides synergy examples with gemcitabine and radiation."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how mutations in these pathways are detected in tumors, which is through genetic testing of tumor tissue from a biopsy or through a blood test.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Recommends testing and mentions HRD assays but does not explicitly describe detection methods (tumor tissue biopsy testing and/or germline blood testing)."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide references to scientific literature with PMID for any of the FDA-approved treatments listed in rubric 4.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs provided; only a clinical trial NCT number is mentioned."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss tumor genetic testing with their oncologist to understand if they are a candidate for any DNA damage repair pathway mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises ensuring the tumor is tested and to consult the oncology team/genetic counselor."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the patient inquire about clinical trials in their local area that might be evaluating new drugs that target DNA damage repair pathways, or inquire about a referral to a local institution that might have general clinical trials for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages inquiry about ongoing clinical trials for DDR inhibitors; although not specifying 'local area,' the recommendation to pursue trials is clear."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that around 5-10 percent of pancreatic cancers have these mutations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that BRCA1/2 mutations are found in approximately 5\u201310% of pancreatic cancers."
      }
    ],
    "question_number": 206,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:56:42.541499",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must clearly define inflammation using terms such as \u201cimmune response,\u201d \u201ctissue injury,\u201d or \u201cprotective mechanism.\u201d",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines inflammation as a natural immune response and discusses its role, satisfying the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly distinguish between acute and chronic inflammation, mentioning characteristics like \u201cshort-term\u201d vs. \u201clong-term\u201d or \u201crapid onset\u201d vs. \u201cpersistent.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "It explains chronic inflammation as long-term activation but does not explicitly contrast it with acute/short-term inflammation."
      },
      {
        "criterion_number": 3,
        "description": "The response must describe at least two medical strategies for managing inflammation, such as \u201ctargeted therapies,\u201d \u201cimmunotherapies,\u201d \u201csteroids,\u201d or \u201cpain management.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists multiple medical strategies including NSAIDs, COX-2 inhibitors, cytokine inhibitors, metformin, and immunotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is no formal, evidence-based strategy to quantify and target inflammation in cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions ongoing research and limited evidence but does not explicitly state that no formal, evidence-based strategy exists to quantify and target inflammation."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that treating the cancer itself, such as through \u201csurgery\u201d or \u201cradiation,\u201d is postulated to improve cancer-related inflammation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states chemotherapy may indirectly reduce inflammation by shrinking tumors and discusses surgery, chemotherapy, and radiation as mainstays, satisfying the concept that treating the cancer can reduce inflammation."
      },
      {
        "criterion_number": 6,
        "description": "The response must mention chronic pancreatitis or chronic pancreatic injury as a factor in cancer formation and provide at least one scientific reference with a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chronic pancreatitis is mentioned as a risk factor, but no scientific reference with a PMID is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response must recommend at least two lifestyle interventions to decrease inflammation, such as \u201cplant-based diet,\u201d \u201cexercise,\u201d \u201chydration,\u201d or \u201cgood quality sleep.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends an anti-inflammatory diet, maintaining a healthy weight, and regular exercise."
      },
      {
        "criterion_number": 8,
        "description": "The response must recommend against nicotine and alcohol use and reference their role in promoting inflammation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises quitting smoking and limiting alcohol, stating both contribute to chronic inflammation."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend that the patient report any symptoms to their oncology team for symptom management.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it encourages working with specialists and mentions palliative care for symptom management, it does not explicitly instruct reporting symptoms to the oncology team."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that chronic inflammation promotes tumor growth. Synonyms for \u201cpromotes\u201d include \u201csupports,\u201d \u201caids,\u201d or \u201cfacilitates.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states inflammation contributes to cancer development and progression and promotes angiogenesis and metastasis, which supports tumor growth."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that inflammatory signaling pathways are overactivated in cancer, using terms like \u201coveractivated,\u201d \u201cupregulated,\u201d or \u201cenhanced.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions pathways like NF-\u03baB but does not state they are overactivated/upregulated/enhanced in cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that the immune system can be activated to recognize and attack cancer, using terms like \u201cempower,\u201d \u201cstimulate,\u201d or \u201cleverage.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that checkpoint inhibitors enhance the immune system\u2019s ability to attack cancer cells."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that anti-inflammatory drugs are not used as a primary treatment for pancreatic cancer. Synonyms for \u201cprimary\u201d include \u201cmain\u201d or \u201cfirst-line.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes anti-inflammatory management complements standard treatments but does not explicitly state they are not a primary/first-line treatment for pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that NSAIDs and steroids are prescribed to manage symptoms associated with cancer, using terms like \u201csymptom management,\u201d \u201csymptom control,\u201d or \u201calleviate symptoms.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "NSAIDs are discussed but not in the context of symptom management, and steroids are not mentioned."
      }
    ],
    "question_number": 207,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:57:28.073708",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention using a pill organizer with compartments for different times of the day and days of the week.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends weekly pill organizers with labeled compartments for days/times (e.g., AM/PM)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention using a medication management application, with examples such as Medisafe, MyTherapy, or CareZone.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Names specific apps including Medisafe and MyTherapy, which meet the examples requested."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention setting alarms or reminders on digital devices to alert when it\u2019s time to take medication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that apps send dose reminders and integrate with calendars, fulfilling the reminders/alarms requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention creating a physical chart or digital document listing all medications, dosages, and times.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends a medication log (notebook, spreadsheet, or app) including drug name, dose, time, and route."
      },
      {
        "criterion_number": 5,
        "description": "The response should direct the patient to discuss options for medication management with their oncology team and/or pharmacy team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages pharmacist consultation and telehealth with the care team, and explicitly says to consult the oncology team."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend exploring medication delivery services and bubble packs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends blister packaging services and cites PillPack (a mail-order delivery pharmacy), covering both bubble packs and delivery services."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient have a loved one help with their medication management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests caregiver assistance and notes apps that allow caregivers to monitor adherence, implying loved one involvement."
      },
      {
        "criterion_number": 8,
        "description": "The response should empathize about the medication burden in patients undergoing cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Uses empathetic tone acknowledging stress and need for a compassionate approach; includes supportive closing."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention meeting with a pharmacist or provider to complete a medication reconciliation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically advises scheduling a medication reconciliation and consulting an oncology pharmacist."
      }
    ],
    "question_number": 208,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:58:09.928399",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define oncogenes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines proto-oncogenes as normal growth/survival regulators and explains that mutations convert them into oncogenes that drive uncontrolled growth."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that oncogenes can undergo mutation, which might put the individual at risk for developing cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that mutations turn proto-oncogenes into oncogenes and that these mutations lead to uncontrolled growth, resistance to apoptosis, angiogenesis, metastasis, and treatment resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how oncogenes mutate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States that genes undergo mutations but does not describe mechanisms (e.g., point mutations like KRAS codon 12, gene amplifications, translocations/fusions, copy-number gains) or processes leading to these mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference which mutated oncogenes are implicated in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names key oncogenes in pancreatic cancer, especially KRAS (~90%), and also mentions BRAF and receptor tyrosine kinases (EGFR/HER2/MET). Although some prevalence estimates may be high for BRAF, it satisfies the criterion by listing implicated oncogenes."
      },
      {
        "criterion_number": 6,
        "description": "The response should state whether there are FDA-approved treatments available for pancreatic cancers with mutated oncogenes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions FDA approval of sotorasib for KRAS G12C-mutated cancers generally and references EGFR-targeted agents, but does not clearly state whether FDA-approved targeted treatments exist specifically for pancreatic cancer oncogenic drivers (e.g., tumor-agnostic approvals). Lacks a direct, accurate statement for pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that patients with pancreatic cancer undergo tumor genetic testing either with biopsy of primary tumor or blood test.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends genetic testing of the tumor to identify active oncogenes to guide therapy, meeting the criterion to undergo tumor genomic testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that patients inquire with their oncology team if there are clinical trial opportunities available to them, or a local institution.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises consulting the oncologist to discuss available treatments or clinical trials, fulfilling the recommendation to inquire about clinical trial opportunities."
      }
    ],
    "question_number": 209,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T16:59:05.512464",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe that treatment sequencing in pancreatic cancer is determined by the stage of the cancer and the intent of the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states sequencing depends on stage and other factors and distinguishes curative vs palliative intents (e.g., resectable vs unresectable/metastatic with quality-of-life focus)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that sometimes pancreatic cancer management requires different modalities of treatments, such as chemotherapy and surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple modalities are discussed, including chemotherapy, surgery, radiation, targeted therapy, and immunotherapy, and how they are combined/sequenced."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe that in pancreatic tumors thought to be surgically resectable, patients often undergo chemotherapy prior to surgery to shrink the tumor and kill any micrometastases for the best possible surgical outcome.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly describes neoadjuvant chemotherapy before surgery in resectable cases, with goals to shrink the tumor and reduce microscopic disease."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that surgery rarely plays a role in advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it emphasizes systemic therapy for advanced/metastatic disease, it does not explicitly state that surgery rarely plays a role in advanced disease."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe what treatment sequencing in pancreatic cancer is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that sequencing is the ordered combination of treatments and provides detailed examples of sequences for resectable and unresectable scenarios."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain the goal of treatment sequencing in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The goals are stated (maximize effectiveness, improve survival, manage side effects) and further illustrated (increase surgical success, reduce micrometastases, relieve symptoms)."
      },
      {
        "criterion_number": 7,
        "description": "The response should state risks involved if cancer treatment is not appropriately sequenced.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit risks of improper sequencing (e.g., losing surgical window, increased toxicity, worse outcomes) are described."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient request a multidisciplinary conference to discuss their pancreatic cancer management recommendations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises consultation with a multidisciplinary team but does not specifically recommend requesting a multidisciplinary conference/tumor board."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe what a tumor board (or multidisciplinary conference) is for discussions on management of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No description or definition of a tumor board or multidisciplinary conference is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain that the oncology care team needs to gather information to make informed recommendations on pancreatic cancer treatment, such as imaging studies, tumor biomarkers, and possibly tumor genetic testing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Genetic testing is mentioned, but the response does not explicitly state the need to gather comprehensive information (e.g., imaging, biomarkers) to guide recommendations."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize that treatment sequencing is individualized to the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that the plan is personalized and tailored to the patient\u2019s biology, preferences, and goals."
      },
      {
        "criterion_number": 12,
        "description": "The response should define the following terms: neoadjuvant, adjuvant, perioperative.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Neoadjuvant and adjuvant are effectively defined by context (before and after surgery), but perioperative is not defined or mentioned."
      }
    ],
    "question_number": 210,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:00:11.070210",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define hypoxia as a low oxygen state often seen in tumors because the tumor outgrows its blood supply.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines hypoxia as low oxygen within tumors and attributes it to tumor outgrowing its blood supply."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe why cancer cells that exist in a hypoxic environment are difficult to treat.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains treatment difficulty via chemotherapy resistance and reduced radiation sensitivity in hypoxic regions."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how hypoxic environments affect cancer\u2019s response to treatment.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Explicitly states decreased effectiveness of chemotherapy and radiation in hypoxic tumor areas."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that radiation therapy becomes less effective in hypoxic conditions because oxygen plays a role in radiation-induced DNA damage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States radiation depends on oxygen to damage cancer cells and that hypoxia reduces radiation effectiveness."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the mechanism of action of VEGF inhibitors and their postulated role in the treatment of hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions anti-angiogenic therapy and vascular normalization but does not describe VEGF inhibition mechanism or explicitly reference VEGF inhibitors."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain whether there is evidence-based information about hyperbaric oxygen therapy in hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of hyperbaric oxygen therapy or its evidence base."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how hypoxic environments affect the immune system\u2019s ability to access cancer cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address immune system effects of hypoxia (e.g., impaired immune infiltration or function)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend the patient discuss whether there are clinical trials focusing on tumor cell hypoxic environments available in their area.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically recommends discussing clinical trials testing hypoxia-targeted therapies."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that hypoxia can make the tumor more aggressive and promote metastasis (spread).",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not state that hypoxia increases aggressiveness or promotes metastasis."
      }
    ],
    "question_number": 211,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:00:51.920669",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend documenting questions/concerns in advance of appointments",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises writing down questions and lists example questions to bring to appointments."
      },
      {
        "criterion_number": 2,
        "description": "Encourage asking for clarification and questions during appointments",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly encourages asking for clarification with example phrases and emphasizes summarizing and confirming the plan."
      },
      {
        "criterion_number": 3,
        "description": "Recommend requesting a language interpreter if needed",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of interpreter services or language assistance."
      },
      {
        "criterion_number": 4,
        "description": "Recommend bringing a loved one to appointments and taking notes/recording",
        "score_given": 110,
        "max_points": 110,
        "justification": "Advises bringing a family member/friend to appointments to take notes and suggests recording conversations (with permission)."
      },
      {
        "criterion_number": 5,
        "description": "Recommend using online patient portals to send messages",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends using patient portals (e.g., MyChart) for secure communication and record access."
      },
      {
        "criterion_number": 6,
        "description": "Recommend inquiring about best communication contacts/channels and establishing a point person",
        "score_given": 7,
        "max_points": 7,
        "justification": "Suggests identifying a primary contact (e.g., oncologist, nurse coordinator, social worker) for urgent concerns."
      },
      {
        "criterion_number": 7,
        "description": "Provide a list of online resources for patients and families",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes multiple reputable resources: American Cancer Society, National Cancer Institute, PanCAN, CancerCare, and Patient Advocate Foundation."
      },
      {
        "criterion_number": 8,
        "description": "Recommend additional points of contact (patient advocates, social workers, nurses, palliative specialists)",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions patient navigators/case managers, social workers, nurse coordinators, and patient advocacy services as resources."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize importance of feeling supported",
        "score_given": 5,
        "max_points": 5,
        "justification": "Reassures the family that they are not alone, promotes self-care, and suggests counseling/support groups."
      },
      {
        "criterion_number": 10,
        "description": "Inform that patients can ask for a written summary of visits",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages personal note-taking and summarizing but does not mention requesting a written visit summary from the team."
      },
      {
        "criterion_number": 12,
        "description": "State that patient navigators can assist with coordination and communication",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends involving patient navigators/case managers to coordinate care and improve communication."
      }
    ],
    "question_number": 212,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:01:26.955927",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell plasticity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines plasticity as the ability of cancer cells to adapt phenotype, behavior, and gene expression to environmental pressures, with context specific to pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cancer cell plasticity makes cancer cells more difficult to treat.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains multiple resistance mechanisms: intratumoral heterogeneity, adaptive resistance pathways (PI3K/Akt/mTOR, NF-\u03baB), drug efflux, CSC-mediated relapse, quiescence, and TME-driven resistance, linking them to chemo and immunotherapy failure."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the epithelial-mesenchymal transition in pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Describes EMT mechanism with key transcription factors (Snail, Slug, Twist), its impact on chemoresistance and invasiveness, and ties EMT to PDAC-specific stroma and signaling (TGF-\u03b2, Hedgehog), with examples (gemcitabine resistance)."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role plasticity plays in the metastatic potential of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links EMT-driven phenotypic switching to increased motility, invasiveness, and metastasis; notes PDAC\u2019s early metastasis and how plasticity exacerbates this behavior."
      },
      {
        "criterion_number": 5,
        "description": "The response should define and describe cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines dormancy/quiescence as a non-proliferative state and outlines mechanisms (p53, CDK inhibitors) and clinical consequences (reduced chemo efficacy, late recurrences)."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how cancer cell plasticity can contribute to cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Places dormancy/quiescence as a key mechanism under plasticity and explains that the ability to transition into a dormant state helps cells evade therapies targeting dividing cells."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how cancer cell plasticity allows cancer cells to evade the immune system, making immunotherapy relatively ineffective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes modulation of immune recognition via PD-L1 upregulation and MHC class I downregulation and connects this to reduced immunotherapy efficacy; also mentions EMT-associated immune evasion."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention ways that cancer-directed therapy can be used to attempt to overcome cancer cell plasticity, such as treatment sequencing and medication combinations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple strategies: targeting EMT/CSC pathways, combination therapies (chemo + immunotherapy; metabolic inhibitors + standard therapy), epigenetic modulators, anti-stromal approaches, and dormancy-targeting tactics."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that therapeutic strategies to target plasticity is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section on current research and clinical trials (EMT inhibitors, CSC-targeted therapies, immunotherapy combinations) and explicitly states ongoing research in the conclusion."
      }
    ],
    "question_number": 213,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:01:53.137049",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define mechanical forces in relation to cancer cells, explicitly mentioning \u201cphysical forces\u201d or \u201cpressure.\u201d",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines mechanical forces as pressure, tension, and shear stress arising from the tumor\u2019s physical environment, explicitly mentioning both \u201cmechanical forces,\u201d \u201cpressure,\u201d and the physical context."
      },
      {
        "criterion_number": 2,
        "description": "Describe the effect of different mechanical forces on cancer growth and proliferation, including activation of pathways or signaling pathways.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explains how stiffness and stretch influence proliferation, invasion, and drug resistance and details mechanotransduction via integrins, Rho/ROCK, and YAP/TAZ pathways."
      },
      {
        "criterion_number": 3,
        "description": "Define desmoplastic stroma, which is often seen in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses a dense, stiff ECM and fibroblast-driven collagen deposition, it does not explicitly define or name \u201cdesmoplastic stroma.\u201d"
      },
      {
        "criterion_number": 5,
        "description": "Describe the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes key TME features: ECM stiffness, cancer-associated fibroblasts, vessel compression/abnormal vasculature, interstitial pressure, and hypoxia in PDAC."
      },
      {
        "criterion_number": 6,
        "description": "Mention future research directions as it pertains to desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Outlines research directions including ECM-targeting (e.g., hyaluronan-modifying approaches, integrin inhibitors), nanoparticle/drug strategies for hypoxic regions, and combination approaches with chemo/immunotherapy."
      },
      {
        "criterion_number": 7,
        "description": "Explain if there are FDA approved therapies that act on the desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address FDA approval status; only notes therapies are being studied and in trials, without stating whether any are FDA-approved."
      },
      {
        "criterion_number": 8,
        "description": "State that in pancreatic cancer, the stroma is very dense and stiff, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly notes PDAC has a dense, stiff ECM and describes increased interstitial pressure compressing vessels with impaired blood flow and limited oxygen delivery; nutrient delivery is implied in the context of disrupted supply."
      },
      {
        "criterion_number": 9,
        "description": "State that the dense stroma can impede treatment delivery and induce hypoxia, explicitly mentioning \u201chypoxia\u201d and \u201ctreatment resistance.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "States stiff ECM physically blocks drug delivery and mentions \u201chypoxia,\u201d and refers to \u201ctreatment-resistant\u201d cells, satisfying both required terms."
      },
      {
        "criterion_number": 10,
        "description": "State that the dense stroma can impede immune cells from reaching the tumor, explicitly mentioning \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention immune cell exclusion, immune evasion, or reduced efficacy of immunotherapy."
      }
    ],
    "question_number": 214,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:02:35.217135",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing the primary medical team responsible for tracking referrals and oncologic care; usually the medical oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises designating a lead coordinator (primary care physician or oncologist) but does not state that this role is usually the medical oncologist, nor does it explicitly frame this as discussing which team is primarily responsible for oncologic care and referrals."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that a clinician is designated as the main provider responsible for care coordination and continuity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends identifying a primary care physician or oncologist to act as the main coordinator, fulfilling the requirement to designate a clinician for continuity and coordination."
      },
      {
        "criterion_number": 3,
        "description": "Describe the potential medical teams involved in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists surgeons, medical oncologists, radiation oncologists, gastroenterologists, radiologists, and palliative care, and mentions tumor boards, adequately describing the multidisciplinary team."
      },
      {
        "criterion_number": 4,
        "description": "Recommend keeping a comprehensive log of test results and progress notes to provide to providers if they did not receive everything.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends a centralized health record/patient binder containing medical reports and treatment plans and emphasizes appointing a liaison to ensure no critical details are missed, which supports the purpose of supplying records if not all information is received."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly recommend creating a centralized document listing all providers, their roles, and test results, which can be taken to appointments.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it suggests a patient binder with reports and contact details, it does not explicitly include provider roles nor explicitly advise bringing this document to appointments."
      },
      {
        "criterion_number": 6,
        "description": "Recommend that a loved one accompany the patient to all appointments, preferably the same person, and take notes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests appointing a liaison and optionally recording visits but does not explicitly recommend having a consistent loved one accompany all appointments and take notes."
      },
      {
        "criterion_number": 7,
        "description": "Recommend using online patient portals to ask questions and contact the oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions a centralized health record system and apps like MyChart for organizing symptoms, it does not explicitly recommend using patient portals for messaging or contacting the oncology team."
      },
      {
        "criterion_number": 8,
        "description": "Describe different professionals that can help with care coordination, such as nurse case managers and social workers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It identifies case managers, patient navigators, and social workers as resources for coordination and support, satisfying the criterion."
      }
    ],
    "question_number": 215,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:03:24.502349",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define senescence in cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines senescence as permanent cell-cycle arrest with cells remaining alive but not dividing, using accurate language and context."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how senescence can lead to secretion of inflammatory molecules (senescence-associated secretory phenotype) which can alter the microenvironment to make it more amenable to tumor progression.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that senescent cells secrete inflammatory molecules (SASP) and that this can promote tumor growth or metastasis, indicating a pro-tumor microenvironmental effect."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe senescence-associated secretory phenotype factors.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions SASP as 'inflammatory molecules' but does not specify example factors (e.g., IL-6, IL-8, MMPs, chemokines, growth factors)."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of senescence in normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States that senescence is a natural protective mechanism preventing proliferation of damaged cells that could lead to cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which cancer cells evade senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that cancer cells bypass senescence via mutations, specifically citing defects in p53 and RB pathways and discussing 'senescence bypass.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how some cancer therapies induce senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes chemotherapy and radiation causing DNA damage that triggers senescence, and mentions targeted therapies and immunotherapies potentially inducing senescence."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain what senolytics are, and describe if there are any FDA approved in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines senolytics and provides examples (dasatinib + quercetin) and states this approach is experimental and not standard care, effectively conveying no FDA-approved senolytics for pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that this is an active area of research in the scientific community.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes senescence-based strategies and senolytics as active areas of research and mentions ongoing clinical trials."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that senescence is caused by cellular stressors such as DNA damage or activation of tumor suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States senescence is triggered by stresses such as DNA damage and oxidative stress, and references p53 and RB tumor suppressor pathways driving senescence."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that senescence can be a positive factor as it stops tumor growth.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that inducing senescence can stop cancer cells from dividing and slow tumor growth, highlighting its positive role."
      }
    ],
    "question_number": 216,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:03:58.364257",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define exosomes as vesicles that cells can release into their surroundings.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines exosomes as small membrane-bound vesicles released by most cell types, including cancer cells."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe what exosomes contain, such as proteins, lipids, and RNA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States exosomes carry proteins, lipids, and nucleic acids (including microRNAs and DNA), fulfilling content requirements."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of exosomes in cancer cells, including cell-cell communication.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explains exosomes act as messengers mediating intercellular communication and details their complex roles in cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of exosomes in tumor promotion.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Describes oncogenic cargo promoting proliferation and survival and stromal reprogramming that enhances growth and invasion."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the role of exosomes in immune evasion.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Covers PD-L1 on exosomes, delivery of TGF-\u03b2 and immunosuppressive miRNAs, and antigen decoy effects suppressing immune responses."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the role of exosomes in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Notes exosomal efflux of drugs and transfer of resistance-conferring molecules to other cells."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the emerging or experimental role of exosomes as tumor biomarkers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions liquid biopsies, tumor-specific cargo in blood and other fluids, and PDAC-associated miRNAs and proteins as biomarkers."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how exosomes travel in the body.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Indicates exosomes are present in blood and other bodily fluids and act at distant sites, implying circulation-based transport."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain how exosomes are thought to facilitate metastases in cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explains pre-metastatic niche formation via ECM remodeling, immune cell recruitment, and increased vascular permeability. Note: a minor inaccuracy suggests exosomes might carry whole tumor cells, but the main mechanism is correctly described."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe if there are any FDA approved treatments that are associated with cancer exosomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses investigational inhibitors and early-phase trials but does not state FDA approval status; no FDA-approved exosome-targeted cancer therapies are identified."
      }
    ],
    "question_number": 217,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:04:31.079728",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define advance directive and living will, and recommend that a patient have these documents completed and/or updated as they reach end of life.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines living will/advance directive as outlining wishes for life-sustaining treatments if unable to communicate and recommends completing paperwork early and revisiting plans as illness progresses."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend a palliative medicine consultation to consider transitioning treatment focus from disease-targeted to comfort-focused care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with a palliative care specialist and highlights goals-of-care conversations (comfort vs aggressive treatment) and early integration of palliative care."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe Hospice, and ensure to include that patients with a prognosis of less than 6 months are eligible to enroll.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines hospice and explicitly states eligibility when a patient has 6 months or less to live (physician certified), emphasizing comfort-focused support."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the different categories of tasks that need to be addressed when a patient is approaching end of life due to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers multiple categories: medical decisions, legal/financial planning, emotional/spiritual support, practical daily needs, legacy, timing/next steps, and caregiver self-care."
      },
      {
        "criterion_number": 5,
        "description": "The response should define what a medical durable power of attorney is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains Healthcare Proxy/POA as designating someone to make medical decisions on the patient's behalf when needed, which aligns with a medical durable power of attorney."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the steps one needs to take in order to elect a medical durable power of attorney.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not provide steps (e.g., selecting an agent, completing state-specific forms, witnessing/notarization, distributing copies)."
      },
      {
        "criterion_number": 7,
        "description": "The response should define a POLST and recommend that a patient have this filled out and displayed in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of POLST or recommendation to complete and display it."
      },
      {
        "criterion_number": 8,
        "description": "The response should ensure the patient\u2019s healthcare provider teams have a copy of the patient\u2019s POLST.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No instruction to share a POLST with healthcare provider teams."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that Hospice benefits vary across insurance plans, so it is important to understand what their specific benefits are.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions reviewing insurance coverage generally but does not state that hospice benefits vary by insurance plan."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information about Hospice, namely that services are provided for the patient but also for the family and caregivers of the patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes hospice for the patient but does not state that hospice provides services/support for family and caregivers."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient elects a financial durable power of attorney as someone to make financial decisions for the patient if they are unable to make decisions for themselves from illness.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Discusses wills, trusts, and financial practicalities but does not recommend a financial durable power of attorney."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient consider what funeral arrangements they would prefer after their death, and communicate this to their loved ones and family.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises pre-planning and pre-paying for funeral/cremation arrangements and discussing related preferences."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient plan for their death with regard to any religious or spiritual rituals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages respecting and accommodating spiritual or religious practices, including rituals and final ceremonies."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe the importance of open communication between the patient and their decision makers to ensure their wishes can be respected as they approach death.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes family meetings and honest conversations about wishes to align care and decisions."
      },
      {
        "criterion_number": 16,
        "description": "The response should state that end of life planning is highly individualized and should follow the wishes of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States the process is deeply personal with no 'right' timeline and repeatedly centers the patient\u2019s wishes."
      }
    ],
    "question_number": 218,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:05:17.817595",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell dormancy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines dormancy as a state where cancer cells stop dividing and remain inactive, distinct from active growth/metastasis."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how long a cancer cell can remain dormant in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States dormant cells can persist for years or decades and notes pancreatic cancer late recurrences (5\u201310+ years)."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain why it is advantageous for cancer cells to be able to enter a dormant state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains advantages including survival under unfavorable conditions, immune evasion, and resistance to treatment with potential for later reactivation."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe scenarios in which a cancer cell may be prompted to enter dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes entry triggers such as nutrient/oxygen limitation, microenvironmental signals, metastatic niches, and immune pressure."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what is known about cancer cell dormancy in pancreatic cancer, preferably with references to the scientific literature with PMID.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides pancreatic cancer\u2013specific context including aggressiveness, recurrence timelines, and minimal residual disease; although no PMIDs are provided, the description is accurate and specific."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that dormancy can occur because of microenvironmental or genetic factors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions microenvironmental influences and genetic/molecular factors (e.g., KRAS, TP53) affecting dormancy."
      },
      {
        "criterion_number": 8,
        "description": "The dormant cells will often be less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States dormant/cancer stem cells resist treatment and that surgery/chemotherapy/radiation may leave dormant cells untouched."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that these dormant cells can lead to disease recurrence after treatments as they can reactivate after a long period of time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes dormant cells can reactivate after years and cause recurrence, including late recurrences."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that dormancy is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that researchers are studying dormancy, CSCs, and microenvironment to prevent reactivation; emphasizes ongoing research."
      }
    ],
    "question_number": 219,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:05:45.192919",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines mechanical stress as physical forces and pressures exerted on and within a tumor mass, arising from tumor growth, interactions with surrounding tissues, and the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states mechanical stress refers to physical forces and pressures within the tumor microenvironment influenced by tissue stiffness, ECM composition, and cellular interactions, which aligns with forces arising from tumor growth and surrounding tissue interactions."
      },
      {
        "criterion_number": 2,
        "description": "Describes how mechanical stress impacts tumor cell growth and metastasis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains mechanotransduction pathways (Rho/ROCK, YAP/TAZ) promoting survival, proliferation, and migration, and details EMT, invasion, and metastasis in stiff ECM, directly linking mechanical stress to growth and spread."
      },
      {
        "criterion_number": 3,
        "description": "Describes the relationship between mechanical stress and hypoxia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly notes vascular compression from mechanical pressure reduces blood flow causing hypoxia, with HIF-1\u03b1 activation driving metabolic shifts and angiogenesis."
      },
      {
        "criterion_number": 4,
        "description": "Explains that mechanical stress is implicated in treatment resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states that a stiff ECM limits drug penetration and upregulates survival mechanisms (anti-apoptotic proteins), contributing to resistance; also discusses effects that limit immunotherapy access."
      },
      {
        "criterion_number": 5,
        "description": "Defines the tumor microenvironment.",
        "score_given": 8,
        "max_points": 8,
        "justification": "While not a single-sentence definition, the response functionally defines the microenvironment by referencing ECM, fibroblasts/desmoplasia, immune cells, vasculature compression, and cellular interactions, adequately conveying what the TME comprises."
      },
      {
        "criterion_number": 6,
        "description": "Describes sources of mechanical stress in tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies desmoplasia/ECM stiffening, cellular interactions, rapid tumor growth causing vascular compression, and mechanical tension/stretch as sources."
      },
      {
        "criterion_number": 7,
        "description": "Informs that effects of mechanical stress are not fully elucidated and are an area of active research.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states mechanical stress is underappreciated, outlines ongoing research and emerging therapeutics, and notes efforts to better understand these interactions, indicating active investigation and incomplete understanding."
      },
      {
        "criterion_number": 8,
        "description": "Mentions the effect of mechanical stress on angiogenesis, invasion, metastasis, and promotion of tumor cell survival.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Angiogenesis via HIF-1\u03b1 is mentioned; invasion and metastasis through EMT; and survival advantages via reduced apoptosis and pro-survival signaling are all covered."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly states that pancreatic cancer has a very dense and stiff stroma, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes dense, stiff stroma and hypoxia from vascular compression, but does not explicitly mention high interstitial pressure or reduced nutrient delivery."
      },
      {
        "criterion_number": 11,
        "description": "States that dense stroma can impede immune cells from reaching the tumor, aiding immune evasion and reducing the efficacy of immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states dense stroma impedes immune cell infiltration and fosters an immunosuppressive environment (immune evasion), but does not explicitly state that this reduces the efficacy of immunotherapy."
      }
    ],
    "question_number": 220,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:06:35.673118",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define tumor organoids as a miniature 3D model of the patient\u2019s tumor grown in a lab from the patient\u2019s own cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines tumor organoids as three-dimensional cultures derived from a patient's tumor biopsy that mimic the structure and behavior of the original tumor, matching the requirement."
      },
      {
        "criterion_number": 2,
        "description": "Describe how tumor organoids are used for testing cancer medications to determine the most effective one.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states organoids can be exposed to various treatments to predict which therapies will work best for the individual, fulfilling the criterion."
      },
      {
        "criterion_number": 3,
        "description": "Explain that the use of tumor organoids is experimental and not available at all cancer centers, and that there are no large randomized clinical trials for tumor organoids.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions clinical trials and research use, it does not state that organoid-guided treatment is experimental, not available at all centers, nor that there are no large randomized trials."
      },
      {
        "criterion_number": 5,
        "description": "Describe how tumor organoids are grown.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes obtaining a tumor biopsy, isolating cells, growing them in a matrix (e.g., Matrigel) with growth factors, and potentially co-culturing with stromal/immune cells, adequately covering the growth process."
      },
      {
        "criterion_number": 6,
        "description": "Explain how tumor organoids are different than cultured cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response contrasts organoids with immortalized 2D cell lines, noting organoids better preserve original tumor characteristics, which meets the criterion."
      },
      {
        "criterion_number": 7,
        "description": "Describe how tumor organoids are used to tailor treatments to the patient from which they are derived.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses personalized cancer treatment, using organoids to predict individual therapy response and tailor treatment accordingly, including a direct note about applying this to the patient's case."
      },
      {
        "criterion_number": 8,
        "description": "Describe advantages of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advantages listed include better preservation of tumor characteristics, accessibility, cost-effectiveness, ethical benefits versus animal models, and human-specific biology."
      },
      {
        "criterion_number": 9,
        "description": "Describe limitations of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Limitations mentioned include difficulty in culturing some tumors, complexity of including stromal/immune components, and scalability challenges."
      }
    ],
    "question_number": 221,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:06:59.944837",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient choose a medical decision maker, or medical durable power of attorney, who will make medical decisions for her in the event she is unable to do so herself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends checking for advance directives and appointing a healthcare proxy/power of attorney if none exist, clearly addressing decision-maker designation."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that the patient and her legal next of kin request assistance from social work from their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises exploring social work support and mentions hospital patient advocates; while not explicitly stating 'from the oncology team,' it clearly recommends engaging social work resources to assist the family."
      },
      {
        "criterion_number": 3,
        "description": "The response should inform the patient about the role of palliative medicine in cancer care, who are providers who can help establish a patient\u2019s goals of care and can assist with documentation of this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions palliative/hospice options and their focus on comfort, but does not state that the palliative care team helps establish goals of care and assists with documentation."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient designate a primary family member who can attend appointments and relay information to other family members.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Suggests dividing responsibilities and obtaining written summaries, but does not recommend designating a single primary family member for appointments and information relay."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend the establishment of a meeting schedule, where the primary family member or patient meets with a greater group of family members for regular updates.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends holding a family meeting and setting boundaries but does not propose a recurring meeting schedule for regular updates."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that the priority should be the patient\u2019s own personal wishes and that she should be as involved in the decision-making process as possible.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly prioritizes the mother's autonomy and emphasizes centering decisions on her wishes and involvement when able."
      },
      {
        "criterion_number": 8,
        "description": "The response must recommend holding family meetings with the healthcare team so that family members can hear information directly from the physician.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends requesting a family conference with the healthcare team to clarify options and goals of care."
      },
      {
        "criterion_number": 9,
        "description": "The response must emphasize the importance of clear communication between family members.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strong emphasis on open communication, ground rules, listening, and conflict resolution among family members."
      }
    ],
    "question_number": 222,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:07:50.869559",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define circadian rhythms as the body\u2019s natural 24-hour internal clock regulated by the brain and influenced by external cues, including hormone regulation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines circadian rhythms as the body's internal 24-hour clock and mentions hormone release and external cues (light, meals, activity), but it does not state that circadian rhythms are regulated by the brain (e.g., the suprachiasmatic nucleus). Because the brain regulation component is missing, full credit cannot be awarded."
      },
      {
        "criterion_number": 2,
        "description": "Describe chronotherapy as timing cancer treatments to align with circadian rhythms for better efficacy and fewer side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly defines chronotherapy as tailoring treatment timing based on biological rhythms and notes that timing doses may optimize efficacy and reduce toxicity. This meets the requirement."
      },
      {
        "criterion_number": 3,
        "description": "Explain how disruptions in circadian rhythm are thought to promote pancreatic cancer growth, including references to scientific literature or reputable sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions circadian disruption in cancer generally and uncontrolled growth, it does not specifically address pancreatic cancer growth mechanisms nor provide references to scientific literature or reputable sources supporting this link."
      },
      {
        "criterion_number": 4,
        "description": "Recommend ways to promote normal circadian rhythms in pancreatic cancer patients, including consistent sleep, regular meal times, exposure to natural light, and avoiding screens/blue light at night.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response recommends consistent sleep patterns, morning light exposure, and regular meal times, but it does not include avoiding screens/blue light at night. Because all specified elements are required, full credit cannot be given."
      },
      {
        "criterion_number": 5,
        "description": "Explain the effect of poor or interrupted sleep on circadian rhythms, stating that disruptions can affect overall health and potentially promote cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that disruptions such as sleep deprivation can affect overall health and disease progression, and notes that poor sleep may weaken the immune system or worsen outcomes. This satisfies the requirement."
      },
      {
        "criterion_number": 6,
        "description": "Explain the effect of poor or inadequate diet on circadian rhythms, mentioning that irregular eating can disrupt circadian rhythms and that maintaining regular meal times is important.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although the response encourages regular meal times, it does not explicitly state that irregular eating can disrupt circadian rhythms or discuss poor/inadequate diet effects. The requirement for explicitly mentioning disruption from irregular eating is not met."
      },
      {
        "criterion_number": 7,
        "description": "Provide general recommendations for sleep hygiene, including consistent sleep duration, avoiding screens/blue light at night, and exposure to natural light during the day.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response includes consistent sleep patterns and morning light exposure but omits avoiding screens/blue light at night. Because all specified elements must be included, no credit is awarded."
      },
      {
        "criterion_number": 8,
        "description": "Recommend that the patient consult a nutritionist familiar with nutritional challenges associated with pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no recommendation to consult a nutritionist or dietitian familiar with pancreatic cancer-specific nutritional challenges."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient inquire with their oncology team about clinical trials pertaining to circadian rhythms in pancreatic cancer, mentioning resources like ClinicalTrials.gov.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response advises asking about ongoing trials exploring circadian effects in pancreatic cancer and explicitly mentions ClinicalTrials.gov and the NCI. Full credit is warranted."
      },
      {
        "criterion_number": 11,
        "description": "Clearly state that there is no current high-quality data supporting timed treatment in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that chronotherapy is not yet standard and that application in pancreatic cancer is evolving, but it does not clearly state that there is no current high-quality data supporting timed treatment in pancreatic cancer."
      }
    ],
    "question_number": 223,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:08:39.453844",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mitochondria.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses mitochondrial functions (oxidative phosphorylation, apoptosis regulation, ROS production) but never explicitly defines mitochondria as cellular organelles responsible for energy production and other roles."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the roles of mitochondria in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains normal mitochondrial functions: energy generation via oxidative phosphorylation, regulation of apoptosis through cytochrome c release and caspases, and serving as a major source of ROS in cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain what is known about how the role of mitochondria in cancer cells differs from that of normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It clearly contrasts cancer vs. normal: Warburg effect (glycolysis preference), evasion of apoptosis via BCL-2 family changes, altered ROS handling, mtDNA mutations, and changes in mitochondrial biogenesis/dynamics."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the increased metabolic demands on cancer cells and why this happens.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states cancer cells use glycolysis to rapidly generate ATP and metabolic intermediates for biosynthesis (lipids, nucleotides), and mentions increased energy demands and compensatory mitochondrial biogenesis."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain the Warburg effect.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It accurately defines the Warburg effect as aerobic glycolysis despite oxygen availability, contrasts it with mitochondrial oxidative phosphorylation, and notes consequences like lactate production and provision of biosynthetic intermediates."
      },
      {
        "criterion_number": 6,
        "description": "The response should define apoptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes apoptosis in functional terms\u2014mitochondrial outer membrane permeabilization leading to cytochrome c release, caspase cascade, and cell death\u2014adequately conveying that apoptosis is a regulated cell death process."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain the role of mitochondria in apoptosis in normal cells, and explain how this can be altered in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains mitochondrial outer membrane permeabilization and cytochrome c release (normal apoptotic role) and details cancer alterations via overexpression of anti-apoptotic BCL-2 family proteins and downregulation of pro-apoptotic members."
      },
      {
        "criterion_number": 8,
        "description": "The response should define reactive oxygen species and how they are created with regard to the role that mitochondria play.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it states mitochondria are a major source of ROS and that cancer cells have elevated ROS, it does not define ROS (e.g., superoxide, hydrogen peroxide) nor explain their generation via electron leakage from the electron transport chain."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how ROS can damage surrounding cells, and the subsequent cellular signaling pathways that are stimulated as a result.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions ROS can cause DNA damage and mutations but does not discuss effects on surrounding cells or specify downstream signaling pathways (e.g., NF-\u03baB, HIF-1\u03b1, MAPK, Nrf2) activated by ROS."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe that as a facilitator of cellular energy, mitochondria are a potential treatment target.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly frames mitochondria as central to energy metabolism and describes targeting mitochondrial enzymes, metabolism, and dynamics as therapeutic strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response should define glutamine and how this substance is used in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Glutamine is not mentioned; no definition or description of glutamine metabolism in cancer cells is provided."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that cancer treatment targeting mitochondrial functions are experimental and not part of FDA-approved treatment regimens at this time.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It states such therapies are \"still largely experimental,\" highlights ongoing clinical trials, and frames them as emerging/experimental approaches, which conveys they are not standard (FDA-approved) treatments."
      }
    ],
    "question_number": 224,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:09:34.856417",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing insurance coverage issues with the oncology team administering the experimental treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises talking to the oncologist about trial options, expanded access, and alternative treatments, but does not explicitly recommend discussing insurance coverage issues with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "Mention that financial assistance programs exist for some experimental drugs and explicitly state this varies by drug, requiring inquiry.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions manufacturer assistance and resources like RxAssist and PAN Foundation, it does not explicitly state that availability varies from drug to drug and that patients must inquire specifically."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly mention that travel to and from the trial center is often not covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not address travel costs to/from trial centers or their typical lack of coverage."
      },
      {
        "criterion_number": 5,
        "description": "Describe what compassionate use is and recommend asking the oncology team about it.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines Expanded Access/Compassionate Use and directs patients to ask the treating physician to submit a request, satisfying both description and recommendation."
      },
      {
        "criterion_number": 6,
        "description": "Recommend discussing concerns with the cancer center\u2019s financial team and/or patient advocacy office.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It suggests involving a hospital social worker and contacting external patient advocacy organizations, but does not specifically recommend speaking with the cancer center\u2019s financial team or its patient advocacy office."
      },
      {
        "criterion_number": 7,
        "description": "Recommend becoming familiar with the insurance policy to understand what is or is not covered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises contacting the insurer to understand policy exclusions and the appeal process, and to request detailed denial explanations."
      },
      {
        "criterion_number": 8,
        "description": "Inform the patient they have the right to appeal any insurance decision.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It outlines filing an appeal and requesting an external review if denied again, clearly conveying the right to appeal."
      },
      {
        "criterion_number": 9,
        "description": "Recommend seeking out patient advocacy groups online to learn how other patients navigated the same issues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it lists advocacy organizations and support groups, it does not explicitly recommend seeking online patient advocacy groups to learn from others\u2019 experiences navigating insurance and access."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that insurance usually only covers standard of care treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response implies FDA-approved treatments are covered and experimental coverage is rare, but it does not explicitly state that insurance usually only covers standard-of-care treatments."
      },
      {
        "criterion_number": 11,
        "description": "Indicate that trials typically cover the experimental treatment, while insurance covers standard-of-care components (e.g., imaging).",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that trials may cover treatment costs but does not clarify the common division where the trial covers the investigational agent and insurance covers routine care such as imaging and labs."
      }
    ],
    "question_number": 225,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:10:13.467577",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ferroptosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ferroptosis as a regulated, iron-dependent cell death caused by accumulation of toxic lipid peroxides that damage membranes."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role of iron in ferroptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains iron dependency, Fe2+-catalyzed ROS/lipid peroxide generation, and mentions transferrin receptors increasing intracellular iron."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of ferroptosis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Discusses exploration of ferroptosis to overcome treatment resistance in pancreatic cancer, relevance of tumor vulnerabilities/biomarkers, and clinical trial context."
      },
      {
        "criterion_number": 4,
        "description": "State that there are currently drugs under investigation with the aim to induce ferroptosis in pancreatic cancer cells but there are no current available established treatments that target ferroptosis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions investigational drugs and early/preclinical trials but does not explicitly state that no established/approved ferroptosis-targeting treatments currently exist."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references in the scientific literature about ferroptosis and link PMID if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why ferroptosis occurs.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explains it occurs when antioxidant defenses (glutathione/GPX4) are insufficient to neutralize lipid peroxides leading to membrane damage."
      },
      {
        "criterion_number": 7,
        "description": "The response should define apoptosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not define apoptosis."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe the difference between apoptosis and ferroptosis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No comparison between apoptosis and ferroptosis provided."
      }
    ],
    "question_number": 226,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:10:36.509159",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly connects mechanical properties (ECM stiffness, interstitial pressure, vessel mechanics) to invasion, migration, intravasation, and metastasis in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response includes descriptions of the mechanical properties of tissue: elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Discusses stiffness/elasticity and pressure broadly but does not address viscosity or density, and does not explicitly describe compression as a mechanical property; therefore the full set (elasticity, viscosity, density, compression) is not covered."
      },
      {
        "criterion_number": 3,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions high interstitial pressure and physical constraints from dense stroma, but does not explicitly describe the tumor compressing surrounding tissue structures."
      },
      {
        "criterion_number": 4,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplasia as dense ECM rich in collagen/fibronectin, driven by PSCs/TAFs; explains its dual role in constraining growth, guiding migration, limiting drug delivery, and affecting immunity."
      },
      {
        "criterion_number": 5,
        "description": "The response describes ways by which cancer metastasizes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains local invasion along aligned collagen, ECM degradation by MMPs, intravasation into blood/lymphatic vessels driven by vascular abnormalities and pressure, and colonization considerations (e.g., liver)."
      },
      {
        "criterion_number": 6,
        "description": "The response describes epithelial-to-mesenchymal transition and what environmental factors trigger this transition in pancreatic cells and pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly mention EMT or describe its features; while TGF-\u03b2 and stiffness are named, the EMT process and its triggers in pancreatic cells are not specifically described."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details interactions via integrins and mechanotransduction, migration along aligned collagen, ECM remodeling by MMPs, and stromal modulation by PSCs/TAFs and TGF-\u03b2."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses ECM, PSCs/TAFs, and TGF-\u03b2, it does not explicitly address hypoxia or provide a substantive discussion of inflammatory signaling as drivers of cell migration."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of KRAS or other genetic mutations and their roles in invasion/metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response explains other methods for the spread of pancreatic cancer besides invasion into solid tissue, such as hematologic spread, lymphatic spread, and perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions invasion into blood and lymphatic vessels and entry into circulation; although perineural invasion is not discussed, the criterion of explaining other methods beyond solid-tissue invasion is met."
      },
      {
        "criterion_number": 11,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links stromal stiffness/desmoplasia to impaired drug delivery and immune entry; mentions elastography for stiffness assessment; discusses ECM-targeted approaches (hyaluronidase, LOX inhibitors, antifibrotics, losartan) and mechano-responsive delivery systems."
      },
      {
        "criterion_number": 12,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to specific published studies are provided."
      }
    ],
    "question_number": 227,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:11:23.314169",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s healthcare team or oncology team about patient advocacy opportunities within their organization.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response advises contacting hospitals or cancer centers to find regional groups and mentions partnering with oncology departments, which effectively directs readers to engage with their care organizations for advocacy opportunities."
      },
      {
        "criterion_number": 2,
        "description": "The response offers examples of patient advocacy groups and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While multiple organizations are named (e.g., PanCAN, ACS, NPF, CancerCare, Patient Advocate Foundation), consistent contact information or websites are not provided for each listed group; only a few example URLs are mentioned generally later."
      },
      {
        "criterion_number": 3,
        "description": "The response defines patient advocacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The opening sentence frames patient advocacy as contributing to improved care, research, and support for others, which serves as a clear definition of patient advocacy."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of patient advocacy work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Numerous concrete examples are provided, including volunteering with organizations, research advocacy, policy/legislative advocacy, peer support, awareness campaigns, corporate/hospital partnerships, legal/insurance advocacy, and education/training."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of patient advocacy opportunities specific to pancreatic cancer and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Pancreatic cancer\u2013specific opportunities (e.g., PanCAN, PurpleStride, PanCAN\u2019s Clinical Trial Matching Service) are listed, but individual contact information or URLs are not provided for each specific opportunity."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends joining pancreatic cancer support groups, either online or in-person, to learn about advocacy opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends joining or moderating online/in-person support groups (e.g., through PanCAN, CancerCare, local hospitals) and suggests connecting with online communities to learn from experienced advocates."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions at least three different areas of advocacy for pancreatic cancer patients, such as direct patient support, support groups, funding for cancer research, awareness of clinical trials, or political lobbying.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers multiple areas: direct support/peer mentoring, support groups, research funding, clinical trials awareness, policy/legislative advocacy, awareness campaigns, legal/insurance advocacy, and education/speaking\u2014well beyond the minimum of three."
      }
    ],
    "question_number": 228,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:11:56.260418",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains normal cellular metabolism in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Normal metabolism is referenced using technical terms (Krebs cycle, electron transport chain) without a clear, layperson-friendly explanation of how healthy cells typically use oxygen and mitochondria to produce energy."
      },
      {
        "criterion_number": 2,
        "description": "The response outlines the differences between normal cellular metabolism and cancer cell metabolism.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly contrasts cancer cells\u2019 reliance on aerobic glycolysis, increased glucose uptake, glutamine dependence, PPP activation, lipid metabolism changes, and microenvironment interactions with normal oxidative phosphorylation-dominant metabolism."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the Warburg effect.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The Warburg effect is explicitly named and described as aerobic glycolysis in the presence of oxygen."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of how cancer cell metabolism affects its clinical behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes lactate-driven tumor acidosis, hypoxia-induced adaptations/angiogenesis, and stromal nutrient shuttling, all of which influence tumor aggressiveness and progression."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of targeting the differences in cancer cell metabolism as a means of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples including glycolysis inhibitors (e.g., hexokinase/GLUT1), glutaminase inhibitors, mitochondrial targets (metformin, dichloroacetate), and combination strategies."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No scientific citations or PMIDs are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should define glycolysis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Glycolysis is defined as the breakdown of glucose without oxygen (in context of the Warburg effect), which satisfies a basic definition."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how cancer cells use glutamine, and how this is different than normal cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While glutamine dependence and roles in biosynthesis are described, there is no explicit comparison to how normal cells use glutamine."
      },
      {
        "criterion_number": 9,
        "description": "The response should define lactic acid and describe how excess lactic acid can be produced by cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lactate production and export via LDH/MCTs are mentioned, but lactic acid itself is not defined, and the explanation does not explicitly define lactic acid or clearly link Warburg-driven excess production to lactic acidosis."
      },
      {
        "criterion_number": 10,
        "description": "The response should not recommend specific diets for management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "No diet recommendations are made."
      },
      {
        "criterion_number": 11,
        "description": "The response should not reference specific diets unless it provides PMID to studies that examine the effect of diet on pancreatic cancer, and the response should provide a summary of the findings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No diets are referenced, so the condition is met."
      },
      {
        "criterion_number": 12,
        "description": "The response should not indicate that restrictive diets, such as ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No restrictive diets are suggested."
      },
      {
        "criterion_number": 13,
        "description": "The response should clearly state if treatments are experimental or if they are evidence-based and/or FDA approved.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Metabolic therapies are described as under investigation/in trials and experimental, clarifying status."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises consulting oncologists generally but does not specifically recommend discussing diet or requesting a nutritionist referral."
      }
    ],
    "question_number": 229,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:13:03.831129",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussion with the oncologist and healthcare team and lists the oncologist in the multidisciplinary team."
      },
      {
        "criterion_number": 2,
        "description": "The response states peripheral neuropathy is a common side effect of certain chemotherapy agents used to treat pancreatic cancer, including oxaliplatin.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention chemotherapy causation or specific agents such as oxaliplatin."
      },
      {
        "criterion_number": 3,
        "description": "The response should define chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No definition of CIPN is provided; neuropathy is discussed generally without defining chemo-induced nerve damage."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of symptoms of peripheral neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions neuropathic pain, sensitivity to pressure, and references possible weakness; these are symptom examples."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of how peripheral neuropathy symptoms may affect a patient\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses functional impacts including balance problems, fall risk, difficulty with daily tasks and gripping, and need for mobility aids."
      },
      {
        "criterion_number": 6,
        "description": "The response states some patients may see an improvement in symptoms when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that symptoms may improve after stopping the offending medication."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe that some patients have diminishment of chemotherapy-induced peripheral neuropathy over time, but sometimes it is permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of the typical time course or possibility of permanence of CIPN."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends physical therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends PT with examples (stretching, balance training, mobility maintenance)."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends occupational therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends OT with adaptive strategies for daily tasks and ergonomic tools."
      },
      {
        "criterion_number": 10,
        "description": "The response states medication may help with some symptoms of peripheral neuropathy and provides examples like gabapentin, pregabalin, and duloxetine.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States meds can help and gives examples including duloxetine and gabapentin (plus topical lidocaine)."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the grading system oncologists use to quantify the severity of chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of CTCAE or any grading system for CIPN severity."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that patients with peripheral neuropathy can adapt to their environment to prevent adverse events.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple adaptation strategies: ergonomic tools, grip modifications, orthotics/braces, mobility aids, avoiding extreme temperatures, and daily foot inspection."
      },
      {
        "criterion_number": 13,
        "description": "The response should inform patients of the importance of protecting body parts that are experiencing neuropathy, such as appropriately sized and firm shoes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises supportive shoes, custom inserts, and diligent foot care to prevent injury."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage patients to participate in activities that promote general wellness such as exercise, balanced nutrition with an emphasis on plant-based foods, good sleep hygiene, and adequate hydration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages gentle exercise, plant-forward anti-inflammatory diet, stress reduction/mind-body practices; while sleep and hydration are not explicitly named, general wellness activities are clearly encouraged."
      }
    ],
    "question_number": 230,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:13:51.882121",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what liquid-liquid phase separation is in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines LLPS as biomolecules separating into liquid-like droplets that organize cellular functions without membranes, using accessible language and examples."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how liquid-liquid phase separation relates to cancer cell biology.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Connects LLPS to cancer via nucleolar dysfunction, stress granule misregulation, oncogenic condensates, and metabolic reprogramming, demonstrating how aberrant condensates can promote tumor biology."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the role of liquid-liquid phase separation in normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes membraneless organelles (nucleolus, stress granules, P-bodies) and roles in signaling, gene expression, and metabolism, accurately reflecting physiological LLPS functions."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of liquid-liquid phase separation in pancreatic cancer and specific ways it can be affected.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a PDAC-specific section discussing nucleolar stress and stress response in hypoxic, nutrient-poor environments, and how LLPS dysregulation may support survival and growth, meeting the criterion despite some questionable gene examples."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the link between common mutations seen in pancreatic cancer and dysregulated liquid-liquid phase separation, including references to the scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not link LLPS to common PDAC mutations (KRAS, TP53, CDKN2A, SMAD4) and provides no literature citations; mentions NPM1 and c-Myc in a way that is not representative of common PDAC drivers."
      },
      {
        "criterion_number": 6,
        "description": "The response explains that this is an active area of scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that this is experimental, that much remains unknown, and discusses future directions, indicating an active research area."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that there are no FDA-approved treatments that target liquid-liquid phase separation at this time.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States that clinical applications are not yet available but does not specifically mention the absence of FDA-approved LLPS-targeted therapies."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends that the patient consider inquiring about liquid-liquid phase separation in pancreatic cancer with their oncology team and ask about local clinical trial availability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages discussing LLPS with the oncologist but does not advise asking about local clinical trial availability."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No scientific citations or references are provided."
      }
    ],
    "question_number": 231,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:14:38.448013",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly discusses a 'Stiff Extracellular Matrix (ECM)' and describes the dense, fibrotic ECM and its stiffness."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links high interstitial fluid pressure and ECM stiffness to reduced drug penetration and mentions that stiffness promotes survival and drug resistance, affecting efficacy."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes 'aberrant tumor vasculature' with poor perfusion and notes 'hypoxic/necrotic regions' that drugs may not reach."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to specific published journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines mechanical properties of tissues, including at least two of the following: interstitial fluid pressure, solid stress, or fibrotic structure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains elevated interstitial fluid pressure (IFP) and a dense, fibrotic ECM, meeting the requirement for at least two specified properties."
      },
      {
        "criterion_number": 6,
        "description": "The response describes compression of surrounding tissue by the tumor, specifically mentioning blood vessels or lymphatics.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions abnormal vasculature, it does not describe tumor-induced compression of blood vessels or lymphatics (solid stress)."
      },
      {
        "criterion_number": 7,
        "description": "The response defines desmoplastic stroma and describes its role in pancreatic cancer, including its composition.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The term 'desmoplastic stroma' is not used or defined; composition is partially implied (collagen, hyaluronic acid) but not framed as desmoplasia."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer remodels the extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states that stiff ECM promotes survival and resistance but does not describe cancer-driven ECM remodeling processes (e.g., CAF activity, MMPs) that create a supportive niche."
      },
      {
        "criterion_number": 9,
        "description": "The response states that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It labels the area as an active research focus, includes a 'Current Research and Clinical Trials' section, and notes ongoing investigations and trials."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly advises consulting specialists, asking about combination approaches, and exploring clinical trials with resources like clinicaltrials.gov."
      }
    ],
    "question_number": 232,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:15:17.081576",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends having a plan for emergencies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises setting up emergency protocols including a medical alert system and listing emergency contacts in a visible place, which constitutes clear emergency planning."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker or patient care navigator.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of consulting a social worker, patient navigator, or case manager for assistance."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends utilizing telemedicine when available and appropriate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends scheduling telehealth visits/virtual consultations with the medical team."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends engaging family and friends for assistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises designating a local contact (friend or family), creating family group updates, and delegating tasks, which clearly engage family/friends."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s healthcare team may have resources to help patients at home and lighten caregivers\u2019 load.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions home health services and discussing palliative/hospice with the oncology team, it does not state that the healthcare team has resources to support at-home care or to lighten caregiver burden."
      },
      {
        "criterion_number": 6,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statistics, prevalence data, or citations to published scientific literature are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses burnout prevention strategies but does not list signs/symptoms such as fatigue, sleep disturbance, irritability, anxiety/depression, or difficulty concentrating."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions assisted living, home health aides, and respite homes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references home health services and hospice/palliative care, it does not specifically mention assisted living, home health aides, or respite homes."
      },
      {
        "criterion_number": 9,
        "description": "The response offers resources for cancer patients and their caregivers and provides contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Organizations such as PanCAN, the American Cancer Society, and CancerCare are named, but no URLs, phone numbers, or specific contact details are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of regular and comprehensive communication with the patient to ensure they feel well supported.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes frequent, predictable check-ins, shared schedules, messaging, and explicitly highlights staying connected and compassionate communication in the key takeaways."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend shared apps or other technological tools to share information between the patient and distant caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends messaging apps (WhatsApp/Telegram), shared documents, shared calendars, medication reminder apps, and patient portals for information sharing."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend ways that caregivers can provide support from afar.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides multiple actionable remote support strategies, including coordinating local care, arranging home services, telehealth participation, sending care packages, remote monitoring, scheduling, and organizing documentation."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient look into their insurance to understand if they have a benefit for paid caregiving.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It generically mentions researching insurance options and financial assistance but does not specifically recommend checking insurance for paid caregiving benefits."
      },
      {
        "criterion_number": 14,
        "description": "The response should provide online resources for patients with pancreatic cancer to learn more about local caregiving opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references the Pancreatic Cancer Action Network (PanCAN) as a resource for education and support networks, which is an online resource relevant to pancreatic cancer and local caregiving connections."
      }
    ],
    "question_number": 233,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:16:19.458205",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cell competition for oxygen and nutrients within a tumor in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly describes competition for glucose, oxygen, and amino acids, explains hypoxia and resource scarcity in accessible language, and ties it to PDAC\u2019s dense stroma."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses how cell competition may lead to clonal evolution of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly covers Darwinian selection within tumors and clonal evolution, with examples (KRAS, TP53) and how fitter clones dominate."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses how clonal evolution in cancer can lead to drug resistance and progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly links clonal evolution to therapy resistance and recurrence, noting survival of resistant subclones after treatment and worse prognosis."
      },
      {
        "criterion_number": 4,
        "description": "The response describes cancer cell competition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a comprehensive description across metabolic, signaling, physical, and epigenetic dimensions, including interactions with the microenvironment."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the origin of cancer, from a single mutated cell that proliferates over time.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state the single-cell origin/monoclonal start of cancer; focuses on mutation accumulation and heterogeneity without describing initial origin."
      },
      {
        "criterion_number": 6,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells oppose each other, and how.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details antagonistic interactions such as nutrient deprivation, inhibitory signaling (e.g., TGF-\u03b2), physical displacement, and inducing senescence in neighbors."
      },
      {
        "criterion_number": 7,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells are aligned and their effect benefits all of the cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No clear examples of cooperative/aligned interests (e.g., shared growth factors, public goods). Pro-growth signaling is framed as self-serving and inhibitory to others."
      },
      {
        "criterion_number": 8,
        "description": "The response explains ways pancreatic cancer cells differ and how they compete with each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses PDAC-specific features (desmoplasia, hypoxia), genetic differences (KRAS/TP53), phenotypic states (mesenchymal traits, CSCs), and how these drive competition."
      }
    ],
    "question_number": 234,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:16:52.977932",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly references a stiff extracellular matrix (ECM) in pancreatic tumors and ties stiffness to mechanotransduction."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It links stiffness and mechanotransduction to survival signaling, ABC transporter upregulation, EMT, and drug penetration barriers, directly connecting mechanics to resistance and treatment efficacy."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not discuss blood flow or hypoxia; vascular compression, perfusion, or hypoxic effects are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to specific published studies are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that stiffness and compressive forces can induce EMT, increasing invasiveness and metastasis."
      },
      {
        "criterion_number": 6,
        "description": "The response includes descriptions of the mechanical properties of tissue: stiffness, elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions stiffness, a dense ECM, and compressive forces, but does not describe elasticity or viscosity; therefore the full set is not covered."
      },
      {
        "criterion_number": 7,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While 'compressive forces' are mentioned, there is no explicit description of the tumor compressing surrounding tissues (e.g., vasculature or adjacent organs)."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Desmoplastic stroma is not defined or explicitly discussed, though fibrosis and CAFs are mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response explains what the tumor microenvironment is.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains the TME contextually as including ECM stiffness, stromal cells (CAFs), and cytokines, and describes their interactions affecting tumor behavior."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how pancreatic cancer is able to remodel its surrounding extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although CAF activity and collagen deposition are mentioned, the response does not explicitly describe tumor-driven ECM remodeling mechanisms (e.g., LOX cross-linking, MMP-mediated remodeling) as a cancer-driven process."
      },
      {
        "criterion_number": 11,
        "description": "The response explains that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes the field is largely preclinical with early-stage human trials and ongoing clinical trial exploration targeting stroma/mechanotransduction."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials in their area with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly advises discussing emerging trials and strategies with the oncology team."
      }
    ],
    "question_number": 235,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:17:37.453418",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains proteostasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines proteostasis clearly as the balance of making, folding, and disposing of proteins and explains why it matters, using accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how proteostasis may be altered in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes increased protein synthesis, misfolded proteins from mutations, activation of the unfolded protein response, and how these changes support survival and resistance in cancer cells."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of cancer treatments that target proteostasis in cancer cells and explains their mechanism of action in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Gives multiple examples (proteasome inhibitors, HSP inhibitors, autophagy modulators, UPR targeting) with plain-language mechanisms and specific drug examples like bortezomib, carfilzomib, and hydroxychloroquine."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises discussing options, including clinical trials and emerging therapies, with the patient\u2019s oncology team."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the role of proteostasis in normal cells, including protein synthesis, protein folding, protein trafficking, and protein degradation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Covers synthesis, folding, and degradation but does not mention protein trafficking."
      },
      {
        "criterion_number": 6,
        "description": "The response explains different steps and phases of proteostasis, which could be potential targets for cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies multiple proteostasis steps as therapeutic targets, including proteasome function, chaperones/HSPs, autophagy, and the unfolded protein response."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions whether there are any FDA-approved therapies for pancreatic cancer that target proteostasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes investigational status and clinical trials but does not explicitly state whether any proteostasis-targeting therapies are FDA-approved for pancreatic cancer."
      }
    ],
    "question_number": 236,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:18:14.414412",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises engaging the oncologist/care team, requesting written summaries, and asking the team to slow down and focus on one step at a time."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a Palliative Care team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of palliative care or palliative care teams."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups and online resources for cancer patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends support groups and specific organizations with links and helplines (PanCAN, CancerCare, Cancer Support Community)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends breaking up decisions into smaller portions and creating pros and cons lists to organize thoughts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises breaking decisions into smaller steps and using decision aids like pros/cons lists."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing goals of care with the patient to help with decision making.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly recommend a goals-of-care discussion; focuses on shared decision-making and comfort but without explicit goals-of-care framing."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a patient care navigator or social worker.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically suggests asking about patient navigators and social workers to help clarify options and assist with decisions."
      },
      {
        "criterion_number": 7,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No data or citations from scientific literature are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions feeling exhausted and anxious, which are symptoms of caregiver burnout, and discusses burnout explicitly."
      },
      {
        "criterion_number": 9,
        "description": "The response should attempt to normalize treatment decision fatigue for patients undergoing cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly normalizes decision fatigue as real and common, reassuring the caregiver they are not alone."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining mental health while undergoing cancer treatments, for both the patient and their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages therapy/counseling, support groups, and self-care; notes mental health services at cancer centers, addressing caregiver well-being and broadly applicable to patients."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients lean on their support network for assistance in making medical decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises involving family, delegating tasks, holding family meetings, and explicitly says to lean on the support network."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that the patient request more frequent appointments with their oncology team for ongoing conversations and to answer questions that arise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not suggest scheduling more frequent oncology appointments; only suggests asking the team to slow down and provide summaries."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that documentation of thoughts can be helpful to reflect upon when it comes time to make a medical decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends journaling to track decisions, questions, and emotions, and using apps/spreadsheets to organize information."
      }
    ],
    "question_number": 237,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:19:07.647767",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clear, step-by-step explanation of metastasis using accessible language (local invasion, intravasation, travel, extravasation, growth) with limited jargon and definitions (e.g., EMT explained)."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit description of local invasion through the basement membrane into adjacent organs and subsequent spread via blood and lymph."
      },
      {
        "criterion_number": 3,
        "description": "The response describes lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes entry into the lymphatic system during intravasation and that lymphatic spread can occur, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response describes hematologic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes entry into blood vessels, circulation, survival challenges, and seeding of distant sites."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "EMT is explicitly named and briefly explained as enabling mobility and invasion."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions research areas (targeted therapy, immunotherapy) but does not discuss the role/limitations of surgery, radiation, or systemic therapy specifically in metastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises discussing personalized options, clinical trials, and supportive care with the medical team."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions proteases degrading ECM, EMT, adhesion/extravasation, angiogenesis, immune evasion, tumor microenvironment, cytokines, and cancer stem cells."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not frame metastasis as a stress-response process; only notes cells face stress in circulation without linking stress to initiation of metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of CT, MRI, PET/CT, or imaging for staging/metastasis detection."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe perineural invasion and describe how cancer can spread this way.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Perineural invasion is not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe how cancer cells lodge in tissues distant from their original site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains adhesion to vessel walls, extravasation into tissues, angiogenesis, and colonization."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe that pancreatic cancer is often diagnosed at advanced stages, when it has already spread outside of the original site.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States pancreatic cancer is often diagnosed at an advanced stage due to late symptoms from local invasion."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain the most common sites that cancer cells spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists common metastatic sites for pancreatic cancer: liver, lungs, peritoneum, and bones."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe patterns of spread in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes local invasion to adjacent structures and typical metastatic patterns including liver, lungs, peritoneum (including carcinomatosis)."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe characteristics of cancers that have higher predilection for spreading.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes drivers of metastatic propensity such as KRAS/TP53 mutations, tumor microenvironment, and cancer stem cells."
      }
    ],
    "question_number": 238,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:20:03.265259",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines cancer stem cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response characterizes CSCs as cells with stem-like traits including self-renewal, survival, tumorigenicity, and therapy resistance, which constitutes a functional definition."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the role of cancer stem cells in cancer biology using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The discussion is highly technical (e.g., RhoA/ROCK, YAP/TAZ, integrins) and not framed in lay language, limiting accessibility for non-experts."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the role cancer stem cells may play in cancer recurrence.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly links CSCs to recurrence in multiple places, including a dedicated section on recurrence and the conclusion."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "ECM stiffness is repeatedly discussed as a key mechanical cue affecting CSC traits and signaling."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It connects ECM stiffness and collagen alignment to migration/invasion and discusses shear stress survival during circulation, linking to metastasis."
      },
      {
        "criterion_number": 6,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains how stiff environments and mechanotransduction promote drug resistance, dormancy, and survival mechanisms (e.g., efflux pumps), impacting treatment efficacy."
      },
      {
        "criterion_number": 7,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to published journal articles are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although components of the tumor microenvironment are discussed (ECM, pressure, hypoxia), there is no explicit definition of the tumor microenvironment as the collection of non-cancerous cells, matrix, vasculature, and signals surrounding tumor cells."
      },
      {
        "criterion_number": 9,
        "description": "The response describes mechanical cues as they pertain to solid tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanical factors relevant to solid tumors\u2014ECM stiffness, architecture, interstitial fluid pressure, and shear stress\u2014are clearly described."
      },
      {
        "criterion_number": 10,
        "description": "The response delineates between other types of environmental inputs that cells experience and mechanical forces, such as chemical or hormonal cues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It contrasts mechanical forces with biochemical inputs by referencing hypoxia and biochemical signaling and notes context-dependence and interactions between mechanical and biochemical cues."
      },
      {
        "criterion_number": 11,
        "description": "The response describes that pancreatic cancer promotes desmoplasia in its microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that PDAC has a desmoplastic stroma with dense collagen."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how mechanical forces in the tumor microenvironment influence the behavior of cancer stem cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Detailed mechanisms are provided (integrin signaling, RhoA/ROCK, YAP/TAZ activation) linking stiffness and other forces to CSC self-renewal, survival, therapy resistance, and niche maintenance."
      },
      {
        "criterion_number": 13,
        "description": "The response links scientific literature with PMID on the subject, if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs or direct links to the scientific literature are included."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how mechanical forces in the tumor microenvironment affect disease recurrence and metastatic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It connects mechanical cues to recurrence (post-treatment stiffening, reactivation) and to metastasis (ECM alignment, survival under shear stress)."
      },
      {
        "criterion_number": 15,
        "description": "The response mentions how mechanical cues affect tumor cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Dormancy/quiescence induced by stiff environments and subsequent reactivation are explicitly discussed."
      },
      {
        "criterion_number": 16,
        "description": "The response mentions that the desmoplastic tumor microenvironment in pancreatic cancer is actively being researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes that mechanobiology insights are largely preclinical with growing human trials and suggests discussing mechanobiology-targeted therapies, indicating active research in this area, including PDAC\u2019s desmoplastic stroma."
      }
    ],
    "question_number": 239,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:20:51.215977",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises, \"Work with the medical team to ask questions, clarify treatment plans, and ensure your loved one\u2019s comfort,\" directly encouraging engagement with the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends \"Therapy or Counseling\" with a therapist specializing in grief, trauma, or chronic illness, fulfilling the counselor component of this criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises joining support groups for caregivers or those affected by pancreatic cancer and references organizations (PCAN, ACS) that host such groups."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Sections on \"Seek Emotional and Social Support\" and \"Lean on Trusted Relationships\" emphasize building and relying on a support system."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of stress relief strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides multiple concrete strategies including journaling, art, music, mindfulness, deep breathing, progressive muscle relaxation, and gentle exercise; also mentions apps like Headspace/Calm."
      },
      {
        "criterion_number": 6,
        "description": "The response offers examples of organizations that offer support for cancer patients and their families and provides contact information or a website.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists PCAN (pancan.org), ACS (cancer.org) with helpline 1-800-227-2345, Caregiver Action Network (caregiveraction.org), and National Alliance for Caregiving (caregiving.org), all with websites and a phone number."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends prioritizing self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated section \"Prioritize Self-Care\" discusses maintaining physical health, emotional expression, and relaxation practices."
      },
      {
        "criterion_number": 8,
        "description": "The response should normalize the range of emotions felt after a loved one receives a serious cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It validates feelings as \"entirely valid\" and encourages allowing emotions like anger, grief, and fear without judgment; also notes grief and stress are natural."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of maintaining mental health during times of strife.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It stresses therapy/counseling, setting boundaries to prevent burnout, and mindfulness practices, emphasizing mental health maintenance."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining healthy lifestyle habits to support wellbeing during times of stress, such as a cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends balanced meals, adequate sleep, and gentle exercise, linking physical health to emotional resilience."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend organization of thoughts and questions to discuss with the oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests working with the medical team and asking questions, it does not explicitly recommend organizing thoughts or preparing a written list of questions for the oncology team."
      },
      {
        "criterion_number": 12,
        "description": "The response should emphasize the importance of understanding the diagnosis to the patient and suggest ways to educate themselves.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It includes a directive to \"Educate Yourself\" about pancreatic cancer and references reputable sources (PCAN, ACS) for information."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention the importance of getting one\u2019s affairs in order upon receiving a cancer diagnosis, as this can provide some peace of mind about the future.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of advance care planning, legal/financial preparations, or getting affairs in order; legacy projects are discussed but do not meet this criterion."
      },
      {
        "criterion_number": 14,
        "description": "The response should emphasize the importance of avoiding isolation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages joining support groups and leaning on trusted relationships, and explicitly notes that sharing experiences can reduce isolation."
      }
    ],
    "question_number": 240,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:21:42.687678",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what phase separation is using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines phase separation as formation of membrane-less compartments that concentrate specific molecules to organize cellular functions; sufficiently accessible for a lay reader despite mentioning LLPS."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how phase separation relates to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly links phase separation to oncogenic transcription, DNA repair defects, metabolic changes, stress responses, invasion/metastasis, and drug resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response defines biomolecular condensates.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly describes condensates as membrane-less compartments formed via phase separation that concentrate proteins and RNA."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how phase separation affects drug resistance in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses sequestration of therapeutics within condensates and enhanced DNA repair via phase-separated complexes, both contributing to resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response describes how phase separation affects gene manipulation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains condensate-driven concentration of transcription factors (e.g., MYC) that amplifies gene expression programs; sufficient coverage of gene regulation effects."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the role that phase separation plays in the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links desmoplastic, stiff PDAC microenvironment and stress conditions (hypoxia/nutrient deprivation) to induction of condensates in cancer and stromal cells."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect that phase separation has on cellular metabolism and survival.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers metabolic rewiring via nucleolar activity and describes stress granules protecting cells and aiding survival under hostile conditions."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that phase separation is the topic of ongoing research at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that understanding phase separation could lead to new therapies and frames clinicians\u2019 mention as related to ongoing research."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the role of phase separation in the facilitation of invasion and metastasis of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses cytoskeletal condensates organizing motility structures, EMT regulation via condensates, and membrane-associated condensates aiding invasion."
      },
      {
        "criterion_number": 10,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific articles are provided."
      }
    ],
    "question_number": 241,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:22:23.365673",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains sensing via cytoskeleton deformation, integrins/focal adhesions, primary cilia, mechanosensitive ion channels (Piezo1/2), and the nuclear envelope in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes cytoskeletal rearrangement, activation of Rho/ROCK and YAP/TAZ, calcium influx, downstream gene/epigenetic changes, and effects on migration, proliferation, and survival in clear, lay-friendly terms."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how these processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Connects stiffness in the pancreatic tumor microenvironment to activation of YAP/TAZ and Rho pathways, increased invasion, and therapy resistance, directly addressing alterations in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "Define mechanotransduction as the process by which cells convert mechanical stimuli into biochemical signals.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Defines mechanotransduction as how cells sense and respond to mechanical forces but does not explicitly state conversion of mechanical stimuli into biochemical signals."
      },
      {
        "criterion_number": 6,
        "description": "Include the relevance of mechanotransduction in normal physiology and disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States mechanotransduction is crucial in normal physiology and can be dysregulated in diseases like pancreatic cancer, and elaborates on disease relevance."
      },
      {
        "criterion_number": 7,
        "description": "Describe at least two types of mechanical forces acting on tissues, such as stretch, pressure, stiffness, compression, tension, shear stress, or hydrostatic pressure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions pressure, tension, and stiffness (three distinct mechanical forces)."
      },
      {
        "criterion_number": 8,
        "description": "Explain how mechanical forces in tumors and/or the surrounding tissues differ from normal tissue, specifically mentioning the creation of a stiff and dense extracellular matrix (ECM).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes a stiff, fibrotic microenvironment due to desmoplasia with excessive collagen deposition, meeting the requirement for stiff/dense ECM in tumors."
      },
      {
        "criterion_number": 9,
        "description": "Describe at least two ways cells detect mechanical forces, including structures like ion channels, integrins, cell surface receptors, or the cytoskeleton.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Details multiple sensors: integrins/focal adhesions, mechanosensitive ion channels (Piezo1/2), cytoskeleton, primary cilia, and nuclear envelope."
      },
      {
        "criterion_number": 10,
        "description": "Describe how pancreatic cancer cells respond to mechanical forces in their environment, particularly focusing on stiffness or desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiffness activates YAP/TAZ and Rho signaling, promoting proliferation, invasion, and treatment resistance in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "Define desmoplastic stroma as a key feature of pancreatic cancer characterized by excessive fibrous tissue formation around the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies desmoplasia as excessive collagen deposition by stromal cells and notes a stiff, fibrotic microenvironment around pancreatic tumors, effectively defining desmoplastic stroma."
      }
    ],
    "question_number": 242,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:23:13.082784",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends meeting with a Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends partnering with hospice or palliative care teams for guidance."
      },
      {
        "criterion_number": 2,
        "description": "The response explains Advanced Care Planning and how it impacts a patient\u2019s clinical course.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes using an advance healthcare directive/living will to outline medical preferences (e.g., life support, palliative care), indicating how preferences shape care decisions."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions code status.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention code status, DNR/DNI, or resuscitation preferences explicitly."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions an advanced directive or living will.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends a living will/advance healthcare directive."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions financial planning and recommends discussing this with a professional with experience in this.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises working with a financial advisor experienced in end-of-life planning and consulting an estate attorney."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a social worker or counselor.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends connecting with counselors; although social worker is not mentioned, counselor meets the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights support groups, family meetings, open communication, and caregiver self-care, emphasizing support systems."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or websites.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions the Pancreatic Cancer Action Network but provides no contact information or website links."
      },
      {
        "criterion_number": 9,
        "description": "The response should instruct patients to create a POLST with their healthcare provider, and post this in a visible place in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of POLST or posting it at home."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the patient elect a healthcare durable power of attorney.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends establishing powers of attorney, including healthcare POA."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ensure their financial affairs are in order.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises budgeting, reviewing insurance, and organizing financial documents."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient elect a financial durable power of attorney.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends establishing powers of attorney, including financial POA."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient complete a will and designate beneficiaries on life insurance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends completing a will but does not explicitly advise designating beneficiaries on life insurance."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient consider reaching out to friends and loved ones in order to connect and spend time together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages a family meeting, open conversations, and memory preservation activities, facilitating connection and time together."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consider how to reconcile their affairs in the financial, legal, and social realms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses legal (wills, directives), financial (advisors, insurance), and social/emotional legacies (family meetings, memory projects)."
      },
      {
        "criterion_number": 16,
        "description": "The response should provide online references and links to resources regarding legacy planning.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No online references or links are provided."
      },
      {
        "criterion_number": 17,
        "description": "The response should suggest the patient inquire about assistance with some of these aspects of legacy planning with their oncology team, to understand if there are resources available.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not suggest asking the oncology team about available resources."
      }
    ],
    "question_number": 243,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:24:24.423641",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains cell-cell adhesion (cadherins) and cell-matrix adhesion (integrins) and introduces ECM in accessible language with simple definitions and examples."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cell adhesion processes are changed in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details loss of E-cadherin, switch to N-cadherin, EMT, ECM degradation by MMPs, and mechanisms for re-attachment (selectins/integrins, MET) in metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions integrins and cadherins multiple times with roles in adhesion."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Discusses dense fibrotic stroma in pancreatic tumors, role of MMPs in this context, high EMT-related proteins, and association of CTCs with metastasis and prognosis in pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines ECM as a network of proteins and sugars and gives examples (collagen, fibronectin); explains its structural role and remodeling in tumors."
      },
      {
        "criterion_number": 7,
        "description": "The response explains epithelial-mesenchymal transition (EMT).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes EMT as loss of epithelial traits and gain of mesenchymal features, increasing mobility and detachment."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how EMT facilitates cancer cell spread.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links EMT to detachment, invasion, intravasation as circulating tumor cells, and subsequent reattachment with MET at metastatic sites."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the components of cell adhesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers adhesion molecules (cadherins, integrins, selectins) and ECM components; distinguishes cell-cell and cell-matrix adhesion."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the components of cell detachment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions reduction of E-cadherin, cadherin switching, ECM degradation by MMPs, and EMT as mechanisms enabling detachment."
      },
      {
        "criterion_number": 11,
        "description": "The response includes different enzymes implicated in cell adhesion and detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only matrix metalloproteinases are specifically named; 'proteases' is a generic category and not a distinct enzyme example."
      },
      {
        "criterion_number": 12,
        "description": "The response describes factors in the tumor microenvironment that promote or facilitate tumor cell detachment and migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes stromal cells and their signals, ECM remodeling/stiffening, increased collagen, and hypoxia inducing EMT."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions if there are any FDA-approved treatments that target cancer cell detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses experimental strategies (integrin/cadherin inhibitors, MMP inhibitors, EMT reversal) but does not state whether any are FDA-approved for targeting detachment."
      }
    ],
    "question_number": 244,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:24:59.852257",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises asking the oncology team candid questions about prognosis, treatment options, and goals of treatment, including best- and worst-case scenarios."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages open dialogue within the family, using \u201cI feel\u201d statements and validating hopes and fears."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends professional counseling (therapists, grief counselors) and exploring spiritual/philosophical supports; also mentions palliative/hospice options in advance care planning."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages asking about goals of treatment, focusing on quality of life, and conducting advance care planning to align care with patient values."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically suggests connecting with support groups, citing organizations like the American Cancer Society and Pancreatic Cancer Action Network."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Organizations (ACS, PanCAN, NCI) are named but no contact information or website URLs are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights mental health through counseling, validation of emotions, spiritual supports, and caregiver self-care, emphasizing ongoing emotional well-being."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Normalizes the experience by stating many navigate this challenge, validating all emotions, and noting there is no single 'right' way."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions focusing on quality of life and symptom management but does not describe specific treatment-related factors (e.g., pain, fatigue, GI effects) that influence quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides recognizable online resources by name (National Cancer Institute, American Cancer Society, Pancreatic Cancer Action Network) and suggests connecting with support groups, meeting the requirement to offer online resources and community options."
      }
    ],
    "question_number": 245,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:25:40.209400",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what condensates are using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines condensates as membraneless, liquid-like cellular structures that organize molecules and functions, with accessible language and examples."
      },
      {
        "criterion_number": 2,
        "description": "The response defines biomolecular condensates as membrane-less organelles containing proteins, RNA, and other molecules.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes condensates as membraneless structures composed of proteins, RNA, and other molecules; cites examples like stress granules, P bodies, and nucleolus."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how condensates relate to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Connects condensates to multiple cancer-relevant processes including gene expression, DNA repair, metabolism, proliferation, signaling, metastasis, drug resistance, and tumor microenvironment."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how biomolecular condensates become deregulated in cancer cells, including at least one mechanism of deregulation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides mechanisms of deregulation such as malfunctioning DNA repair condensates (PML bodies), sequestration/stabilization of RNAs, nucleolar enlargement increasing ribosome biogenesis, and concentration of signaling molecules."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response references at least one scientific literature source regarding biomolecular condensates, including a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No literature references or PMIDs are included."
      },
      {
        "criterion_number": 7,
        "description": "The response defines liquid-liquid phase separation (LLPS) as the process by which condensates form.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'phase separation' but does not explicitly define or name liquid-liquid phase separation (LLPS)."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the role of biomolecular condensates in normal cells, including at least one function such as gene regulation or stress response.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes normal functions including RNA processing, signaling, metabolic organization, stress granules, and nucleolar roles in ribosome production."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the protein YAP/TAZ and its role in biomolecular condensates in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "YAP/TAZ is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response lists at least two ways that biomolecular condensates encourage cancer cell growth, proliferation, or migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies multiple ways, including enhanced ribosome biogenesis for proliferation, amplified growth signaling, stabilization of pro-metastatic RNAs, and support of invasion/metastasis."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the study of biomolecular condensates and their role in cancer is an area of active scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that targeting condensates is an emerging research focus and references ongoing/preclinical research."
      },
      {
        "criterion_number": 12,
        "description": "The response states whether there are FDA-approved therapies that target biomolecular condensates in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Indicates approaches are in preclinical stages, implying there are no FDA-approved therapies targeting condensates."
      }
    ],
    "question_number": 246,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:26:21.381101",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly references tissue stiffness and defines it explicitly."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links stiffness to EMT, invasion, invadopodia formation, barrier disruption, and metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains drug delivery barriers, hypoxia-related resistance, and strategies to improve delivery."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No primary literature citations or specific journal references are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines desmoplasia as a dense, fibrous stroma produced by CAFs with excess ECM (e.g., collagen)."
      },
      {
        "criterion_number": 6,
        "description": "The response explains how and why pancreatic cancer promotes the formation of desmoplastic stroma around itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes CAF activation and a mechanical feedback loop where tumor activity stimulates further ECM production."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the process of cell adhesion in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While integrin-ECM interactions are mentioned, the response does not explicitly describe normal tissue cell adhesion."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how increased stiffness in tumors and the tumor microenvironment influences cell adhesion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mechanotransduction via integrins is discussed, but there is no explicit description of how stiffness alters adhesion properties (e.g., focal adhesion maturation, adhesion strength)."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the effect of tissue stiffness on angiogenesis and drug resistance.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Drug resistance and delivery barriers are covered, but angiogenesis is not explicitly mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how the development of desmoplastic stroma around pancreatic cancer tumors is a protective factor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explains that dense, stiff ECM hinders immune cell infiltration and blocks drug delivery, protecting the tumor."
      },
      {
        "criterion_number": 11,
        "description": "The response explains whether there are FDA-approved treatments that target tissue stiffness in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions trials and investigational strategies but does not state if any FDA-approved stiffness-targeting treatments exist."
      },
      {
        "criterion_number": 12,
        "description": "The response defines mechanotransduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It describes how cells sense stiffness through integrins and activate signaling (e.g., YAP/TAZ), which constitutes mechanotransduction."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests that the patient discuss the role of clinical trials in their cancer care with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly advises discussing with the oncologist whether stiffness is a factor and the availability of relevant clinical trials."
      }
    ],
    "question_number": 247,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:26:59.978067",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly emphasizes clear communication, such as recommending regular family meetings or using communication tools.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends a centralized information hub, regular family meetings with summaries, and tailored updates for less tech-savvy members."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the patient\u2019s healthcare team or medical providers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting the oncology team for a clear care plan and ensuring all understand the diagnosis, treatment, and prognosis."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions counseling and spiritual support, it does not explicitly recommend engagement with a social worker or palliative care specialist."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of a strong support system, such as building a caregiver network or ensuring emotional support.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It highlights caregiver role division, emotional/spiritual care, support networks, intergenerational bonding, and caregiver respite."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It lists organizations (e.g., ACS, PCAN, CancerCare, CFAC, PAF) but does not include contact information or website links."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It directly recommends connecting with cancer support groups and encourages participation in virtual or in-person sessions."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to ensure all family members understand the diagnosis, treatment options, and prognosis."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that one family member is designated as a communication person, and perhaps accompany the patient to their medical appointments and take notes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It designates a family coordinator and a medical liaison to manage doctor visits and health records, meeting the intent of the criterion."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the communication person to develop a strategy to deliver information to the multi-generational family members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It outlines a strategy with centralized hubs, regular meetings, and simplified updates for less tech-savvy members."
      },
      {
        "criterion_number": 10,
        "description": "The response should reinforce the importance of boundaries for the pancreatic cancer patient while they undergo treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It emphasizes patient autonomy but does not explicitly discuss setting or maintaining boundaries for the patient."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient inquire with their oncology team if there are resources available for group support or for cultural mediation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit recommendation to ask the oncology team about group support or cultural mediation resources."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient or loved ones identify care needs, such as cleaning or food prep, and assign roles to family members according to their strengths.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises assigning roles by availability/skills and covers tasks like transportation, meal trains, grocery delivery, and errands."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage the patient to focus on their own wellbeing and mental health.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It encourages emotional and spiritual support for the patient and participation in support groups, promoting mental wellbeing."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend online resources for pancreatic cancer information as well as support services that the patient and family members can access to answer questions, etc.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cites online resources and services (e.g., PCAN, CancerCare, ACS, CFAC, PAF, apps like MyChart and OurFamilyWizard) that can provide information and support."
      }
    ],
    "question_number": 248,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:27:43.647777",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains epithelial-mesenchymal transition and how this affects a cell\u2019s ability to migrate.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes EMT as loss of epithelial 'stickiness' and gain of mesenchymal mobility, enabling detachment and movement through tissue."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Discusses local invasion but does not mention spread via lymphatic system or bloodstream."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses multiple mechanisms: ECM degradation by MMPs, altered adhesion (E-cadherin/integrins), cytoskeletal changes, signaling pathways, and microenvironmental contributions."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions hypoxia signaling promoting invasion but does not explicitly frame metastasis as a response to cell stress."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of imaging modalities (CT, MRI, PET/CT) or staging evaluations."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss treatment approaches or their utility in the metastatic setting."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises consulting the oncologist and discussing options with the care team."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Uses accessible language for invasion but does not explain metastasis (spread to distant sites) in plain terms."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how a cancer cell develops, including DNA mutations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Briefly mentions mutations (e.g., KRAS) but does not describe how cancer cells develop or clonal evolution driven by DNA mutations."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe tumor suppressor genes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention or description of tumor suppressor genes."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe oncogenes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "References KRAS and Hedgehog pathway genes but does not define or describe oncogenes."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe cell adhesion, and how this process can be altered in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains reduced E-cadherin and altered integrin use, detailing how adhesion changes facilitate invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response should explain the phenomenon of loss of cell-cell adhesion in cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly addresses loss of cell-cell adhesion through decreased E-cadherin leading to detachment."
      },
      {
        "criterion_number": 14,
        "description": "The response should define tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes the stroma, cancer-associated fibroblasts, immune cells, and matrix properties, effectively defining the tumor microenvironment."
      },
      {
        "criterion_number": 15,
        "description": "The response should explain how cancer cells can use enzymes to change the tumor microenvironment to their advantage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains MMP-mediated ECM degradation creating paths for invasion, demonstrating enzymatic remodeling of the microenvironment."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe other ways cancer cells can interact with the tumor microenvironment to promote migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes CAF-secreted factors, stromal stiffness/density guiding movement, and immune cell-derived signals that aid invasion."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe any unique ways pancreatic cancer cells are thought to metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions desmoplasia in pancreatic tumors but does not address unique metastatic patterns such as perineural invasion or portal venous spread to the liver."
      },
      {
        "criterion_number": 18,
        "description": "The response should recommend websites that help explain different aspects of pancreatic cancer and provide resources for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No resource or website recommendations provided."
      }
    ],
    "question_number": 249,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:28:40.518210",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response discusses the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system and blood vessels using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response focuses on tumor-related abnormalities and does not clearly explain the normal baseline fluid movement from capillaries to interstitial space and into lymphatics in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how fluids move in normal tissue to perform tasks such as nutrient and oxygen delivery, and to manage waste products.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Normal physiology of fluid-mediated nutrient/waste transport is not described; the answer centers on abnormal tumor conditions like hypoxia and high IFP without establishing normal function."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses changes to fluid flow that may occur in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly details elevated interstitial fluid pressure, compressed/abnormal vasculature, dense ECM, and lymphatic dysfunction specific to pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response describes abnormalities seen in tumors with fluid management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Abnormal, leaky blood vessels, impaired lymphatics, high IFP, and stiff ECM are accurately described."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, including reduced drug delivery or immune cell penetration into the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses poor diffusion, uneven perfusion, hypoxia-driven barriers, and impaired immune infiltration; also mentions therapeutic strategies to overcome these issues."
      },
      {
        "criterion_number": 6,
        "description": "The response describes how fluid flow affects cancer behavior.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains impacts on hypoxia, metabolic adaptation, therapy resistance, angiogenesis, metastasis, immune evasion, and tumor heterogeneity linked to fluid dynamics."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that hypoxia from poor perfusion promotes pro-growth pathways (angiogenesis), therapy resistance, and selection for aggressive phenotypes, supporting further tumor development."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions how altered cellular biology and extracellular structures can impact cancer behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses ECM stiffness, desmoplastic stroma, fibroblasts, immune cells, and hypoxia-induced metabolic changes affecting behavior."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence of its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No scientific journal citations are provided; only general organizations are mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response describes different fluids that exist in a tumor and its environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "References blood within abnormal vasculature, interstitial fluid (via IFP), and lymphatic fluid (lymphatic dysfunction), meeting the requirement."
      },
      {
        "criterion_number": 11,
        "description": "The response describes the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear overview of the tumor microenvironment including stroma, ECM, fibroblasts, immune cells, vasculature, and hypoxia."
      },
      {
        "criterion_number": 12,
        "description": "The response describes attributes of tumors and the surrounding tissue that disrupt the normal function of fluids.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies dense collagen-rich ECM, vessel leakiness/compression, and lymphatic impairment as disruptors of normal fluid transport."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages the development of this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While desmoplastic reaction is described as excessive collagen deposition, the mechanism by which pancreatic cancer promotes its development is not explained."
      },
      {
        "criterion_number": 14,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 5,
        "max_points": 5,
        "justification": "IFP is effectively defined in context as pressure in the interstitial space that traps fluids and impedes diffusion, with causes (impaired lymphatics, rigid ECM)."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly connects elevated IFP with hindered diffusion and describes uneven perfusion causing hot/cold spots in drug delivery."
      },
      {
        "criterion_number": 16,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a dedicated section on research and future directions, indicating active investigation into tumor fluid mechanics and related therapies."
      }
    ],
    "question_number": 250,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:29:25.992846",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response references the 'medical team' but does not explicitly recommend discussing dignity-preserving approaches with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with a Palliative Care specialist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends involving a 'Palliative Care Team' for quality of life and symptom management."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions Advance Care Planning and includes either Advance Directives or Living Wills.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advance Care Planning is mentioned, but there is no explicit mention of 'Advance Directives' or 'Living Wills.'"
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care, including understanding and documenting the patient\u2019s preferences and involving them in decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes asking what he values, involving him in decisions, and 'documenting these preferences' under Advance Care Planning."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for cancer patients.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends connecting with pancreatic cancer support groups and specifically mentions PCAN and ACS."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Organizations (PCAN, ACS) are named, but no contact information or websites are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize feelings of loss of control for cancer patients at the time of diagnosis and/or during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It validates emotions, notes dignity may fluctuate, and reassures 'You\u2019re not alone in this,' which normalizes these feelings."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe components of personal dignity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It addresses autonomy, privacy, independence, respectful communication, comfort, legacy, spiritual/cultural support, and social connection."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient, family, and friends of the patient, and oncology care team to respect the patient\u2019s bodily autonomy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "While autonomy and privacy are emphasized, it does not explicitly encourage the oncology care team (or all parties listed) to respect bodily autonomy."
      },
      {
        "criterion_number": 10,
        "description": "The response should encourage the patient to prioritize management of side effects and symptoms of cancer or cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It encourages working with the medical team on eating difficulties and involves palliative care for pain and symptom management."
      },
      {
        "criterion_number": 11,
        "description": "The response should encourage the patient to communicate any side effects or symptoms of cancer or cancer treatment to their oncology care team to ensure they are being offered management solutions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises working with the 'medical team' but does not explicitly instruct communicating side effects to the oncology care team."
      },
      {
        "criterion_number": 12,
        "description": "The response should encourage the patient and family to have open and ongoing communication about the patient\u2019s wishes for medical care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes ongoing conversations about needs and values, privacy choices, and Advance Care Planning."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient and loved ones promote independence and normalcy in the patient\u2019s life as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends assistive devices for independence and maintaining routines and 'small joys' to preserve normalcy."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage the patient to always remember that anything that happens to their body with regard to cancer treatment is their choice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It supports autonomy broadly but does not explicitly state that all treatment decisions about the body are the patient's choice."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient disclose any feelings of overwhelm or loss of autonomy with their oncology team and inquire about resources for support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests therapy and support groups but does not recommend disclosing feelings of overwhelm to the oncology team or asking them for resources."
      },
      {
        "criterion_number": 16,
        "description": "The response should emphasize the importance of prevention of caregiver burnout.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly addresses caregiver support and recommends respite care and self-care to prevent burnout."
      }
    ],
    "question_number": 251,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:30:06.826779",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cells respond to mechanical stress, including processes like ECM remodeling, increased contractility, and effects on proliferation, invasion, metastasis, and drug resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response describes increased cell contractility, invasion and metastasis, drug resistance, and ECM remodeling (CAF collagen deposition, MMP-mediated breakdown). It links mechanotransduction (YAP/TAZ) to proliferation/survival and discusses limited drug penetration."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly relates tissue properties, such as stiffness and fibrous stroma, to their potential effect on cancer spread, including invasiveness and metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states PDAC has a stiff, fibrotic stroma, and that stiffness activates YAP/TAZ to drive metastasis and promotes invasive behaviors."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including drug penetration and resistance mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It ties stiff ECM to limited drug penetration and survival signaling, mentions protection of cancer stem cells, and cites losartan improving chemotherapy efficacy by reducing fibrosis."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how cells sense mechanical stress, including mechanosensing mechanisms like mechanoreceptors, integrins, or mechanotransduction pathways.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mechanosensing is covered via integrins, focal adhesions, and downstream YAP/TAZ activation, which constitutes a clear mechanotransduction pathway."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific citations from published scientific journal articles as evidence for its statements.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No journal citations are provided; only general resources (ClinicalTrials.gov, PanCAN) are mentioned without specific published article references."
      },
      {
        "criterion_number": 6,
        "description": "The response must explain normal cell contractility, including the role of the actomyosin complex in generating mechanical forces for movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines cell contractility as force generation enabling movement and highlights actin and myosin filaments and focal adhesions, which together represent the actomyosin machinery driving force and motion."
      },
      {
        "criterion_number": 7,
        "description": "The response must define actin, including its role in cellular structure and function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Actin is mentioned but not defined; there is no explicit explanation of its structural role or specific functions."
      },
      {
        "criterion_number": 8,
        "description": "The response must define myosin, including its function in cell contractility.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Myosin is referenced but not defined; the contractile role of myosin is not explicitly described."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly describe the tumor microenvironment, including its components and characteristics.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It describes TME characteristics (stiffness, fibrosis) and components (ECM proteins, CAFs) and mentions immune cell infiltration effects."
      },
      {
        "criterion_number": 10,
        "description": "The response must define the extracellular matrix, including its composition and function.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The ECM is defined as a protein network (collagen, fibronectin) providing structural support, meeting composition and function requirements."
      },
      {
        "criterion_number": 11,
        "description": "The response must define mechanobiology, including its relevance to cancer progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mechanobiology is not defined; while mechanotransduction is discussed, the term 'mechanobiology' and its definition are not provided."
      },
      {
        "criterion_number": 12,
        "description": "The response must explain epithelial-mesenchymal transition (EMT), including its occurrence in pancreatic cancer cells and its impact on cancer spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "EMT is not mentioned; no explanation of EMT in pancreatic cancer or its role in metastasis is provided."
      }
    ],
    "question_number": 252,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:30:57.719744",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines the extracellular matrix and explains its role in normal cellular biology.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The answer discusses ECM components and functions in pancreatic cancer but does not define ECM or explain its roles in normal biology (e.g., structural support, cell signaling, tissue homeostasis)."
      },
      {
        "criterion_number": 2,
        "description": "The response contrasts the role of the extracellular matrix in cancer cell biology with normal cell biology.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no explicit contrast between normal ECM roles and cancer-associated ECM roles; the focus is solely on cancer contexts."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the potential consequences of an altered extracellular matrix for cancer treatment effectiveness and resistance, including examples like decreased drug and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states ECM is a barrier to drug and immune cell penetration, mentions drug sequestration, immune evasion, protection of cancer stem cells, and strategies like hyaluronidase to improve delivery."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential consequences of an altered extracellular matrix on cancer cell biology, including examples like angiogenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details integrin-mediated signaling, proliferation/survival pathways (AKT/mTOR), migration/invasion, EMT via TGF-\u03b2, metastatic niche preparation, and release of VEGF/FGF promoting angiogenesis."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the different components of the extracellular matrix in normal tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists ECM components such as collagen I/III, fibronectin, laminin, hyaluronan, and proteoglycans, which constitute normal ECM components, even though not explicitly framed as 'normal tissue'."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how the extracellular matrix changes in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes desmoplasia with excessive collagen/proteoglycan deposition, increased stiffness, CAF activation and remodeling, immunosuppressive milieu, and hyaluronan accumulation."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how the changes in the extracellular matrix in pancreatic cancer promote cancer growth and facilitate movement of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mechanotransduction via integrins/FAK/Src, enhanced survival (AKT/mTOR), EMT, directed migration, invasion, and metastasis are clearly described as consequences of ECM changes."
      },
      {
        "criterion_number": 9,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains desmoplastic reaction/stroma as excessive ECM (collagen, fibronectin, proteoglycans) deposition leading to a stiff, fibrotic microenvironment."
      },
      {
        "criterion_number": 10,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the term 'tumor microenvironment' is used, it is not defined (e.g., composition of cells, ECM, vasculature, immune elements)."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how desmoplastic stroma causes hypoxia in the tumor microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Hypoxia and its mechanistic link to desmoplasia (e.g., vascular compression, impaired perfusion) are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response describes how hypoxia in the tumor microenvironment causes inflammation, and how this promotes cancer growth.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Hypoxia-driven inflammation and its pro-tumor effects are not addressed."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment contributes to treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly links desmoplastic ECM to treatment resistance via physical barriers, drug sequestration, immune exclusion, and protection of cancer stem cells."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment can cause symptoms and complications due to mechanical forces on the surrounding structures, specifically mentioning the effect on blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of symptoms or complications from mechanical forces on surrounding structures or effects on blood vessels (e.g., compression, ischemia)."
      }
    ],
    "question_number": 253,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:31:51.713329",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing relationship challenges or support strategies with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of discussing relationship challenges with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing relationship challenges with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends working with oncology social workers and therapists/counselors to navigate challenges."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends joining a support group for cancer patients or their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends support groups for patients, caregivers, or couples and cites organizations offering them."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Has a dedicated self-care section with concrete strategies (rest, recharge, healthy coping)."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly emphasizes the importance of having a support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "\u201cBuild a Supportive Network\u201d section emphasizes leaning on family/friends, support groups, and professionals."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists CancerCare (https://www.cancercare.org/), American Cancer Society (https://www.cancer.org/), and PanCAN (https://www.pancan.org/)."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that loved ones of a patient with pancreatic cancer seek education about the disease and common symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit recommendation to learn about pancreatic cancer or its symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage open communication between the patients and their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "\u201cPrioritize Open and Honest Communication\u201d with specific guidance on sharing feelings, discussing needs, and active listening."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient to seek support from their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages leaning on each other, asking family/friends for specific help, and staying connected."
      },
      {
        "criterion_number": 10,
        "description": "The response should attempt to normalize the stress that patients feel after receiving a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Frames the situation as emotionally and physically draining, validates strained relationships, and reassures \u201cYou\u2019re not alone.\u201d"
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend against behaviors that might isolate the patient after a serious medical diagnosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages staying connected to friends via check-ins, engaging community/online support, and nurturing relationships\u2014implicitly discouraging isolation."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient prioritize symptom control to feel as normal as possible.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice on symptom control or managing treatment side effects to maintain normalcy."
      },
      {
        "criterion_number": 13,
        "description": "The response should indicate that some people may not feel comfortable discussing a serious cancer diagnosis with a friend or loved one, and that this can be a normal response.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly acknowledge that some people may be uncomfortable discussing the diagnosis as a normal response."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient observe which people in their social circle want to be supportive, and to lean on these people.",
        "score_given": 0,
        "max_points": 0,
        "justification": "This criterion has zero maximum points; no credit is awarded by design."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient continue to reach out to friends and loved ones, and try to participate in the same activities they previously did, to maintain relationships.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages brief check-ins with friends and maintaining/adapting routines and activities to preserve connection."
      },
      {
        "criterion_number": 16,
        "description": "The response should suggest that the patient consider creating boundaries with people, including how to handle unsolicited advice.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Dedicated \u201cSet Boundaries\u201d section with scripts and managing others\u2019 expectations; addresses overstepping even if not labeled as unsolicited advice."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend that the patient consider activities where they can be fully present with the people they are with, for the best quality interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests quality, presence-focused activities (quiet walks, shared meals, board games) and celebrating small moments."
      }
    ],
    "question_number": 254,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:32:41.079201",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cancer cells detect mechanical characteristics of their environment.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Although the response explains detection via integrins, focal adhesions, and ion channels, this criterion has a maximum of 0 points per the rubric."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how cancer cells respond to mechanical characteristics of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly describes responses to stiffness and forces including proliferation/survival via YAP/TAZ, migration/invasion via RhoA-driven contractility and MMPs, EMT, effects of shear stress on metastasis, and metabolic adaptations."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how mechanosensing processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details PDAC-specific alterations: dense fibrotic (stiff) stroma, KRAS-driven hyperactivation of RhoA and YAP/TAZ, CAF-mediated ECM deposition and feedback loops, and durotaxis relevant to PDAC."
      },
      {
        "criterion_number": 4,
        "description": "The response defines mechanosensing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition in context: cells detect and respond to mechanical cues (stiffness, tension, shear) through integrins/focal adhesions and cytoskeletal-linked signaling."
      },
      {
        "criterion_number": 5,
        "description": "The response describes mechanosensing in normal cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Focuses on cancer cells and dysregulation; does not describe how mechanosensing operates in normal (non-cancer) cells."
      },
      {
        "criterion_number": 6,
        "description": "The response defines desmoplastic stroma and describes its development in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Accurately describes PDAC\u2019s dense, fibrotic, collagen-rich stroma and explains CAF-driven ECM deposition and TGF-\u03b2 signaling creating a stiff TME, which constitutes desmoplastic stroma and its development."
      },
      {
        "criterion_number": 7,
        "description": "The response describes integrins, cytoskeleton, ion channels, and membrane sensors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically discusses integrins, focal adhesions (talin, vinculin, FAK), the cytoskeleton (actin, microtubules, intermediate filaments), and mechanosensitive ion channels (Piezo1/2)."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the YAP/TAZ pathway and its role in the development of desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While YAP/TAZ signaling is described and linked to proliferation and aggressiveness, the response does not connect YAP/TAZ activity to fibroblast activation or ECM deposition contributing to desmoplastic stroma development in PDAC."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions if there are FDA-approved therapies that target the cancer cells\u2019 ability to mechanosense.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Lists ROCK inhibitors, YAP/TAZ inhibitors, integrin antagonists (e.g., cilengitide), and ECM-modulating enzymes but does not state FDA approval status; examples provided are not FDA-approved for targeting mechanosensing in PDAC."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how cancer cells migrate in response to cues from mechanical forces in their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains durotaxis (migration toward stiffer regions), increased contractility via RhoA, invadopodia formation, ECM degradation, and effects of vascular shear stress on dissemination and extravasation."
      },
      {
        "criterion_number": 11,
        "description": "The response defines epithelial-mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions EMT and cadherin switch but does not provide a definition of EMT as the transition from epithelial to mesenchymal phenotype with loss of polarity and increased motility."
      },
      {
        "criterion_number": 12,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific journal articles are provided."
      }
    ],
    "question_number": 255,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:33:22.617758",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system, including nutrient and oxygen delivery and waste management.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not describe normal physiologic fluid dynamics (capillary filtration to interstitium to lymphatic return) or nutrient/waste handling; focuses on tumor abnormalities only."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how fluid flow becomes compromised in tumors, including increased intratumoral pressure due to abnormal blood vessels, poor lymphatic drainage, and dense stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains elevated IFP from desmoplastic stroma compressing vessels, aberrant/leaky angiogenesis, and restricted fluid drainage; addresses key mechanisms of compromised flow."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, specifically mentioning reduced drug delivery and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states reduced chemotherapy penetration and impaired immune cell/drug access due to high IFP and dense stroma."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that high IFP pushes drugs out and limits intratumoral levels, but does not address uneven/heterogeneous intratumoral distribution."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the impact of altered fluid flow on radiation therapy due to hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links elevated IFP to hypoxia and describes resultant radioresistance due to oxygen dependence of radiation-induced DNA damage."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions the impact of altered cellular biology and extracellular structures on cancer behavior, including tumor growth, metastasis, and resistance to therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions treatment resistance but does not address tumor growth or metastasis related to altered microenvironment; incomplete per criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that low perfusion/flow promotes further cancer growth/development."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages its development.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplastic stroma as dense, collagen-rich matrix produced by CAFs and notes pancreatic tumors are characterized by it."
      },
      {
        "criterion_number": 9,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines IFP as elevated pressure in tumor interstitium higher than normal tissues, acting as a barrier to diffusion."
      },
      {
        "criterion_number": 10,
        "description": "The response describes ways that increased pressure from interrupted fluid dynamics and desmoplastic stroma can cause compression on surrounding structures, leading to blockages and symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions vessel compression but does not link to specific surrounding structure compression, blockages, or related symptoms (e.g., biliary or duodenal obstruction)."
      },
      {
        "criterion_number": 11,
        "description": "The response provides specific published scientific journal articles as evidence of its claims, with proper citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to specific peer-reviewed studies are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that ongoing trials and emerging research are exploring microenvironment-targeting and delivery strategies."
      }
    ],
    "question_number": 256,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:34:08.263156",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends clear communication with the family regarding how everyone is dealing with the patient\u2019s cancer diagnosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicit guidance on family communication is provided, including centralized updates (group chat/shared document), individual check-ins, open conversations, and clarity on prognosis. These steps directly promote clear, compassionate communication among family members."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response advises attending appointments and asking questions alongside the patient to navigate medical decisions, which constitutes engaging and discussing concerns with the healthcare team."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While therapy and support groups are recommended and hospice is mentioned, there is no explicit recommendation to consult a social worker, chaplain/spiritual counselor, or palliative care specialist."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of self-care and healthy boundaries.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Dedicated sections on self-care for caregivers and the user\u2019s own well-being emphasize rest, breaks (respite care), healthy habits, and explicitly endorse setting and communicating boundaries."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system for patients with cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It encourages forming a 'family care team,' connecting with support groups, coordinating tasks, and fostering connection through shared moments\u2014clearly highlighting the role of a strong support network."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations that support cancer patients and their families and includes contact information or websites.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It cites PanCAN (https://www.pancan.org/) and the American Cancer Society (https://www.cancer.org/) with direct website links."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends support groups and points to PanCAN and ACS for counseling and peer support."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The 'Education & Resources' section urges sharing trusted information so family members understand the disease and what to expect, along with transparent updates about prognosis."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage that family members provide emotional support to each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It promotes open conversations, safe spaces to share feelings, individual check-ins, and family gatherings focused on connection, all encouraging mutual emotional support."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend pursuit of professional mental health counseling for family members of a patient with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly suggests grief or family counseling, offers help to find therapists, and recommends therapy for the user if overwhelmed."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend resources that patients and families of patients with pancreatic cancer can access for information about the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends sharing trusted information from medical journals and cancer organizations and specifically lists PanCAN and ACS, which provide disease information."
      },
      {
        "criterion_number": 12,
        "description": "The response should list sources and/or websites for support groups for patients with pancreatic cancer and their family members.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists PanCAN (https://www.pancan.org/) and ACS (https://www.cancer.org/), which host and connect to support groups for patients and families."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage family members to provide assistance and support to their loved ones affected by pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages practical assistance through task coordination (meals, childcare, transportation), forming a 'family care team,' providing respite for caregivers, and advocating during appointments."
      }
    ],
    "question_number": 257,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:34:52.552642",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines metastasis as the spread of cancer to distant tissues and walks through intuitive steps (invasion, entry to blood, survival in circulation, exit, colonization) with generally accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It covers direct invasion (ECM navigation), spread through blood (intravasation, survival in circulation, extravasation), and mentions lymphatic involvement (\u201cinvade lymphatic/vascular systems\u201d)."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mechanisms include cytoskeletal dynamics, Rho GTPase signaling, membrane fluidity, protease-mediated ECM degradation (MMPs), and phenotypic plasticity affecting motility modes."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it refers to mesenchymal-like and amoeboid states, it does not explicitly mention epithelial-to-mesenchymal transition (EMT)."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It discusses survival under shear stress and environmental cues but does not explicitly frame metastasis as a response to cellular stress."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Deformability is defined and linked to functional outcomes at each metastatic step, with mechanisms such as cytoskeletal remodeling and membrane fluidity."
      },
      {
        "criterion_number": 7,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes ECM as a network of proteins and fibers restricting movement and identifies the cytoskeleton (actin, microtubules) as a dynamic structure enabling shape change."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although integrins and endothelial barriers are mentioned, there is no clear explanation of adhesion processes (e.g., cell-cell or cell-ECM adhesion dynamics, cadherins/integrin function in attachment/detachment)."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states cancer cells are more deformable, have altered membrane fluidity and cytoskeletal organization, and notes evidence that pancreatic cancer cells show increased deformability versus normal cells."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links higher deformability to improved ECM invasion, intravasation, survival in circulation, extravasation, and colonization, detailing how shape change facilitates each step."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that deformable cells better withstand shear stress in circulation and mechanical stresses, whereas stiffer cells may fragment or undergo apoptosis."
      },
      {
        "criterion_number": 12,
        "description": "The response describes desmoplastic stroma in the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes PDAC\u2019s dense, stiff, fibrotic stroma consistent with desmoplasia, noting that it physically impedes invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states that in PDAC\u2019s stiff, fibrotic microenvironment, cells may rely on deformability to navigate and invade, including following tracks and local ECM degradation."
      }
    ],
    "question_number": 258,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:35:42.534704",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal physiological flow of fluid from blood vessels to the extracellular space and lymphatic system in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response identifies fluid compartments (blood, interstitial fluid, lymph) but does not explain the normal process of fluid leaving capillaries into the interstitial space and returning via lymphatics in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses changes to fluid flow in pancreatic cancer, such as increased intratumoral pressure, and how these changes differ from normal tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that PDAC has a dense desmoplastic stroma that impedes fluid flow, alters shear stress distribution, causes poor vascularization and hypoxia, and traps nutrients and drugs, contrasting with normal tissue."
      },
      {
        "criterion_number": 3,
        "description": "The response addresses how altered fluid flow impacts cancer treatment, including drug delivery and immune cell penetration into tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that stromal barriers and altered flow reduce drug penetration and contribute to treatment resistance, and that high shear may hinder immune cell adhesion and anti-tumor immunity."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential impacts of altered fluid flow on cancer behavior, including metastasis, proliferation, migration, and invasion.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes shear stress effects on EMT, migration, invasiveness, metastatic selection, activation of survival/proliferation pathways, and angiogenesis-related changes, covering the listed behaviors."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article as evidence for its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific journal citations are provided; only general references to organizations and topic areas."
      },
      {
        "criterion_number": 6,
        "description": "The response defines shear stress.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Shear stress is defined as the frictional force exerted by moving fluid on surfaces it contacts, which is accurate and clear."
      },
      {
        "criterion_number": 7,
        "description": "The response describes what sources of shear stress exist in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Sources listed include blood flow, interstitial fluid movement within tumors, and lymphatic drainage; also mentions endothelial shear and stromal effects."
      },
      {
        "criterion_number": 8,
        "description": "The response defines mechanobiology.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The term mechanobiology is not defined; while mechanical pathways are mentioned, no explicit definition of mechanobiology is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains that cancer cells can encounter shear stress forces in the tumor, in the bloodstream, and in lymph channels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions shear in blood, interstitial (tumor) fluid, and lymphatic drainage, and discusses circulating tumor cells under high shear."
      },
      {
        "criterion_number": 10,
        "description": "The response describes desmoplastic stroma and how this forms in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It describes desmoplastic stroma as dense and fibrotic in PDAC but does not explain how it forms (e.g., activation of stellate cells/fibroblasts, ECM deposition mechanisms)."
      },
      {
        "criterion_number": 11,
        "description": "The response explains the effect that the desmoplastic stroma has on fluid flow in and around a pancreatic cancer tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states the stroma impedes fluid flow, creates barriers, alters shear stress, and traps nutrients and drugs, directly addressing effects on fluid dynamics."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased shear stress encourages cancer cells to proliferate and metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links shear stress to activation of NF-\u03baB/MAPK/YAP-TAZ pathways promoting survival/proliferation and to EMT and metastatic selection, satisfying the criterion."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how shear stresses on cancer cells impact drug resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes shear stress can enhance drug resistance in vitro and promote survival signaling that contributes to treatment resistance and reduced drug penetration."
      }
    ],
    "question_number": 259,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:36:37.520332",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises working closely with the oncology team to understand diagnosis, stage, treatment options, and prognosis, including asking questions about survival rates and side effects."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages open dialogue about fears, hopes, and wishes; suggests using \u201cI feel\u201d statements and validating perspectives; promotes addressing prognosis together."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends professional counseling, spiritual/emotional support, and explicitly mentions palliative and hospice care as part of the care plan."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses advance care planning, preferences for treatment and end-of-life care, and emphasizes honoring the patient\u2019s wishes including potential decision to stop treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically suggests joining pancreatic cancer support groups (online or in-person) to share experiences and gain insights."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists organizations (Pancreatic Cancer Action Network, American Cancer Society, local hospice services) but does not provide URLs, phone numbers, or other contact information."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights mental health through counseling, mindfulness, avoiding toxic positivity, and caregiver self-care; addresses coping with grief, anxiety, and depression."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Normalizes emotional conflict with statements such as \u201cIt\u2019s okay to feel this way,\u201d and notes there\u2019s no \u201cright\u201d way to balance hope and realism."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses focusing on quality of life and comfort, managing pain, maintaining dignity, and mentions potential side effects of treatment as considerations affecting quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides online resources and communities including Pancreatic Cancer Action Network, American Cancer Society, CaringBridge, and Inspire."
      }
    ],
    "question_number": 260,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:37:15.699207",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mechanosensing is described using technical terms (integrins, FAK, ILK) without a clear lay explanation of how cells 'feel' forces."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cellular responses are framed in technical signaling language (Rho GTPases, YAP/TAZ, MMPs) rather than in accessible lay terms."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links ECM stiffness/desmoplasia and collagen alignment to invasion and metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects stiff microenvironment to therapy resistance (via YAP/TAZ) and discusses strategies that might improve therapy effectiveness by altering mechanics."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No references or citations to scientific journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response defines traction forces that exist in normal cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Traction forces are defined in the context of cancer cells; there is no explicit definition or discussion of traction forces in normal cells."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 3,
        "justification": "ECM is mentioned repeatedly but not explicitly defined (e.g., as the network of proteins and sugars outside cells)."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how traction forces are changed in cancer cells, as opposed to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that cancer cells generate stronger traction forces and alter cytoskeleton to navigate stiffness, contrasting with baseline conditions."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how increased traction forces from pancreatic cancer cells on their environment promote cancer cell proliferation and migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links higher forces to ECM deformation, collagen fiber alignment (migration) and to activation of YAP/TAZ driving proliferation."
      },
      {
        "criterion_number": 10,
        "description": "The response describes changes in the pancreatic cancer environment that are prompted by traction forces from the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes ECM remodeling, collagen alignment, CAF activation to deposit ECM, and pre-metastatic niche influences driven by forces."
      },
      {
        "criterion_number": 11,
        "description": "The response defines mechanotransduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains that forces transmitted via adhesion receptors activate intracellular signaling pathways, effectively defining mechanotransduction."
      },
      {
        "criterion_number": 12,
        "description": "The response defines desmoplastic stroma in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplastic reaction as a dense, collagen-rich, stiff stroma characteristic of pancreatic tumors."
      },
      {
        "criterion_number": 13,
        "description": "The response describes the effect of desmoplastic stroma on cancer cell\u2019s ability to metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiff, fibrotic stroma necessitates higher traction, aligns collagen to form tracks, and facilitates invasion/metastasis."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how traction forces in cancer cells contribute to drug resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Resistance is attributed to stiffness/YAP-TAZ, but the response does not clearly link cancer cell traction forces themselves to drug resistance."
      }
    ],
    "question_number": 261,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:37:57.717693",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response links ECM density/viscosity and stiffness to integrin signaling, MMP upregulation, invasion, and metastasis, directly relating tissue properties to cancer spread."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains how high ECM viscosity raises interstitial fluid pressure, impairs drug penetration, and contributes to treatment resistance, and discusses ECM-targeted strategies to improve efficacy."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions reduced blood flow and hypoxia as potential consequences of tissue thickness which may have effects on treatment effectiveness.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While hypoxia and disordered angiogenesis are discussed, the response does not explicitly mention reduced blood flow; the criterion requires mention of both reduced blood flow and hypoxia."
      },
      {
        "criterion_number": 4,
        "description": "Define viscosity and explain its role in normal cells, including the term \u201cviscosity\u201d and its function in cellular environments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Viscosity is defined as resistance to flow, but the response does not explain its role in normal cells or normal cellular environments."
      },
      {
        "criterion_number": 5,
        "description": "Describe changes in viscosity within the pancreatic cancer microenvironment, mentioning \u201cviscosity\u201d and specific alterations in cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly mentions increased ECM viscosity in PDAC due to hyaluronic acid and cross-linking, with resulting increased interstitial pressure and impaired diffusion."
      },
      {
        "criterion_number": 6,
        "description": "Define the tumor microenvironment, using the term \u201ctumor microenvironment\u201d and describing its components.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The term \u201ctumor microenvironment (TME)\u201d is used and components including ECM (collagen, fibronectin, hyaluronic acid), immune cells, and vasculature/angiogenesis are described."
      },
      {
        "criterion_number": 7,
        "description": "Define desmoplastic stroma and explain its formation in pancreatic cancer, using the term \u201cdesmoplastic stroma\u201d and describing its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "\u201cDesmoplastic stroma\u201d is named and described as dense fibrotic ECM, but its formation/development mechanisms in PDAC (e.g., stellate cell/CAF activation) are not explained."
      },
      {
        "criterion_number": 8,
        "description": "Describe the influence of desmoplasia on cancer cells, mentioning \u201cdesmoplasia\u201d and its effects on proliferation, migration, or invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although migration/invasion effects from ECM mechanics are discussed, the term \u201cdesmoplasia\u201d is not used in this context as required."
      },
      {
        "criterion_number": 9,
        "description": "Describe how desmoplasia limits oxygen delivery to tumor tissue, attributing reduced oxygen delivery specifically to \u201cdesmoplasia.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hypoxia due to thick ECM is described, but reduced oxygen delivery is not specifically attributed to \u201cdesmoplasia.\u201d"
      },
      {
        "criterion_number": 10,
        "description": "Explain how hypoxia affects cancer cell behavior, describing hypoxia\u2019s role in selecting aggressive, therapy-resistant cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states hypoxia triggers metabolic reprogramming (Warburg effect), promotes treatment resistance, and metastasis, indicating selection for aggressive, therapy-resistant cells."
      },
      {
        "criterion_number": 11,
        "description": "Describe how desmoplasia limits tumor access by the immune system, mentioning \u201cdesmoplasia\u201d and its impact on immune cell infiltration.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes that dense ECM blocks immune cell infiltration, but does not attribute this specifically to \u201cdesmoplasia.\u201d"
      },
      {
        "criterion_number": 12,
        "description": "Explain how desmoplasia causes drug resistance in pancreatic cancer, connecting \u201cdesmoplasia\u201d to reduced treatment efficacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Drug resistance is linked to ECM viscosity and pressure, but not explicitly connected to \u201cdesmoplasia.\u201d"
      },
      {
        "criterion_number": 13,
        "description": "Explain how desmoplastic stroma selects for aggressive tumor cell behavior, linking \u201cdesmoplastic stroma\u201d to increased migratory behavior.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Increased migration/invasion due to ECM mechanics is discussed, but not explicitly linked to \u201cdesmoplastic stroma.\u201d"
      },
      {
        "criterion_number": 14,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific journal articles are provided."
      }
    ],
    "question_number": 262,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:39:07.981666",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends working with social workers for financial/logistical support and suggests engaging religious figures/community leaders; this meets the criterion (though it does not mention palliative care specifically)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends respectful and open communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes empathy, active listening, avoiding assumptions, family meetings, and ongoing dialogue\u2014clear promotion of respectful, open communication."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions cultural mediators.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly suggests involving a cultural liaison to bridge gaps."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends that the patient and family members communicate their important cultural beliefs to their oncology team for better understanding.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises organizing meetings with the healthcare team and advocating for the team to learn the family\u2019s cultural context, including sharing resources\u2014prompting the family/patient to communicate their cultural beliefs."
      },
      {
        "criterion_number": 5,
        "description": "The response strongly recommends that a medical interpreter is present for all medical appointments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests involving an interpreter only if language is a barrier; it does not strongly recommend interpreter presence for all appointments."
      },
      {
        "criterion_number": 6,
        "description": "The response suggests that the patient request more time for their appointments, especially if a medical interpreter is needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to request longer appointments is made; \u201callow time\u201d is general and not specifically about scheduling or interpreter use."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests the patient and/or family inquire about services a patient advocacy office could provide.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of a patient advocacy office or inquiring about its services."
      },
      {
        "criterion_number": 8,
        "description": "The response encourages the patient to communicate their preferences around medical decision-making with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages the patient to express their wishes and describes joint discussions with the medical team about decision-making."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends online resources for both patients and medical teams to learn about particular cultural norms around medical care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions sharing resources and cultural sensitivity training, it does not recommend specific online resources or websites."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends medical teams to complete thorough documentation on patient preferences surrounding communication and medical decision-making.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises summarizing decisions in writing, including cultural considerations, which constitutes thorough documentation."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends organizations that support cancer patients and their families and includes contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends setting boundaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit mention of setting boundaries."
      }
    ],
    "question_number": 263,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:39:49.636310",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit discussion of stiffness appears throughout, including ECM/tissue stiffness and the dense, fibrotic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links stiffness/softness to invasion and metastasis (EMT, matrix remodeling, ability to squeeze through spaces) and explains how ECM stiffness activates pro-metastatic signaling."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States stiffer cells may resist chemotherapy, mentions tighter cell-ECM adhesions and gemcitabine resistance correlations, and explores stiffness-targeted therapies."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific journal citations or references are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines stiffness/softness conceptually, explains measurement methods (AFM, micropipette), and discusses how deformability affects movement through confined spaces."
      },
      {
        "criterion_number": 6,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cytoskeleton is defined (actin, myosin; structure/movement). ECM is identified as the surrounding matrix influencing cells and stiffness, satisfying concise definitions."
      },
      {
        "criterion_number": 7,
        "description": "The response explains cell adhesion processes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes loss of adhesion during EMT and mentions cell-ECM adhesions affecting therapy resistance, providing a qualitative explanation of adhesion changes."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States many cancer cells (including PDAC) may become stiffer and notes some cancers may be softer, describing changes relative to noncancer states."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that softer, more deformable cells can squeeze through narrow spaces (e.g., vasculature) aiding dissemination."
      },
      {
        "criterion_number": 10,
        "description": "The response explains ways that cancer cells migrate from the primary tumor, including hematologic and lymphatic spread, perineural invasion, and direct invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions invasion and metastasis in general but does not explicitly describe hematologic, lymphatic, or perineural routes."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes stiffer cells withstanding mechanical stress and softer cells squeezing through spaces, but does not explicitly link increased deformability to survival under stresses that normal cells cannot endure."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions desmoplastic stroma and stiffness but does not explicitly state that increased deformability is required for navigation through this matrix."
      }
    ],
    "question_number": 264,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:40:49.070870",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how physical space restriction affects cancer cells, mentioning at least two effects such as \u201cenhanced migration,\u201d \u201cnuclear deformation,\u201d or \u201cadaptation.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response details multiple effects of confinement, including enhanced invasion/metastasis, quiescence, drug resistance, metabolic flexibility, and cytoskeletal changes. This exceeds the requirement of at least two effects."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how confinement enhances migration and invasion, using terms like \u201camoeboid migration,\u201d \u201cincreased speed,\u201d or \u201cmetastasis.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly links confinement and stiffness to EMT, increased motility, invasion, and metastasis, and notes that inner hypoxic cells become more invasive. While it does not use \u2018amoeboid\u2019 or \u2018increased speed,\u2019 it clearly addresses invasion/metastasis mechanisms."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how confinement can promote genetic mutations, mentioning \u201cnuclear deformation,\u201d \u201cDNA damage,\u201d or \u201cgenomic instability.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of nuclear deformation, DNA damage, or genomic instability; thus it does not address confinement-driven mutational mechanisms."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how confinement enhances cancer cells\u2019 ability to survive and adapt to stress, using terms like \u201cupregulate survival signals,\u201d \u201cresistant to therapies,\u201d or \u201cmechanical stress.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses mechanical stress, therapy resistance due to limited drug penetration, survival of persister cells, quiescence, and metabolic flexibility, satisfying the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mechanotransduction and YAP/TAZ are mentioned but with technical jargon and no lay analogy or simple explanation."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Responses to stress (EMT, invasion, stem-like traits) are described in technical terms without lay analogies or plain-language examples."
      },
      {
        "criterion_number": 7,
        "description": "The response provides at least one specific citation from a published scientific journal article as evidence for its statements.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to specific journal articles are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly relates tissue properties to their potential effect on cancer spread, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly connects stiff, collagen-rich desmoplastic stroma to increased invasion/EMT and metastasis, meeting the requirement."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that dense stroma and confinement limit drug penetration, promote persister cells, and reduce systemic therapy efficacy, providing specific mechanisms."
      },
      {
        "criterion_number": 10,
        "description": "The response defines confinement in the context of cancer cells, using terms like \u201cphysical restriction,\u201d \u201ctumor microenvironment,\u201d or \u201cnarrow spaces.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines confinement as physical space restriction and gives concrete examples (dense tumor regions, spheroids), satisfying the criterion."
      },
      {
        "criterion_number": 11,
        "description": "The response defines desmoplastic stroma in pancreatic cancer, using terms like \u201cdense,\u201d \u201cfibrous,\u201d \u201cscar-like tissue,\u201d or \u201cstiff extracellular matrix,\u201d and describes its formation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it describes desmoplastic stroma as dense, collagen-rich, and stiff, it does not explain its formation (e.g., activation of stellate cells/fibroblasts depositing ECM) explicitly."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly connects desmoplastic stroma to the confinement of cancer cells, explaining how it creates physical restriction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that desmoplastic stroma physically confines cancer cells within a stiff, collagen-rich matrix."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions the role of hypoxia in pancreatic cancer and describes why pancreatic tumors are in a hypoxic environment, using terms like \u201clow-oxygen\u201d or \u201cdense stroma.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "It discusses hypoxia due to diffusion limits in confined spaces and notes that PDAC\u2019s dense stroma creates hypoxic, nutrient-poor microenvironments, activating HIF-1\u03b1."
      },
      {
        "criterion_number": 14,
        "description": "The response states that understanding confinement is an area of active scientific research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly notes that research is ongoing, fulfilling the criterion."
      }
    ],
    "question_number": 265,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:41:25.796645",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends flexibility in plans and modifications to allow the father to participate in family traditions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly emphasizes flexibility and offers concrete adaptations (shortened events, virtual connections, simplifying roles, modifying activities) to facilitate participation despite limitations."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends professional help via family counseling and consulting the healthcare team, which satisfies the counselor criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Highlights leaning on community/resources, support networks, and support groups, underscoring the value of strong support."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions the American Cancer Society and provides its website (https://www.cancer.org)."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Begins with 'Prioritize Open Communication and Planning,' suggests family meetings, and encourages validating feelings and open conversations."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly recommends support groups (including ACS-related) and connecting with online/local cancer support groups."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient prioritize management of cancer or cancer-treatment related side effects to feel as \u201cnormal\u201d as possible to be present for himself and his family.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it suggests scheduling around energy levels and consulting the care team, it does not explicitly recommend proactive management of treatment-related side effects (e.g., pain, nausea, appetite, fatigue) to optimize functioning."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the family members consider documentation of the family traditional events with their father, as a way to reminisce and honor his presence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends recording stories, creating a memory book, and taking photos/videos to document traditions."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the family members to be thoughtful about ways their father can feel included in family events.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides multiple inclusion strategies (symbolic gestures, adapted roles, planning involvement, choosing activities)."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the family seek their father\u2019s input on what meaningful events and activities he desires to participate in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing values/preferences, asking which traditions matter most, and including him in planning and selection of activities."
      }
    ],
    "question_number": 266,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:41:54.264147",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, using accessible language and avoiding jargon, including the concept of cancer cells moving from the primary tumor to other parts of the body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible language to describe metastasis, movement to other tissues, extravasation, and invasion; clearly conveys cells moving from the primary tumor to new sites."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, explicitly mentioning direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions direct invasion (invade nearby tissues), lymphatic spread (movement in lymph), and hematogenous spread (bloodstream challenges, extravasation)."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads in the body, such as amoeboid, mesenchymal, or collective migration, enzyme production, or environmental signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers amoeboid and mesenchymal motility, MMP-mediated ECM degradation, and chemotaxis (environmental signals)."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned by name."
      },
      {
        "criterion_number": 5,
        "description": "The response clarifies that cancer cells do not swim, explicitly stating they lack the cellular machinery (e.g., flagella or cilia) to do so.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that cancer cells lack flagella/cilia or explicitly say they do not swim."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways cancer cells migrate, including in solid tissues and through a fluid-filled environment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes crawling/ECM degradation in tissues and movement/adhesion/chemotaxis in blood and lymph."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain hematologic spread and lymphatic metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains bloodstream transit, shear stress, platelet cloaking, extravasation, and movement in lymph/interstitial fluid."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain amoeboid motility that some cancer cells can perform to actively travel through fluid.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines amoeboid movement with pseudopodia and notes its use in blood/lymph."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain membrane fluctuations and how some cancer cells can do this to actively travel through fluid.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention membrane fluctuations (e.g., blebbing/ruffling) as a mode for movement in fluid."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain chemical gradients and provide examples, and should define chemotaxis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines chemotaxis and gives examples of gradients (growth factors, oxygen)."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe passive movements of cancer cells in fluid-filled environments.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes flowing with current, clustering with platelets/RBCs, and hitchhiking on immune cells."
      },
      {
        "criterion_number": 12,
        "description": "The response should provide links to the scientific literature that discusses ways cancer cells can move through fluid substances, with PMIDs if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations, links, or PMIDs are provided."
      },
      {
        "criterion_number": 13,
        "description": "The response should define desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned or defined."
      },
      {
        "criterion_number": 14,
        "description": "The response should summarize ways pancreatic cancer cells migrate in their solid tissue environment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No pancreas-specific summary of migration in the tumor microenvironment is provided."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the most common way that pancreatic cancer cells are thought to spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state which pathway is most common for pancreatic cancer spread."
      }
    ],
    "question_number": 267,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:42:22.411808",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines surface tension.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit definition provided: 'Surface tension is the energy required to increase the surface area of a liquid interface,' with cellular context (lipid bilayer and proteins)."
      },
      {
        "criterion_number": 2,
        "description": "The response defines interfacial forces.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The term 'interfacial forces' is used and exemplified (e.g., cell-ECM interface) but not explicitly defined."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the influence of surface tension on pancreatic cancer cells, specifically mentioning cell detachment, migration, or tumor spheroid formation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links surface tension to detachment ('reduced tension might weaken adhesion, allowing cells to detach and spread'), invasion/migration, and spheroid formation; also references PDAC-specific context."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of interfacial forces during cancer cell metastasis, specifically mentioning cell detachment, migration, or invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes interfacial effects on cell-ECM adhesion, invadopodia-mediated ECM degradation, detachment, and invasion/migration during metastasis."
      },
      {
        "criterion_number": 5,
        "description": "The response states interfacial tissue planes typically serve as barriers for cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention that tissue planes (e.g., fascial/serosal planes) serve as barriers to spread."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No clear lay explanation of metastasis; language remains technical and does not plainly describe the process in simple terms."
      },
      {
        "criterion_number": 7,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions direct invasion ('penetration through ECM barriers'), and travel via lymphatic or blood vessels; also discusses shear stress in blood vessels."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mechanisms include invadopodia, ECM degradation, EMT, cadherin downregulation, adhesion dynamics, and mechanosensing."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "EMT is explicitly mentioned with E-cadherin downregulation."
      },
      {
        "criterion_number": 10,
        "description": "The response describes cell-to-cell adhesion, specifically in the context of tumor spheroid formation and the balance with surface tension.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses cell-cell adhesion via cadherins and separately explains spheroid compactness versus looseness as a function of surface tension, implying the adhesion\u2013tension balance."
      },
      {
        "criterion_number": 11,
        "description": "The response describes at least two mechanical cues in the tumor microenvironment, such as stiffness or surface tension, and how cancer cells sense these signals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies surface tension and fluid shear stress as cues and notes cellular mechanosensing."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions desmoplastic stroma and its relevance to pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References 'dense pancreatic stroma' but does not use or explain the term 'desmoplastic stroma.'"
      },
      {
        "criterion_number": 13,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ECM is referenced multiple times but not defined."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how normal cells and cancer cells interact with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes cancer cell interactions (adhesion changes, invadopodia, ECM degradation) but does not contrast with normal cell-ECM interactions."
      }
    ],
    "question_number": 268,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:43:07.576057",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing uncertainty or care planning with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises working with the healthcare team and asking about treatment options and outcomes, but it does not explicitly mention discussing uncertainty or care planning with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends seeing a therapist or counselor specializing in chronic illness or grief. Although palliative care and social work are not mentioned, counselor is included."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends support groups and provides examples of organizations offering forums and local groups."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends open conversations about what is most important now, hopes and fears, advance directives, and planning\u2014core elements of establishing goals of care."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly encourages open communication, including talking about fears, hopes, and how to support each other."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names the Pancreatic Cancer Action Network and the American Cancer Society."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize the challenge of living with long-term uncertainty.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It validates feelings, emphasizes that it\u2019s normal to have good and bad days, and states 'You\u2019re not alone.'"
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend attempting to preserve normal routines in the home as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends establishing small, manageable daily routines such as morning walks and shared meals."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of quality of life when facing a serious diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes meaningful moments, joy, mindfulness, and celebrating small victories, which collectively center quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest ways to maintain good quality of life for patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests mindfulness, grounding, gentle exercise, rest, shared activities, and creating meaningful moments."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients and family members learn about the disease to understand expected outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking about treatment options, potential outcomes, what to expect, and staying informed with boundaries."
      }
    ],
    "question_number": 269,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:43:31.745816",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly describes how cells detach, enter blood vessels (intravasation), and spread to distant organs, using accessible language and analogies."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions local invasion and spread through blood (intravasation) but does not mention lymphatic spread."
      },
      {
        "criterion_number": 3,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It uses lay descriptions (integrins as hooks, focal adhesions as traction points) to explain cell-ECM adhesion effectively."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Integrins are mentioned repeatedly, but cadherins are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response contrasts the biology of cancer cell adhesion with normal cell adhesion using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit comparison to normal cell adhesion is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No references or citations are included."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It discusses ECM density and alignment in pancreatic cancer but does not describe specific adhesion changes (e.g., integrin switching or cadherin loss) in pancreatic cancer cells."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe cell-to-cell adhesion and include definitions of integrins, collagen, and fibronectin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not describe cell-to-cell adhesion and does not define collagen or fibronectin; only integrins are described."
      },
      {
        "criterion_number": 9,
        "description": "The response should define extracellular matrix.",
        "score_given": 0,
        "max_points": 7,
        "justification": "ECM is discussed but not explicitly defined in lay terms."
      },
      {
        "criterion_number": 10,
        "description": "The response should define actin and myosin, and describe how these proteins act to deform cells to assist in traction and movement.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Actin is described functionally, but myosin is not mentioned; no full explanation of actin\u2013myosin-based contraction is provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should define chemotaxis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes cells following chemical gradients acting like a compass, which constitutes a lay definition of chemotaxis."
      },
      {
        "criterion_number": 12,
        "description": "The response should define amoeboid migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains amoeboid movement as squeezing through gaps with low adhesion in softer matrices, which is an accurate lay definition."
      },
      {
        "criterion_number": 13,
        "description": "The response should define desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains desmoplasia creating a dense, collagen-rich, fibrous environment in pancreatic cancer, effectively describing desmoplastic stroma."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how pancreatic cancer forms desmoplastic stroma in its environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While desmoplasia is named, the mechanism (e.g., activation of stellate cells/fibroblasts by tumor-derived signals) is not described."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It details how cells grip aligned collagen tracks via integrins and use proteases to remodel the ECM, directly addressing interactions."
      },
      {
        "criterion_number": 16,
        "description": "The response should define tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions components (fibroblasts, immune cells) but does not provide a clear definition of the tumor microenvironment."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes fibroblast-produced ECM, immune-cell signals promoting motility, and hypoxia-induced pathways enhancing migration."
      },
      {
        "criterion_number": 18,
        "description": "The response should describe the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of genetic drivers (e.g., KRAS) or their impact on invasiveness/migration."
      }
    ],
    "question_number": 270,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:44:25.834160",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how normal tissue structure is disrupted in solid cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains disruption of basement membrane, loss of epithelial polarity, ECM remodeling, and stromal desmoplasia leading to altered tissue architecture and invasion."
      },
      {
        "criterion_number": 2,
        "description": "The response describes that cancer cells proliferate in an unchecked fashion, disrupting the architecture of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states that disruption of polarity leads to uncontrolled proliferation and notes invasion into surrounding stroma, indicating unchecked growth disrupting architecture."
      },
      {
        "criterion_number": 3,
        "description": "The response defines geometry in biology and medicine, and with regards to human cells and their surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It frames geometry as shapes, spatial organization, and mechanical properties (tumor shape, ECM stiffness, collagen fiber orientation, vascular patterns) influencing cell behavior and tissue context."
      },
      {
        "criterion_number": 4,
        "description": "The response describes that normal cells exist in a neat, orderly, and structured space within their respective tissues.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes normal pancreatic acinar cell polarity and ductal epithelial organization, implying orderly, structured tissue architecture that cancer disrupts."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the components of normal tissue architecture, such as collagen and extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses extracellular matrix, collagen-rich stroma, collagen fiber orientation, and basement membrane integrity as key components of tissue architecture."
      },
      {
        "criterion_number": 6,
        "description": "The response describes desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Desmoplasia is repeatedly emphasized as a dense, fibrotic, collagen-rich stromal response characteristic of pancreatic cancer, with functional implications."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect of desmoplastic stroma on pancreatic cell proclivity to migrate and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links ECM stiffness and collagen alignment to guided migration and invasion, and notes stroma-driven mechanobiology (including EMT) that enhances invasiveness."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the role of blood vessels in drug delivery, and how this can be impacted by pancreatic tumors and desmoplastic stroma.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While abnormal vasculature and hypoxia are discussed and vessel normalization is mentioned, the response does not explicitly connect blood vessels to systemic drug delivery or how desmoplastic stroma impairs drug delivery."
      },
      {
        "criterion_number": 9,
        "description": "The response clearly explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing accessible explanations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Metastasis is referenced with significant jargon (e.g., sinusoidal architecture, niches) and without a simple, accessible explanation for a lay audience."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions all three main routes of cancer spread: direct invasion, lymphatic spread, and hematogenous spread.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Direct invasion and entry into the bloodstream are implied/mentioned, but lymphatic spread is not explicitly discussed, so all three routes are not covered."
      },
      {
        "criterion_number": 11,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads, such as changes in cell shape, loss of adhesion, or influence of the microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It covers loss of polarity, reduced cell\u2013cell adhesion (E-cadherin downregulation), basement membrane degradation (MMPs), ECM stiffness/alignment cues, and EMT\u2014well over two mechanisms."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name or describes the process.",
        "score_given": 5,
        "max_points": 5,
        "justification": "EMT is explicitly named and linked to increased invasiveness in response to mechanical forces and stromal stiffness."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions cancer metastasis as a response to cell stress, including stress-induced mechanisms.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It associates hypoxia (a cellular stress) due to poor vasculature with aggressive behavior and metastasis, satisfying the stress-induced mechanism criterion."
      }
    ],
    "question_number": 271,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:45:06.791651",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends respectful and honest communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides clear, respectful communication strategies and sample scripts that are honest and compassionate."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends maintaining personal boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses setting and reinforcing boundaries, limiting details, and assigning a spokesperson to control information flow."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages participation in cancer support groups for the patient and caregiver support groups for family."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions the American Cancer Society and other tools but does not provide any contact information or website links."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Stresses defining a core support network, leveraging community resources, and caregiver well-being, underscoring the value of support."
      },
      {
        "criterion_number": 6,
        "description": "The response should inform the patient and family members that medical records are subject to HIPAA laws, which prevent divulgence of medical information unless a patient has specifically consented to this.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of HIPAA or legal protections of medical records and disclosure rules."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient inform their oncology care team of their wishes to keep their diagnosis confidential.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises creating a brief statement for medical staff outlining how information should be handled, which instructs informing the care team of confidentiality preferences."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient and family members be careful and thoughtful with social media posting to maintain her confidentiality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly recommends avoiding public platforms, using strict privacy settings, and limiting details in posts."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient and/or family members seek a balance; it is OK to be selective with sharing her diagnostic information however isolation for patients and/or caregivers can accelerate burnout.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages selectivity and support utilization but does not explicitly warn that isolation can accelerate burnout."
      }
    ],
    "question_number": 272,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:45:32.929462",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing context for a lay audience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible language and analogies (e.g., squeezing through gaps, toothpaste tube) to explain concepts like cytoskeletal changes, ECM breakdown, and guidance cues; overall clear for lay readers."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly mentions and explains the three main routes of cancer spread: direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention lymphatic or blood-borne spread or explicitly outline the three routes; focuses on local movement through tight spaces."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least three cellular mechanisms by which cancer spreads, such as changes in cell shape, breakdown of the extracellular matrix, increased deformability, use of filopodia/invadopodia, or epithelial-to-mesenchymal transition (EMT).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions changes in cell shape via cytoskeleton, ECM breakdown by MMPs, nuclear deformability, adhesion changes, mechanical forces, chemotaxis, and EMT\u2014well over three mechanisms."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial-to-mesenchymal transition (EMT) and explains its relevance to cancer cell migration and invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit EMT section explains loss of epithelial traits, gain of motility/invasiveness, and enhanced ability to squeeze through barriers."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of metastasis being triggered by cellular stress or microenvironmental stressors."
      },
      {
        "criterion_number": 6,
        "description": "The response should define the extracellular matrix.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines ECM in context as the dense tumor environment composed of collagen and proteins and explains that cells degrade it to move."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the different components of the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only collagen is specifically named; other key ECM components (e.g., laminin, fibronectin, proteoglycans, hyaluronan) are not described."
      },
      {
        "criterion_number": 8,
        "description": "The response should define desmoplastic stroma and describe how this is formed in the pancreatic cancer environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions dense, fibrotic stroma but does not define 'desmoplastic stroma' or explain formation mechanisms (e.g., activated stellate cells, fibroblasts, fibrosis)."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how cancer cells are able to deform their shapes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains cytoskeletal rearrangement with actin and myosin, mechanical force generation, and nuclear deformation enabling squeezing."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain the cellular cytoskeleton and its main component parts, such as actin and myosin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes cytoskeleton as a network including actin filaments and myosin, and their roles in protrusion and contraction."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe amoeboid movement in cells and include a description of filopodia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention amoeboid movement or filopodia/invadopodia specifically."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe mesenchymal movement in cancer cells and provide examples of enzymes used by cancer cells in this phenomenon.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links EMT to a mesenchymal, mobile state and discusses MMP-mediated ECM degradation, which exemplifies mesenchymal-mode invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response should provide links to any scientific literature it references, including PMID.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or PMIDs provided."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain how cells can use ion gradients to prompt movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Ion gradients or ion channels/pumps in motility are not discussed."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the importance of pancreatic cancer cells\u2019 ability to deform or \u201csqueeze\u201d in the desmoplastic stromal environment for survival and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States pancreatic tumors have dense fibrotic stroma and that cells rely on deformation and ECM degradation to move through it, implying importance for invasion/spread."
      },
      {
        "criterion_number": 16,
        "description": "The response should include information about how the nucleus is thought to be deformable in cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses nuclear deformation, lamin alterations, and increased nuclear flexibility during migration."
      }
    ],
    "question_number": 273,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:46:09.336443",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines topology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response frames topology as the structural and connectivity properties of tissues (ECM fiber orientation, pore size; vascular/lymphatic network connectivity), effectively defining the term in context."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers direct invasion via basement membrane degradation, hematogenous spread via leaky, aberrant vasculature, and lymphatic spread to regional nodes."
      },
      {
        "criterion_number": 3,
        "description": "The response states that in cancer care, topology may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit links are made between topology and the organization/architecture of ECM, vasculature, and lymphatic networks."
      },
      {
        "criterion_number": 4,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses therapeutic implications (e.g., vascular normalization), it does not state that anatomic organization affects cancer stage or likelihood to respond to surgery or radiation."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It uses accessible concepts (e.g., tunnels/corridors, barrier vs highway, leaky vessels as entry points) to explain how cells move and spread, meeting a lay explanation threshold."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms mentioned include MMP-mediated basement membrane degradation, invadopodia-like pathways, integrin-mediated mechanosensing, cytoskeletal changes, and angiogenesis."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe tissue networks and their component parts.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes ECM networks, vascular and lymphatic networks, and cellular components (cancer cells, fibroblasts, immune cells) within the tumor microenvironment."
      },
      {
        "criterion_number": 8,
        "description": "The response should define the extracellular matrix and describe its component parts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ECM is described as dense and collagen-rich and mentions the basement membrane, but it lacks a clear definition and does not describe key components (e.g., proteoglycans, glycoproteins like fibronectin/laminin) comprehensively."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the desmoplastic stroma that pancreatic cancer encourages to grow in its environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes PDAC\u2019s hallmark dense, collagen-rich desmoplastic stroma and its effects on rigidity and invasion."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how abnormal tissue, such as desmoplastic stroma, increases in density of tissue network structures and encourages cancer growth and spread.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explains that dense, stiff stroma can create corridors, channel migration, exclude immune cells, and interact with proteolytic activity to promote invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the roles of blood and lymph vessels in cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details aberrant, leaky angiogenesis facilitating intravasation and lymphatic network connectivity driving nodal spread."
      },
      {
        "criterion_number": 12,
        "description": "The response should explain how disrupted tissue architecture can encourage cancer growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses basement membrane disruption, chaotic vasculature, ECM discontinuities, and immune exclusion as architectural changes that favor spread."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe cell-to-cell adhesions in normal cells, and how cancer cells can disrupt these adhesions making them more able to migrate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Cell\u2013cell adhesion (e.g., E-cadherin) and its disruption are not described; focus is on cell\u2013ECM interactions and mechanosensing."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how mechanical properties of tissue can stimulate tumor growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains stiffness gradients, rigidity of desmoplastic stroma, and mechanotransduction via integrins guiding invasion and suggests stiffness-targeting therapies."
      }
    ],
    "question_number": 274,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:46:47.164187",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references 'doctors' and 'medical professionals' in general but does not explicitly recommend discussing communication or planning with the patient's oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests consulting pediatric psychologists and grief counselors, which meets the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends honest and open communication between patient and caregivers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it emphasizes honest communication with children and aligning messaging between partners, it does not specifically recommend open communication between the patient and caregivers."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends tailoring the discussion to the age of the children.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides clear age-based guidance (younger children vs. preteens/teens) with examples and strategies."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends connecting with support groups and cancer support networks."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it mentions the American Cancer Society and the Child Mind Institute, it does not include contact information or website links."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing contingency plans and end-of-life care with medical professionals, which aligns with establishing goals of care."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It strongly emphasizes mental health: normalizing emotions, monitoring behavior, consulting counselors, and encouraging caregiver self-care."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it normalizes emotions generally, it does not explicitly state that feeling conflicted between optimism and honesty is normal in the context of pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not define quality of life or discuss treatment-related factors (e.g., side effects, symptom burden) that impact it."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient and/or family members leverage support systems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages leaning on support networks, using support groups, and seeking professional resources, fulfilling the criterion."
      }
    ],
    "question_number": 275,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:47:26.711180",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes metastatic routes for pancreatic cancer, including local solid tissue invasion, hematologic spread, lymphatic spread, or perineural invasion.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response focuses on collective migration mechanics and the tumor microenvironment but does not describe specific metastatic routes (local invasion, hematogenous, lymphatic, or perineural spread)."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses cell-to-cell adhesions in both normal cells and cancer cells, highlighting differences.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While cadherins and junctions are discussed and changes in cancer (e.g., E-cadherin loss, N-cadherin upregulation) are mentioned, there is no explicit discussion contrasting normal cell adhesion with cancer cell adhesion."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Integrins and cadherins are explicitly named and discussed in the context of adhesion and migration."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The explanation is technical (e.g., Rho GTPases, MMPs, chemotaxis) and does not provide a clear, lay explanation of metastasis."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mechanisms such as leader-follower dynamics, cytoskeletal polarization, integrin-mediated adhesion, MMPs, actomyosin contraction, and microenvironmental signaling are well described."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Partial EMT is explicitly mentioned and contextualized within collective migration."
      },
      {
        "criterion_number": 7,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Adhesion biology is discussed using technical terminology without simplification suitable for lay readers."
      },
      {
        "criterion_number": 8,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific literature are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains the concept of \u201cleader cells\u201d and implies the presence of \u201cfollower cells\u201d in a group of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Leader-follower dynamics are clearly described, including functional roles of leaders and followers."
      },
      {
        "criterion_number": 10,
        "description": "The response describes amoeboid movement in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid movement is not mentioned or described."
      },
      {
        "criterion_number": 11,
        "description": "The response describes mesenchymal migration in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although mesenchymal traits and EMT are mentioned, mesenchymal migration as a distinct mode (elongated, protease-dependent, integrin-based single-cell migration) is not explicitly described."
      },
      {
        "criterion_number": 12,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 3,
        "justification": "ECM components and interactions are discussed, but a clear definition of the ECM is not provided."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Desmoplastic stroma is characterized as dense, stiff, and fibrotic in PDAC, which amounts to a functional definition."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how pancreatic cancer cells interact with desmoplastic stroma to encourage cancer cell growth and migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains that stiffer ECM in PDAC promotes collective migration and that stromal cells secrete factors guiding movement, indicating pro-migratory interactions."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how \u201cleader cells\u201d influence a clump of traveling cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Leader cells are described as sensing the ECM, forming protrusions, and guiding direction, with followers maintaining adhesion and traction, demonstrating influence on group movement."
      },
      {
        "criterion_number": 16,
        "description": "The response defines at least one other protein involved in cell-to-cell adhesions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Tight junctions and gap junctions are mentioned; gap junctions are defined as cytoplasmic channels enabling ionic and molecular signaling."
      },
      {
        "criterion_number": 17,
        "description": "The response describes how cells communicate with each other, such as through chemical signals or enzymes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cell-cell communication is addressed via gap junctions, autocrine/paracrine signaling, and chemokine/growth factor gradients."
      }
    ],
    "question_number": 276,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:48:06.490736",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines curvature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Curvature is referenced (concave/convex geometries), but no explicit definition of curvature as a measure of surface bending or deviation from flatness is provided."
      },
      {
        "criterion_number": 2,
        "description": "The response states that in cancer care, curvature may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response links curvature to anatomical structures including pancreatic ducts, blood vessels, and lymphatics, and discusses how these geometries influence tumor behavior."
      },
      {
        "criterion_number": 3,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While treatment resistance and drug penetration are mentioned, there is no explicit connection to cancer staging or specific responsiveness to surgery or radiation."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Metastasis is discussed with technical terms (e.g., extravasation, collective migration) without a plain-language explanation such as 'spread of cancer to other parts of the body.'"
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Direct invasion into nearby organs is mentioned, as are interactions with and movement through blood vessels and lymphatics, including extravasation."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms such as mechanotransduction via integrins, invadopodia formation, EMT, and signaling pathways (YAP/TAZ) are discussed in the context of invasion and spread."
      },
      {
        "criterion_number": 7,
        "description": "The response should define the extracellular matrix.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The ECM is referenced and its interactions are discussed, but it is not defined (e.g., as the network of proteins and polysaccharides surrounding cells)."
      },
      {
        "criterion_number": 8,
        "description": "The response should define epithelial-to-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is named and the acronym expanded, but no explanatory definition is provided (e.g., loss of epithelial traits and gain of mesenchymal migratory/invasive properties)."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response describes how cells migrate differently on curved surfaces, including directional migration and switching between collective and single-cell modes."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe the effect of mechanical forces on cell signaling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanotransduction via integrins and downstream signaling including YAP/TAZ activation and effects on proliferation/survival are clearly described."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe how varying levels of positive or negative curvature at the cellular level influence EMT and cancer cell migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Concave curvature effects are mentioned (promoting invadopodia/invasion and increased EMT), but there is no description contrasting positive vs. negative curvature or varying levels."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe the effect of mechanical forces of tissues on cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Tissue-level mechanical context is discussed (dense stroma, hypoxia, drug penetration, immune cell infiltration), linking these mechanical properties to cancer cell behavior."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes fibroblast-driven ECM (collagen) production and dense tumor microenvironment in PDAC, which are characteristic of desmoplastic stroma."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that cellular curvature acts as both a signal and constraint in cancer cell progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Curvature as a signaling cue is discussed, but it is not explicitly described as a constraint on cancer cell progression."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe cancer cell membrane tension, and what occurs when this force is too high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Membrane and cytoskeletal forces are mentioned generally, but membrane tension and consequences of excessively high tension are not described."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe how high cell surface membrane tension, such as from curvature, can hinder movement of the cytoskeleton.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no explicit explanation that high membrane tension can impede cytoskeletal protrusions or remodeling, limiting cell movement."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe the effects of mechanical tension at the level of tissue and organs, particularly if imbalanced, on the spread of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While tissue-level features are discussed, the specific role of mechanical tension imbalance at tissue/organ scales on pancreatic cancer spread is not described."
      },
      {
        "criterion_number": 18,
        "description": "The response should define paracrine signaling and explain its role in pancreatic cancer cell communication.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Paracrine signaling is not defined or discussed."
      }
    ],
    "question_number": 277,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:49:15.810540",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing plans for celebrations with the patient\u2019s healthcare or oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not suggest consulting the healthcare or oncology team about planning or timing celebrations."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends seeking professional support from a therapist (counselor)."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises using a support group to navigate emotional complexities."
      },
      {
        "criterion_number": 4,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations, contact information, or websites are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It focuses on comfort, meaningful low-pressure moments, rest, and respecting limits, underscoring quality of life."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights leaning on support systems, delegating tasks, and seeking professional support."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of controlling symptoms related to pancreatic cancer or its treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions fatigue and comfort, it does not address symptom control strategies (e.g., pain, nausea) or coordinating with clinicians."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that caregivers take measures to prevent burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises caregiver self-care, taking breaks, and seeking support to prevent burnout."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that loved ones plan small, meaningful gatherings with the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends small, intimate gatherings and simple activities."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of flexibility when planning events with a patient with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes adaptability, backup plans, and keeping celebrations short and low-key."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that planners of celebrations consider incorporating time for rest and keep gatherings small and simple.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises rest-friendly environments, avoiding overstimulation, short visits, and small/simple gatherings."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that a professional therapist or counselor can help maintain mental health in patients experiencing pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends seeing a therapist to help navigate emotional complexities."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that patients and/or family members take care of any legal and/or medical paperwork as soon as possible.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of legal or medical paperwork (e.g., advance directives, power of attorney)."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain that there will likely be a decline in overall health of the patient over time, and expectation management should be discussed by the patient and their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss expected health decline or recommend discussing expectations with the oncology team."
      }
    ],
    "question_number": 278,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:49:46.243279",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response clearly explains how changes in tissue density and architecture (cell jamming) influence cancer cell movement, tumor aggressiveness, and metastasis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains dense/stiff ECM and crowded stroma restricting movement and altering motility; links microenvironment to aggressiveness and notes effects on metastasis (barrier vs adaptation)."
      },
      {
        "criterion_number": 2,
        "description": "The response defines and explains cancer cell jamming.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly define 'cell jamming' as a collective solid-like, density-driven state or phase transition; uses general 'crowded conditions' without a formal jamming definition."
      },
      {
        "criterion_number": 3,
        "description": "The response defines and describes cancer cells that are in an unjammed state.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit description of an 'unjammed' state (fluid-like, higher cell rearrangements); terms and definition are absent."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how cancer cells become unjammed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions adaptation (phenotypic switching, MMPs, collective invasion) but does not frame these as mechanisms of unjamming or describe an unjamming transition."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the intrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses intrinsic factors: adhesion molecules (E-/N-cadherin), integrin/Rho-ROCK signaling, cytoskeletal mechanics, protease (MMP) activity, and phenotypic switching."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers ECM density, stiffness, desmoplasia, stromal/immune signaling, and physical space constraints as external contributors."
      },
      {
        "criterion_number": 7,
        "description": "The response explains how unjamming of cancer cells contributes to cancer spread and migration of cancer cells.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not use or explain 'unjamming' as a driver of migration; mentions adaptive invasion modes but not explicitly linked to unjamming."
      },
      {
        "criterion_number": 8,
        "description": "The response explains methods of cancer cell movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes mesenchymal vs amoeboid motility, protease dependence, protrusions, and collective invasion."
      },
      {
        "criterion_number": 9,
        "description": "The response explains how jamming occurs in normal cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of jamming in normal tissues (e.g., epithelial monolayers, development, wound healing)."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly discusses changes to tissue architecture specific to pancreatic cancer, such as desmoplastic reaction, fibrosis, or stromal remodeling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly discusses desmoplasia, dense fibrous stroma, collagen-rich ECM in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly discusses the implications of altered tissue architecture on cancer treatment, specifically mentioning reduced drug delivery or immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States the stroma protects cancer cells from drugs and immune attacks, implying reduced delivery and immune infiltration."
      },
      {
        "criterion_number": 12,
        "description": "The response includes citations from published scientific journal articles to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No journal citations provided."
      }
    ],
    "question_number": 279,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:50:22.696179",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly mentions both tissue stiffness and fibrosis in the context of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses mechanical forces (compression, stress) and ECM but does not explicitly mention tissue stiffness or fibrosis, nor does it tie these concepts specifically to pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly discusses intercellular communication between pancreatic cancer cells and stromal cells, such as fibroblasts or pancreatic stellate cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response describes signaling via growth factors and cytokines and specifically mentions stromal fibroblasts and immune cells secreting factors that shape tumor structure. The overall framing is pancreatic cancer, satisfying the requirement for intercellular communication with stromal components."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly connects specific tissue properties, such as stiffness or fibrosis, to the process of cancer spread, including invasion or metastasis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While ECM-guided migration and invasive 'fingers' are mentioned, there is no explicit linkage of stiffness or fibrosis to invasion or metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly relates specific tissue properties, such as stiffness or fibrosis, to treatment response or resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit connection is made between stiffness or fibrosis and treatment response or resistance in pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the concept of pattern formation in cellular structures, including at least two biological processes contributing to these patterns.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple processes are described: molecular signaling gradients, ECM interactions, genetic/epigenetic heterogeneity, self-organization (adhesion/motility, reaction\u2013diffusion), stromal/immune interactions, mechanical forces, and developmental pathway repurposing."
      },
      {
        "criterion_number": 7,
        "description": "The response provides at least two commonly recognizable examples of biological pattern formation, such as embryonic development or tissue architecture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references developing embryos and animal coat patterns (stripes/spots) as recognizable pattern formation examples."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how organized structures develop in tumors, mentioning at least two mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms include angiogenesis via VEGF, hypoxia-driven zonation, ECM-guided adhesion/migration, stromal/immune shaping, and mechanical forces."
      },
      {
        "criterion_number": 9,
        "description": "The response explains how DNA mutations in cancer cells can change their behavior, linking these changes to pattern formation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes genetic instability and heterogeneity, specialization of leader cells, and adaptation to microenvironmental niches leading to spatially organized subpopulations."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how cancer cells promote angiogenesis, including the secretion of signals for new blood vessel growth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that tumors secrete VEGF to recruit blood vessels and discusses hypoxia-driven pro-angiogenic responses."
      },
      {
        "criterion_number": 11,
        "description": "The response explains how cancer cells interact with tissues in their environment, including interactions with the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The ECM section details integrin-mediated adhesion, migration, and structural organization, demonstrating interactions with the microenvironment."
      },
      {
        "criterion_number": 12,
        "description": "The response defines and describes the extracellular matrix, including its composition or function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The ECM is defined as a 3D network of proteins (e.g., collagen) and signaling molecules that physically supports cells, covering composition and function."
      },
      {
        "criterion_number": 13,
        "description": "The response defines and describes desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not mentioned or described."
      },
      {
        "criterion_number": 14,
        "description": "The response explains the influence of the tumor microenvironment on tumor cell pattern formation, including at least one component.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple microenvironmental components are addressed, including fibroblasts, immune cells, ECM, hypoxia, and mechanical forces shaping tumor architecture."
      },
      {
        "criterion_number": 15,
        "description": "The response describes evolutionary pressures on cancer cells and the acquisition of DNA mutations, including at least one selective advantage.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It discusses genetic instability and adaptation to distinct niches, with specialized 'leader' cells conferring invasive advantages\u2014illustrating selection and advantageous traits."
      }
    ],
    "question_number": 280,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:51:20.156725",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response repeatedly centers on meaningful time, presence, comfort, adapting to energy, and respecting limits (e.g., 'Prioritize Quality Time & Presence,' 'Be Present, Not Perfect,' 'Respect His Limits'), which emphasizes quality of life."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages seeking support from 'a therapist' and to 'Lean on Hospice Services,' which are palliative care resources and typically include social workers/counselors."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no explicit recommendation to talk with the patient's oncologist/primary healthcare team or care providers outside of hospice; 'healthcare team' language is not used."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly advises connecting with support groups (online or in-person) for caregivers and those facing similar situations."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It names Hospice Foundation and American Cancer Society and provides URLs to both."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights involving others, organizing small gatherings, connecting with support groups, and leaning on hospice services\u2014clearly emphasizing a support system."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to open lines of communication with their affected family member, such as daily phone calls to check in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It promotes open communication through meaningful questions, letters, shared journals, and expressing love, which encourages ongoing dialogue."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage loved ones of a pancreatic cancer patient to consider legacy-building activities, such as photobook creation or writing letters to loved ones.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Multiple legacy projects are suggested, including photo/video montages, scrapbooks, memory jars, letters/journals, and recording his voice."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend keeping family members and loved ones involved in the patient\u2019s life, being mindful of the patient\u2019s energy level.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises involving others via small gatherings and shared activities while emphasizing 'Adapt to His Energy' and 'Respect His Limits.'"
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the patient and/or family members prioritize symptom management related to cancer or treatment, in order to ensure the patient is feeling their physical best if possible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it encourages rest and respecting limits, it does not explicitly mention symptom management, pain control, or coordinating with clinicians to optimize physical comfort."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend ways to document events and/or moments for future reference.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests recording voice memos, creating photo/video montages, shared journals, letters, scrapbooks, and memory jars\u2014clear documentation strategies."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the use of technology, such as video calls (e.g., Zoom) to keep in contact with loved ones without having to travel.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Technology is mentioned for recording voice memos, but there is no recommendation for video calls or remote contact tools to keep in touch without travel."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of preventing caregiver burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The 'Self-Care & Support' section advises taking breaks, resting, seeking support, and connecting with a therapist/support groups\u2014explicitly addressing caregiver well-being."
      }
    ],
    "question_number": 281,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:51:51.251012",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response reviews intercellular communication in pancreatic cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses paracrine/autocrine signaling, gap junctions, cell-cell adhesion, mechanical coupling, and heterotypic interactions; ties these to PDAC specifically in the microenvironment section."
      },
      {
        "criterion_number": 2,
        "description": "The response states that tumors are not typically functioning tissues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit statement that tumors are not typically functioning tissues."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the biology of intercellular communication.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a clear overview of cell-cell adhesion, leader-follower dynamics, chemokine gradients, gap junctions, calcium signaling, mechanotransduction, and ECM remodeling."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines cancer cell waves and explicitly states that there are several different types of waves known to exist in cancer cell biology.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions wave-like propagation generally and calcium waves, but does not define 'cancer cell waves' explicitly nor state that multiple distinct wave types exist."
      },
      {
        "criterion_number": 6,
        "description": "The response describes calcium waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Briefly mentions calcium waves via gap junctions but provides no detailed description or PMID."
      },
      {
        "criterion_number": 7,
        "description": "The response describes bioelectric waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bioelectric waves are not discussed and no PMID is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response describes metabolic (glycolytic) waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metabolic or glycolytic waves are not mentioned and no PMID is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains at least three different mechanisms of cell-to-cell communication, such as cell-cell adhesion, signaling pathways, chemokine gradients, mechanical forces, or heterotypic interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains multiple mechanisms including cell-cell adhesion (cadherins/integrins), chemokine/growth factor signaling (paracrine/autocrine), gap junctions, mechanical forces/ECM remodeling, and heterotypic interactions (CAFs, immune cells)."
      },
      {
        "criterion_number": 10,
        "description": "The response defines and describes paracrine signaling explicitly.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly defines paracrine signaling as leader-cell secretion of chemoattractants/growth factors creating gradients that recruit and guide follower cells."
      }
    ],
    "question_number": 282,
    "source": "allenai_olmo-3-32b-think",
    "graded_at": "2026-01-22T17:52:14.345004",
    "grader_model": "gpt-5"
  }
]